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RNA	   Polymerase	   II	   (RNAPII)	   transcribes	   protein-­‐coding	   and	   small	   structural	   genes,	   and	   its	  
functions	   are	   critical	   for	   appropriate	   gene	   regulation	   in	   the	   cell.	   Post-­‐translational	  
modifications	   of	   RNAPII	   integrate	   transcription,	   chromatin	   modification	   and	   co-­‐
transcriptional	  RNA	  processing	  to	  allow	  correct	  and	  efficient	  gene	  expression.	  	  
	  
Lineage-­‐specific	   genes	   have	   complex	   regulation	   in	   Embryonic	   Stem	   (ES)	   cells.	   They	   are	  
repressed	  by	  Polycomb-­‐repressive	  complexes	  (PRC)	  but	  primed	  with	  RNAPII	  complexes	  that	  
have	  atypical	  modification,	  and	  occupy	  promoter	  and	  coding	  regions,	  in	  the	  absence	  Serine2	  
phosphorylation	   (Brookes	   et	   al.,	   2012)	   suggesting	   chromatin	   modification	   and	   RNA	  
processing	  may	   be	   compromised.	   Low-­‐level	   transcription	   has	   been	  detected	   at	   a	   panel	   of	  
PRC-­‐repressed	   genes	   (Stock	   et	   al.,	   2007)	   but	   little	   else	   is	   known	   about	   the	   transcriptional	  
activity	  of	  RNAPII	  at	  these	  genes,	  to	  shed	  light	  on	  the	  mechanisms	  of	  PRC	  repression.	  I	  have	  
investigated	   features	   of	   RNAPII	   transcription	   in	   ES	   cells	   focussing	   on	   understanding	  
transcription	  at	  PRC-­‐repressed	  genes.	  
	  
To	  capture	  nascent	  transcripts,	  I	  optimised	  RNA-­‐ChIP	  using	  RNAPII	  antibodies	  to	  extract	  RNA	  
associated	   with	   chromatin	   at	   active	   and	   PRC-­‐repressed	   genes.	   Genome-­‐wide	   analysis	   by	  
Next	   Generation	   Sequencing	   (NGS)	   showed	   that	   PRC-­‐repressed	   genes	   are	   transcribed	  
throughout	   coding	   regions,	   and	   in	   a	   sense	   orientation,	   but	   at	   lower	   levels	   than	   expected	  
from	  RNAPII	  abundance	  detected	  by	  DNA-­‐ChIP.	  Promoter-­‐associated	  antisense	  transcription	  
is	   lacking,	   in	   contrast	   to	   active	   genes.	   Minimal	   transcript	   capping	   and	   lack	   of	   RNAPII	  
transcription	  beyond	  transcription	  end	  sites	   (TES)	  at	  PRC-­‐repressed	  genes	  suggest	  multiple	  
regulatory	  mechanisms	  may	  accompany	  PRC	  repression,	  which	  are	  linked	  with	  compromised	  
RNA	   processing.	   Exosome	   regulates	   a	   proportion	   of	   PRC-­‐repressed	   genes	   at	   the	   level	   of	  
transcription	  and	  capping	  although	  the	  extent	  of	  involvement	  is	  still	  under	  scrutiny.	  
	  
The	   present	   work	   and	   ongoing	   analysis	   add	   valuable	   information	   to	   help	   elucidate	  
mechanisms	   of	   gene	   regulation	   associated	   with	   Polycomb	   repression	   to	   increase	   our	  





First	   and	   foremost,	   I	   would	   like	   to	   thank	   my	   supervisor	   and	   friend	   Ana,	   for	   her	  
encouragement,	  expertise	  and	  dedication.	  Her	  enthusiasm	  and	  advice	  has	  been	   invaluable	  
over	   this	   PhD	   journey.	   Thank	   you	   for	   always	  making	   the	   time	   and	   creating	   a	   lab	   that	   has	  
been	  a	  great	  place	  to	  work.	  	  
	  
I	  would	  like	  to	  thank	  Emily,	  for	  taking	  me	  under	  her	  wing	  and	  teaching	  me	  the	  ways	  of	  the	  
lab.	  For	  always	  being	  there	  when	  I	  needed	  advice	  whether	  it	  was	  in	  the	  lab	  or	  out.	  Thanks	  to	  
Ines	   S,	   for	   her	   bioinformatics	   expertise	   and	   dedication	   to	   the	   project.	   For	   her	   endless	  
patience	  in	  teaching	  us	  what	  is	  possible.	  	  
	  
A	  special	   thank	  you	  to	  Mita	   for	  her	   friendship,	  and	  encouragement	  every	  step	  of	   the	  way.	  
Thanks	  to	  Claudia	  for	  her	  friendship,	  calm	  nature	  and	  advice,	  and	  thanks	  to	  Carmelo	  for	  his	  
discussions	  and	   laughter.	  For	  their	  support	  throughout	   I	  would	   like	  to	  thank	   Ines	  C,	  Sheila,	  
Liron,	  Rob,	  Joao	  and	  Kedar.	  	  
	  
Thanks	   to	   collaborators	   who	   have	   helped	   immensely	   during	   the	   project,	   namely	   Adam,	  
Nathan,	  Vanja,	  Gopu,	  Tom,	  Jiannis	  and	  Carme.	  
	  
I	  would	  like	  to	  thank	  some	  special	  friends	  and	  family	  who	  have	  made	  the	  journey	  an	  exciting	  
one.	  To	  Gillian,	  Mike	  and	  Gareth,	  we	  started	  the	  journey	  together	  and	  had	  some	  good	  times	  
along	   the	  way,	   thank	  you!	  Thanks	   to	  Emma	  who	  has	  become	  a	  great	   friend	  and	  thanks	   to	  
Bryony	  for	  her	  friendship	  and	  endless	  enthusiasm.	  Thanks	  to	  my	  JuJitsu	  buddies	  Rick,	  Robin	  
and	  Jason,	  who	  kept	  me	  going	  while	  I	  was	  preparing	  and	  writing	  my	  thesis.	  For	  their	  love	  and	  
friendship	  I	  would	  like	  to	  thank	  my	  amazing	  friends	  Hayley,	  Liz,	  Kirstie	  and	  Amanda.	  To	  my	  
fantastic	  family	  who	  always	  encouraged	  me,	  thank	  you!	  A	  special	  thanks	  to	  my	  Dad	  who	  is	  
always	  there,	  during	  the	  good	  times	  and	  the	  tough,	  and	  to	  Mum,	  without	  whom	  I	  wouldn’t	  
be	  where	  I	  am	  today.	  	  	  
	  
Last	   but	   not	   least,	   to	   Ben	   for	   his	   love	   and	   understanding	   over	   the	   years.	   For	   always	  
encouraging	  me,	  and	  believing	  in	  me.	  Thank	  you!	  	  
List	  of	  publications	  
 
3	  
List	  of	  publications	  
Brookes	  E,	  de	  Santiago	  I,	  Hebenstreit	  D,	  Morris	  KJ,	  Carroll	  T,	  Xie	  SQ,	  Stock	  JK,	  Heidemann	  M,	  
Eick	   D,	   Nozaki	   N,	   Kimura	   H,	   Ragoussis	   J,	   Teichmann	   SA,	   Pombo	   A.	   Polycomb	   associates	  
genome-­‐wide	  with	   a	   specific	   RNA	  polymerase	   II	   variant,	   and	   regulates	  metabolic	   genes	   in	  
ESCs.	  Cell	  Stem	  Cell.	  2012	  Feb	  3;10(2):157-­‐70.	  
Morris	   KJ,	   Chotalia	   M,	   Pombo	   A.	   Nuclear	   architecture	   in	   stem	   cells.	   Adv	   Exp	   Med	   Biol.	  
2010;695:14-­‐25.	  
Clear	  AJ,	  Lee	  AM,	  Calaminici	  M,	  Ramsay	  AG,	  Morris	  KJ,	  Hallam	  S,	  Kelly	  G,	  Macdougall	  F,	  Lister	  
TA,	   Gribben	   JG.	   Increased	   angiogenic	   sprouting	   in	   poor	   prognosis	   FL	   is	   associated	   with	  
elevated	   numbers	   of	   CD163+	   macrophages	   within	   the	   immediate	   sprouting	  
microenvironment.	  Blood.	  2010	  Jun	  17;115(24):5053-­‐6.	  Epub	  2010	  Apr	  7.	  
Pereira	  CF,	  Terranova	  R,	  Ryan	  NK,	  Santos	  J,	  Morris	  KJ,	  Cui	  W,	  Merkenschlager	  M,	  Fisher	  AG.	  
Heterokaryon-­‐based	  reprogramming	  of	  human	  B	  lymphocytes	  for	  pluripotency	  requires	  Oct4	  
but	  not	  Sox2.	  PLoS	  Genet.	  2008	  Sep	  5;4(9):e1000170.	  
Proto-­‐Siqueira	  R,	  Panepucci	  RA,	  Careta	  FP,	  Lee	  A,	  Clear	  A,	  Morris	  K,	  Owen	  C,	  Rizzatti	  EG,	  Silva	  
WA	  Jr,	  Falcão	  RP,	  Zago	  MA,	  Gribben	  JG.	  SAGE	  analysis	  demonstrates	  increased	  expression	  of	  
TOSO	  contributing	  to	  Fas-­‐mediated	  resistance	  in	  CLL.	  Blood.	  2008	  Jul	  15;112(2):394-­‐7.	  Epub	  













	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  of	  contents	  
 
4	  
Table	  of	  contents	  
Abstract	  .....................................................................................................................................	  1	  
Acknowledgements	  ...................................................................................................................	  2	  
List	  of	  publications	  .....................................................................................................................	  3	  
Table	  of	  contents	  .......................................................................................................................	  4	  
Index	  of	  Figures	  and	  Tables	  ........................................................................................................	  9	  
Abbreviations	  ..........................................................................................................................	  13	  
 
1	   Introduction	  .............................................................................................................	  17	  
 
1.1	   RNA	  Polymerase	  II	  .......................................................................................................	  18	  
1.1.1	   Carboxy	  Terminal	  Domain	  (CTD)	  ................................................................................	  18	  
1.1.2	   RNAPII	  modifications	  and	  the	  ‘CTD	  code’	  ..................................................................	  18	  
 
1.2	   RNAPII	  Transcription	  Cycle	  and	  CTD	  Modifications	  at	  Active	  Genes	  .............................	  19	  
1.2.1	   Transcription	  Initiation	  and	  Serine	  5	  and	  Serine	  7	  phosphorylation	  .........................	  19	  
1.2.2	   Promoter	  Proximal	  Pausing	  .......................................................................................	  23	  
1.2.3	   Transcription	  Elongation	  and	  Serine	  2	  Phosphorylation	  ...........................................	  24	  
1.2.4	   Transcription	  Termination	  .........................................................................................	  25	  
1.2.5	   Additional	  CTD	  modifications	  and	  transcription	  ........................................................	  27	  
 
1.3	   Integration	  of	  RNAPII	  transcription	  with	  RNA	  processing	  and	  chromatin	  
modification	  ....................................................................................................................	  28	  
1.3.1	   Chromatin	  modifications	  and	  the	  CTD	  .......................................................................	  29	  
1.3.2	   Co-­‐transcriptional	  RNA	  Processing	  ............................................................................	  30	  
 
1.4	   Polycomb	  repressive	  complexes	  ..................................................................................	  33	  
1.4.1	   Structure	  and	  function	  of	  Polycomb	  repressive	  complexes	  ......................................	  34	  
1.4.2	   Polycomb	  complex	  recruitment	  .................................................................................	  35	  
1.4.3	   Polycomb	  gene	  silencing	  in	  ES	  cells	  ...........................................................................	  37	  
1.4.4	   Interplay	  between	  Polycomb	  and	  RNAPII	  in	  ES	  cells	  .................................................	  38	  
1.4.5	   RNAPII	  transcription	  at	  Polycomb	  repressed	  genes	  ..................................................	  40	  
 
1.5	   RNAPII	  transcription	  across	  the	  genome	  ......................................................................	  41	  
1.5.1	   Pervasive	  transcription	  in	  the	  mammalian	  genome	  ..................................................	  42	  
1.5.2	   Methods	  to	  study	  transcription	  .................................................................................	  43	  
 
1.6	   Aims	  ............................................................................................................................	  44	  
 
2	   Materials	  and	  Methods	  ............................................................................................	  46	  
 
2.1	   Cell	  culture	  ..................................................................................................................	  46	  
2.1.1	   Murine	  ES-­‐OS25	  cell	  culture	  ......................................................................................	  46	  
2.1.2	   Murine	  ES-­‐Ert2	  cell	  culture	  ........................................................................................	  46	  
2.1.3	   Conditional	  knockout	  of	  Ring1B	  in	  ES-­‐Ert2	  cells	  ........................................................	  46	  
2.1.4	   Drug	  treatments	  ........................................................................................................	  46	  
 
2.2	   Chromatin	  Immunoprecipitation	  for	  RNA	  and	  DNA	  ......................................................	  47	  
2.2.1	   Fixed	  chromatin	  preparation	  .....................................................................................	  47	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  of	  contents	  
 
5	  
2.2.2	   Confirmation	  of	  fragment	  size	  of	  fixed	  chromatin	  ....................................................	  48	  
2.2.3	   Immunoprecipitation	  with	  magnetic	  beads	  ...............................................................	  48	  
2.2.4	   ChIP	  washes	  and	  elution	  ............................................................................................	  49	  
2.2.5	   DNA	  purification,	  quantification	  and	  analysis	  ............................................................	  49	  
2.2.6	   RNA	  purification,	  quantification	  and	  analysis	  ............................................................	  49	  
 
2.3	   Gene	  expression	  analysis	  by	  quantitative	  RT-­‐PCR	  ........................................................	  50	  
 
2.4	   RNA	  extraction	  for	  CAGE	  sequencing	  ...........................................................................	  51	  
 
2.5	   mRNA	  sequencing	  library	  preparation	  .........................................................................	  51	  
 
2.6	   RNA-­‐ChIP	  sequencing	  library	  preparation	  ....................................................................	  52	  
2.6.1	   Non-­‐directional	  RNA-­‐ChIP	  sequencing	  library	  preparation	  .......................................	  52	  
2.6.2	   Directional	  RNA-­‐ChIP	  sequencing	  library	  preparation	  ...............................................	  52	  
 
2.7	   Multiplex	  DNA-­‐ChIP	  sequencing	  library	  preparation	  ....................................................	  53	  
 
2.8	   Analysis	  of	  genome-­‐wide	  data	  .....................................................................................	  53	  
2.8.1	   Datasets	  .....................................................................................................................	  54	  
2.8.2	   Sequence	  read	  alignment	  ..........................................................................................	  54	  
2.8.3	   Confirmation	  of	  sequencing	  data	  ..............................................................................	  54	  
2.8.4	   Generating	  average	  profiles	  and	  boxplots	  .................................................................	  55	  
 
2.9	   Western	  analysis	  .........................................................................................................	  55	  
2.9.1	   RNAPII	  Western	  analysis	  ............................................................................................	  55	  
 
2.10	   Microarray	  analysis	  .....................................................................................................	  56	  
 
2.11	   siRNA	  knockdown	  in	  ES-­‐OS25	  cells	  ...............................................................................	  56	  
 
3	   Genome-­‐wide	  mapping	  of	  nascent	  RNAs	  associated	  with	  chromatin-­‐bound	  RNA	  
polymerase	  II	  ...............................................................................................................	  65	  
 
3.1	   Introduction	  ................................................................................................................	  65	  
3.1.1	   RNA	  Chromatin	  Immunoprecipitation	  (RNA-­‐ChIP)	  ....................................................	  65	  
3.1.2	   RNAPII	  transcription	  at	  active	  and	  Polycomb-­‐repressed	  chromatin	  in	  ES	  cells	  .........	  65	  
3.1.3	   Aims	  ...........................................................................................................................	  66	  
 
3.2	   Results	  .........................................................................................................................	  68	  
3.2.1	   DNA-­‐ChIP	  using	  RNAPII	  antibodies	  at	  active,	  poised	  and	  silent	  genes	  ......................	  68	  
3.2.2	   RNAPII	  RNA-­‐ChIP	  Optimisation	  ..................................................................................	  69	  
3.2.3	   Chromatin-­‐bound	  RNA	  can	  be	  detected	  after	  RNA-­‐ChIP	  using	  RNAPII	  antibodies	  ....	  72	  
3.2.4	   Adapting	  RNA-­‐ChIP	  for	  genome-­‐wide	  sequencing	  ....................................................	  75	  
3.2.5	   Fragmentation	  of	  RNA	  prior	  to	  preparation	  of	  sequencing	  libraries	  .........................	  77	  
3.2.6	   RNAPII-­‐S5p	  RNA-­‐ChIP	  sequencing	  libraries	  correlate	  irrespective	  of	  library	  
preparation	  method	  ..................................................................................................	  83	  
3.2.7	   Single	  gene	  profiles	  in	  ES	  cells	  ...................................................................................	  84	  
3.2.8	   Transcriptome	  coverage	  of	  RNAPII-­‐S5p	  RNA	  sequencing	  across	  the	  ES	  cell	  genome	  90	  
3.2.9	   Average	  RNAPII-­‐S5p	  RNA-­‐ChIP	  profiles	  at	  active	  and	  silent	  genes	  ............................	  93	  
3.2.10	   Transcription	  and	  splicing	  through	  coding	  regions	  ....................................................	  97	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  of	  contents	  
 
6	  
3.2.11	   RNAPII-­‐S5p	  RNA-­‐ChIP	  transcripts	  correlate	  with	  RNAPII-­‐S5p	  occupancy	  ................	  101	  
3.2.12	   RNAPII-­‐S5p	  RNA-­‐ChIP	  transcript	  detection	  at	  chromatin	  correlates	  with	  mRNA	  
expression	  ................................................................................................................	  102	  
3.2.13	   Transcripts	  detected	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  undergo	  co-­‐transcriptional	  splicing	  103	  
 
3.3	   Discussion	  ..................................................................................................................	  105	  
3.3.1	   RNAPII	  RNA-­‐ChIP	  ......................................................................................................	  105	  
3.3.2	   Fragmented	  sequencing	  library	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  best	  represents	  transcription	  
in	  ES	  cells	  ..................................................................................................................	  106	  
3.3.3	   Transcription	  at	  active	  genes	  in	  ES	  cells	  ..................................................................	  107	  
 
4	   Transcription	  at	  Polycomb-­‐repressed	  genes	  ...........................................................	  110	  
 
4.1	   Introduction	  ..............................................................................................................	  110	  
4.1.1	   Polycomb	  complexes	  associate	  with	  an	  unusual	  RNAPII	  variant	  in	  ES	  cells	  ............	  110	  
4.1.2	   Transcription	  at	  PRC-­‐repressed	  genes	  .....................................................................	  111	  
4.1.3	   Aims	  .........................................................................................................................	  112	  
 
4.2	   Results	  .......................................................................................................................	  113	  
4.2.1	   Strategy	  to	  detect	  nascent	  transcripts	  from	  PRC	  target	  genes	  in	  ES	  cells	  ...............	  113	  
4.2.2	   Nascent	  transcripts	  from	  PRC-­‐repressed	  genes	  are	  detected	  after	  RNA-­‐ChIP	  with	  
RNAPII-­‐S5p	  antibodies	  .............................................................................................	  114	  
4.2.3	   Ring1B	  and	  Ezh2	  RNA-­‐ChIP	  enrich	  PRC-­‐repressed	  transcripts	  .................................	  116	  
4.2.4	   Genome-­‐wide	  analyses	  of	  nascent	  transcripts	  at	  PRC-­‐repressed	  genes;	  Single	  gene	  
profiles	  .....................................................................................................................	  119	  
4.2.5	   Characterization	  of	  PRC-­‐repressed	  genes	  chosen	  for	  genome-­‐wide	  analyses	  ........	  122	  
4.2.6	   PRC-­‐repressed	  gene	  transcription	  is	  detected	  genome-­‐wide	  ..................................	  124	  
4.2.7	   Evidence	  for	  nascent	  transcription	  through	  coding	  regions	  and	  splicing	  at	  PRC-­‐
repressed	  genes	  .......................................................................................................	  128	  
4.2.8	   PRC-­‐repressed	  genes	  transcribe	  at	  a	  range	  of	  levels	  genome-­‐wide	  ........................	  130	  
4.2.9	   RNAPII-­‐S2p	  is	  not	  associated	  with	  PRC-­‐repressed	  genes	  that	  transcribe	  to	  the	  TES132	  
4.2.10	   RNAPII	  transcribes	  PRC-­‐repressed	  genes	  in	  the	  presence	  of	  Polycomb	  ..................	  133	  
4.2.11	   RNAPII	  at	  the	  TES	  of	  PRC-­‐repressed	  genes	  correlates	  with	  transcription	  but	  not	  an	  
increase	  in	  mRNA	  expression	  ..................................................................................	  135	  
4.2.12	   RNAPII-­‐S5pEnd+	  PRC-­‐repressed	  genes	  transcribe	  to	  the	  TES	  in	  the	  absence	  of	  S2	  
phosphorylation	  .......................................................................................................	  137	  
4.2.13	   RNAPII-­‐S5pEnd+	  transcribe	  the	  whole	  gene	  in	  the	  presence	  of	  high	  levels	  of	  Polycomb	  
marks	  .......................................................................................................................	  138	  
4.2.14	   De-­‐repression	  of	  PRC-­‐repressed	  genes	  in	  Ring1B-­‐conditional	  knockouts	  ...............	  139	  
4.2.15	   Ring1B	  knockout	  results	  in	  de-­‐repression	  of	  PRC-­‐repressed	  genes	  at	  the	  level	  of	  
chromatin	  ................................................................................................................	  140	  
4.2.16	   Transcripts	  detected	  at	  PRC-­‐repressed	  genes	  increase	  upon	  Ring1B	  knockdown	  ..	  142	  
4.2.17	   RNA	  processing	  at	  PRC-­‐repressed	  genes;	  low	  level	  Capping	  ...................................	  143	  
4.2.18	   Ring1B	  knockout	  results	  in	  increased	  5’	  capped	  transcripts	  ...................................	  146	  
 
4.3	   Discussion	  ..................................................................................................................	  148	  
4.3.1	   PRC-­‐repressed	  genes	  transcribe	  genome-­‐wide	  in	  the	  presence	  of	  abundant	  RNAPII-­‐
S5p	  ...........................................................................................................................	  149	  
4.3.2	   PRC-­‐repressed	  gene	  RNA	  processing	  in	  the	  absence	  of	  RNAPII-­‐S2p	  .......................	  151	  
4.3.3	   Antisense	  transcription	  is	  absent	  at	  PRC-­‐repressed	  genes	  ......................................	  154	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  of	  contents	  
 
7	  
4.3.4	   Transcription	  elongation	  at	  PRC-­‐repressed	  genes	  in	  the	  presence	  of	  PRC	  and	  absence	  
of	  RNAPII-­‐S2p	  ...........................................................................................................	  154	  
4.3.5	   Ring1B	  knockout	  results	  in	  de-­‐repression	  of	  PRC-­‐repressed	  genes	  at	  the	  
transcriptional	  level	  .................................................................................................	  156	  
 
5	   The	  role	  of	  RNA	  degradation	  at	  PRC-­‐repressed	  genes	  .............................................	  158	  
 
5.1	   Introduction	  ..............................................................................................................	  158	  
5.1.1	   Aims	  .........................................................................................................................	  159	  
 
5.2	   Results	  .......................................................................................................................	  160	  
5.2.1	   Expression	  of	  exosome	  components	  decreases	  during	  differentiation	  ...................	  160	  
5.2.2	   Strategy	  to	  study	  the	  effect	  of	  exosome	  on	  PRC-­‐repressed	  transcription	  ..............	  160	  
5.2.3	   Xrn2	  depletion	  does	  not	  affect	  PRC-­‐repressed	  gene	  transcription	  .........................	  162	  
5.2.4	   Knockdown	  of	  four	  separate	  exosome	  subunits	  .....................................................	  164	  
5.2.5	   De-­‐repression	  at	  a	  panel	  of	  PRC-­‐repressed	  genes	  upon	  Exosc3	  and	  Exosc5	  
knockdown	  by	  siRNAs	  ..............................................................................................	  167	  
5.2.6	   De-­‐repression	  at	  a	  panel	  of	  PRC-­‐repressed	  genes	  after	  knockdown	  of	  exosome	  
catalytic	  subunits,	  Exosc10	  and	  Dis3	  .......................................................................	  171	  
5.2.7	   De-­‐repressed	  transcripts	  can	  undergo	  splicing	  and	  polyadenylation	  ......................	  173	  
5.2.8	   Genome-­‐wide	  analysis	  of	  Exosc3	  knockdown	  by	  microarray	  ..................................	  175	  
5.2.9	   Deregulation	  of	  gene	  groups	  in	  ES	  cells	  ...................................................................	  178	  
5.2.10	   Validation	  of	  microarray	  analysis	  by	  single	  gene	  analysis	  .......................................	  182	  
5.2.11	   PRC-­‐repressed	  transcripts	  show	  increased	  levels	  of	  capped	  transcripts	  by	  CAGE	  after	  
exosome	  knockout	  ...................................................................................................	  185	  
5.2.12	   Exosome	  associates	  with	  PRC-­‐repressed	  chromatin	  ...............................................	  188	  
 
5.3	   Discussion	  ..................................................................................................................	  190	  
 
6	   RNAPII	  CTD	  Glycosylation	  in	  ES	  cells	  .......................................................................	  193	  
 
6.1	   Introduction	  ..............................................................................................................	  193	  
6.1.1	   RNAPII	  Glycosylation	  ................................................................................................	  194	  
6.1.2	   Aims	  .........................................................................................................................	  194	  
 
6.2	   Results	  .......................................................................................................................	  196	  
6.2.1	   Characterising	  RNAPII-­‐CTD	  Glycosylation	  antibodies	  ..............................................	  196	  
6.2.2	   Glycosylated	  RNAPII-­‐CTD	  is	  a	  marker	  of	  active	  and	  not	  PRC-­‐repressed	  genes;	  single	  
gene	  studies	  .............................................................................................................	  199	  
6.2.3	   Glycosylated	  RNAPII	  is	  associated	  with	  active	  genes	  genome-­‐wide	  ........................	  202	  
 
6.3	   Discussion	  ..................................................................................................................	  207	  
6.3.1	   RNAPII	  glycosylation	  at	  active	  genes	  .......................................................................	  207	  
6.3.2	   RNAPII	  glycosylation	  at	  PRC-­‐repressed	  genes	  in	  ES	  cells	  .........................................	  209	  
 
7	   Discussion	  ..............................................................................................................	  210	  
 
7.1	   RNA-­‐ChIP	  as	  a	  method	  to	  study	  transcription	  in	  ES	  cells	  .............................................	  212	  
 
7.2	   RNAPII	  transcription	  at	  active	  genes	  in	  ES	  cells	  ..........................................................	  213	  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  of	  contents	  
 
8	  
7.3	   Regulation	  of	  transcription	  at	  PRC-­‐repressed	  genes	  ...................................................	  213	  
 
7.4	   Indications	  of	  RNA	  processing	  regulation	  at	  PRC-­‐repressed	  genes	  ..............................	  214	  
 
7.5	   Degradation	  of	  nascent	  transcripts	  as	  a	  mechanism	  of	  PRC-­‐repressed	  gene	  
silencing	  ........................................................................................................................	  217	  
 
7.6	   Summary	  ...................................................................................................................	  218	  
 
8	   References	  .............................................................................................................	  219	  
	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  Index	  of	  Figures	  and	  Tables	  
 
9	  
Index	  of	  Figures	  and	  Tables	  
Chapter	  1	  
Figure	  1.1.	  RNAPII	  transcription	  cycle	  at	  active	  genes.	  ...........................................................	  23 
Figure	  1.2	  .	  RNAPII	  modifications	  integrate	  chromatin	  modifications	  and	  RNA	  processing	  with	  	  	  	  
transcription	  at	  active	  genes	  ...................................................................................................	  29 
Figure	  1.3.	  Polycomb	  repressor	  complexes.	  ............................................................................	  34 
Figure	  1.4.	  Recruitment	  of	  Polycomb	  repressor	  2	  complexes	  .................................................	  36 
Figure	  1.5.	  RNAPII,	  PRC	  and	  histone	  modification	  profiles	  delineate	  PRC-­‐repressed	  genes	  in	  	  	  	  
ES	  	  cells.	  ...................................................................................................................................	  40 
Figure	  1.6.	  RNAPII	  transcription	  dynamics	  and	  methods	  to	  study	  cellular	  RNA	  populations	  ..	  42	  
	  
Chapter	  2 
Figure	  2.1.	  RPB1	  antibodies	  recognising	  specific	  phospho-­‐	  and	  glycosylated-­‐epitopes	  ..........	  47 
Table	  2.2.	  Antibodies	  used	  for	  ChIP	  analysis	  ...........................................................................	  58 
Table	  2.3	  Antibodies	  used	  for	  Western	  analysis	  ......................................................................	  60 
Table	  2.3.	  ChIP	  primers	  ............................................................................................................	  61 
Table.	  2.5.	  Primers	  to	  detect	  transcripts	  at	  the	  5’	  ends	  of	  genes	  (all	  RNAs).	  ..........................	  62 
Table.	  2.5.	  Primers	  to	  detect	  primary	  RNA	  transcripts;	  exon-­‐intron	  primers	  ..........................	  63 
Table.	  2.6.	  Expression	  primers	  to	  detect	  spliced	  transcripts;	  exon-­‐exon	  primers	  ...................	  64	  
	  
Chapter	  3 
Figure	  3.1.	  RNAPII	  binding	  at	  active	  and	  PRC-­‐repressed	  genes	  in	  ES	  cells	  ..............................	  69 
Figure	  3.2.	  Flow	  diagram	  of	  RNA-­‐ChIP	  method	  to	  isolate	  chromatin-­‐bound	  RNA	  associated	  
with	  a	  protein	  of	  interest	  ........................................................................................................	  70 
Table	  3.1.	  Optimisation	  of	  the	  RNA-­‐ChIP	  protocol.	  .................................................................	  70 
Figure	  3.3.	  Reverse	  crosslinking	  incubation	  is	  crucial	  to	  maintain	  RNA	  integrity	  ....................	  71 
Figure	  3.4.	  Chromatin-­‐bound	  RNA	  is	  detected	  by	  RNAPII	  RNA-­‐ChIP	  and	  is	  sensitive	  to	  
flavopiridol	  and	  α-­‐amanitin.	  ....................................................................................................	  74 
Figure	  3.5.	  Library	  preparation	  protocols	  utilised	  to	  generate	  Illumina	  compatible	  RNA-­‐ChIP	  
sequencing	  libraries.	  ................................................................................................................	  76 
Figure	  3.6.	  RNAPII-­‐S5p	  immunoprecipitated	  RNA	  has	  a	  broad	  size	  range.	  .............................	  78 
Figure	  3.7.	  Size	  distributions	  of	  mRNA	  and	  RNA	  extracted	  after	  RNAPII-­‐S5p	  RNA-­‐ChIP	  and	  of	  
corresponding	  DNA	  libraries	  ...................................................................................................	  80 
Figure	  3.8.	  Different	  RNA-­‐ChIP	  library	  preparations	  correlate	  genome-­‐wide	  .........................	  83 
Figure	  3.9.	  Single	  gene	  profiles	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  sequencing	  .....................................	  85 
Figure	  3.10.	  Features	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  at	  an	  active	  gene	  ...........................................	  87 
Figure	  3.11.	  Profiles	  of	  pluripotency	  and	  non-­‐coding	  genes	  ...................................................	  89 
Figure	  3.12.	  Distribution	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  sequencing	  reads	  across	  the	  genome	  ......	  92 
Figure	  3.13.	  Properties	  of	  genes	  assigned	  to	  Active	  and	  Silent	  gene	  groups	  ..........................	  93 
Figure	  3.14.	  Properties	  of	  active	  and	  silent	  genes	  in	  ES	  cells	  ..................................................	  94 
Figure	  3.15.	  Average	  genome-­‐wide	  profiles	  of	  mRNA	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	  at	  Active	  and	  
Silent	  genes	  .............................................................................................................................	  96 
Figure	  3.16.	  Average	  genome-­‐wide	  profiles	  of	  mRNA	  andRNAPII-­‐S5p	  RNA-­‐ChIP	  and	  RNAPII-­‐
S5p	  DNA-­‐ChIP	  through	  coding	  regions	  of	  Active	  and	  Silent	  genes	  ..........................................	  99 
	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  Index	  of	  Figures	  and	  Tables	  
 
10	  
Figure	  3.17.	  Average	  first	  and	  last	  intron	  profiles	  show	  evidence	  for	  co-­‐transcriptional	  
splicing	  in	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  .......................................................................	  101 
Figure	  3.18.	  Nascent	  RNA	  correlates	  with	  RNAPII-­‐S5p	  binding	  genome-­‐wide	  ......................	  102 
Figure	  3.19.	  Nascent	  RNA	  correlates	  with	  mRNA	  expression	  genome-­‐wide	  .........................	  103 
Figure	  3.20.	  Nascent	  transcripts	  detected	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  show	  co-­‐transcriptional	  
splicing	  ...................................................................................................................................	  104	  
	  
Chapter	  4 
Figure	  4.1.	  RNAPII	  complexes	  phosphorylated	  on	  S5	  residues	  are	  present	  at	  promoter	  and	  
coding	  regions	  of	  PRC-­‐repressed	  genes	  ................................................................................	  110 
Figure	  4.2.	  Strategy	  to	  enrich	  nascent	  transcripts	  from	  PRC-­‐repressed	  genes	  in	  ES	  cells	  .....	  113 
Figure	  4.3.	  Nascent	  PRC-­‐repressed	  transcripts	  are	  detected	  by	  RNA-­‐ChIP	  bound	  to	  chromatin
	  ...............................................................................................................................................	  115 
Figure	  4.4.	  Ring1b	  and	  Ezh2	  associate	  with	  PRC-­‐repressed	  genes	  in	  ES	  cells	  .......................	  117 
Figure	  4.5.	  Transcripts	  from	  PRC-­‐repressed	  genes	  are	  associated	  with	  Ring1B	  and	  Ezh2	  at	  the	  
level	  of	  chromatin	  ..................................................................................................................	  118 
Figure	  4.6.	  Single	  gene	  profiles	  of	  DNA	  and	  RNA-­‐ChIP	  for	  RNAPII	  and	  Polycomb	  at	  PRC-­‐
repressed,	  active	  and	  silent	  genes	  ........................................................................................	  121 
Figure	  4.7.	  Classification	  of	  the	  group	  of	  PRC-­‐repressed	  genes	  (H2Aub1+	  and	  H3K27me3+)	  
bound	  by	  RNAPII-­‐S5p+S2p-­‐	  further	  studied	  in	  this	  chapter	  ..................................................	  123 
Figure	  4.8.	  Properties	  of	  the	  cohort	  of	  genes	  chosen	  for	  further	  analyses	  ...........................	  124 
Figure	  4.9.	  Average	  profiles	  detect	  transcription	  genome-­‐wide	  at	  PRC-­‐repressed	  genes	  ....	  127 
Figure	  4.10.	  Transcription	  and	  splicing	  through	  coding	  regions	  of	  PRC-­‐repressed	  genes	  .....	  129 
Figure	  4.11.	  PRC-­‐repressed	  transcriptional	  activity	  covers	  a	  wide	  range	  ..............................	  130 
Table	  4.1.	  Groups	  of	  PRC-­‐repressed	  genes	  based	  on	  RNA	  depth	  from	  RNAPII-­‐S5p	  RNA-­‐ChIP	  
within	  the	  last	  intron	  .............................................................................................................	  131 
Figure	  4.12.	  Characterisation	  of	  three	  groups	  of	  PRC-­‐repressed	  genes	  based	  on	  the	  RNA	  
signal	  detected	  at	  the	  last	  intron	  in	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  .....................................	  132 
Figure	  4.13.	  Higher	  transcript	  levels	  at	  the	  Q3	  group	  of	  PRC-­‐repressed	  genes	  are	  not	  
accompanied	  by	  RNAPII-­‐S2p	  .................................................................................................	  133 
Figure	  4.14.	  RNAPII-­‐S5p+S2p-­‐	  transcribes	  PRC-­‐repressed	  genes	  in	  the	  presence	  of	  Polycomb	  
marks.	  ....................................................................................................................................	  134 
Table	  4.2.	  Classification	  of	  RNAPII-­‐S5p	  at	  the	  TES	  (-­‐2	  to	  0kb)	  of	  PRC-­‐repressed	  genes	  ........	  135 
Figure	  4.15.	  Transcription	  occurs	  throughout	  PRC-­‐repressed	  genes	  bound	  by	  RNAPII-­‐S5p	  at	  
the	  TES	  ...................................................................................................................................	  136 
Figure	  4.16.	  RNAPII-­‐S5p	  can	  elongate	  through	  PRC-­‐repressed	  genes	  to	  the	  TES	  in	  the	  absence	  
of	  RNAPII-­‐S2p	  ........................................................................................................................	  138 
Figure	  4.17.	  Polycomb	  binding	  mirrors	  RNAPII-­‐S5p	  at	  PRC-­‐repressed	  genes	  ........................	  139 
Figure	  4.18.	  Ring1B	  activity	  is	  important	  in	  silencing	  PRC-­‐repressed	  gene	  mRNA	  expression
	  ...............................................................................................................................................	  140 
Figure	  4.19.	  PRC-­‐repressed	  transcripts	  are	  de-­‐repressed	  at	  the	  level	  of	  transcription	  .........	  142 
Figure	  4.20.	  Average	  profiles	  reveal	  transcription	  reminiscent	  of	  active	  transcription	  upon	  
Ring1B	  removal	  ......................................................................................................................	  143 
Figure	  4.21.	  Low-­‐level	  capping	  of	  PRC-­‐repressed	  transcripts	  ...............................................	  145 
Figure	  4.22.	  PRC-­‐repressed	  genes	  have	  low	  level	  capping	  ....................................................	  146 
Figure	  4.23.	  Detection	  of	  capped	  PRC-­‐repressed	  transcripts	  increases	  with	  Ring1B	  knockout
	  ...............................................................................................................................................	  147 
	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  Index	  of	  Figures	  and	  Tables	  
 
11	  
Figure	  4.24.	  Configuration	  of	  RNAPII	  at	  PRC-­‐repressed	  genes	  may	  disrupt	  RNA	  processing.
	  ...............................................................................................................................................	  152 
Figure	  4.25.	  Dissecting	  possible	  RNA-­‐processing	  defects	  from	  differing	  transcript	  profiles	  at	  
PRC-­‐repressed	  genes.	  ............................................................................................................	  156	  
	  
Chapter	  5 
Figure	  5.1.	  Structure	  of	  the	  eukaryotic	  exosome	  ..................................................................	  159 
Figure	  5.2.	  Expression	  of	  exosome,	  but	  not	  Xrn2,	  changes	  through	  ES	  cell	  differentiation	  ..	  160 
Figure	  5.3.	  Strategy	  to	  identify	  the	  role	  of	  exonuclease	  proteins	  in	  PRC-­‐repressed	  gene	  
regulation	  ..............................................................................................................................	  161 
Table	  5.1.	  Proteins	  targeted	  by	  siRNA	  knockdown	  in	  ES	  cells	  ...............................................	  161 
Figure	  5.4.	  Xrn2	  siRNA	  knockdown	  in	  ES	  cells	  results	  in	  depletion	  of	  Xrn2	  RNA	  and	  protein163 
Figure	  5.5.	  Xrn2	  depletion	  has	  no	  effect	  on	  PRC-­‐repressed	  gene	  transcription	  at	  single	  genes
	  ...............................................................................................................................................	  164 
Figure	  5.6.	  Knockdown	  of	  four	  separate	  exosome	  subunits	  by	  siRNA	  ..................................	  165 
Figure	  5.7.	  Protein	  levels	  after	  exosome	  knockdown	  by	  siRNA	  ............................................	  167 
Figure	  5.8.	  De-­‐repression	  of	  PRC-­‐repressed	  genes	  upon	  Exosc3	  and	  Exosc5	  siRNA	  knockdown
	  ...............................................................................................................................................	  169 
Figure	  5.9.	  Exosc3	  knockouts	  retain	  alkaline	  phosphatase	  activity	  .......................................	  170 
Figure	  5.10.	  De-­‐repression	  of	  PRC-­‐repressed	  genes	  upon	  siRNA	  knockdown	  of	  exonuclease	  
components	  of	  the	  exosome	  .................................................................................................	  172 
Figure	  5.11.	  Primary	  and	  spliced	  transcripts	  at	  PRC-­‐repressed	  genes	  increase	  in	  exosome	  
knockouts	  ..............................................................................................................................	  174 
Figure	  5.12.	  Detection	  of	  polyadenylated	  transcripts	  from	  some	  PRC-­‐target	  genes	  after	  
exosome	  knockdown	  .............................................................................................................	  175 
Figure	  5.13.	  Workflow	  for	  microarray	  analysis	  of	  Exosc3	  knockdown	  ..................................	  176 
Figure	  5.14.	  Principle	  component	  analysis	  (PCA)	  of	  microarray	  samples	  ..............................	  177 
Table	  5.2.	  Number	  of	  probesets	  that	  are	  deregulated	  between	  microarray	  samples	  ..........	  178 
Table	  5.3.	  Percentage	  of	  differentially	  regulated	  genes	  ........................................................	  178 
Figure	  5.15.	  Differing	  regulatory	  gene	  groups	  across	  the	  ES	  cell	  genome	  ............................	  179 
Figure	  5.16.	  Exosc3	  siRNA	  knockdown	  deregulates	  primarily	  active	  genes,	  including	  a	  subset	  
of	  Polycomb-­‐target	  genes	  in	  ES	  cells	  .....................................................................................	  180 
Figure	  5.17.	  Validation	  of	  Exosc3	  microarray	  results	  at	  single	  genes	  by	  qRT-­‐PCR	  ................	  183 
Figure	  5.18.	  PRC-­‐repressed	  genes,	  Math1,	  Nkx2-­‐9	  and	  Nkx2-­‐2,	  are	  upregulated	  in	  the	  RNA	  
samples	  used	  for	  microarray	  analysis	  ....................................................................................	  184 
Table	  5.4.	  Comparison	  of	  Log2FC	  from	  the	  same	  sample	  between	  microarray	  and	  RT-­‐PCR	  at	  a	  
panel	  of	  active,	  PRC-­‐repressed	  and	  silent	  genes	  ...................................................................	  185 
Figure	  5.19.	  Average	  profiles	  of	  CAGE	  signal	  at	  active,	  PRC-­‐repressed	  and	  silent	  genes	  upon	  
exosome	  depletion	  ................................................................................................................	  187 
Figure	  5.20.	  PRC-­‐repressed	  capped	  transcripts	  increase	  upon	  exosome	  knockdown	  ..........	  188 
Figure	  5.21.	  Chromatin	  occupancy	  of	  the	  Exosc7	  subunit	  of	  the	  exosome	  at	  PRC-­‐repressed	  
genes	  in	  ES	  cells	  .....................................................................................................................	  189	  
	  
Chapter	  6 
Figure	  6.1.	  Modifications	  of	  the	  RNAPII	  CTD	  .........................................................................	  193 
Figure	  6.2.	  Characterising	  S5G	  and	  T4G	  antibodies	  by	  western	  blotting	  ..............................	  197 
	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  Index	  of	  Figures	  and	  Tables	  
 
12	  
Figure	  6.3.	  Characterising	  S5G	  and	  T4G	  cellular	  distribution	  in	  ES	  cells	  by	  
immunofluorescence	  .............................................................................................................	  199 
Figure	  6.4.	  RNAPII-­‐S5G	  and	  RNAPII-­‐T4G	  bind	  to	  active	  and	  not	  PRC-­‐repressed	  genes	  .........	  201 
Table	  6.1.	  Sequencing	  read	  numbers	  and	  alignment	  for	  RNAPII-­‐S5G	  and	  RNAPII-­‐T4G	  ChIP-­‐seq
	  ...............................................................................................................................................	  202 
Figure	  6.5.	  RNAPII-­‐S5G	  peaks	  at	  promoters	  and	  RNAPII-­‐T4G	  increases	  through	  coding	  regions	  
of	  active	  genes	  .......................................................................................................................	  203 
Figure	  6.6.	  PRC-­‐repressed	  genes	  are	  not	  associated	  with	  RNAPII-­‐S5G	  or	  T4G	  in	  ES	  cells	  .....	  204 
Figure	  6.7.	  RNAPII	  complexes	  modified	  on	  S5G	  and	  T4G	  associate	  genome-­‐wide	  with	  active	  
genes	  .....................................................................................................................................	  206 





A	   	   adenosine	  
ABL	   	   Abelson	  tyrosine	  kinase	  
ab	   	   antibody	  
ac	   	   acetylation	  
AP	   	   alkaline	  phosphatase	  
ATP	   	   adenosine	  tri-­‐phosphate	  
Bmi1	   	   B	  lymphoma	  Mo-­‐MLV	  insertion	  region	  1	  
Br-­‐UTP	  	   bromo	  uridine-­‐5'-­‐triphosphate	  
BRD4	   	   bromodomain-­‐containing	  protein	  4	  
C	   	   cytosine	  
CAGE	   	   cap	  analysis	  of	  gene	  expression	  
CBC	   	   cap	  binding	  complex	  
CDK	   	   cyclin	  dependent	  kinase	  
cDNA	   	   complementary	  DNA	  
CFI/II	   	   cleavage	  factor	  I	  and	  II	  
ChIP	   	   chromatin	  immunoprecipitation	  
CPF	  	   	   cleavage	  and	  polyadenylation	  factor	  
CPSF	  	   	   cleavage	  and	  polyadenylation	  specificity	  factor	  
CstF	  	   	   cleavage	  stimulatory	  factor	  
CTD	   	   carboxy-­‐terminal	  domain	  
Dig	   	   digoxigenin	  
DNase	   	   deoxyribonuclease	  
DNA	   	   deoxyribonucleic	  acid	  
DRB	   	   5,6-­‐dichloro-­‐1-­‐b-­‐D-­‐ribofuranosylbenimidazole	  
DSIF	   	   DRB-­‐sensitivity	  inducing	  factor	  
EDTA	   	   ethylenediaminetetraacetic	  acid	  
Eed	   	   embryonic	  ectoderm	  development	  
ES	   	   embryonic	  stem	  
Exosc1-­‐10	   exosome	  subunit	  1-­‐10	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Abbreviations	  
	  
14	  
Ezh2	   	   enhancer	  of	  zeste	  homolog	  2	  
FCP1	   	   transcription	  factor	  IIF-­‐associated	  CTD	  phosphatase	  1	  
FCS	   	   fetal	  calf	  serum	  
G	   	   guanosine	  
GTFs	  	   	   general	  transcription	  factors	  
h	  	   	   hour	  
H	   	   histone	  
HCE1	   	   human	  capping	  enzyme	  1	  
HCM1	   	   human	  capping	  methyltransferase	  1	  
HMT	   	   histone	  methyl	  transferase	  
Hox	   	   homeobox	  
hsp	   	   heat	  shock	  protein	  
Ig	   	   immunoglobulin	  
IP	   	   immunoprecipitation	  
K	   	   lysine	  
kb	  	   	   kilobase	  pair	  
kDa	  	   	   kiloDalton	  
LIF	   	   leukemia	  inhibitory	  factor	  
m7G	   	   7-­‐methyl	  guanosine	  
me	   	   methylation	  
mRNA	   	   messenger	  RNA	  
miRNA	  	   micro	  RNA	  
ncRNA	  	   non-­‐coding	  RNA	  
NEAA	   	   non-­‐essential	  amino	  acids	  
NELF	   	   negative	  elongation	  factor	  
NGS	   	   next	  generation	  sequencing	  
Oct4	   	   octamer-­‐4	  
OGA	   	   O-­‐linked	  N-­‐acetylglucosaminase	  
O-­‐GlcNAc	   O-­‐linked	  N-­‐acetylglucosamine	  
OGT	   	   O-­‐linked	  N-­‐acetylglucosamine	  transferase	  
P	   	   phosphorylation	  
P	   	   proline	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Abbreviations	  
	  
15	  
PAGE	   	   polyacrylamide	  gel	  electrophoresis	  
PAP	   	   Poly(A)	  polymerase	  
PBS	   	   phosphate-­‐buffered	  saline	  
PCF1	   	   protein	  1	  of	  cleavage	  and	  polyadenylation	  factor	  I	  
Pcl	   	   Polycomb-­‐like	  
PCR	   	   polymerase	  chain	  reaction	  
Pho	   	   pleiohomeotic	  
PIC	   	   pre-­‐initiation	  complex	  
PMSF	   	   phenylmethyl-­‐sulphonyl	  fluoride	  
Plk3	   	   pollo-­‐like	  kinase	  3	  
PRC	   	   Polycomb	  repressive	  complex	  
PRCa	   	   PRC-­‐active	  cluster	  
PRE	   	   Polycomb	  response	  element	  
PRCi	   	   PRC-­‐intermediate	  cluster	  
PRCo	   	   PRC-­‐only	  cluster	  
PRCr	   	   PRC-­‐repressed	  cluster	  
Psc	   	   posterior	  sex	  combs	  
P-­‐TEFb	  	   positive	  transcription	  elongation	  factor	  b	  
RACE	   	   rapid	  amplification	  of	  cDNA	  ends	  
RPB1	   	   RNA	  polymerase	  II	  subunit	  B1	  
REST	   	   RE-­‐1	  silencing	  transcription	  factor	  
Ring	   	   really	  interesting	  new	  gene	  
RNA	   	   ribonucleic	  acid	  
RNAP	   	   RNA	  polymerase	  
RNAPII	  S2p	   RNAPII	  phosphorylated	  on	  serine	  2	  residues	  of	  the	  CTD	  
RNAPII	  S5p	   RNAPII	  phosphorylated	  on	  serine	  5	  residues	  of	  the	  CTD	  
RNAPII	  S7p	   RNAPII	  phosphorylated	  on	  serine	  7	  residues	  of	  the	  CTD	  
RNAPII	  Y1p	   RNAPII	  phosphorylated	  on	  tyrosine	  1	  residues	  of	  the	  CTD	  
RNAPII	  T4p	   RNAPII	  phosphorylates	  on	  threonine	  4	  residues	  of	  the	  CTD	  
RNAPII	  S5G	   RNAPII	  glycosylated	  on	  serine	  5	  residues	  of	  the	  CTD	  
RNAPII	  T4G	   RNAPII	  glycosylated	  on	  threonine	  4	  residues	  of	  the	  CTD	  
rRNA	   	   ribosomal	  RNA	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RPB1-­‐12	  	   RNA	  polymerase	  B	  1-­‐12	  
rpm	   	   revolutions	  per	  minute	  
RNase	   	   ribonuclease	  
RT	   	   real-­‐time	  
RTR1	   	   regulator	  of	  transcription	  1	  
S	   	   serine	  
SCP	   	   small	  CTD	  phosphatase	  
Seq	   	   sequencing	  
SET	   	   suppressor	  of	  variegation,	  enhancer	  of	  zeste	  and	  trithorax	  
snRNA	  	   small	  nuclear	  RNA	  
Sox2	   	   SRY	  (sex	  determining	  region	  Y)-­‐box	  2	  
SPT	   	   suppressor	  of	  Ty	  
SSU72	   	   suppressors	  of	  sua7	  protein	  2	  
Suz12	   	   suppressor	  of	  zeste	  12	  
Sxc	   	   super	  sex	  combs	  
T	   	   threonine	  
T	   	   thymidine	  
TES	   	   termination	  end	  site	  
TF	   	   transcription	  factor	  
TFIIH	   	   transcription	  factor	  II	  H	  
TMX	   	   tamoxifen	  
tRNA	   	   transfer	  RNA	  
TSS	   	   transcription	  start	  site	  
ub	   	   ubiquitination	  
UTR	   	   un-­‐translated	  region	  
UV	   	   ultraviolet	  
WT	   	   wild-­‐type	  
Xrn2	   	   5’-­‐3’	  exoribonuclease	  2	  
Y	   	   tyrosine	  
YY1	   	   yin-­‐yang-­‐1	  
	  




Each	   cell	   that	   makes	   up	   the	   body	   of	   higher	   eukaryotes	   contains	   identical	   genetic	  
information.	   Yet	   within	   each	   organism	   there	   are	   hundreds	   of	   specialised	   cell	   types	   with	  
dramatically	  different	  functions	  and	  phenotypes.	  The	  way	  in	  which	  different	  gene	  expression	  
programs	   are	   specified,	   regulated	   and	   maintained	   at	   the	   molecular	   level	   is	   crucial	   to	  
understand	   growth	   and	   development.	   Regulation	   of	   gene	   expression	   encompasses	   a	  
multitude	  of	  layers.	  These	  range	  from	  the	  organisation	  of	  DNA	  within	  the	  3D	  nuclear	  space,	  
how	  DNA	   is	  packaged	  as	   chromatin,	   to	   the	   interpretation	  of	   sequence	  by	  a	  whole	  host	  of	  
factors	   including:	   (i)	   transcription	   factors,	   that	   bind	   to	   specific	   DNA	   sequences	   at	   gene	  
promoters,	   (ii)	   chromatin	   remodelers	   and	   modifiers,	   that	   modulate	   the	   recognition	   of	  
binding	  sites,	  and	  (iii)	  RNA	  polymerases,	  which	  have	  roles	  in	  recruiting	  chromatin	  modifiers	  
and	   RNA	   processing	   machineries,	   promoting	   co-­‐transcriptional	   processes	   that	   control	   for	  
example,	  alternative	  splicing,	  adding	  to	  the	  complexity	  of	  gene	  expression	  profiles.	  
	  
Eukaryotes	  have	  three	  different	  nuclear	  RNA	  polymerases	  (RNAPI,	  RNAPII	  and	  RNAPIII)	  that	  
transcribe	   specific	   genes;	   additional	   RNA	   polymerases	   are	   found	   in	   mitochondria.	   In	   the	  
nucleus,	  RNAPI	   transcribes	  a	   single	  gene,	   the	   large	   ribosomal	   transcript	  45S	   rRNA	  which	   is	  
then	  processed	  into	  mature	  18S,	  5.8S	  and	  28S	  rRNA	  in	  mammals.	  RNAPII	   is	  responsible	  for	  
transcription	   of	   all	   protein	   coding	   genes	   into	   messenger	   RNA	   (mRNA)	   that	   is	   used	   as	   a	  
template	  to	  make	  proteins,	   the	  building	  blocks	  of	  the	  cell,	  and	  also	  transcribes	  non-­‐coding	  
RNA	  (ncRNA),	  including	  small	  nuclear	  RNA	  (snRNA),	  microRNA	  (miRNA)	  and	  long	  non-­‐coding	  
RNA	  (lncRNA).	  Finally,	  RNAPIII	  transcribes	  different	  small	  structural	  RNAs	  including	  transfer	  
RNAs	  (tRNAs)	  and	  the	  5S	  rRNA.	  
	  
The	  work	  presented	  in	  this	  thesis	  focuses	  on	  understanding	  RNAPII	  regulation	  and	  activity	  in	  
mouse	   ES	   cells,	   and	   its	   interplay	   with	   Polycomb-­‐repressor	   complexes	   (PRC)	   that	   modify	  
histone	   H3K27	   and	   H2AK119.	   I	   will	   start	   by	   discussing	   RNAPII	   regulation	   across	   active	  
genomic	   regions,	   before	   introducing	   Polycomb	   repression	   and	   the	   recently	   identified	  
colocalisation	  of	  a	  novel	  RNAPII	  form	  at	  Polycomb-­‐repressed	  chromatin.	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1.1 RNA	  Polymerase	  II	  
RNAPII	   comprises	   12	   subunits	   (RPB1-­‐12)	   with	   high	   levels	   of	   conservation	   in	   eukaryotes	  
(Young,	   1991).	   Post-­‐translational	   modifications	   of	   RNAPII	   are	   essential	   for	   regulation	   of	  
RNAPII	  activity,	   integrating	   transcription	  with	  chromatin	  modifications	  and	  RNA	  processing	  
ensuring	  efficient	  and	  robust	  gene	  expression	  (de	  Almeida	  and	  Carmo-­‐Fonseca,	  2008).	  
1.1.1 Carboxy	  Terminal	  Domain	  (CTD)	  
The	   largest	   subunit	   of	   RNAPII,	   Rpb1,	   has	   evolved	   a	   carboxy-­‐terminal	   domain	   (CTD)	   that	   is	  
composed	   of	   heptapeptide	   consensus	   sequence	   Tyr1-­‐Ser2-­‐Pro3-­‐Thr4-­‐Ser5-­‐Pro6-­‐Ser7,	  
repeated	  many	   times	   (Corden	   et	   al.,	   1985),	   which	   	   is	   extensively	   and	   reversibly	  modified	  
post-­‐translationally.	  Repeat	  numbers	  increase	  with	  complexity	  of	  organisms	  from	  26	  in	  yeast	  
to	   52	   repeats	   in	   humans	   (Chapman	   et	   al.,	   2008).	   The	   CTD	   does	   not	   hold	   the	   enzymatic	  
activity	  of	  RNAPII	  and	  is	  dispensable	  for	  transcription	  in	  vitro,	  where	  partial	  deletions	  can	  be	  
tolerated	  (West	  and	  Corden,	  1995).	  The	  RNAPII	  CTD	  is	  however	  essential	   for	   integration	  of	  
transcription	   with	   co-­‐transcriptional	   processes	   to	   successfully	   produce	   a	   mature	   mRNA	  
(Buratowski,	  2009).	  Modifications	  of	  the	  CTD	  have	  the	  potential	  to	  change	  its	  3D	  structure,	  
influencing	  accessibility.	  	  
1.1.2 RNAPII	  modifications	  and	  the	  ‘CTD	  code’	  
Early	   studies	   of	   RNAPII	   by	   SDS-­‐PAGE	   suggested	   that	   the	   largest	   subunit	   Rpb1	   could	   be	  
modified	  post-­‐translationally	   (Sklar	  and	  Roeder,	  1976).	   It	   is	  now	  known	   that	  every	   residue	  
that	  makes	  up	  the	  RNAPII	  CTD	  has	  the	  potential	  to	  be	  modified.	  Phosphorylation	  can	  occur	  
at	   tyrosine,	   threonine	   and	   serine	   residues,	   glycosylation	   at	   serines	   and	   threonine,	   and	  
isomerization	  of	  prolines	  (Kelly	  et	  al.,	  1993;	  Egloff	  et	  al.,	  2012).	  Non-­‐canonical	  amino	  acids,	  
such	   as	   a	   single	   arginine	   found	   at	   the	   vertebrate	   CTD	   has	   recently	   been	   shown	   to	   be	  
methylated	  in	  human	  cells	  (Sims	  et	  al.,	  2011).	  CTD	  phosphorylation	  in	  serine	  residues	  is	  the	  
most	  well	   characterised	  modification.	  A	  hallmark	  of	  RNAPII	   is	   its	  dynamic	  phosphorylation	  
state	  at	  different	  stages	  of	  the	  transcription	  cycle	  (Dahmus,	  1996;	  Phatnani	  and	  Greenleaf,	  
2006)	  which	  modulates	  RNAPII	  function	  and	  transcriptional	  regulation.	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Combinations	  of	  CTD	  modifications	  that	  occur	  in	  a	  spatial	  and	  temporal	  manner	  throughout	  
the	   transcription	   cycle,	   from	   initiation	   to	   termination,	   have	   led	   to	   the	   proposal	   of	   a	   ‘CTD	  
code’	  (Buratowski,	  2003;	  Egloff	  et	  al.,	  2012).	  At	  the	  vast	  majority	  of	  genes,	  an	  ordered	  ‘CTD	  
code’	  occurs	  during	  transcription,	  where	  CTD	  phosphorylation	  patterns	  operate	  in	  a	  uniform	  
manner	  across	  virtually	  all	  genes,	  independent	  of	  gene	  length	  (Bataille	  et	  al.,	  2012;	  Mayer	  et	  
al.,	   2012).	   However,	   studies	   in	   yeast	   have	   identified	   gene-­‐specific	   CTD	   phosphorylation	  
patterns	  that	  can	  be	  established	  in	  a	  gene-­‐specific	  manner	  (Tietjen	  et	  al.,	  2010)	  and	  can	  vary	  
depending	   on	   expression	   patterns	   and	   promoter	   structure	   (Kim	   et	   al.,	   2011).	   A	   more	  
complex	   situation	   may	   therefore	   occur	   in	   mammalian	   genes,	   which	   contain	   larger	   genes	  
with	   long	   introns,	  and	  are	  flanked	  by	  regulatory	  elements,	   including	  enhancer	  and	  silencer	  
elements,	  and	  are	  under	  tighter	  regulatory	  control	  from	  more	  complex	  transcription	  factor	  
networks.	  	  
	  
1.2 RNAPII	  Transcription	  Cycle	  and	  CTD	  Modifications	  at	  Active	  Genes	  
RNAPII	   transcription	   of	   protein	   coding	   genes	   to	   produce	   mature	   mRNAs	   occurs	   in	   a	  
coordinated	   fashion	   following	  a	   series	  of	   stages	   that	  make	  up	   the	   transcription	  cycle;	  pre-­‐
initiation,	   initiation,	   elongation	   and	   termination	   (Fig.	   1.1).	   Each	   step	   is	   rate	   limiting	   and	  
highly	  regulated.	  Promoter	  proximal	  pausing	  of	  RNAPII	  is	  a	  well	  described	  rate	  limiting	  step	  
that	   is	   characteristic	   of	   inducible	   genes,	   where	   the	   RNAPII	   is	   arrested	   at	   gene	   promoters	  
after	   initiation	   and	  prior	   to	   productive	   elongation	   (Gilmour	   and	   Lis,	   1986).	  More	   recently,	  
RNAPII	  pausing	  has	  been	  proposed	  as	  a	  general	  regulatory	  mechanism	  in	  transcription	  (Core	  
et	  al.,	   2008).	   Each	   stage	  of	   the	   transcription	  cycle	   is	   tightly	  modulated	  and	  coordinated	   in	  
part	  by	  modification	  of	  the	  CTD.	  The	  most	  studied	  modifications	  are	  the	  phosphorylation	  of	  
serine	   residues	   5,	   2	   and	   7	   that	   mark	   specific	   stages	   of	   the	   transcription	   cycle	   and	   are	  
described	  below.	  	  
1.2.1 Transcription	  Initiation	  and	  Serine	  5	  and	  Serine	  7	  phosphorylation	  
RNAPII	   is	   recruited	   to	   gene	   promoters	   in	   a	   hypo-­‐phosphorylated	   state.	   Recruitment	   of	  
numerous	  sequence	  specific	  transcription	  factors	  (TF’s),	  general	  transcription	  factors	  (GTF’s)	  
including	  TFIIB,	  TFIID,	  TFIIE,	  TFIIF	  and	  TFIIH;	  each	  of	  which	  have	  specific	  functions,	  Mediator	  
and	  RNAPII	   result	   in	   formation	  of	  a	  pre-­‐initiation	  complex	   (PIC;	  Fig.	  1.1),	   that	  primes	  gene	  
Chapter	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Introduction 
 
20	  
transcription	  (Buratowski,	  2009;	  Zhang	  et	  al.,	  2012).	  RNAPII	  complex	  instability	  during	  early	  
stages	   of	   initiation	   can	   result	   in	   transcription	   being	   aborted	   after	   only	   a	   few	   nucleotides	  
(Sims	   et	   al.,	   2004).	   Promoter	   clearance	   and	   transcription	   initiation	   coordinates	  with	   rapid	  
phosphorylation	   of	   serine	   residues	   (S5p)	   on	   the	   CTD	   across	   species	   (Boehm	   et	   al.,	   2003;	  
Morris	  et	  al.,	  2005).	  	  
	  	  
Regulation	  of	  PIC	  formation	  begins	  with	  binding	  of	  sequence	  specific	  TF’s	  to	  DNA	  leading	  to	  
GTF,	  mediator	  and	  RNAPII	  recruitment	  to	  core	  promoters	  of	  subsets	  of	  genes,	  as	  proposed	  in	  
either	   a	   sequential	   fashion	   or	   as	   a	   holoenzyme	   complex	   (Zhang	   et	   al.,	   2011).	   Cell	   type	  
specific	  TF’s,	  for	  example,	  Oct4,	  Nanog	  and	  Sox2	   in	  embryonic	  stem	  (ES)	  cells,	  add	  an	  extra	  
layer	  of	  regulation,	  dictating	  gene	  expression	  programs	  in	  different	  cell	  types.	  Association	  of	  
Oct4	  with	  RNAPII	  has	  been	  demonstrated	   in	  ES	  cells	  via	  elongation	  factor	  Paf1,	  which	  may	  
maintain	  ES	  cell	  self-­‐renewal	  by	  regulating	  specific	  Oct4	  directed	  gene	  expression	  programs	  
(Ponnusamy	  et	  al.,	  2009).	  
	  
Mediator	   is	   a	   complex	   of	   proteins,	   evolutionary	   conserved	   from	   yeast	   to	   mammals.	   The	  
Mediator	  complex	  has	  an	  essential	  role	  in	  transcription	  by	  acting	  as	  a	  coactivator,	  in	  part,	  by	  
bridging	   basal	   machinery	   including	   RNAPII	   with	   regulatory	   factors	   at	   upstream	   promoter	  
elements	  and	  enhancers	  (Conaway	  et	  al.,	  2005).	  Mediator	  drives	  the	  high	  affinity	  interaction	  
of	  RNAPII	  with	  GTF’s,	  and	  also	  chromatin	  modifiers	  and	  remodelers	  such	  as	  SET1	  and	  CHD1,	  
linking	   transcription	   initiation	   and	   the	   chromatin	   environment	   (Chen	   et	   al.,	   2012).	   Much	  
effort	  is	  now	  focussing	  on	  understanding	  the	  interactions	  of	  different	  mediator	  subunits	  with	  
transcriptional	   regulators	   that	   may	   confer	   specific	   interactions	   in	   specific	   cell	   types.	  
Interestingly,	  recruitment	  of	  Mediator	  appears	  to	  require	  the	  RNAPII	  CTD	  although	  a	  physical	  
association	  has	  not	  been	  demonstrated.	   In	   vivo	  Mediator	   is	   required	   for	   transcription	  and	  
has	  been	  shown	  to	  stimulate	  RNAPII	  CTD	  phosphorylation	  at	  S5	  and	  S7	  residues	  (Ries	  et	  al.,	  
2011).	  	  
	  
Serine	  5	  Phosphorylation	  
S5p	  has	  a	  positive	  role	  in	  transcription	  initiation,	  acting	  in	  concert	  with	  RNAPII	  release	  from	  
the	  promoter	  and	  disassociation	  from	  the	  stably	  bound	  pre-­‐initiation	  complex	  (PIC)	  (Jiang	  et	  
al.,	   1996;	   Liu	   et	   al.,	   2004).	   As	   well	   as	   direct	   roles	   on	   RNAPII	   transcription,	   S5p	   acts	   as	   a	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recruitment	  scaffold	  for	  early	  RNA	  processing	  machineries	  (Proudfoot	  et	  al.,	  2002)	  including	  
capping	   enzymes	   (McCracken	   et	   al.,	   1997;	   Ho	   and	   Shuman,	   1999;	   Cowling,	   2010)	   and	  
chromatin	  modifiers	  (Ng	  et	  al.,	  2003). 	  
	  
RNAPII	  S5	  residues	  are	  phosphorylated	  by	  CDK7,	  the	  kinase	  subunit	  of	  general	  transcription	  
factor	  TFIIH	  (Lu	  et	  al.,	  1992;	  Hengartner	  et	  al.,	  1998;	  Trigon	  et	  al.,	  1998).	  In	  yeast,	  TFIIH	  has	  
been	  suggested	  to	  prime	  the	  RNAPII	  CTD	  and	  promote	  recruitment	  of	  the	  S2	  kinase	  complex,	  
pTEFb,	  coupling	  capping	  of	  pre-­‐mRNA	  with	  transcription	  elongation	  (Villadeval	  et	  al.,	  2009).	  
Phosphorylation	  of	  S5	  residues	  occurs	  when	  RNAPII	   is	  bound	  to	  chromatin	  associated	  with	  
mediator	  after	   formation	  of	   the	  PIC	   (Trigon	  et	  al.,	  1998).	   It	   is	  unclear	  whether	  CDK7	   is	   the	  
sole	   S5	   kinase	  and	  differing	  experimental	   strategies	  have	  given	   contrasting	   conclusions.	   In	  
budding	  yeast,	  CDK7	  inactivation	  using	  temperature	  sensitive	  mutants	  resulted	  in	  shutdown	  
of	   global	   RNAPII	   transcription	   (Holstege	   et	   al.,	   1998)	   and	   chemical	   inhibition	   of	   CDK7	  
resulted	   in	   a	   5’	   capping	   defects,	   the	   latter	   suggesting	   that	   CDK7	   is	   not	   required	   for	  
transcription	  per	  se,	  but	  is	  crucial	  for	  RNA	  maturation	  (Kanin	  et	  al.,	  2006).	  In	  contrast,	  CDK7	  
inhibition	  in	  fission	  yeast	  saw	  a	  global	  decrease	  in	  S5p	  levels	  but	  with	  more	  localised	  impact	  
of	  CDK7	  inhibiton	  on	  gene	  expression	  (Lee	  et	  al.,	  2005).	  	  
	  
Interestingly,	  in	  mouse	  ES	  cells	  Inhibition	  of	  CyclinH;	  the	  cyclin	  partner	  of	  CDK7	  in	  the	  TFIIH	  
complex	  leads	  to	  cell	  differentiation	  and	  upregulation	  of	  specific	  subsets	  of	  genes	  including	  
Polycomb	   regulated	   developmental	   regulator	   genes	   (Patel	   et	   al.,	   2010).	   CDK7	   activity	  was	  
reduced	  but	  there	  was	  no	  change	  in	  global	  S5p	  levels.	  	  In	  agreement,	  at	  a	  panel	  of	  genes	  in	  a	  
human	  cell	   line,	  CDK7	   inhibition	  did	  not	  result	   in	  a	  decrease	   in	  RNAPII-­‐S5p,	  suggesting	   it	   is	  
not	  the	  sole	  kinase	  responsible	  for	  S5	  phosphorylation	  (Glover-­‐Cutter	  et	  al.,	  2009)	  and	  may	  
have	  more	  specific	  roles	  in	  certain	  cell	  types.	  In	  ES	  cells	  CyclinH	  is	  suggested	  to	  play	  a	  role	  in	  
repressing	  developmental	  regulator	  genes	  and	  it	  was	  postulated	  that	  this	  occurred	  through	  
the	  elongation	  factor	  Spt5.	  How	  this	  occurs	  mechanistically	  is	  not	  known.	  	  	  
	  
CDK8,	  a	  member	  of	  the	  mediator	  complex	  has	  also	  been	  shown	  to	  phosphorylate	  S5	  in	  vitro	  
when	  RNAPII	   is	  not	  bound	   to	   the	  DNA	   template	  prior	   to	  PIC	   formation	   (Hengartner	  et	  al.,	  
1998;	   Rickert	   et	   al.,	   1999).	   CDK8	   has	   also	   been	   shown	   to	   inhibit	   the	   activity	   of	   TFIIH,	  
suggesting	   a	   role	   for	   the	   kinase	   as	   a	   transcriptional	   repressor	   (Akoulitchev	   et	   al.,	   2000).	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However,	   its	   role	   in	   vivo	   remains	   ill-­‐defined	   and	   a	   number	   of	   studies	   are	   emerging	  which	  
suggest	  a	  positive	  role	  for	  CDK8	  in	  transcription	  (Galbraith	  et	  al.,	  2010).	  In	  vitro	  CDK9,	  a	  well	  
known	  S2	  kinase,	  is	  also	  able	  to	  phosphorylate	  S5	  residues	  and	  in	  vivo	  has	  a	  potential	  role	  as	  
an	  S5	  kinase	  (Glover-­‐Cutter	  et	  al.,	  2009)	  suggesting	  that	  the	  deposition	  of	  S5p	  on	  the	  CTD	  is	  
more	  complex	  than	  previously	  thought,	  and	  the	  presence	  of	  one	  universal	  S5	  kinase	  is	  now	  
appearing	  more	  unlikely.	  	  
	  
Several	   phosphatases	   act	   on	   S5p,	   which	   are	   important	   not	   only	   to	   promote	   RNAPII	  
disassembly,	  but	  also	  to	  modulate	  phosphorylation	  levels	  throughout	  the	  transcription	  cycle.	  
Removal	  of	  S5p	  is	  mediated	  by	  numerous	  phosphatases	  including	  Ssu72	  (suppressor	  of	  sua7	  
protein	  2),	  a	  member	  of	   the	  3’	  processing	  complex	  and	  necessary	   for	   termination	   in	  yeast	  
(Krishnamurthy	   et	   al.,	   2004).	   Rtr1	   (regulator	   of	   transcription	  1)	   is	   an	   S5	  phosphatase	  with	  
apparent	   roles	   in	   the	   transition	   from	   initiation	   to	  elongation.	  Transcription	   is	   reduced	  at	  a	  
number	  of	  genes	  and	  termination	  defects	  occur	  upon	  deletion	  in	  yeast	  (Mosley	  et	  al.,	  2009).	  
A	  family	  of	  small	  CTD	  phosphatases	  (SCPs),	  able	  to	  dephosphorylate	  S5	  residues,	  are	  thought	  
to	   aid	   regulation	  of	   the	   transition	  between	   initiation	  and	  elongation.	   SCPs	  have	  also	  been	  
shown	   to	   have	   a	   more	   specific	   role	   in	   repressing	   neuronal	   genes	   in	   non-­‐neuronal	   cells,	  
where	  they	  are	  recruited	  by	  REST	  (repressor	  element	  1	  silencing	  transcription	  factor)(Yeo	  et	  
al.,	  2003,	  2005).	  
	  
Serine	  7	  Phosphorylation	  
First	  described	  in	  regulation	  of	  small	  nuclear	  RNA	  (snRNA)	  transcription	  (Egloff	  et	  al.,	  2007),	  
S7p	   is	   a	   feature	  of	  actively	   transcribing	  genes	  and	   is	  highly	  enriched	  at	  promoters	   in	  both	  
human	  (Chapman	  et	  al.,	  2007)	  and	  mouse	  ES	  cells	  (Brookes	  et	  al.,	  2012),	  but	  is	  detected	  at	  
lower	   levels	   throughout	   gene	   coding	   regions	   until	   termination.	   CDK7	   (Kin28	   in	   yeast)	   has	  
been	  described	  as	  the	  S7	  kinase	  (Akhtar	  et	  al.,	  2009;	  Glover-­‐Cutter	  et	  al.,	  2009;	  Kim	  et	  al.,	  
2009).	  However,	  absence	  of	  S7p	   in	  the	  presence	  of	  abundant	  S5p,	  at	  a	  group	  of	  Polycomb	  
repressed	   genes	   in	   mouse	   embryonic	   stem	   cells,	   raises	   the	   possibility	   that	   there	  may	   be	  
other	  S7	  kinases	  (Brookes	  et	  al.,	  2012).	  The	  role	  of	  S7p	  in	  the	  transcription	  cycle	   is	  not	  yet	  
understood,	   although	   recent	   reports	   suggest	   it	   may	   enhance	   the	   activity	   of	   PTEFb,	   the	  
primary	   kinase	   responsible	   for	   S2	   phosphorylation,	   therefore	   promoting	   efficient	   RNAPII	  
elongation	  (Czudnochowski	  et	  al.,	  2012).	  




Figure	   1.1	   RNAPII	   transcription	   cycle	   at	   active	   genes.	   RNAPII	   is	   recruited	   in	   an	   unphosphorylated	   state	  
alongside	  numerous	  general	  transcription	  factors	  (GTFs)	  and	  the	  Mediator	  complex,	  forming	  the	  pre-­‐initiation	  
complex	  (PIC).	  During	  initiation,	  TFIIH	  phosphorylates	  S5	  residues	  resulting	  in	  disassociation	  from	  the	  PIC	  and	  
promoter	  clearance.	  S5p	  recruits	  Set1	  enzymes	  that	  methylate	  H3K4	  (H3K4me3),	  and	  the	  capping	  enzyme	  (CE)	  
to	  modify	  the	  emerging	  RNA.	  Elongation	  through	  coding	  regions	  is	  signified	  by	  phosphorylation	  of	  S2	  residues	  
by	  PTEFb	  (CDK9).	  Set2	  HMTs	  are	  recruited	  by	  S2p	  resulting	  in	  the	  trimethylation	  of	  H3K36	  (H3K36me3).	  Splicing	  
factors	   are	   recruited	   to	   RNAPII	   and	   the	   transcript.	   When	   RNAPII	   reaches	   the	   termination	   site,	   the	   RNA	   is	  
cleaved	   and	   polyadenylated,	   ready	   for	   nuclear	   export	   and	   translation.	   Exonuclease	   Xrn2	   is	   thought	   to	   aid	  
release	  of	  RNAPII	  from	  the	  template	  by	  degrading	  susceptible	  RNAs	  transcribed	  downstream	  and	  destabilising	  
RNAPII.	  RNAPII	  undergoes	  de-­‐phosphorylation	  by	  phosphatases	  and	  is	  released	  from	  the	  template	  ready	  for	  a	  
new	  round	  of	  transcription.	  Figure	  adapted	  from	  Tietjen	  et	  al.,	  (2010).	  	  
	  
1.2.2 Promoter	  Proximal	  Pausing	  
Prior	   to	   productive	   elongation,	   RNAPII	   can	   pause	   25-­‐50	   nucleotides	   downstream	   of	   the	  
transcription	   start	   site	   (TSS),	  held	   in	   check	  by	  negative	  elongation	   factors	   (Saunders	  et	  al.,	  
2006),	  a	  phenomenon	  known	  as	  promoter	  proximal	  pausing.	  RNAPII	  pausing	  is	  a	  rate	  limiting	  
step	  first	  described	  at	  the	  hsp70	  gene	  in	  Drosophila,	  where	  engaged	  RNAPII	  prior	  to	  stimuli	  
undergoes	   rapid	   activation	   upon	   heat	   shock	   (Gilmour	   and	   Lis,	   1986).	   Promoter-­‐proximal	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pausing	  was	  denoted	  by	  a	  high	  density	  of	  RNAPII	  occupancy	  at	   the	  5’	  end	  of	  genes	   in	   the	  
absence	   of	  mRNA	   expression.	  Widespread	   promoter	   proximal	   pausing	   has	   been	   linked	   to	  
inactive	   genes	   (Guenther	   et	   al.,	   2007;	   Muse	   et	   al.,	   2007;	   Zeitlinger	   et	   al.,	   2007).	   More	  
recently,	  RNAPII	  pausing	  has	  been	  proposed	  to	  be	  a	  general	  feature	  of	  regulation	  at	  actively	  
transcribed	  genes	  in	  ES	  cells	  and	  Drosophila,	  possibly	  allowing	  a	  window	  of	  time	  for	  correct	  
RNA	  capping,	  recruitment	  of	  accessory	   factors	  or	  as	  a	  control	  of	  bidirectional	   transcription	  
from	  active	  promoters	  (Nechaev	  et	  al.,	  2010;	  Rahl	  et	  al.,	  2010).	  	  
	  
Pausing	   is	   controlled	   by	   the	   association	   of	   negative	   elongation	   factor	   (NELF)	   and	  
DRB-­‐sensitivity	   inducing	   factor	   (DSIF)	   with	   RNAPII	   (Saunders	   et	   al.,	   2006).	   More	   recently,	  
promoter	  proximal	  pausing	  has	  been	  shown	  in	  human	  cells	  to	  be	  stabilized	  by	  association	  of	  
Gdown1	   (Cheng	   et	   al.,	   2012).	   Inhibition	   is	   relieved	   by	   the	   activity	   of	   pTEFb,	   consisting	   of	  
cyclin-­‐dependent	   kinase	   9	   (CDK9)	   and	   cyclin	   T	   (CycT)	   (Peterlin	   and	   Price,	   2006),	   whose	  
activity	   is	   vital	   for	   RNAPII	   release	   into	   productive	   elongation.	   PTEFb	   has	   several	  
phosphorylation	   targets,	   including	   CTD	   S2	   residues,	   NELF,	   DSIF	   and	   possibly	   S5	   residues	  
(Glover-­‐Cutter.,	  2009,	  Komarnitsky,	  2000).	  Phosphorylation	  of	  NELF	  results	  in	  dissociation	  of	  
NELF	  and	  release	  of	  RNAPII	  complexes	  (Wu	  et	  al.,	  2003).	  Phosphorylation	  of	  DSIF	  promotes	  
association	  with	  elongating	  RNAPII	  (Andrulis,	  2000;	  Boehm	  et	  al.,	  2003;	  Aida	  et	  al.,	  2006)	  and	  
may	   act	   as	   an	   elongation	   factor	   (Yamada	   et	   al.,	   2006).	   At	   a	   group	   of	   actively	   transcribed	  
genes	   in	   ES	   cells,	   c-­‐Myc	   also	   regulates	   RNAPII	   pause	   release,	   possibly	   via	   recruitment	   of	  
PTEFb	  (Rahl	  et	  al.,	  2010).	  	  
1.2.3 Transcription	  Elongation	  and	  Serine	  2	  Phosphorylation	  
RNAPII	  pause	  is	  followed	  by	  release	  into	  productive	  elongation	  through	  coding	  regions,	  upon	  
RNAPII	   phosphorylation	  of	   serine	   2	   residues	   (S2p).	   S2p	   is	   required	   for	   efficient	   elongation	  
and	  marks	  coding	  regions	  of	  active	  genes	  (Komarnitsky,	  2000;	  Boehm	  et	  al.,	  2003;	  Morris	  et	  
al.,	  2005;	  Brookes	  et	  al.,	  2012).	   	  S2p	  recruits	  factors	  important	  for	  chromatin	  modifications	  
(Krogan	  et	  al.,	  2003;	  Fuchs	  et	  al.,	  2012)	  and	  RNA	  processing	  (Proudfoot	  et	  al.,	  2002).	  Certain	  
factors	   are	   known	   to	   enhance	   elongation,	   including	   Elongins	   and	   the	   ELL	   family	   by	  
stimulating	   the	   rate	   of	   RNAPII	   transcription	   and	   suppressing	   RNAPII	   pausing	   (Sims	   et	   al.,	  
2004).	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Serine	  2	  Phosphorylation	  
PTEFb	   is	   a	   heterodimer	   of	   the	   kinase	   Cdk9	   and	   cyclin	   component	   CycT1,	  which	   is	   able	   to	  
phosphorylate	  S2	  residues	  on	  the	  CTD	  in	  higher	  eukaryotes	  (Marshall	  et	  al.,	  1996;	  Rahl	  et	  al.,	  
2010)	  and	  its	  activity	  is	  primed	  by	  the	  presence	  of	  Serine	  7	  phosphorylation	  (Czudnochowski	  
et	  al.,	  2012).	  PTEFb	  also	  targets	  pausing	  factors	   including	  NELFE	  and	  a	  component	  of	  DSIF,	  
Spt5,	  resulting	  in	  pause	  release	  as	  described	  above	  (Komarnitsky,	  2000;	  Yamada	  et	  al.,	  2006).	  
Recruitment	  of	  PTEFb	  to	  genes	  is	  thought	  to	  occur	  via	  RNAPII	  CTD	  interactions	  (St.	  Amour	  et	  
al.,	  2012)	  or	  transcription	  factors	  such	  as	  c-­‐Myc	  (Rahl	  et	  al.,	  2010).	  BRD4	  also	  interacts	  with	  
PTEFb	  (Yang	  et	  al.,	  2005),	  possibly	  resulting	  in	  PTEFb	  recruitment	  to	  genes.	  	  BRD4	  is	  also	  able	  
to	  phosphorylate	  S2	  residues	  of	  the	  CTD	  (Devaiah	  et	  al.,	  2012),	  suggesting	  a	  direct	  role	  for	  
BRD4	   in	   transcription	   elongation.	   PTEFb	   activity	   can	   be	   regulated	   in	   the	   cell	   with	   the	  
complex	  being	  inhibited	  by	  binding	  of	  Hexim1	  and	  7SK	  (Michels	  et	  al.,	  2004).	  
	  
In	  yeast,	  two	  kinases	  are	  essential	  for	  S2	  phosphorylation	  and	  transcription	  elongation,	  Ctk1	  
and	  Bur1.	  Initially,	  it	  was	  thought	  that	  Ctk1	  was	  the	  primary	  S2	  kinase	  with	  Bur1	  preventing	  
aberrant	  initiation	  by	  acting	  on	  the	  elongation	  factor	  Spt5.	  However,	  Bur1	  also	  plays	  a	  role	  as	  
an	  S2	  kinase	  (Liu	  et	  al.,	  2009;	  Tietjen	  et	  al.,	  2010;	  Egloff	  et	  al.,	  2012).	  PTEFb	  was	  thought	  to	  
be	  the	  mammalian	  equivalent	  of	  both	  Ctk1	  and	  Bur1	  in	  yeast,	  responsible	  for	  the	  bulk	  of	  S2p	  
on	  the	  CTD	  during	  elongation.	  However,	  more	  recently	  CDK12	  has	  been	  shown	  in	  Drosophila	  
and	  human	  to	  be	  the	  homologue	  of	  yeast	  Ctk1,	  phosphorylating	  S2	  in	  vivo	  (Bartkowiak	  et	  al.,	  
2010;	   Bartkowiak	   and	   Greenleaf,	   2011),	   and	   generating	   a	   more	   complex	   view	   of	   S2p	  
regulation	   and	   transcription	   elongation	   in	   higher	   eukaryotes	   which	   is	   not	   yet	   completely	  
understood.	  	  
	  
Removal	   of	   S2p	   can	   occur	   via	   FCP1	   (transcription	   factor	   IIF	   (TFIIF)-­‐interacting	   C-­‐terminal	  
domain	  phosphatase	   1),	   an	   S2	  phosphatase	   that	   associates	  with	  RNAPII	   and	   is	   thought	   to	  
modulate	  modification	  levels,	  and	  therefore	  elongation	  factor	  recruitment	  to	  coding	  regions	  
of	  genes	  (Cho	  et	  al.,	  2001).	  	  
1.2.4 Transcription	  Termination	  
Completion	   of	   protein-­‐coding	   gene	   transcription	   requires	   that	   the	   nascent	   transcript	   be	  
cleaved	  ready	   for	  polyadenylation,	   followed	  by	  nuclear	  export	  and	   translation	   into	  protein	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(Proudfoot	   et	   al.,	   2002).	   Termination	   and	   dissociation	   of	   RNAPII	   from	   the	   DNA	   template	  
depend	   on	   transcription	   through	   a	   functional	   polyadenylation	   signal.	   Recycling	   of	   RNAPII	  
requires	   CTD	   de-­‐phosphorylation	   by	   CTD	   phosphatases	   (Cho	   et	   al.,	   2001).	   Termination	   of	  
transcription	   involves	   the	   release	   of	   the	   transcript,	   a	   step	   functionally	   linked	   with	  
polyadenylation,	   RNAPII	   dephosphorylation	   and	   recycling	   (Richard	   and	   Manley,	   2009).	  
Unlike	  initiation,	  termination	  in	  mammals	  does	  not	  occur	  at	  conserved	  sites	  and	  can	  occur	  at	  
variable	  distances	  from	  the	  3’	  end	  of	  the	  gene;	  in	  humans	  this	  can	  be	  up	  to	  1.5kb	  upstream	  
of	  the	  termination	  site	  (Proudfoot	  et	  al.,	  2002).	  	  
	  
Termination	   involves	   cleavage	   from	   RNAPII	   and	   polyadenylation	   of	   the	   pre-­‐mRNA.	   A	  
multitude	   of	   proteins	   are	   involved,	   including	   in	   mammals,	   cleavage	   and	   polyadenylation	  
specificity	  factor	  (CPSF),	  cleavage	  stimulatory	  factor	  (CstF)	  and	  cleavage	  factors	  I	  and	  II	  (CFI	  
and	   II)	   that	   cleave	   the	   RNA	  once	   RNAPII	   has	   reached	   a	   canonical	   AAUAAA	  DNA	   sequence	  
followed	   by	   a	   stretch	   of	   G/U-­‐rich	   DNA.	   Recruitment	   of	   3’	   processing	   factors	   is	   intimately	  
linked	   with	   the	   RNAPII	   CTD	   (Proudfoot	   et	   al.,	   2002).	   Cleavage	   is	   followed	   closely	   by	   3’	  
polyadenylation	  of	   the	   transcript	  by	  a	  highly	  conserved	  Poly(A)	  polymerase	   (PAP).	   It	   is	  not	  
completely	   understood	   whether	   polyadenylation	   occurs	   at	   the	   site	   of	   termination.	   In	  
Drosophila,	   transcripts	   can	   be	   cleaved	   after	   RNAPII	   is	   released	   from	  DNA,	   suggesting	   that	  
polyadenylation	   can	   occur	   post-­‐transcriptionally	   (Neugebauer,	   2002).	   However,	  
polyadenylated	   RNA	   has	   been	   detected	   retained	   at	   the	   site	   of	   transcription,	   even	   after	  
RNAPII	  removal	  (Brody	  et	  al.,	  2011).	  	  
	  
Following	   transcript	   cleavage	   and	   polyadenylation,	   RNAPII	   continues	   to	   transcribe	  
downstream	  producing	   a	   transcript	  with	   an	   exposed	   5’	  monophosphate.	   The	   exonuclease	  
Rat1	  in	  yeast,	  and	  Xrn2	  in	  humans,	  appears	  to	  be	  conserved	  (West	  et	  al.,	  2004)	  and	  is	  able	  to	  
degrade	   the	   RNA	   being	   produced.	   Xrn2	   catches	   up	   the	   transcribing	   RNAPII	   causing	  
destabilisation	   and	   disassembly	   of	   RNAPII.	   Rat1/Xrn2	   activity	   does	   not	   solely	   result	   in	  
destabilisation	  and	  release	  as	  depletion	  results	  in	  termination	  defects	  but	  is	  not	  sufficient	  to	  
abolish	  termination	  (Kim	  et	  al.,	  2004),	  suggesting	  other	   factors	  aid	  RNAPII	   termination	  and	  
recycling.	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1.2.5 Additional	  CTD	  modifications	  and	  transcription	  
Phosphorylation	  
In	  addition	  to	  phosphorylation	  of	  serine	  residues	  in	  the	  CTD,	  tyrosine	  and	  threonine	  residues	  
also	   have	   the	   potential	   to	   be	   phosphorylated.	   Tyrosine	   phosphorylation	   (Y1p)	   is	   brought	  
about	   by	   two	   kinases,	   ABL	   and	   ARG.	   In	   yeast	   Y1p	   stimulates	   Spt6	   elongation	   factor	  
recruitment	   and	   impairs	   termination	   factor	   recruitment,	   a	   role	   suggested	   to	   prevent	  
premature	  transcription	  termination	  (Mayer	  et	  al.,	  2012).	  	  
	  
Threonine	  phosphorylation	   (T4p)	  was	   detected	  on	   the	  RNAPII	   CTD	  previously	   although	  no	  
function	   was	   known	   (Zhang	   and	   Corden,	   1991).	   It	   is	   now	   known	   to	   play	   a	   role	   in	   the	   3’	  
processing	  of	  histone	  mRNA	  in	  yeast,	  and	  was	  initially	  found	  to	  be	  the	  target	  of	  CDK9	  of	  the	  
PTEFb	  complex	  (Hsin	  et	  al.,	  2011).	  More	  recently,	  T4p	  has	  been	  ascribed	  a	  more	  general	  role	  
in	  elongation	  efficiency	  and	  can	  be	  phosphorylated	  by	  Polo-­‐like	  kinase	  3	  (Plk3)	  in	  mammalian	  
cells	  (Hintermair	  et	  al.,	  2012).	  
	  
Glycosylation	  
Glycosylation,	   in	   particular	   O-­‐GlcNAc,	   is	   one	   of	   the	   most	   abundant	   post-­‐translational	  
modifications	  present	  in	  all	  eukaryotes.	  Serine	  and	  threonine	  residues	  are	  susceptible	  to	  O-­‐
GlcNAc	   in	   a	   dynamic	   and	   reversible	   manner,	   functioning	   as	   sensors	   of	   environmental	  
conditions	   in	   the	   cell	  with	   links	   to	  epigenetic	   regulation	   (Hart	   et	   al.,	   2007;	  Hanover	   et	   al.,	  
2012).	  
	  
Serine	  and	  threonine	  residues	  within	  the	  RNAPII	  CTD	  can	  be	  directly	  modified	  with	  O-­‐GlcNAc	  
(Kelly	  et	  al.,	  1993;	  Comer	  and	  Hart,	  2001)	  changing	  its	  structural	  conformation	  (Simanek	  et	  
al.,	  1998).	  Only	  CTD	  repeats	  that	  are	  unphosphorylated	  are	  able	  to	  be	  glycosylated	   in	  vitro	  
(Kelly	  et	  al.,	  1993),	  suggesting	  the	  two	  modifications	  are	  mutually	  exclusive.	  A	  repressive	  role	  
for	  glycosylation	  in	  transcription	  has	  been	  suggested,	  with	  the	  modification	  being	  linked	  to	  
RNAPII	   storage	   and	   control	   of	   RNAPII	   recruitment	   to	  promoters	   (Kelly	   et	   al.,	   1993;	   Comer	  
and	  Hart,	  2001).	   	   In	  agreement,	   inhibition	  of	  O-­‐GlcNAc	  transferase	  (OGT)	  and	  O-­‐GlcNAcase	  
(OGA),	   the	  enzymes	  responsible	   for	  addition	  and	  removal	  of	   the	  modification	  respectively,	  
blocked	  transcription	  initiation	  during	  PIC	  formation	  in	  lymphocytes	  (Ranuncolo	  et	  al.,	  2012).	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OGT	   was	   shown	   to	   associate	   with	   RNAPII	   and	   PIC,	   where	   RNAPII	   was	   an	   OGT	   substrate	  
(Ranuncolo	  et	  al.,	  2012).	  In	  a	  separate	  study,	  OGT	  has	  been	  shown	  to	  associate	  with	  histone	  
deacetylase	  Sin3a	  in	  mouse,	  resulting	  in	  co-­‐repression	  of	  target	  genes	  (Yang	  et	  al.,	  2002).	  	  
	  
Interestingly,	   OGT	   is	   required	   for	   embryonic	   stem	   cell	   viability	   (Shafi	   et	   al.,	   2000).	   In	  
Drosophila,	   OGT	   is	   encoded	   by	   the	   Polycomb-­‐repressor	   complex	   component,	   super	   sex	  
combs	  (sxc)	  (Gambetta	  et	  al.,	  2009;	  Sinclair	  et	  al.,	  2009)	  and	  is	  directly	  involved	  in	  Polycomb	  
repression	  (Gambetta	  et	  al.,	  2009),	  although	  the	  mechanism	  is	  unknown.	  
	  
Methylation	  
A	   single	   arginine	   residue	   present	   in	   the	   non-­‐consensus	   region	   of	   the	   CTD	   repeats	   of	  
vertebrates	  has	  been	  shown	  to	  be	  methylated	  by	  Carm1	  in	  human	  cells	  (Sims	  et	  al.,	  2011).	  
Gene-­‐specific	   effects	   including	   the	   mis-­‐expression	   of	   snRNA	   and	   snoRNA	   have	   been	  
attributed,	  although	  the	  molecular	  mechanism	  involved	  in	  this	  defect	  is	  unknown.	  
	  
1.3 Integration	  of	  RNAPII	   transcription	  with	  RNA	  processing	  and	  chromatin	  
modification	  
A	   whole	   host	   of	   co-­‐transcriptional	   processes	   are	   required	   to	   promote	   efficient	   and	  
productive	   synthesis	   of	  mature	   transcripts.	   Chromatin	   accessibility	   is	  modulated	   to	   define	  
promoter	   and	   coding	   regions,	   and	   RNA	   processing	  machinery	   is	   brought	   to	   chromatin	   to	  
produce	   a	   mature	   mRNA.	   Pre-­‐mRNA	   requires	   processing	   including	   5’	   capping,	   splicing,	  
cleavage	  and	  polyadenylation	  to	  allow	  export	  to	  the	  cytoplasm	  and	  translation	  into	  protein.	  
Modification	  of	  the	  CTD	  of	  RNAPII	  is	  vital	  for	  integration	  of	  chromatin	  modification	  and	  RNA	  
processing,	  through	  the	  coordinated	  recruitment	  of	  specific	  chromatin	  remodelers	  and	  RNA	  
processing	   machineries	   orchestrating	   a	   successful	   transcription	   cycle.	   A	   typical	   profile	   of	  
RNAPII	  and	  histone	  modifications	  at	  active	  genes	   in	  mammals	   is	  represented	   in	  Figure	  1.5.	  
Co-­‐transcriptional	  recruitment	  of	  the	  RNA	  processing	  machinery	  may	  also	  depend	  directly	  on	  
specific	  histone	  modifications	  independently	  of	  RNAPII	  (Sims	  et	  al.,	  2007;	  Luco	  et	  al.,	  2011).	  
Every	  stage	  is	  open	  to	  regulation	  creating	  a	  complex	  system	  that	  is	  a	  major	  focus	  of	  research.	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1.3.1 Chromatin	  modifications	  and	  the	  CTD	  
RNAPII	   modifications	   are	   intimately	   linked	   with	   histone	   modifications	   giving	   rise	   to	   an	  
accessible	  chromatin	  environment	  for	  RNAPII	   transcription	  (Fig.	  1.2).	  Histone	  modifications	  
are	   themselves	   able	   to	   recruit	   additional	   machineries	   that	   aid	   successful	   production	   of	  
mRNA	   (Sims	   et	   al.,	   2007;	   Luco	   et	   al.,	   2011).	   RNAPII-­‐S5p	   recruits	   SET1	   histone	  
methyltransferases	   in	  yeast,	   that	  methylate	  histone	  H3K4	  around	  promoter	   regions	   (Ng	  et	  
al.,	  2003).	  During	  elongation,	  RNAPII-­‐S2p	  recruits	  Set2	  HMTs	  that	  methylate	  histone	  H3K36	  
throughout	   coding	   regions	   of	   active	   genes	   (Krogan	   et	   al.,	   2003).	   In	   yeast	   methylation	  
requires	   the	   C-­‐terminal	   domain	   of	   Set2	   along	  with	   the	   RNAPII	   CTD	   and	   elongation	   factor	  
Spt6	   (Youdell	   et	   al.,	   2008).	   Set2	   protein	   stability	   is	   intimately	   linked	   with	   RNAPII	   CTD	  




Figure	  1.2	  RNAPII	  modifications	  integrate	  chromatin	  modifications	  and	  RNA	  processing	  with	  transcription	  at	  
active	   genes.	   RNAPII	   phosphorylation	   states	   recruit	   specific	   HMTs	   and	   RNA	   processing	   factors	   during	   the	  
transcription	   cycle.	   RNAPII-­‐S5p	   recruits	   H3K4	   HMTs	   as	   well	   as	   RNA	   capping	   machinery.	   RNAPII-­‐S2p	   during	  
elongation	   recruits	   H3K36	  HMTs	   that	   result	   in	   histone	  modification	   throughout	   coding	   regions.	   Splicing	   and	  
polyadenylation	  machinery	  components	  can	  also	  be	  recruited	  by	  RNAPII-­‐S2p	  promoting	  correct	  processing	  and	  
production	  of	  an	  mRNA	  for	  export	  and	  translation.	  Figure	  modified	  from	  (Brookes	  and	  Pombo,	  2009).	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1.3.2 Co-­‐transcriptional	  RNA	  Processing	  
Co-­‐transcriptional	  RNA	  processing	  implies	  a	  coupling	  of	  transcription	  with	  RNA	  processing,	  a	  
mechanism	  first	  demonstrated	  with	  the	  direct	  visualisation	  of	  nascent	  pre-­‐mRNA	  splicing	  in	  
Drosophila	   (Osheim	  et	  al.,	  1985).	  Each	  stage	  of	  RNA	  processing	  has	  the	  ability	  to	  occur	  co-­‐
transcriptionally,	  where	  CTD	  modifications	  can	  play	  critical	  roles	  in	  coordinating	  each	  stage	  
(Fig.	  1.2).	  	  
	  
Capping	  
As	  the	  nascent	  RNA	  emerges	  from	  the	  elongating	  RNAPII,	  a	  7-­‐methylguanosine	  cap	  is	  added	  
to	  the	  5’	  end	  of	  the	  transcript.	  This	  process	  occurs	  from	  yeast	  to	  human	  and	  is	  essential	  for	  
gene	  expression	  and	   translation,	   as	  well	   as	   for	  protecting	   the	   transcript	   from	  exonuclease	  
digestion	  (Cowling,	  2010).	  Capping	  occurs	  when	  the	  transcript	  is	  20-­‐40	  nucleotides	  long	  and	  
is	  performed	  by	  two	  proteins	  in	  humans	  (HCE1	  and	  HCM1)	  and	  three	  in	  yeast	  (Ceg1p,	  Cet1p	  
and	   Abdp1),	   comprising	   triphosphatase,	   methyltransferase	   and	   guanylyltransferase	  
activities.	  	  
	  
RNAPII-­‐S5p	  promotes	  recruitment	  of	  the	  capping	  enzyme	  (Fig.	  1.2;	  McCracken	  et	  al.,	  1997;	  
Ho	  and	  Shuman,	  1999).	   In	  vitro,	  RNAPII-­‐S5p	  stimulates	  the	  guanylyltransferase	  and	  activity	  
correlates	  with	  levels	  of	  S5p,	  while	  S2p	  has	  no	  affect	  (Ho	  and	  Shuman,	  1999).	  Pausing	  factor	  
Spt5	   has	   also	   been	   shown	   to	   associate	  with	   and	   stimulate	   the	   human	   capping	   enzyme	   in	  
vitro,	   suggesting	   a	   link	   between	   promoter	   proximal	   pausing	   and	   capping,	   prior	   to	   release	  
into	  elongation	  (Wen	  and	  Shatkin,	  1999).	  	  
	  
Capped	  pre-­‐mRNA	  recruits	  CBC	  (cap	  binding	  complex)	  that	  comprises	  two	  subunits	  involved	  
in	  splicing.	  CBC	  also	  facilitates	  recognition	  of	  splice	  sites	  by	  U1	  snRNP	  (Lewis	  et	  al.,	  1996)	  and	  
is	   necessary	   for	   spliceosomal	   assembly	   (Görnemann	   et	   al.,	   2005)	   not	   only	   linking	   capping	  
with	  the	  RNAPII	  CTD	  but	  also	  with	  later	  processing	  events.	   It	   is	  suggested	  that	  capping	  is	  a	  








Splicing	   involves	  the	  removal	  of	   introns	  and	   ligation	  of	  exons	  by	  the	  spliceosome	  in	  a	  two-­‐
step	   trans-­‐esterification	   reaction.	   The	   spliceosome	   in	   yeast	   and	   humans	   consists	   of	   five	  
spliceosomal	  small	  nuclear	  ribonucleoproteins	  (snRNPs)	  and	  numerous	  non-­‐snRNP	  proteins	  
(Wahl	  et	  al.,	  2009).	  Recognition	  of	  5’	  splice	  sites	  within	  introns	  leads	  to	  an	  ordered	  chain	  of	  
events	  where	  spliceosomes	  are	  assembled	  step	  by	  step	  on	  the	  pre-­‐mRNA.	  	  	  	  
	  
Co-­‐transcriptional	   splicing	   is	   now	   becoming	   widely	   documented	   genome-­‐wide	   in	   human	  
(Ameur	  et	  al.,	  2011;	  Tilgner	  et	  al.,	  2012)	  and	  yeast	   (Carrillo	  Oesterreich	  et	  al.,	  2010),	  even	  
though	   the	   latter	   have	   infrequent	   and	   generally	   short	   introns.	   Quantification	   of	   active	  
spliceosomes	   in	   HeLa	   cells	   suggests	   that	   around	   80%	   of	   transcripts	   are	   spliced	   co-­‐
transcriptionally,	   while	   the	   remaining	   20%	   are	   spliced	   post-­‐transcriptionally	   in	   splicing	  
speckles	  (Girard	  et	  al.,	  2012).	  Interestingly,	  splicing	  of	  non-­‐coding	  long	  RNAs	  may	  not	  occur	  
efficiently	  co-­‐transcriptionally	  (Tilgner	  et	  al.,	  2012).	  	  
	  
Co-­‐transcriptional	  splicing	  has	  been	  suggested	  to	  be	  a	  more	  efficient	  way	  of	  processing	  RNA,	  
as	   opposed	   to	   post-­‐transcriptional	   splicing	   (Moore	   and	   Proudfoot,	   2009).	   RNAPII	  
transcription	   and	   splicing	   are	   intimately	   linked,	   and	   RNAPII	   elongation	   rate	   through	   gene	  
coding	   regions	   is	   a	   crucial	   determinant	   of	   co-­‐transcriptional	   splicing	   (Oesterreich	   et	   al.,	  
2011).	   In	   yeast,	   RNAPII	   pausing	   in	   terminal	   exons	   has	   been	   documented	   to	   act	   as	   a	  
regulatory	  step	  allowing	  for	  splicing	  completion,	  although	  it	  is	  not	  clear	  whether	  this	  occurs	  
in	   higher	   eukaryotes	   and	   how	   RNAPII	   is	   implicated	   (Carrillo	   Oesterreich	   et	   al.,	   2010).	   In	  
human	  cells,	  incompletely	  spliced	  but	  polyadenylated	  transcripts	  have	  been	  found	  retained	  
at	  the	  3’	  end	  of	  genes,	  even	  after	  RNAPII	  release,	  with	  suggestions	  that	  post-­‐transcriptional	  
splicing	  can	  occur	  at	  the	  site	  of	  transcription	  (Brody	  et	  al.,	  2011).	  
	  
RNAPII	   is	   crucial	   for	  coordinating	  splicing,	  although	  direct	  evidence	   for	  CTD	  recruitment	  of	  
factors	   is	  minimal.	   	   RNAPII	   CTD	  does	   however	   enhance	   splicing	   (Fong	   and	  Bentley,	   2001),	  
and	  splicing	  factors	  do	  associate	  with	  RNAPII	  such	  as	  SC35	  which	  promotes	  elongation	  (Lin	  et	  
al.,	   2008).	   Human	   U1	   snRNP	   and	   SR	   proteins	   interact	   with	   RNAPII	   and	   possibly	   the	   CTD	  
directly.	   Recruitment	   of	  U1	   is	   thought	   to	   promote	   coordinated	   assembly	   of	   other	   snRNPs	  
(Das	  et	  al.,	  2007).	  Histone	  modifications	  such	  as	  H3K4me3	  are	  able	  to	  recruit	  splicing	  factors	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(Sims	   et	   al.,	   2007).	  H3K4me3	   is	   intimately	   associated	  with	  RNAPII-­‐S5p	   suggesting	   that	   the	  
CTD	   may	   not	   directly	   recruit	   many	   splicing	   factors.	   The	   CTD	   does	   instigate	   the	   chain	   of	  
events	   leading	   to	   spliceosomal	   assembly	   and	   orchestration	   of	   numerous	   other	   events	  
including	  chromatin	  modification,	  resulting	  in	  efficient	  RNA	  processing.	  
	  
In	  yeast,	  RNA	  is	  packaged	  by	  messenger	  ribonucleoproteins	  (mRNPs)	  preventing	  naked	  RNA	  
intercalating	  with	  DNA,	  structures	  known	  as	  R-­‐loops	  that	  impair	  further	  transcription	  as	  well	  
as	   cleavage	   and	   polyadenylation.	   Pre-­‐mRNA	   packaging	   in	   higher	   eukaryotes	   as	   yet,	   is	   not	  
well	  studied	  (Moore	  and	  Proudfoot,	  2009).	  
	  
Cleavage	  and	  Polyadenylation	  	  
Addition	  of	  a	  polyA	  tail	  to	  the	  3’	  end	  of	  pre-­‐mRNA	  is	  essential	  for	  nuclear	  export,	  translation	  
and	  stability.	  Cleavage	  and	  polyadenylation	  of	  the	  transcript	  are	  functionally	  linked	  and	  both	  
processes	  are	  dependent	  on	  recruitment	  of	  factors	  by	  the	  RNAPII	  CTD.	  	  
	  
RNAPII	   CTD	   stimulates	   polyadenylation	   in	   human	   and	   yeast	   (Fong	   and	   Bentley,	   2001;	  
Licatalosi	  et	  al.,	  2002).	  In	  vitro,	  cleavage	  stimulation	  factor	  (CstF)	  binds	  to	  the	  CTD	  and	  Pcf11,	  
part	   of	   the	   cleavage/polyadenylation	   factor	   in	   yeast	   binds	   to	   RNAPII-­‐S2p	   coupling	   3’	  
processing	  and	  transcription	   (Licatalosi	  et	  al.,	  2002).	  More	  recently,	  polyadenylation	   factor	  
CPSF	  was	  shown	   in	  humans	  to	  associate	  with	  RNAPII	  at	   the	  5’	  and	  3’	  ends	  of	  genes,	  while	  
CstF	   was	   only	   detected	   at	   the	   termination	   site	   (Glover-­‐Cutter	   et	   al.,	   2010),	   in	   agreement	  
with	  a	  preference	  of	  CstF	  for	  RNAPII-­‐S2p.	  The	  significance	  of	  3’	  processing	  factor	  recruitment	  
at	  transcription	  initiation	  sites	  is	  not	  understood.	  
	  
Degradation	  
RNAPII	   transcription	  at	  active	  genes	   is	   tightly	   regulated	  and	   if	   at	  any	  point	   transcription	   is	  
aborted	  or	  the	  pre-­‐mRNA	  is	  not	  correctly	  processed,	  there	  are	  surveillance	  mechanisms	  to	  
rid	  the	  cell	  of	  unwanted	  message.	  A	  prominent	  activity	  for	  RNA	  surveillance,	  conserved	  from	  
yeast	  to	  human,	  is	  the	  exosome	  complex.	  	  
	  
Eukaryotic	   RNA	   exosome	   is	   a	   400kDa	   multi-­‐subunit	   complex	   with	   exonuclease	   and	  
endonuclease	   activity	   present	   in	   the	   nucleus	   and	   cytoplasm	   with	   multiple	   roles	   in	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transcriptional	   regulation	   (Tomecki	   et	   al.,	   2010).	   First	   discovered	   in	   yeast,	   the	   exosome	   is	  
highly	   conserved	  among	   species	   (Kiss	  and	  Andrulis,	   2011)	  and	  deletion	  of	   certain	   subunits	  
compromises	  viability	  (Allmang	  et	  al.,	  1999).	  The	  complex	  is	  composed	  of	  a	  structural	  core	  of	  
nine	  proteins	  and	  two	  catalytic	  subunits	  which	  have	  3’	  to	  5’	  exonuclease	  and	  endonuclease	  
activity	  (Lebreton	  et	  al.,	  2008;	  see	  Chapter	  5,	  Fig.	  5.2	  for	  structure).	  
	  
The	   exosome	   is	   involved	   in	   the	  maturation	   of	   structural	   RNAs,	   including	   rRNA,	   tRNA	   and	  
snoRNA.	   	   It	   has	   a	   general	   role	   in	   pre-­‐mRNA	   surveillance,	   degrading	   improperly	   spliced	  
(Eberle	  et	  al.,	  2010)	  or	  processed	  protein	  coding	  transcripts	  (Saguez	  et	  al.,	  2008;	  de	  Almeida	  
et	   al.,	   2010).	  More	   recently,	   the	   exosome	  has	   been	   shown	   to	   regulate	  non-­‐coding	  RNAPII	  
transcription	  in	  yeast	  and	  humans	  (Wyers	  et	  al.,	  2005;	  Preker	  et	  al.,	  2008).	  How	  the	  exosome	  
is	  targeted	  to	  such	  a	  vast	  array	  of	  transcripts	  is	  unknown.	  At	  RNAPII	  transcribed	  genes,	  the	  
exosome	   associates	   directly	  with	   RNAPII	   and	   elongation	   factors	   Spt5	   and	   Spt6	   at	   induced	  
heat	   shock	   genes,	   suggesting	   direct	   regulation	   of	   nascent	   RNA	   production	   during	  
transcription	  elongation	  (Andrulis	  et	  al.,	  2002).	  In	  Drosophila,	  specific	  exosome	  subunits	  are	  
recruited	   to	  nascent	   transcription	  via	  direct	   interactions	  with	   ribonucleoprotein	  complexes	  
(hnRNPs)	  (Hessle	  et	  al.,	  2009).	  	  	  
	  
1.4 Polycomb	  repressive	  complexes	  
Work	  from	  our	  laboratory	  has	  shown	  that,	  in	  addition	  to	  paused	  and	  active	  states	  described	  
above,	   RNAPII	   is	   present	   at	   Polycomb-­‐target	   genes	   in	   ES	   cells	   in	   a	   novel	   and	   unexpected	  
configuration.	   RNAPII	   can	   elongate	   through	   coding	   genes	   in	   the	   absence	   of	   S7p	   and	   S2p	  
modifications,	  and	  in	  the	  absence	  of	  productive	  mRNA	  synthesis.	  
	  
Initially	  discovered	  as	   regulators	  of	  homeotic	   gene	   clusters	   in	  Drosophila,	   Polycomb	  group	  
(PcG)	   gene	   silencing	   is	  now	  known	   to	  be	  a	   conserved	  mechanism	   regulating	  a	  plethora	  of	  
genes	   in	  numerous	  cellular	   systems.	  PcG	  complexes	  are	   integral	   in	   the	   regulation	  of	  many	  
biological	   events	   including	   cell	   cycle	   control,	   genomic	   imprinting,	   tissue	   homeostasis	   and	  
tumorigenesis	  (Surface	  et	  al.,	  2010).	  In	  ES	  cells,	  Polycomb	  repression	  is	  vital	  for	  maintaining	  
pluripotency	   and	   setting	   the	   stage	   for	   efficient	   differentiation	   programs.	   Loss	   of	   certain	  
Polycomb	  components	  results	  in	  embryonic	  lethality	  (Carroll	  et	  al.,	  2001;	  Pasini	  et	  al.,	  2004)	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and	   knockout	   ES	   cells	   show	   de-­‐repression	   of	   lineage	   specific	   genes	   and	   differentiation	  
(Azuara	  et	  al.,	  2006;	  Boyer	  et	  al.,	  2006;	  Stock	  et	  al.,	  2007).	  
1.4.1 Structure	  and	  function	  of	  Polycomb	  repressive	  complexes	  
PcG	  proteins	  have	  been	  identified	  in	  several	  complexes,	  of	  which	  the	  best	  characterised	  are	  
Polycomb	   repressive	   complexes	   1	   and	   2	   (PRC1	   and	   PRC2,	   respectively;	   Fig.	   1.3).	   These	  
complexes	   function	   primarily	   by	   post-­‐translational	   modification	   of	   histones.	   PRC2	   is	  
responsible	  for	  deposition	  of	  repressive	  di-­‐	  and	  tri-­‐methylation	  of	  H3K27	  via	  the	  enzymatic	  
subunits	   Ezh1	   and	   Ezh2	   (Cao	   and	   Zhang,	   2004)	   while	   PRC1	  monoubiquitylates	   Lys	   119	   of	  
histone	  H2A	  (H2AK119ub)	  via	  the	  ubiquitin	   ligase	  enzymes	  Ring1A	  and	  Ring1B.	  Other	  PRC2	  
components	  include	  Eed	  and	  Suz12	  while	  PRC1	  components	  are	  more	  variable	  with	  only	  one	  
other	   core	   component,	   Bmi1	   or	  Mel18.	   Recently,	   further	   components	   of	   PRC2	   have	   been	  
identified,	  including	  the	  histone	  demethylase	  Jarid2	  (Herz	  and	  Shilatifard,	  2010),	  zinc	  -­‐finger	  
protein	  AEBP2	  which	  enhances	  PRC2	  activity	  (Cao	  and	  Zhang,	  2004)	  and	  protein	  Polycomb-­‐
like	  (PCLs)	  	  (Margueron	  and	  Reinberg,	  2011).	  Jarid2	  has	  been	  linked	  to	  fine	  tuning	  H3K27me3	  














Figure	  1.3	  Polycomb	   repressor	   complexes.	   PRC2	   comprises	  of	   Eed,	   Suz12	  and	  Ezh2,	  where	  Ezh2	  methylates	  
H3K27	  (H3K27me).	  PRC1	  can	  be	  recruited	  via	  H3K27me3	  and	  comprises	  subunits	  including	  Ring1A	  and	  Ring1B	  
and	   Bmi1.	   Ring1B	   acts	   as	   an	   E3	   ubiquitin	   (Ub)	   ligase	   for	   H2AK119	   resulting	   in	   monoubiquitination	   of	   H2A	  
(H2AK119ub1).	  Exact	  mechanisms	  of	  Polycomb-­‐mediated	  repression	  are	  not	  known.	  How	  PRC2	  is	  recruited	  to	  
genes	   is	   not	   fully	   understood	   but	   may	   include	   binding	   via	   transcription	   factors	   or	   possibly	   via	   an	   RNA	  
intermediate.	  Figure	  from	  Spivakov	  and	  Fisher	  (2007).	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Initially,	   the	   role	  of	  PcG	   in	   repression	  was	  predominantly	   thought	   to	  be	  due	   to	   chromatin	  
compaction,	   and	   therefore	   restriction	   of	   the	   accessibility	   of	   transcription	   complexes	   to	  
chromatin.	   Although	   vital	   in	   PRC	   repression	   a	   role	   of	   Polycomb	   in	   chromatin	   compaction	  
only	  does	  not	  explain	  why	  the	  transcription	  machinery	  can	  be	  recruited	  to	  Polycomb	  targets	  
(Breiling	  et	  al.,	  2004;	  Bracken	  et	  al.,	  2006;	  Schwartz	  et	  al.,	  2006;	  Tolhuis	  et	  al.,	  2006;	  Stock	  et	  
al.,	   2007;	   Chopra	   et	   al.,	   2009;	   Kanhere	   et	   al.,	   2010;	   Brookes	   et	   al.,	   2012).	   This	   suggests	  
Polycomb	  also	  plays	  additional	  roles	  in	  regulating	  repression	  of	  target	  genes.	  Polycomb	  has	  
roles	   independent	  of	   its	   catalytic	   ability,	   such	   as	  being	   able	   to	   influence	  DNA	  methylation	  
(Sakamoto	   et	   al.,	   2007)	   and	   interactions	   with	   histone	   H3K4	   demethylases	   (Pasini	   et	   al.,	  
2008).	  Interestingly,	  Polycomb	  is	  required	  to	  maintain	  chromatin	  organisation	  at	  Hox	  loci	  in	  
ES	  cells	  independently	  of	  Ring1B	  catalytic	  activity	  (Eskeland	  et	  al.,	  2011),	  supporting	  roles	  for	  
Polycomb	  repression	  independent	  of	  histone	  modifications.	  
1.4.2 Polycomb	  complex	  recruitment	  
PRC2	   deposition	   of	   H3K27me3	   is	   specifically	   recognised	   by	   PRC1	   via	   its	   chromodomain	  
component	  Pc	  or	  CBX	  in	  mammals	  (Cao	  and	  Zhang,	  2004),	   leading	  to	  the	  general	   idea	  that	  
PRC1	  is	  recruited	  downstream	  of	  PRC2	  (Fig	  1.3).	  However,	  genes	  bound	  only	  by	  PRC2	  have	  
been	  documented	  in	  ES	  cells	  (Ku	  et	  al.,	  2008)	  suggesting	  that	  recruitment	  of	  PRC2	  followed	  
by	  PRC1	  can	  be	  regulated	  in	  different	  scenarios.	  
	  
The	  way	  in	  which	  PRC2	  is	  recruited	  to	  target	  genes	  in	  mammals	  remains	  unknown,	  and	  more	  
than	   one	   mechanism	   may	   be	   involved	   (Margueron	   and	   Reinberg,	   2011;	   Fig.	   1.4).	   In	  
Drosophila,	  specific	  DNA	  sequences	  known	  as	  Polycomb	  response	  elements	  (PRE)	  are	  targets	  
for	   PcG	   via	   DNA	   binding	   proteins.	   However,	   no	   such	   sequences	   have	   been	   detected	   in	  
mammals	  and	  the	  only	  common	  DNA	  sequence	  feature	  at	  PRC	  targets	  is	  the	  presence	  of	  CpG	  
islands	   (Ku	   et	   al.,	   2008).	   Transcription	   factors	   have	   been	   implicated	   in	   PRC2	   recruitment.	  
YY1,	  the	  mammalian	  homologue	  of	  the	  Drosophila	  protein	  PHO,	  has	  been	  suggested	  to	  have	  
an	   important	   role	   in	  PRC	  recruitment	   (Wilkinson	  et	  al.,	  2006),	  although	  PRC2	  occupancy	   is	  
underrepresented	  at	  YY1	   response	  elements	   (Ku	  et	  al.,	  2008).	  PRC	  components	  Suz12	  and	  
Ezh2	  have	  the	  capability	  to	  bind	  RNA,	  leading	  to	  a	  more	  recent	  hypothesis	  that	  recruitment	  
may	   involve	   ncRNA	   guidance	   of	   PRC2.	   In	   agreement,	   ncRNA	   HOTAIR	   represses	   the	   HOXD	  
locus	  in	  ES	  cells	  (Rinn	  et	  al.,	  2007)	  and	  binds	  to	  phosphorylated	  Ezh2	  (Kaneko	  et	  al.,	  2010).	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Large	  scale	  studies	  revealed	  a	  widespread	  interaction	  of	  numerous	  ncRNA	  with	  PRC2	  (Khalil	  
et	  al.,	  2009)	  suggesting	  that	  targeting	  of	  PRC2	  somehow	  involves	  ncRNA	  as	  a	  more	  general	  
mechanism.	  How	  specificity	  of	  targeting	  occurs	   is	  not	  known.	  PRC	  target	  genes	  themselves	  
have	  been	  shown	  to	  be	  transcribed	  into	  short	  transcripts	  that	  appear	  to	  interact	  with	  Suz12,	  
suggesting	   a	   mechanism	   of	   directing	   PRC2	   recruitment	   to	   target	   genes	   (Kanhere	   et	   al.,	  




























Figure	   1.4	   Recruitment	   of	   Polycomb	   repressor	   2	   complexes.	   Possible	  mechanisms	   for	   PRC2	   recruitment	   to	  
chromatin	  (a)	  Cell-­‐type	  or	  gene	  specific	  transcription	  factors	  associate	  and	  recruit	  PRC2	  to	  chromatin	  perhaps	  
through	  a	  PRE-­‐like	  element.	  (b)(i)	  Trans-­‐ncRNA	  (e.g.	  HOTAIR)	  binds	  and	  recruits	  PRC2	  to	  chromatin.	  (ii)	  PRC2	  is	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1.4.3 Polycomb	  gene	  silencing	  in	  ES	  cells	  
Embryonic	  Stem	  Cells	  
Embryonic	   stem	  cells	   (ES	  cells)	  derive	   from	  the	   inner	  cell	  mass	   (ICM)	  of	   the	  early	  embryo.	  
They	   are	   defined	   by	   their	   ability	   in	   vivo	   to	   differentiate	   into	   all	   derivatives	   of	   the	   three	  
primary	   germlayers	   (ectoderm,	   endoderm	   and	   mesoderm)	   and	   eventually	   over	   200	   cell	  
types	   in	   the	   mammalian	   body.	   This	   unique	   genomic	   plasticity	   is	   a	   characteristic	   termed	  
pluripotency.	   In	   culture,	   ES	   cells	   are	   able	   to	   self-­‐renew	   indefinitely	   making	   them	   a	   vital	  
system	   in	   which	   to	   study	   pluripotency	   and	   differentiation.	   Understanding	   the	   molecular	  
mechanisms	   that	   underpin	   ES	   cell	   pluripotency	   holds	   vital	   promise	   for	   scientific	   and	  
therapeutic	  advances.	  
	  
The	  ability	  of	  ES	  cells	  to	  self-­‐renew	  in	  a	  pluripotent	  state	  and	  commit	  to	  any	  cell	   lineage	  is	  
associated	   with	   the	   existence	   of	   opposing	   regulatory	   constraints	   on	   the	   genome.	   The	  
process	   of	   self-­‐renewal	   requires	   the	   ES	   cell	   genome	   to	   maintain	   a	   molecular	   memory	   of	  
pluripotency	   through	   cell	   division,	   activating	   appropriate	   genes	   and	   repressing	   lineage	  
specific	   genes.	   ES	   cells	   need	   to	   achieve	   this	  while	   also	  maintaining	   the	   potential	   to	   enter	  
specific	   cell	   commitment	   pathways	   in	   response	   to	   the	   appropriate	   cues.	   Numerous	  
chromatin	   modifiers	   and	   key	   transcription	   factors	   (TFs)	   maintain	   pluripotency	   through	   a	  
complex	  regulatory	  network.	  Critical	  TF’s	  involved	  in	  both	  activation	  and	  repression	  include	  
Oct4,	  Sox2	   and	  Nanog,	  among	  others,	   that	   are	   able	   to	   act	   in	   concert	   or	   independently	   of	  
each	  other	   (Chambers	   and	   Tomlinson,	   2009).	   Polycomb	   complexes	   repress	   developmental	  
genes	  in	  ES	  cells	  and	  are	  instrumental	  in	  preparing	  them	  for	  early	  lineage	  commitment.	  Their	  
binding	  at	  lineage	  specific	  and	  signaling	  genes	  has	  been	  documented	  genome-­‐wide	  (Boyer	  et	  
al.,	  2006;	  Lee	  et	  al.,	  2006;	  Ku	  et	  al.,	  2008)	  although	  their	  mechanism	  of	  regulation	  at	  these	  
genes	  is	  not	  well	  understood.	  
	  
ES	  cell	  Bivalency	  
Silent	  developmental	  genes	  adopt	  a	  specific	  epigenetic	  profile	  coined	  as	  ‘Bivalent’	  in	  ES	  cells.	  
These	  genes	  are	   targets	  of	  Polycomb	  and	  marked	  by	  H3K27me3	   in	   the	  presence	  of	   active	  
H3K4me3	  and	  H3K9ac	  (Azuara	  et	  al.,	  2006;	  Bernstein	  et	  al.,	  2006).	  	  Bivalency	  is	  a	  chromatin	  
conformation	   suggested	   to	   prime	   genes	   for	   activation	   or	   repression	   upon	   differentiation	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(Jorgensen	   et	   al.,	   2006).	   Bivalent	   genes	   are	   characterised	   also	   by	   CpG	   rich	   promoters	  
(Mikkelsen	  et	  al.,	  2007)	  as	  well	  as	  being	  early	  replicating	  (Azuara	  et	  al.,	  2006),	  a	  feature	  of	  
activity	   and	   accessible	   chromatin.	   Histone	   variant	   H2A.Z,	   usually	   associated	   with	   gene	  
activity,	  is	  enriched	  at	  PRC2	  target	  gene	  promoters	  and	  is	  required	  for	  ES	  cell	  differentiation.	  
H2A.Z	   may	   protect	   promoters	   from	   DNA	   methylation,	   and	   allow	   a	   more	   accessible	  
chromatin	  state	  primed	  for	  differentiation	  (Creyghton	  et	  al.,	  2008).	  	  Upon	  differentiation	  of	  
ES	   cells,	   chromatin	   is	   thought	   to	   mostly	   resolve	   into	   monovalent	   states	   characterized	   by	  
active	  or	  repressed	  modifications	  (Mikkelsen	  et	  al.,	  2007).	  	  
	  
Bivalency	   is	   not	   restricted	   to	   a	   few	   genes,	   and	   has	   been	   demonstrated	   genome-­‐wide	   in	  
mouse	   (Mikkelsen	   et	   al.,	   2007)	   and	   human	   (Pan	   et	   al.,	   2007)	   ES	   cells.	   This	   intriguing	  
phenomenon	   is	   also	  a	   feature	  of	  more	  differentiated	   cell	   types	   such	  as	  neural	  precursors,	  
mouse	  embryonic	   fibroblasts	   (Mikkelsen	  et	  al.,	  2007)	  and	  human	  T	  cells	   (Roh	  et	  al.,	  2006),	  
suggesting	   that	   bivalency	   and	   PRC	   repression	   are	   general	   and	   important	   	   mechanisms	   of	  
regulation.	  Bivalent	  marks	  also	  operate	  earlier	  in	  development	  prior	  to	  blastocyst	  stage	  and	  
can	  be	  retained	   in	  extra-­‐embryonic	  restricted	  cells	  at	  a	  subset	  of	  genes,	  although	  they	  are	  
predominantly	   repressed	   and	   not	   primed	   for	   activation	   (Alder	   et	   al.,	   2010).	   Importantly,	  
bivalent	   domains	   have	   been	   documented	   at	   silent	   genes	   in	   zebrafish	   blastomeres	   in	   vivo	  
(Vastenhouw	  et	  al.,	  2010).	  	  
	  
Additional	  clues	  about	  how	  Polycomb	  repression	  and	  bivalency	  is	  maintained	  and	  regulated	  
come	  from	  the	  demonstration	  that	  RNAPII	  is	  recruited	  to	  Polycomb	  targets	  and	  is	  restrained	  
by	  Ring1B	  (Stock	  et	  al.,	  2007;	  Brookes	  et	  al.,	  2012).	  Polycomb	  repression	  at	   these	  genes	   is	  
therefore	  not	  only	  the	  result	  of	  chromatin	  compaction,	  and	  may	  involve	  direct	  interference	  
with	  the	  transcriptional	  apparatus	  (Brookes	  and	  Pombo,	  2009).	  
1.4.4 Interplay	  between	  Polycomb	  and	  RNAPII	  in	  ES	  cells	  
A	  large	  proportion	  of	  Polycomb	  target	  genes	  in	  ES	  cells	  associate	  with	  an	  unusually	  modified	  
form	   of	   ‘poised’	   RNAPII	   that	   is	   incompatible	  with	   gene	   expression,	   and	   are	   from	   here	   on	  
referred	   to	   as	   PRC-­‐repressed	   (Stock	   et	   al.,	   2007;	   Brookes	   et	   al.,	   2012).	   RNAPII	   at	   PRC-­‐
repressed	  genes	  is	  phosphorylated	  at	  S5	  residues	  in	  the	  absence	  of	  elongation	  associated	  S7	  
and	  S2	  phosphorylation	  (Stock	  et	  al.,	  2007;	  Brookes	  et	  al.,	  2012)	  and	  H3K36me3	  (E.Brookes	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personal	   communication;	   Fig.	   1.5).	   Surprisingly,	   RNAPII	   is	   found	   through	   coding	   regions	  of	  
PRC-­‐repressed	  genes	   (Fig.	  1.5),	  suggesting	  that	   it	   is	  able	  to	  elongate	   in	   the	  absence	  of	  S2p	  
(Brookes	   et	   al.,	   2012).	   In	   addition,	   an	   antibody	   that	   recognises	   un-­‐phosphorylated	   S2	  
residues	   (8WG16)	   binds	   at	  minimal	   levels	   or	   is	   absent	   at	   RNAPII	   at	   PRC-­‐repressed	   genes,	  
suggesting	   structural	   changes	   in	   the	   CTD	   or	   additional	   modifications	   that	   may	   impede	  
antibody	   binding	   (Brookes	   and	   Pombo,	   2009).	   RNAPII	   modification	   patterns	   and	   histone	  
modifications	   across	   PRC-­‐repressed	   genes	   are	   markedly	   different	   from	   that	   detected	   at	  
active	  or	  silent	  genes;	  represented	  here	  in	  ES	  cells	  (Fig.	  1.5).	  	  
	  
RNAPII	   conformation	   at	   PRC-­‐repressed	   genes	   is	   also	   different	   to	   that	   detected	   at	   paused	  
genes,	   such	   as	   rapidly	   inducible	   genes,	   where	   low	   levels	   of	   RNAPII-­‐S5p	   are	   restricted	   to	  
promoters	   and	   8WG16	   binds	   in	   the	   absence	   of	   S2p	   (Boehm	   et	   al.,	   2003;	   Espinosa	   et	   al.,	  
2003;	   Kim	   et	   al.,	   2005).	   Interestingly,	   PRC	   binding	   and	   associated	   histone	   modifications	  
mirror	  RNAPII	  distribution	  genome-­‐wide.	  Sequential	  ChIP	  shows	  that	   the	  catalytic	   subunits	  
of	   PRC2	   and	   PRC1,	   Ezh2	   and	   Ring1B,	   respectively,	   both	   simultaneously	   co-­‐associate	   with	  
RNAPII	   at	   Polycomb	   target	   genes	   (Brookes	   et	   al.,	   2012),	   suggesting	   regulatory	   interplay	  
between	   the	   two	   complexes.	   The	   way	   in	   which	   co-­‐occupancy	   of	   PRC	   and	   RNAPII	   affects	  



















Figure	   1.5	   RNAPII,	   PRC	   and	   histone	   modification	   profiles	   delineate	   PRC-­‐repressed	   genes	   in	   ES	   cells.	  
Representative	  DNA-­‐ChIP	  profiles	   for	   the	   three	  pure	  gene	  regulatory	  states	   in	  ES	  cells.	   I)	  Silent	  genes	  do	  not	  
associate	  with	  RNAPII	  or	  histone	  modifications.	  II)	  Actively	  transcribing	  genes	  are	  associated	  with	  S5P,	  8WG16,	  
S7P	  and	  H3K4me3	  peaking	  at	  the	  promoters;	  S5P	  is	  detected	  though	  gene	  coding	  regions.	  S2P	  and	  H3K36me3	  
increase	   through	  active	  gene	  coding	   regions,	  and	  S2P	  continues	   to	   increase	  beyond	   the	  3’	  end;	  S2P	  shows	  a	  
peak	   ~1	   kb	   downstream	   of	   the	   TES	   of	   active	   genes,	   accompanied	   by	   enrichment	   of	   other	   RNAPII	   phospho-­‐
forms.	   III)	   In	   the	  PRC-­‐repressed	   state,	   S5P,	  H3K27me3	  and	  H2Aub1	  co-­‐occupy	  promoter	   regions,	   and	  extend	  
into	   gene	   coding	   regions	   for	   a	   variable	   distance,	   depending	   on	   the	   gene;	   H3K4me3	   is	   detected	   at	   PRC-­‐
repressed	   promoter	   regions.	   The	   RNAPII	   modifications	   8WG16,	   S7P	   and	   S2P,	   and	   the	   histone	   modification	  
H3K36me3	   are	   not	   detected	   at	   PRC-­‐repressed	   genes	   suggesting	   that	   they	   are	   specific	   marks	   for	   the	   active	  
state.	  Schematic	  representation	  compiled	  from	  data	  published	  in	  Brookes	  et	  al.,	  2012.	  
	  
1.4.5 RNAPII	  transcription	  at	  Polycomb	  repressed	  genes	  
Transcriptional	  activity	  has	  been	  detected	  from	  PRC	  target	  genes	  in	  several	  systems	  (Breiling	  
et	   al.,	   2004;	   Bracken	   et	   al.,	   2006;	   Tolhuis	   et	   al.,	   2006;	  Guenther	   et	   al.,	   2007;	   Stock	   et	   al.,	  
2007;	  Carter	  et	  al.,	  2009;	  Chopra	  et	  al.,	  2009;	  Kanhere	  et	  al.,	  2010;	  Min	  et	  al.,	  2011).	   In	  ES	  
cells,	   low	   levels	   of	   α-­‐amanitin-­‐sensitive	   transcripts	   are	   produced	   from	   a	   panel	   of	   bivalent	  
PRC-­‐repressed	  genes,	  and	  transcripts	  are	  polymerised	  and	  spliced	  to	  at	   least	  the	  first	  exon	  
junction	   (Stock	   et	   al.,	   2007).	   This	   is	   in	   contrast	   to	   paused	   polymerases	   at	   inducible	   genes	  
where	   synthesis	   of	   short	   10-­‐50bp	   transcripts	   occurs.	   Levels	   of	  mRNA	   from	   PRC-­‐repressed	  
genes	   are	   minimal	   (Guenther	   et	   al.,	   2007;	   Mikkelsen	   et	   al.,	   2007;	   Brookes	   et	   al.,	   2012)	  
suggesting	   a	   regulatory	   step	   that	   prevents	   maturation	   of	   any	   transcripts	   produced	   into	  
mRNA.	  	  
	  
Presence	  of	  appreciable	  occupancy	  of	  RNAPII-­‐S5p	  that	  extends	   into	  coding	  regions	  of	  PRC-­‐
repressed	  genes	  and	  produces	  low-­‐level	  transcripts,	  suggests	  that	  Polycomb	  regulation	  may	  
act	   at	   the	   level	   of	   transcription	   elongation	   and	   maturation	   of	   nascent	   transcripts,	   by	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preventing	  recruitment	  of	  the	  transcription	  machinery.	  The	  absence	  of	  RNAPII-­‐S2p	  is	  likely	  to	  
affect	   RNA	   processing	   including	   splicing	   and	   polyadenylation,	   possibly	   leading	   to	   RNA	  
degradation	  strategies	  to	  rid	  the	  cell	  of	  unwanted	  message	  (Brookes	  and	  Pombo,	  2009).	  	  
	  
In	   this	   thesis,	   I	   will	   focus	   on	   Polycomb	   repressed	   genes	   with	   the	   aim	   of	   characterising	  
transcription	   at	   single	   genes	   and	   genome-­‐wide	   with	   the	   aim	   of	   elucidating	   possible	  
regulatory	   mechanisms	   of	   Polycomb	   repression	   in	   ES	   cells.	   To	   study	   transcription	  
comprehensively	  requires	  knowledge	  of	  technologies	  and	  strategies	  employed	  to	  study	  RNA	  
transcripts,	  as	  well	  as	  information	  on	  what	  is	  being	  discovered	  about	  transcription	  regulation	  
genome-­‐wide	  using	  these	  strategies.	  
	  
1.5 RNAPII	  transcription	  across	  the	  genome	  
Understanding	   the	   functional	   RNA	   elements	   of	   the	   genome	   is	   crucial	   to	   unravel	   the	  
molecular	  mechanisms	  of	  gene	  regulation.	  The	  field	  has	  generated	  a	  wealth	  of	  information	  
regarding	   RNAPII	   dynamics	   and	   RNA	   processing,	   with	   more	   targeted	   approaches	   such	   as	  
single	  gene	  or	  microarray	  expression	  analyses.	  The	  advent	  of	  Next	  Generation	  Sequencing	  
(NGS)	  technology	  and	  the	  coming	  together	  of	  consortiums	  such	  as	  ENCODE	  (Encyclopedia	  of	  
DNA	  Elements)	  and	  FANTOM	  (Functional	  Annotation	  of	  the	  Mammalian	  genome)	  has	  meant	  
that	   the	   rate	   at	   which	   new	   information	   is	   becoming	   available	   about	   RNA	   populations	  
genome-­‐wide	  in	  numerous	  cell	  lines,	  tissue	  and	  disease	  samples	  is	  astounding.	  	  	  
	  
Studies	  into	  the	  dynamics	  of	  RNAPII	  transcription	  in	  higher	  eukaryotes	  reveal	  the	  intriguing	  
fact	  that	  <5%	  of	  all	  RNAPII	  transcription	  results	  in	  production	  of	  protein-­‐coding	  mRNA	  that	  is	  
exported	   to	   the	   cytoplasm	   for	   translation	   into	   protein	   (Jackson	   et	   al.,	   2000;	   Moore	   and	  
Street,	  2002).	  Surprisingly,	  the	  remaining	  95%	  of	  transcripts	  mostly	  turnover	  in	  the	  nucleus	  	  
(Fig.	   1.6).	   The	   biological	   importance	   of	   this	   non-­‐coding	   transcription	   has	   recently	   become	  
apparent;	   it	   includes	   a	  wide	   variety	   of	   non-­‐coding	   RNA	  with	   regulatory	   and/or	   functional	  
properties,	   introns	   removed	   from	   mRNA	   before	   export,	   and	   degradation	   products.	  
Understanding	   the	   complexity	   of	   transcription	   and	   its	   regulation	   that	   extends	   beyond	  
expression	  of	  protein-­‐coding	  mRNA	  encompasses	  a	  major	  effort	  in	  biology.	  	  
	  
































Figure	  1.6	  RNAPII	   transcription	  dynamics	  and	  methods	   to	  study	  cellular	  RNA	  populations.	  A	  small	  proportion	  
(5%)	  of	  RNAPII	   transcription	  yields	  mRNA	  while	   the	  remaining	  95%	   is	  nuclear	  and	  comprises	   introns,	  ncRNAs	  
and	   degradation	   products.	   Methods	   to	   study	   populations	   of	   cellular	   or	   chromatin-­‐associated	   RNAs	   are	  
indicated.	  
 
1.5.1 Pervasive	  transcription	  in	  the	  mammalian	  genome	  
Protein	  coding	  genes	  in	  the	  mammalian	  genome	  account	  for	  only	  1.2%	  of	  the	  genomic	  space	  
(Clark	  et	  al.,	  2011),	   yet	  mounting	  evidence	   is	   revealing	   that	   the	  majority	  of	   the	  genome	   is	  
transcribed	  as	  coding	  or	  non-­‐coding	  RNA,	  a	  phenomenon	  known	  as	  ‘pervasive’	  transcription	  
(Katayama	  et	  al.,	  2005;	  Birney	  et	  al.,	  2007;	  Djebali	  et	  al.,	  2012),	  whereby	  each	  base	  within	  
the	   genome	   is	   associated	   with	   at	   least	   one	   primary	   transcript	   (Birney	   et	   al.,	   2007).	   The	  
extent	   of	   ncRNA	   transcription	   in	   different	   cell	   types	   is	   also	   being	   realised	   (Carninci	   et	   al.,	  
2005;	   Cheng	   et	   al.,	   2005;	   Kampa	   et	   al.,	   2004)	   and	   whether	   the	   majority	   has	   functional	  
relevance	  is	  only	  beginning	  to	  be	  elucidated.	  	  
	  
Genome-­‐wide	   studies	   have	   revealed	   that	   non-­‐coding	   transcription	   may	   impact	   on	   the	  
regulation	  of	  protein	   coding	  genes.	  Recent	   studies	  using	  methods	   that	  measure	   total	  RNA	  
populations	  or	  primed	  RNAPII	  by	  GRO-­‐seq	  have	  identified	  antisense	  transcription	  from	  active	  
gene	  promoters	  in	  humans	  (Core	  et	  al.,	  2008;	  Preker	  et	  al.,	  2008;	  Seila	  et	  al.,	  2008)	  and	  bi-­‐
directional	   transcription	  at	  active	  enhancers	   (Kim	  et	  al.,	  2010).	  These	  antisense	   transcripts	  
are	   correlated	  with	   protein	   coding	   gene	   activity	   (Preker	   et	   al.,	   2008)	   and	   higher	   levels	   of	  
H3K4me3	  and	  RNAPII	  at	  promoters	  (Core	  et	  al.,	  2008).	  Divergent	  transcription	  from	  RNAPII	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promoters	   in	   ES	   cells	   correlates	   with	   CpG	   islands	   at	   genes	   that	   are	   depleted	   for	   PcG	  
component	   Suz12	   (Core	   et	   al.,	   2008).	   The	   significance	   of	   this	   phenomenon	   is	   unclear	   but	  
thought	   to	   involve	   RNAPII	   regulation	   of	   the	   local	   chromatin	   environment	   that	   will	   allow	  
rapid	   gene	   induction,	   or	   antisense	   transcription	   that	   will	   result	   in	   a	   local	   abundance	   of	  
primed	  RNAPII	  molecules.	  Further	  investigation	  into	  the	  significance	  of	  antisense	  transcripts	  
from	  promoters	  is	  required.	  	  
1.5.2 Methods	  to	  study	  transcription	  
Different	  approaches	  can	  be	  used	  to	  isolate	  different	  populations	  of	  cellular	  RNA	  (Fig.	  1.6).	  
They	   include	  analyses	  of	   total	  RNAs,	  capped	  RNAs,	  polyA+	  RNAs	  and	  RNAs	  associated	  with	  
chromatin.	  
	  
Total	   RNA	   preparations	   of	   whole	   cells	   or	   purified	   nuclei	   allow	   investigation	   of	   cellular	   or	  
nuclear	  populations	  of	  RNA,	  respectively,	  transcribed	  by	  RNAPI,	  II	  or	  III	  and	  independent	  of	  
RNA	   maturity.	   Characterising	   total	   RNA	   populations	   can	   be	   applied	   successfully	   to	   study	  
nascent	  transcription	  (Wada	  et	  al.,	  2009;	  Ameur	  et	  al.,	  2011;	  Rodriguez	  et	  al.,	  2012)	  but	  may	  
fail	   to	   detect	   nascent	   transcripts,	   that	   are	   present	   at	   low	   levels	   and	   potentially	   hold	  
regulatory	   functions,	   amongst	   the	   vast	   population	   of	   mature	   transcripts.	   Analyses	   of	   co-­‐
transcriptional	  regulation,	  such	  as	  alternative	  splicing,	  will	  also	  be	  challenging	  without	  high	  
sequencing	  depth.	  Cap	  analysis	  of	  gene	  expression	  (CAGE)	  and	  rapid	  amplification	  of	  cDNA	  
ends	  (RACE)	  measure	  promoter	  usage	  and	  transcription	  start	  sites	  from	  total	  RNA	  pools,	  but	  
do	  not	   provide	   information	   about	   the	   rest	   of	   the	   transcriptional	   unit.	   Both	  methods	  have	  
been	  adapted	  to	  study	  expression	  levels	  and	  promoter	  usage	  genome-­‐wide	  (Katayama	  et	  al.,	  
2005;	  Olivarius	  et	  al.,	  2009).	  CAGE	  relies	  on	  the	  presence	  of	  a	  Cap	  structure	  on	  the	  5’end	  of	  
the	  RNA,	  allowing	  very	  precise	  TSS	  mapping,	  but	  excludes	  nascent	  transcripts	  that	  may	  not	  
possess	  a	  cap	  structure,	  and	  yet	  contribute	  to	  gene	  regulation	  at	  the	  transcriptional	  level.	  	  
	  
Other	  methods	   focus	  more	  on	  RNAPII	   transcriptional	   regulation	  at	   the	   level	   of	   chromatin.	  
GRO-­‐seq	   is	   a	   genome-­‐wide	   nuclear	   run-­‐on	   that	   labels	   short	   stretches	   of	   nascent	   RNA	   by	  
controlled	   incorporation	  of	  modified	  nucleotides	   in	   vitro	   in	   isolated	  nuclei.	  GRO-­‐seq	  helps	  
infer	  presence	  and	  orientation	  of	  engaged	  RNAPII	  and	  has	  detected	  transcription	  at	  virtually	  
all	  genes	  in	  various	  cell	  types	  (Core	  et	  al.,	  2008;	  Min	  et	  al.,	  2011).	  Due	  to	  its	   in	  vitro	  nature	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GRO-­‐seq	   is	  not	  used	  to	  study	  RNA	  splicing	  or	  expression.	  Chromatin	  fractionation	  followed	  
by	  RNA	  isolation	  is	  another	  method	  that	  focuses	  on	  identifying	  chromatin-­‐associated	  RNA.	  It	  
simultaneously	   characterises	   the	  whole	   complement	   of	   nuclear	   RNA,	   including	   transcripts	  
produced	  by	  all	  three	  nuclear	  RNAPs,	  as	  well	  as	  any	  mRNA	  or	  ncRNA	  populations	  associated	  
with	   chromatin.	   It	   has	   been	   used	   successfully	   to	   study	   the	   first	   stages	   of	   transcription	   in	  
different	  organisms	   (Carrillo	  Oesterreich	  et	  al.,	  2010;	  Khodor	  et	  al.,	  2011;	  Rodriguez	  et	  al.,	  
2012).	   The	   complexity	   of	   chromatin-­‐associated	   RNA	   makes	   it	   difficult	   to	   detect	   rare	   or	  
unstable	  transcripts	  without	  deep	  sequencing.	  	  
	  
1.6 Aims	  
Presence	  of	  RNAPII	   in	  concert	  with	  Polycomb	  at	  developmental	  regulator	  genes	  suggests	  a	  
novel	  mechanism	  of	  gene	  priming	  in	  ES	  cells.	  How	  interplay	  between	  RNAPII	  and	  Polycomb	  
results	   in	  gene	   repression	  at	   the	   transcriptional	   level	   is	  not	  known.	   In	  order	   to	   investigate	  
RNAPII	   transcription	   at	   PRC-­‐repressed	   genes,	   I	   have	   examined	   whether	   transcripts	   are	  
produced	  at	  both	  the	  single	  gene	  and	  genome-­‐wide	  level.	  	  
	  
To	  study	  the	  first	  stages	  of	  transcription	  and	  capture	  the	  complete	  cohort	  of	  RNA	  in	  ES	  cells,	  I	  
isolated	  RNA	  associated	  with	  RNAPII	  and	  PRCs	  bound	  to	  chromatin	  using	  RNA-­‐ChIP	  at	  single	  
genes.	   The	  RNA-­‐ChIP	  method	  was	   subsequently	   adapted	   to	   look	   at	   transcription	   genome-­‐
wide	   in	   ES	   cells	   and	   dissect	   regulatory	   features	   including	   extent	   of	   transcript	   coverage,	  
direction	   and	   splicing	   of	   active	   and	   PRC-­‐repressed	   transcripts.	   In	   concert	   with	   published	  
genome-­‐wide	   RNAPII,	   PRC	   and	   histone	   modification	   datasets,	   I	   aimed	   to	   investigate	  
relationships	  between	  transcription	  and	  protein	  and	  chromatin	  configurations	  that	  may	  lead	  
to	   mechanisms	   of	   regulation.	   To	   assess	   the	   mechanistic	   implications	   of	   RNAPII	   and	   PRC	  
interplay	  on	  transcription,	  I	  made	  use	  of	  PRC-­‐inducible	  knockout	  cell	  systems.	  
	  
Detection	   of	   low-­‐level	   transcription	   throughout	   the	   coding	   regions	   of	   PRC	   targets	   in	   the	  
presence	  of	  abundant	  RNAPII-­‐S5p	  raised	  the	  hypothesis	  that	  mechanisms	  of	  PRC	  repression	  
may	  involve	  RNA	  degradation.	  To	  explore	  whether	  RNA	  degradation	  is	  a	  feature	  of	  Polycomb	  
repression	  in	  ES	  cells,	  I	  have	  investigated	  the	  role	  of	  known	  enzymes	  that	  play	  fundamental	  
roles	   in	   regulation	   and	   may	   repress	   inappropriate	   ES	   cell	   gene	   expression.	   An	   RNA	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interference	  approach	  based	  on	  candidate	  activities	   involved	   in	  RNA	  degradation	  has	  been	  
used	   to	   investigate	   their	   effect	   on	   the	   repression	   of	   PRC-­‐target	   genes.	   The	   subsequent	  
identification	  of	  exosome	  as	  a	  promising	  regulator	  in	  single-­‐gene	  analyses	  has	  prompted	  us	  
to	  advance	  investigations	  genome-­‐wide.	  
	  
Mechanisms	   of	   Polycomb	   repression	   may	   involve	   additional	   RNAPII-­‐CTD	   modifications	   to	  
uncouple	   transcription	   from	   productive	   mRNA	   processing.	   	   Glycosylation	   of	   the	   CTD	   was	  
previously	   suggested	   to	   play	   a	   role	   in	   gene	   repression	   by	   counteracting	   CTD	  
phosphorylation.	   I	   have	   explored	  whether	   this	  modification	   is	   a	  marker	   of	   PRC-­‐repressed	  
genes	   in	   ES	   cells,	   to	   further	   elucidate	   the	   characteristics	   of	   poised	   RNAPII	   complexes	   at	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2 Materials	  and	  Methods	  
2.1 Cell	  culture	  
2.1.1 Murine	  ES-­‐OS25	  cell	  culture	  
Mouse	   ES-­‐OS25	   cells	   (kindly	   donated	   by	   A.	   Smith)	   were	   grown	   on	   0.1%	   gelatin-­‐coated	  
surfaces	  in	  GMEM-­‐BHK21	  supplemented	  with	  10%	  fetal	  calf	  serum	  (FCS),	  2	  mM	  L-­‐glutamine,	  
1%	   MEM	   non-­‐essential	   amino	   acids	   (NEAA),	   1	   mM	   sodium	   pyruvate,	   50	   μM	   2-­‐
mercaptoethanol,	   1000	   U/ml	   of	   human	   recombinant	   leukaemia	   inhibitory	   factor	   (LIF;	  
Chemicon,	  Millipore,	  Chandler’s	  Ford,	  UK)	  and	  0.1	  mg/ml	  Hygromycin	  (Roche)	  as	  described	  
previously	  (Billon	  et	  al.,	  2002;	  Niwa	  et	  al.,	  2000).	  
2.1.2 Murine	  ES-­‐Ert2	  cell	  culture	  
Mouse	  ES-­‐ERT2	  cells	  were	  a	  kind	  gift	  from	  M.Vidal	  and	  H.Koseki	  (Cales	  et	  al.,	  2008).	  ES-­‐ERT2	  
were	   cultured	   in	   0.1%	   gelatin-­‐coated	   flasks	   on	   mitomycin-­‐inactivated	   SNLs	   as	   described	  
previously	  (Stock	  et	  al.,	  2007),	  in	  DMEM	  supplemented	  with	  7.5%	  distilled	  water,	  15%	  FCS,	  2	  
mM	  L-­‐glutamine,	  1%	  MEM	  NEAA,	  50	  μM	  2-­‐mercaptoethanol,	  and	  2,400	  U/ml	  LIF.	  
2.1.3 Conditional	  knockout	  of	  Ring1B	  in	  ES-­‐Ert2	  cells	  
For	   Ring1B	   conditional	   deletion,	   ES-­‐ERT2	   cells	   were	   plated	   feeder-­‐free	   on	   gelatin-­‐coated	  
plates	  12	  h	  before	  supplementing	  medium	  with	  800	  nM	  4-­‐hydroxytamoxifen	  (H7904,	  Sigma,	  
Poole,	  UK)	  for	  12-­‐72	  h.	  
2.1.4 Drug	  treatments	  
To	  inhibit	  CDK9	  and	  therefore	  RNAPII-­‐S2p,	  ES-­‐OS25	  cells	  were	  treated	  (1	  h)	  with	  0.1-­‐100	  µM	  
flavopiridol	  (from	  50	  mM	  stock	  in	  DMSO;	  a	  kind	  gift	  from	  Sanofi-­‐Aventis,	  provided	  by	  Drug	  
Synthesis	   and	  Chemistry	   Branch,	  Developmental	   Therapeutics	   Program,	  Division	  of	   Cancer	  
Treatment	  and	  Diagnosis,	  National	  Cancer	  Institute,	  Bethesda,	  MD).	  
	  
To	  inhibit	  RNAPII	  transcription,	  ES-­‐OS25	  cells	  were	  treated	  for	  7	  h	  with	  75	  µg/ml	  α-­‐amanitin	  
(Sigma).	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2.2 Chromatin	  Immunoprecipitation	  for	  RNA	  and	  DNA	  
Antibodies	   used	   for	   chromatin	   immunoprecipitation	   (ChIP),	   including	   control	   and	   bridging	  
antibodies,	   are	   presented	   in	   Table	   2.2.	   Antibodies	   towards	   different	   epitopes	   of	   RPB1	   are	  
schematically	   represented	   in	   Fig.	   2.1.	   A	   brief	   outline	   of	   the	   RNA-­‐ChIP	   protocol	   is	   also	  
depicted	  in	  Chapter	  3	  (Fig.	  3.2).	  
	  
	  
Figure	  2.1.	  RPB1	  antibodies	   recognising	   specific	  phospho-­‐	  and	  glycosylated-­‐epitopes. Clone	  4H8	   recognises	  
S5p	  residues	  (blue)	  but	  binding	  is	  differentially	  influenced	  by	  other	  modifications.	  Clones	  H5,	  3D12	  and	  1G7	  are	  
used	  for	  detection	  of	  S2p	  (pink)	  and	  Y1p	  (red)	  and	  T4p	  (dark	  purple),	  respectively.	  8WG16	  (purple)	  recognises	  
un-­‐phosphorylated	   S2	   residues.	   Clones	   SC7	   and	   SG8	   recognise	   T4-­‐Glyc	   (green)	   and	   S5-­‐Glyc	   (orange),	  
respectively.	  
	  
2.2.1 Fixed	  chromatin	  preparation	  
Fixed	  chromatin	  was	  prepared	  as	  described	  previously	  (Stock	  et	  al.,	  2007).	  Briefly,	  cells	  were	  
treated	  with	  1%	  formaldehyde	  (37°C,	  10	  min)	  and	  the	  reaction	  was	  stopped	  by	  addition	  of	  
glycine	   to	   a	   final	   concentration	   of	   0.125	   M.	   Cells	   were	   washed	   in	   ice-­‐cold	   PBS,	   before	  
“swelling”	   buffer	   (25	  mM	  HEPES	   pH	   7.9,	   1.5	  mM	  MgCl2,	   10	  mM	  KCl	   and	   0.1%	  NP40)	  was	  
added	  to	  lyse	  the	  cells	  (4°C,	  10	  min).	  Cells	  were	  scraped	  from	  flasks,	  and	  nuclei	   isolated	  by	  
Dounce	  homogenization	  (50	  strokes,	  “Tight”	  pestle)	  and	  centrifugation.	  After	  re-­‐suspension	  
in	   “sonication”	  buffer	   (50	  mM	  HEPES	  pH	  7.9,	  140	  mM	  NaCl,	  1	  mM	  EDTA,	  1%	  Triton	  X100,	  
0.1%	  Na-­‐deoxycholate	  and	  0.1%	  SDS),	  nuclei	  were	  sonicated	  to	  produce	  DNA	  fragments	  with	  
a	   length	   of	   <1.6	   kb	   (Stock	   et	   al.,	   2007)	   using	   a	   Diagenode	   Bioruptor	   (Liege,	   Belgium;	   full	  
power;	  1	  h:	  30	  s	   ‘on’,	  30	  s	   ‘off’;	  4°C).	  The	  resulting	  material	  was	  centrifuged	  twice	  (4°C,	  10	  
min)	   at	   14,000	   rpm	   to	   remove	   insoluble	   material.	   Swelling	   and	   sonication	   buffers	   were	  
supplemented	   with	   phosphatase	   inhibitors	   5	   mM	   NaF,	   2	   mM	   Na3VO4,	   1	   mM	   PMSF,	   and	  
protease	  inhibitor	  cocktail	  (Roche,	  Burgess	  Hill,	  UK).	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For	   RNA	   chromatin	   immunoprecipitation,	   RNAse	   inhibitors	   (Roche,	   Burgess	   Hill,	   UK)	  were	  
added	  to	  swelling	  (20	  U/ml)	  and	  sonication	  buffers	  (50	  U/ml).	  	  	  
	  
“Chromatin	   concentration”	   was	   obtained	   by	   measuring	   absorbance	   (280	   nm)	   of	   alkaline-­‐
lysed,	   crosslinked	   chromatin,	   and	   converting	   into	   arbitrary	   chromatin	   units	   using	   the	  
conversion	  50	  mg/ml	  for	  1	  absorbance	  unit.	  
2.2.2 Confirmation	  of	  fragment	  size	  of	  fixed	  chromatin	  
To	   confirm	   appropriate	   shearing	   or	   enzymatic	   fragmentation	   had	   occurred,	   DNA	   was	  
purified	  from	  chromatin	  and	  subjected	  to	  agarose	  electrophoreses.	  Fixed	  chromatin	  first	  had	  
aldehyde	  cross-­‐links	  reversed	  by	  adding	  NaCl	  and	  RNase	  A	  to	  final	  concentrations	  of	  160	  mM	  
and	  20	  μg/ml,	  respectively,	  followed	  by	  incubation	  at	  65°C	  overnight.	  With	  all	  samples,	  the	  
EDTA	  concentration	  was	  adjusted	  to	  5	  mM,	  and	  then	  200	  μg/ml	  proteinase	  K	   (Roche)	  was	  
added	   (45°C,	   2	   h).	   DNA	   was	   recovered	   by	   phenol-­‐chloroform	   extraction	   and	   ethanol	  
precipitation,	   and	   re-­‐suspended	   in	   TE.	   DNA	  was	   separated	   on	   a	   1%	   agarose	   gel	   to	   check	  
fragmentation	  efficiency.	  
2.2.3 Immunoprecipitation	  with	  magnetic	  beads	  
For	  mouse	  IgG	  and	  IgM	  antibodies,	  protein-­‐G-­‐magnetic	  beads	  (Active	  Motif)	  were	  incubated	  
with	   rabbit	   anti-­‐mouse	   (IgG+IgM)	   or	   anti-­‐IgM	   bridging	   antibodies,	   respectively	   (Jackson	  
Immunoresearch;	  10	  μg	  per	  50	  μl	  beads)	  for	  1	  h	  (4°C)	  and	  washed	  with	  sonication	  buffer.	  For	  
rabbit	  antibodies,	  magnetic	  beads	  were	  just	  washed	  with	  sonication	  buffer.	  Fixed	  chromatin	  
(700	  μg)	  was	   immunoprecipitated	  (4°C,	  overnight)	  with	  10-­‐50	  μg	  antibody	  and	  50	  μl	  beads	  
(with/without	  bridging	  antibody).	  
	  
Magnetic	  beads	  were	  used	  for	  all	  RNA-­‐ChIP	  experiments	  where	  RNase	   inhibitors	  (50	  U/ml)	  
were	  included	  during	  immunoprecipitation.	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2.2.4 ChIP	  washes	  and	  elution	  	  
For	   Protein	   G	   immunoprecipitations,	   beads	  were	  washed	   (1x)	  with	   sonication	   buffer,	   (1x)	  
sonication	  buffer	   containing	  500	  mM	  NaCl,	   (1x)	  20	  mM	  Tris	  pH	  8.0,	  1	  mM	  EDTA,	  250	  mM	  
LiCl,	  0.5%	  NP40	  and	  0.5%	  Na-­‐deoxycholate,	  and	  (2x)	  TE	  buffer	  (1	  mM	  EDTA,	  10	  mM	  Tris	  HCl	  
pH	   8.0).	   After	   immunoprecipitations	   using	   IgM	   antibodies,	   beads	   were	   washed	   (2x)	   with	  
sonication	  buffer,	  (1x)	  2	  mM	  Tris	  pH	  8.0,	  0.02	  mM	  EDTA,	  50	  mM	  LiCl,	  0.1%	  NP40	  and	  0.1%	  
Na-­‐deoxycholate;	   and	   (1x)	  TE	  buffer.	   Immune	  complexes	  were	  eluted	   from	  beads	   (65°C,	  5	  
min;	  and	  room	  temperature,	  15	  min)	  with	  50	  mM	  Tris	  pH	  8.0,	  1	  mM	  EDTA	  and	  1%	  SDS.	  The	  
elution	  was	  repeated	  and	  eluates	  pooled.	  
2.2.5 DNA	  purification,	  quantification	  and	  analysis	  
For	  fixed	  chromatin	  samples,	  reverse	  cross-­‐linking	  was	  carried	  out	  (16	  h,	  65°C)	  with	  addition	  
of	  NaCl	  and	  RNase	  A	   to	   final	   concentrations	  of	  160	  mM	  and	  20	  µg/ml,	   respectively.	   EDTA	  
was	  increased	  to	  a	  final	  concentration	  of	  5	  mM	  and	  samples	  were	  incubated	  with	  200	  µg/ml	  
proteinase	  K	   (50°C,	  2	  h).	  DNA	  was	  recovered	  by	  phenol-­‐chloroform	  extraction	  and	  ethanol	  
precipitation.	   The	   final	   DNA	   concentration	   was	   determined	   by	   PicoGreen	   fluorometry	  
(Molecular	   Probes,	   Invitrogen)	   and	   samples	   were	   diluted	   to	   the	   same	   concentration	   (0.2	  
ng/µl).	  The	  same	  amount	  (0.5	  ng)	  of	   immunoprecipitated	  and	  input	  DNA	  were	  analyzed	  by	  
quantitative	   real-­‐time	   PCR	   (RT-­‐PCR).	   Amplifications	   (40	   cycles)	   were	   performed	   using	  
SensiMix	  NoRef	  (Quantace,	  London,	  UK)	  with	  DNA	  Engine	  CFX96	  (BioRad,	  Hemel	  Hempstead,	  
Hertfordshire,	  UK).	  
	  
IP	   or	   control	   “cycle	   over	   threshold”	   (Ct)	   values	   from	   the	   quantitative	   PCR	   (IP)	   were	  
subtracted	   from	   the	   input	   Ct	   values	   (Input	   Ct).	   This	   figure	   was	   converted	   into	   the	   fold	  
enrichment	  by	  2(input	  Ct	  –	  IP	  Ct).	  
2.2.6 RNA	  purification,	  quantification	  and	  analysis	  
Reverse	   cross-­‐linking	   was	   carried	   out	   (4	   h,	   65°C)	   with	   addition	   of	   NaCl	   to	   a	   final	  
concentration	  of	  200	  mM.	  EDTA	  was	  increased	  to	  a	  final	  concentration	  of	  5	  mM	  and	  samples	  
were	  incubated	  with	  200	  µg/ml	  proteinase	  K	  (50°C,	  1	  h).	  RNA	  was	  recovered	  by	  acid	  phenol-­‐
chloroform	   extraction	   pH	   4.5	   (Ambion)	   and	   isopropanol	   precipitation.	   Nucleic	   acid	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concentration	   was	   determined	   by	   spectrophotometry	   (Nanodrop).	   Samples	   were	   then	  
DNase	   I	   treated	   (Turbo	   DNA-­‐free,	   Ambion)	   with	   some	   modifications.	   Treatment	   of	   equal	  
amounts	  (1-­‐2	  µg)	  of	  nucleic	  acid	  from	  each	  sample	  was	  performed	  in	  a	  volume	  of	  16	  µl	  with	  
4	  U	  DNase	  I	  (37°C,	  30	  min)	  followed	  by	  inactivation	  according	  to	  manufacturers	  instructions.	  
Final	   quantification	   of	   RNA	   concentration	   was	   determined	   by	   RiboGreen	   fluorometry	  
(Molecular	   Probes,	   Invitrogen).	   Equal	   amounts	   were	   converted	   to	   copyDNA	   (cDNA,	  
Superscript	   II	   kit,	   Invitrogen)	   in	   a	   20	   µl	   reaction	   volume,	   including	   a	   minus	   reverse	  
transcription	  reaction	  excluding	  the	  Superscript	  reverse	  transcriptase	  (“-­‐RT”),	  as	  a	  control	  for	  
DNA	  contamination.	  Samples	  were	  diluted	  1:5	  except	  for	  control	  antibodies.	  
	  
The	   same	   volumes	   (2.5	   µl)	   of	   immunoprecipitated	   and	   input	   RNA	   were	   analyzed	   by	  
quantitative	   real-­‐time	   PCR	   (RT-­‐PCR).	   Amplifications	   (40	   cycles)	   were	   performed	   using	  
SensiMix	  NoRef	  (Quantace,	  London,	  UK)	  with	  DNA	  Engine	  CFX96	  (BioRad,	  Hemel	  Hempstead,	  
Hertfordshire,	  UK).	  
	  
IP	   or	   control	   “cycle	   over	   threshold”	   (Ct)	   values	   from	   the	   quantitative	   PCR	   (IP)	   were	  
subtracted	   from	   the	   total	   chromatin	   (Input)	   Ct	   values	   and	   converted	   into	   the	   fold	  
enrichment	  by	  2(input	  Ct	  –	  IP	  Ct).	  
In	   the	  case	  when	  no	  RNA	  was	  detected	   in	  control	   Input	   samples,	   IP	  or	  control	   “cycle	  over	  
threshold”	  (Ct)	  values	  from	  the	  quantitative	  PCR	  were	  converted	  to	  levels	  using	  2(input	  Ct)	  or	  2(	  
IP	  Ct).	  
	  
2.3 Gene	  expression	  analysis	  by	  quantitative	  RT-­‐PCR	  
RNA	  was	  extracted	  by	  Trizol	  extraction	  using	  Phase	  Lock	  Gel	   tubes.	  Samples	  were	  DNase	   I	  
treated	  according	  to	  the	  manufacturers	   instructions	   (Turbo	  DNA-­‐free,	  Ambion).	   	  Total	  RNA	  
(1-­‐2	  µg)	  was	   retrotranscribed	  with	   50	   ng	   Random	  primers	   and	   10	  U	   reverse	   transcriptase	  
(Superscript	  II	  kit,	  Invitrogen),	  in	  a	  20	  µl	  reaction.	  The	  synthesized	  cDNA	  was	  diluted	  1:10	  and	  
2.5	  µl	  used	  for	  RT-­‐PCR.	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2.4 RNA	  extraction	  for	  CAGE	  sequencing	  
Total	  RNA	   including	  miRNA	  was	  extracted	  by	  Trizol	   lysis	  and	  miRNeasy	  column	  purification	  
according	  to	  manufacturer’s	   instructions	  with	  modifications.	  Chloroform	  was	  added	  at	  200	  
µl/ml	   of	   Trizol	   lysate	   before	   centrifugation.	   To	   bind	   total	   RNA	   including	   miRNA	   to	   the	  
columns,	   1.5x	   volumes	   of	   100%	   ethanol	   was	   added	   to	   the	   aqueous	   phase	   of	   the	   lysate.	  
Sample	  quality	  was	  analysed	  by	  Agilent	  Bioanalyser	  to	  ensure	  integrity	  of	  RNA.	  Samples	  with	  
a	   RIN	   score	   above	   8	  were	   sent	   for	   CAGE	   analysis.	   Final	   concentration	  was	   determined	   by	  
spectrophotometry	  (Nanodrop).	  Samples	  were	  sent	  to	  Riken	  Institute,	  Omics	  Science	  Centre	  
(OSC),	  Yokohama,	  Japan,	  for	  CAGE	  library	  preparation	  and	  sequencing	  on	  the	  Helicos	  single-­‐
molecule	   sequencing	   platform	   (Helicos	   Biosciences).	   CAGE	   datasets	   used	   to	   generate	  
average	  profiles	  and	  boxplots	  of	  CAGE	  tags	  per	  million	  (TPM)	  in	  this	  thesis	  are	  listed	  in	  Table	  
2.1.	  	  
	  
Table	  2.1	  List	  of	  CAGE	  sequencing	  datasets	  described	  in	  this	  thesis.	  
Cell	  line	   Cell	  conditions	  
ES-­‐OS25	   Untreated	  
ES-­‐OS25	   Scrambled	  
ES-­‐OS25	   Exosc3	  KD	  
ES-­‐Ert2	   Ring1A-­‐	  Ring1B+	  
ES-­‐Ert2	   Ring1A-­‐	  Ring1B-­‐	  
	  
2.5 mRNA	  sequencing	  library	  preparation	  
Total	  RNA	  was	  prepared	  from	  ES-­‐OS25	  cells	  by	  Trizol	  extraction	  using	  Phase	  Lock	  Gel	  tubes	  
and	   8	  µg	  was	   prepared	   for	  mRNA	   sequencing	   in	   collaboration	  with	   Jiannis	   Ragoussis	   and	  
Carme	   Camps	   (Wellcome	   Trust	   Centre	   for	   Human	   Genetics,	   WTCHG,	   Oxford).	   The	   mRNA	  
library	   was	   prepared	   according	   to	   Illumina’s	   instructions	   (#1004898	   Rev	   A)	   with	   some	  
modifications.	   After	   selection	   of	   polyA-­‐containing	   mRNA	   molecules,	   RNA	   was	   further	  
depleted	   for	   ribosomal	   RNA	   (rRNA)	   using	   the	   Ribominus	   kit	   (Invitrogen),	   according	   to	   the	  
manufacturer’s	   instructions.	  Bioanalyser	  traces	  (Agilent)	  validated	  the	  loss	  of	  rRNA	  and	  the	  
size	   distribution	   of	   fragments.	   The	   library	   was	   then	   prepared	   according	   to	   the	   Illumina	  
protocol.	  The	   library	  was	  quantified	  by	  QuBit	   (Invitrogen),	  and	   library	  size	  was	  analysed	  by	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Bioanalyser	  (Agilent).	  mRNA-­‐seq	  dataset	  has	  been	  published	  and	  available	  at	  GEO	  repository	  
under	  accession	  number	  GSE34520.	  
	  
2.6 RNA-­‐ChIP	  sequencing	  library	  preparation	  
Immunoprecipitated	   RNA	   from	   ES-­‐OS25	   and	   ES-­‐Ert2	   cells	   (50-­‐100	   ng)	   was	   used	   for	  
sequencing	   library	   preparation	  using	   two	  different	  methods.	  Details	   of	   library	   preparation	  
are	  schematically	  represented	  in	  Chapter	  3	  (Fig.	  3.5).	  
2.6.1 Non-­‐directional	  RNA-­‐ChIP	  sequencing	  library	  preparation	  
Paired-­‐end	  libraries	  with	  no	  directional	  information	  were	  prepared	  using	  the	  Illumina	  mRNA-­‐
seq	  library	  preparation	  kit	  according	  to	  Illumina’s	   instructions	  (#1004898	  Rev	  A)	  with	  some	  
modifications.	  The	  purification	  of	  polyA+	  RNA	  was	  omitted	  to	  capture	  the	  total	  population	  of	  
chromatin-­‐bound	  RNA	  associated	  with	  RNAPII	  and	  PRC	  proteins.	  Fragmentation	  of	  RNA	  was	  
omitted	  in	  one	  preparation	  and	  included	  in	  the	  other	  with	  the	  aim	  to	  incorporate	  the	  whole	  
population	   of	   immunoprecipitated	   RNA	   regardless	   of	   size.	   We	   reasoned	   that	   short	   RNA	  
(<200	   nt)	   may	   be	   lost	   in	   the	   fragmentation	   but	   captured	   in	   the	   library	   that	   had	   not	  
undergone	   chemical	   fragmentation,	  whereas	   longer	   RNA	   (>200	   nt)	  will	   be	   included	   in	   the	  
fragmented	  library.	  
2.6.2 Directional	  RNA-­‐ChIP	  sequencing	  library	  preparation	  
Single-­‐read	   libraries	   were	   prepared	   that	   retain	   directional	   information	   using	   the	   Illumina	  
small	  RNA	  sample	  preparation	  kit	  with	  the	  v1.5	  sRNA	  3’	  adaptor	  (#1021009	  Rev	  B),	  following	  
the	   directional	   mRNA-­‐Seq	   Library	   preparation	   pre-­‐release	   protocol	   (Rev	   A),	   with	  
modifications.	  Libraries	  were	  made	  in	  collaboration	  with	  Jiannis	  Ragoussis	  and	  Carme	  Camps	  
(WTCHG).	  PolyA+	  purification	  was	  omitted.	  Bioanalyser	  chips	  were	   run	  after	   fragmentation	  
and	  PCR	  enrichment	   to	  monitor	   size	  of	   library.	   Purification	  of	   library	   using	  AMPure	  beads	  
(Agencourt)	  was	  adapted	  to	  isolate	  different	  fragment	  sizes.	  
	  
Libraries	  were	  quantified	  by	  QuBit	   (Invitrogen)	  and	  quantitative	  RT-­‐PCR	   (Illumina	   Inc),	   and	  
library	  size	  was	  analysed	  by	  Agilent	  Bioanalyser	  (Agilent).	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2.7 Multiplex	  DNA-­‐ChIP	  sequencing	  library	  preparation	  
Libraries	  were	   prepared	   from	  10	   ng	  DNA	   (quantified	   by	   PicoGreen)	   according	   to	  NEBNext	  
ChIP-­‐Seq	   Library	   Prep	   Master	   Mix	   Set	   for	   Illumina	   (New	   England	   Biolabs,	   E6240S)	   and	  
Illumina	  multiplex	  protocols	  (Part	  #1005361	  Rev	  B),	  with	  some	  modifications.	  
	  
Samples	  were	  PCR	  amplified	  prior	  to	  size	  selection	  on	  an	  agarose	  gel,	  enabling	  visualisation	  
with	   EtBr	   of	   the	   amplified	   DNA	   fragments,	   and	   therefore	   more	   careful	   extraction	   of	  
appropriate	   sized	   fragments.	  After	  purification	  by	  QIAgen	  Gel	  Extraction	  kit,	   libraries	  were	  
quantified	   by	   QuBit	   (Invitrogen)	   and	   qPCR,	   and	   library	   size	   was	   analysed	   by	   Bioanalyser	  
(Agilent).	   Fragment	   sizes	   of	   200-­‐450	  bp	   (including	   adapters)	   for	   all	   libraries	  were	   selected	  
due	  to	  the	  distribution	  of	  these	  marks	  at	  promoters,	  where	  there	  is	  evidence	  that	  protection	  
of	  DNA	  may	  occur	  (Ferrai	  et	  al.,	  2007).	  Libraries	  were	  made	  that	  incorporated	  multiplex	  tags	  
within	   the	  adapter	  sequence	  to	  allow	  sample	  pooling	   in	  one	  sequencing	   lane.	  To	   this	  end,	  
Illumina	   paired-­‐end	   adapters	   were	   ligated	   to	   ChIP	   DNA	   instead	   of	   single-­‐end	   adapters.	  
During	   the	  PCR	  amplification,	  a	   third	  primer	  was	   included	  that	   incorporates	  a	  4	  bp	  unique	  
tag	   into	   the	  adapter	  sequence.	  By	  using	  different	  primers	   for	   separate	   libraries	   in	   the	  PCR	  
enrichment,	   unique	   library	   tags	   can	   denote	   library	   identity	   on	   the	   sequencing	   flow	   cell.	  
Libraries	   were	   de-­‐multiplexed	   post-­‐sequencing,	   so	   that	   unique	   tags,	   and	   therefore	  
sequences,	  can	  be	  assigned	  to	  the	  respective	  ChIP-­‐seq	  libraries.	  
	  
2.8 Analysis	  of	  genome-­‐wide	  data	  
Bioinformatic	  analyses	  of	  mRNA-­‐seq,	  RNA-­‐ChIP-­‐seq	  and	  DNA-­‐ChIP-­‐seq	  datasets	  was	  carried	  
out	  by	  I.	  de	  Santiago	  (our	  laboratory).	  Analyses	  of	  RNA	  splicing	  in	  mRNA-­‐seq	  and	  RNA-­‐ChIP-­‐
seq	   datasets	   was	   performed	   by	   R.Beagrie	   (our	   laboratory).	   Analysis	   of	   CAGE	   data	   was	  
performed	  by	  N.Harmston	  and	  V.Haberle	  (Computational	  Regulatory	  Genomics	  Group,	  MRC	  
CSC).	  	  




We	  used	  our	  own	  RNA-­‐ChIP	   seq	  data	   for	  RNAPII-­‐S5p	   (Intact,	   Fragmented	  and	  Directional),	  
Ring1B	   and	   Ezh2	   in	   ES-­‐OS25	   cells.	   We	   also	   used	   RNAPII-­‐S5p	   in	   ES-­‐Ert2	   Control	   (Ring1A-­‐
Ring1B+)	  and	  Tamoxifen	  treated	  (Ring1A-­‐Ring1B-­‐)	  cells.	  
We	   used	   published	   ChIP-­‐seq	   data	   from	   our	   own	   laboratory	   (Brookes	   et	   al.,	   2012)	   for	   the	  
RNAPII	  modifications	  S5p,	  S7p,	  S2p	  and	  8WG16,	   for	   the	  Polycomb	  protein	  Ring1B,	  and	   for	  
the	  histone	  modifications	  H3K36me3	  and	  H2Aub1	  as	  well	  as	  mRNA.	  We	  used	  published	  ChIP	  
seq	  data	   for	  H3K4me3	   (GSM307618)	  and	  H3K27me3	   (GSM307619)	   from	   (Mikkelsen	  et	  al.,	  
2007);	  and	  Ezh2	  (GSM327668)	  from	  (Ku	  et	  al.,	  2008).	  
	  
For	   CAGE	   analysis,	   we	   used	   our	   own	   datasets	   from	   control,	   scrambled	   and	   Exosc3	   siRNA	  
treated	  ES-­‐OS25	  cells.	  Also	  control	  (Ring1A-­‐	  Ring1B+)	  and	  tamoxifen	  treated	  (Ring1A-­‐,	  Ring1B)	  
ES-­‐Ert2	  cells.	  Samples	  are	  listed	  in	  Table	  2.1.	  	  
2.8.2 Sequence	  read	  alignment	  
Sequenced	   reads	   that	   passed	   the	   Illumina	   quality	   control	   filters	  were	   aligned	   to	   the	  most	  
recent	  mouse	  genome	  annotation	  (assembly	  mm9,	  July	  2007)	  allowing	  for	  a	  maximum	  of	  2	  
mismatches	  per	  read.	  This	  allows	  for	  sequencing	  error	  or	  the	  presence	  of	  small	  nucleotide	  
polymorphisms	   (SNPs)	   that	   may	   not	   be	   annotated	   in	   the	   reference	   genome.	   ChIP	   seq	  
datasets	  were	  aligned	  using	  ELAND	  pipeline	  versions	  1.3	  or	  above	  and	  mRNA-­‐seq	  and	  RNA-­‐
ChIP-­‐seq	  datasets	  were	  aligned	  with	  the	  ELAND	  RNA	  implementation	  of	  CASAVA	  1.6,	  which	  
incorporates	  known	  splice	  junctions	  for	  reads	  that	  span	  exon	  junctions.	  
2.8.3 Confirmation	  of	  sequencing	  data	  
Quality	   control	   (QC)	   checks	  were	   performed	   on	   sequencing	   data	   prior	   to	   further	   analysis.	  
Correlations	  between	   replicate	   sequencing	   lanes	  was	   analysed	  prior	   to	   combining	  data	  by	  
calculating	  sequencing	  depth	  across	  1	  kb	  sliding	  windows	  covering	   the	  whole	  genome	  and	  
performing	   correlations.	  After	   combining	   sequencing	   lanes	  data	  was	   visualized	  on	  a	   single	  
gene	   basis	   using	   the	  UCSC	   genome	  browser	   to	   inspect	   active	   and	   silent	  QC	   genes.	  mRNA	  
sequencing	   data	  was	   compared	   to	   published	   datasets	   to	   ensure	   and	   demonstrate	   quality	  
and	  reproducibility	  of	  data	  (Brookes	  et	  al.,	  2012).	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2.8.4 Generating	  average	  profiles	  and	  boxplots	  
Analysis	  of	  sequencing	  data	  was	  performed	  using	  a	  non-­‐redundant	  list	  of	  18860	  UCSC	  genes,	  
and	  their	  corresponding	  RefSeq	  IDs	  (described	  in	  Brookes	  et	  al.,	  2012).	  Due	  to	  the	  complex	  
arrangement	  of	  the	  genome,	  it	  is	  possible	  that	  when	  analyzing	  average	  profiles	  for	  groups	  of	  
genes	  at	  the	  5’	  and	  3’	  end	  there	  may	  be	  overlapping	  windows	  from	  adjacent	  or	  overlapping	  
genes.	   Genes	   with	   overlapping	   windows	   of	   interest	   were	   removed	   leaving	   15,404	   genes	  
classified	  as	  non-­‐overlapping.	  
	  
Average	   profiles	   for	   mRNA,	   RNA-­‐ChIP-­‐seq	   and	   DNA-­‐ChIP-­‐seq	   datasets	   were	   generated	   by	  
calculating	   read	   depth	   per	   nucleotide	   at	   10	   nucleotide	   intervals	   over	   regions	   of	   interest.	  
Boxplots	   displaying	   the	   range	  of	   values,	   as	  well	   as	   the	  median,	   upper	   and	   lower	   quartiles	  
were	   generated	   by	   calculating	   depth	   per	   nucleotide	   in	   windows	   of	   interest.	   Log10	  
transformation	  was	  applied	  before	  plotting	  boxplots	  and	  correlations.	  Plots	  were	  generated	  
using	  R	  software.	  
	  
2.9 Western	  analysis	  
Antibodies	  used	  for	  western	  analysis,	  including	  loading	  control	  antibodies,	  are	  presented	  in	  
Table	  2.3.	  Antibodies	   towards	  different	  epitopes	  of	  RPB1	  are	   schematically	   represented	   in	  
Fig.	  2.1.	  	  
2.9.1 RNAPII	  Western	  analysis	  
Whole	   cell	   extracts	   for	   RNAPII	   westerns	   were	   prepared	   by	   lysing	   cells	   in	   ice-­‐cold	   “lysis”	  
buffer	   (Daniel	   and	   Carling,	   2002),	   scraping,	   and	   shearing	   DNA	   by	   passage	   through	   a	   25G	  
needle.	  Cell	  lysates	  (0.5	  µg	  total	  protein	  for	  4H8	  antibody,	  10	  µg	  for	  S5G	  and	  T4G	  antibodies,	  
5	  µg	  for	  all	  other	  RNAPII	  antibodies)	  were	  resolved	  on	  3-­‐8%	  Tris-­‐acetate	  SDS-­‐PAGE	  gels	  in	  a	  
NuPAGE	  gel	  system.	  Membranes	  were	  blocked	  (1	  h),	  incubated	  (2	  h)	  with	  primary	  antibody,	  
washed,	   and	   incubated	   (1	   h)	   with	   HRP-­‐conjugated	   secondary	   antibodies,	   all	   in	   blocking	  
buffer	   (10	   mM	   Tris-­‐HCl,	   150	   mM	   NaCl,	   0.1%	   Tween-­‐20,	   pH	   8.0;	   5%	   non-­‐fat	   dry	   milk).	  
Membranes	   were	   washed	   (30	   min)	   in	   blocking	   buffer	   without	   milk	   and	   briefly	   in	   0.1%	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Tween-­‐20	   in	   PBS.	   HRP-­‐conjugated	   antibodies	   were	   detected	   with	   ECL	   western	   blotting	  
detection	  reagents	  (Amersham),	  according	  to	  the	  manufacturer’s	  instructions.	  	  
	  
2.10 Microarray	  analysis	  
RNA	  was	   extracted	   by	   Trizol	   lysis	   and	  miRNeasy	   column	  purification	   as	   for	   CAGE	   analysis.	  
Samples	   were	   DNase	   I	   treated	   (Turbo	   DNA-­‐free,	   Ambion)	   according	   to	   manufacturers	  
instructions	   and	   quality	   analysed	   by	   Bioanalyser	   (Agilent).	   Final	   concentration	   was	  
determined	  by	  spectrophotometry	  on	  a	  Nanodrop	  system.	  
	  
Samples	   (100	   ng)	   were	   prepared	   for	   microarray	   using	   the	   Ambion	   WT	   Expression	   Kit	  
according	  to	  manufacturer’s	  instructions	  (4425209	  Rev.	  D).	  Labelling	  of	  cDNA	  for	  microarray	  
was	  performed	  using	  GeneChip	  WT	  Terminal	  Labelling	  Kit	  (Affymetrix	  900671)	  according	  to	  
manufacturers	  instructions.	  Labelled	  samples	  were	  hybridised	  to	  GeneChip	  Mouse	  Gene	  1.0	  
ST	  Arrays	  (Affymetrix)	  and	  scanned	  by	  the	  MRC	  Genome	  facility.	  Analysis	  of	  microarray	  data	  
was	  performed	  by	  G.Dharmalingam	  (CSC,	  MRC).	  
	  
2.11 siRNA	  knockdown	  in	  ES-­‐OS25	  cells	  
All	  siRNA	  sequence	  and	  targets	  including	  negative	  control	  siRNA	  were	  commercially	  available	  
and	   obtained	   from	   Qiagen.	   Negative	   control	   siRNA	   with	   no	   homology	   to	   any	   known	  
mammalian	   gene	   conjugated	   to	   AlexaFluor	   488	   (Allstars	   negative	   control	   siRNA,	   Qiagen)	  
were	  used	  in	  parallel	  to	  monitor	  transfection	  efficiency	  and	  off	  target	  effects	  of	  using	  siRNA.	  
Transfection	  of	  OS25-­‐ES	  cells	  was	  performed	  with	  125	  pmole	  siRNA	  (Qiagen)	  per	  5x105	  cells	  
in	  a	  6	  well	  plate.	  All	  following	  incubations	  are	  at	  room	  temperature	  for	  20	  min.	  Briefly,	  each	  
125	   pmole	   siRNA	   was	   diluted	   in	   250	   µl	   Opti-­‐MEM	   reduced	   serum	   medium	   (Invitrogen)	  
followed	  by	   incubation.	  Lipofectamine-­‐2000	  reagent	  (5	  µl/well,	   Invitrogen)	  was	  mixed	  with	  
Opti-­‐MEM	  (250	  µl/well)	  and	  incubated.	  Lipofectamine	  mix	  and	  siRNA	  mix	  were	  pooled	  and	  
incubated	   at	   room	   temperature	   for	   20	   min.	   Meanwhile,	   ES-­‐OS25	   cells	   were	   trypsinized,	  
washed	  and	  resuspended	   in	  culture	  media.	  5x105	  cells	   in	  2	  ml	  media	  were	  combined	  with	  
the	   pooled	   transfection	   reagent	   mix	   and	   plated	   onto	   a	   6	   well	   plate.	   Cells	   were	   grown	  
normally	   and	   fresh	   ES	   cell	   media	   added	   at	   24	   h	   after	   initial	   transfection	   and	   every	   24	   h	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thereafter.	   Transfection	   efficiency	   of	   the	   negative	   control	   siRNA	   was	   monitored	   by	  
fluorescence	  microscopy	  at	  24,	  48	  and	  72	  h	  time	  points.	  
For	   each	   siRNA	   time	   point,	   protein	   and	   RNA	   extracts	   were	   harvested	   for	   further	   analysis	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RNAPII	  S2p	   H5	  (MMS-­‐129R)	   Mouse	  (IgM)	   1:500	   Covance	  
RNAPII	  S5p	   CTD4H8	  (MMS-­‐128P)	   Mouse	  (IgG)	   1:200,000	   Covance	  
Non-­‐phosphorylated	  




hybridoma)	   1:200	   Covance	  
RNAPII-­‐S5	  
Glycosylation	   SG8	  
Rat	  (IgG,	  
hybridoma)	   1:10	   Kind	  gift	  from	  Dirk	  Eick	  
RNAPII-­‐T4	  
Glycosylation	   SC7	  
Rat	  (IgG,	  
hybridoma)	   1:10	   Kind	  gift	  from	  Dirk	  Eick	  
RNA	  degradation	  components	  
Exosc3	   15062-­‐1-­‐AP	   Rabbit	  (IgG)	   1:200	   Proteintech	  
Exosc5	   15627-­‐1-­‐AP	   Rabbit	  (IgG)	   1:1000	   Proteintech	  
Exosc7	   A-­‐25	   Rabbit	  (IgG)	   1:100	   Santa	  Cruz	  
Exosc10	   	   Rabbit	  (IgG)	   1:500	   Abcam	  
Xrn2	   Ab72181	   Rabbit	  (IgG)	   1:5000	   Abcam	  
Controls	   	   	   	   	  
PCNA	   ab18197	   Rabbit	   1:5000	   Abcam	  	  
LaminB1	   C-­‐20	  or	  M-­‐20	  (sc-­‐6216/7)	  
Goat	  (IgG)	   1:1500	   Santa	  Cruz	  	  
α-­‐Tubulin	   B-­‐5-­‐1-­‐2	   Mouse	  (IgG)	   1:10000	   Sigma-­‐Aldrich	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Table	  2.3.	  ChIP	  primers	  
Active	  genes	  
β-­‐actin	  promoter	  F	   GCAGGCCTAGTAACCGAGACA	  
β-­‐actin	  promoter	  R	   AGTTTTGGCGATGGGTGCT	  
β-­‐actin	  coding	  F	   TCCTGGCCTCACTGTCCAC	  
β-­‐actin	  coding	  R	   GTCCGCCTAGAAGCACTTGC	  
Oct4	  promoter	  F	   GGCTCTCCAGAGGATGGCTGAG	  
Oct4	  promoter	  R	   TCGGATGCCCCATCGCA	  
Oct4	  coding	  F	   CCTGCAGAAGGAGCTAGAACA	  
Oct4	  coding	  R	   TGTGGAGAAGCAGCTCCTAAG	  
Sox2	  promoter	  F	   CCATCCACCCTTATGTATCCAAG	  
Sox2	  promoter	  R	   CGAAGGAAGTGGGTAAACAGCAC	  
Sox2	  coding	  F	   GGAGCAACGGCAGCTA	  	  
Sox2	  coding	  R	   GTAGCGGTGCATCGGT	  	  
PRC-­‐repressed	  genes	   	  
Math1	  promoter	  F	   CCTTCTTTGACTGGGCAGAC	  
Math1	  promoter	  R	   ACTCGGAGATCGCACACC	  
Math1	  coding	  F	   CCAGTTGCCATTGCTTTAT	  
Math1	  coding	  R	   AGGATACTAGATTTGCAACATTCTT	  
Nkx2.2	  promoter	  F	   CAGGTTCGTGAGTGGAGCCC	  
Nkx2.2	  promoter	  R	   GCGCGGCCTCAGTTTGTAAC	  
Nkx2.2	  	  coding	  F	   AGAGCCCTCGGCTGACGAGT	  
Nkx2.2	  	  coding	  R	   CGTGAGACGGATGAGGCTGG	  
Msx1	  promoter	  F	   ACAGAAAGAAATAGCACAGACCATAAGA	  
Msx1	  promoter	  R	   TTCTACCAAGTTCCAGAGGGACTTT	  
Msx1	  coding	  F	   AGATGGCCGCGAAAC	  
Msx1	  coding	  R	   CCAGAGGCACTGTAGAGTGA	  
Nkx2.9	  promoter	  F	   TGGCACCTTCCGGACTTG	  
Nkx2.9	  promoter	  R	   AAGTGCGAGGCGCTCG	  
Nkx2.9	  coding	  F	   AGCTCTGGTCTCCTGGAACT	  
Nkx2.9	  coding	  R	   GTGTGTGTTTGCCGGTTAG	  
Mash1	  promoter	  F	  	   CCAGGCTGGAGCAAGGGA	  
Mash1	  promoter	  R	   CGGTTGGCTTCGGGAGC	  
Mash1	  coding	  F	   CCAGAATGACTTCAGCACCA	  
Mash1	  coding	  R	   AGGCAACCTATGGGAACCAA	  
Cdx2	  promoter	  F	   GGACTCCGCGAGCCAA	  
Cdx2	  promoter	  R	   CTCAGCCCACGGTGCTC	  
Cdx2	  coding	  F	   CCAATGACTGATGGATTGTAGTT	  
Cdx2	  coding	  R	   GCTCACTTTTCCTCCTGATG	  
HoxA7	  promoter	  F	   GAGAGGTGGGCAAAGAGTGG	  
HoxA7	  promoter	  R	   CCGACAACCTCATACCTATTCCTG	  
HoxA7	  coding	  F	   CTGGACCTTGATGCTTCTAACT	  
HoxA7	  coding	  R	   AGCCAGAGAAAGAGGGATTCTA	  	  
Flk1	  promoter	  F	   CCACCCCTCCCGGTAA	  
Flk1	  promoter	  R	   GGTCCGCGCGATCTAA	  
Flk1	  coding	  F	   TTCATGGACCCAAAGACTAC	  
Flk1	  coding	  R	   GTTCTCGGTGATGTACACG	  
Gata4	  promoter	  F	   AAGAGCGCTTGCGTCTCTA	  
Gata4	  promoter	  R	   TTGCTAGCCTCAGATCTACGG	  
Gata4	  coding	  F	   TTGCACATTAACACCACACGTATA	  
Gata4	  coding	  R	   CCACCATTCAATTTTTAAGTCAAGTA	  
Silent	  genes	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Gata1	  promoter	  F	   AGAGGAGGGAGAAGGTGAGTG	  
Gata1	  promoter	  R	   AGCCACCTTAGTGGTATGACG	  
Gata1	  coding	  F	   TGGATTTTCCTGGTCTAGGG	  
Gata1	  coding	  R	   GTAGGCCTCAGCTTCTCTGTAGTA	  
Myf5	  promoter	  F	   GGAGATCCGTGCGTTAAGAATCC	  
Myf5	  promoter	  R	   CGGTAGCAAGACATTAAAGTTCCGTA	  	  
Myf5	  coding	  F	   GATTGCTTGTCCAGCATTGT	  
Myf5	  coding	  R	   AGTGATCATCGGGAGAGAGTT	  
λ5	  promoter	  	   AGGCCCTAACAGCTTCATCTACTC	  
λ5	  promoter	  	  	   GCATCTGGGCCTCGGTTTA	  
λ5	  HS2	  	   ACCCAGTAAGCAAGTTTTCA	  
λ5	  HS2	  	   ATAAGCTCTCCTCCCTCAAG	  
Sequences	  in	  5’	  to	  3’	  orientation.	  
	  
Table.	  2.5.	  Primers	  to	  detect	  transcripts	  at	  the	  5’	  ends	  of	  genes	  (all	  RNAs).	  
Active	  genes	  
β-­‐actin	  F	   CCACCCGCGAGCACA	  
β-­‐actin	  R	   CCGGCGTCCCTGCTTAC	  
Oct4	  F	  	  	   TGAGCCGTCTTTCCACCA	  
Oct4	  R	   TGAGCCTGGTCCGATTCC	  
Btg2	  F	   GTATGAGCCACGGGAAGAGA	  
Btg2	  R	   CGCCCTACTGAAAACCTTGA	  
Slc19a2	  F	   CCAGGGTGTCCAGACGAG	  
Slc19a2	  R	   GAAGGTAGGGCGTGAGGAAC	  
Tmem19	  F	   ATCCTCCCTGCACCTTCTTT	  
Tmem19	  R	   CACCAACCGAACGACAAAAT	  
Insl6	  F	   TCTTGTCTGTTGTGGCTTGG	  
Insl6	  R	   GACTTTGCTCCTCCATCTCG	  
Ints4	  F	   GAGGCCTCTCTATCCAGCAA	  
Ints4	  R	   CCTCATACACCCGCTTTTTC	  
PRC-­‐repressed	  genes	   	  
Math1	  F	  	   TGTGCGATCTCCGAGTGA	  
Math1	  R	  	   CTCGGAGGTGCCGTGTTA	  
Nkx2.2	  F	   CGCTGCGCAGACTCTCCTCT	  
Nkx2.2	  R	   GAAGAGAAGCGCATCAGGCG	  
Msx1	  F	   CGCTCGAGTTGGCCTTCT	  
Msx1	  R	   CGGAGTCCTCCACTTTGACAC	  
Nkx2.9	  F	   GTGCGCAGCCTCCTGAAT	  
Nkx2.9	  R	   GGTCCCTCCTCCGCACTC	  
Cdx2	  F	   ATCCCCGCCTCTACAGCTTACT	  
Cdx2	  R	   CGCAGGGGGCTAGAGATAAA	  
HoxA7	  F	   GAGAGGTGGGCAAAGAGTGG	  
HoxA7	  R	   CCGACAACCTCATACCTATTCCTG	  
Gata4	  F	   GGACTCACGGAGATCGCG	  
Gata4	  R	   GGACTCGGGGAACCCTACC	  
Serpine2	  F	   CCGGCTAGTGCAGTGGTT	  
Serpine2	  R	   TGAACTGGGAGTGCACAGAG	  
Gatm	  F	   AGCTTGGCGACTAGGACCTT	  
Gatm	  R	   CCGAGAGCCGATGTAGTGC	  
Dazl	  F	   GTGGGCTCTCTTTCCACCAC	  
Dazl	  R	   GAGTTCGGGTGGTAAAACCTC	  
Chapter	  2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Materials	  and	  Methods	  
	  
63	  
Pitx1	  F	   CAGATCAGCGTCGGACGATT	  
Pitx1	  R	   CACCACCACCGCACGAC	  
Fgf5	  F	   GAGCCAGCCCTGCAAGAT	  
Fgf5	  R	   GACGCTTCTCCCCGTGA	  
Gata5	  F	   CGGTTCCCGAAGAGTGCAG	  
Gata5	  R	   CTCGCGCGGGGAAAA	  
Lrat	  F	   AGAGCCAGGAGAGCAAGAGAT	  
Lrat	  R	   CCAGGCACACTACCTCTTCA	  
PRC-­‐active	  genes	   	  
Plk2	  F	   GAGCTCCTGCGGACTATCAC	  
Plk2	  R	   CGGTCGCTTCTTCTTTGAGT	  
Serinc5	  F	   GAAGCAAGACGAGCTTCTTCA	  
Serinc5	  R	   ACAGCACCGGGCAGACAT	  
Id2	  F	   CTCCAAGCTCAAGGAACTGG	  
Id2	  R	   AGGCTGACGATAGTGGGATG	  
Ccnd1	  F	   GCGTACCCTGACACCAATCT	  
Ccnd1	  R	   ATCTCCTTCTGCACGCACTT	  
Vav2	  F	   AGCGGACTTGTGTGTGTGAA	  
Vav2	  R	   CTCCTCCTCTTCGGGCTACT	  
Dmrt2a	  F	   TGTTGGACTGCTGTGTTCCT	  
Dmrt2a	  R	   CTCTTGGCCTCGTCCCTCT	  
Silent	  genes	   	  
Myf5	  F	   GGAATATATAAAGAGCCCCAACC	  
Myf5	  R	   TTTGGGACTGTCTCTCTGTAATTAAC	  
Nmur2	  F	   ACAGAGCCTCAAGAGCAAGG	  
Nmur2	  R	   TCAGCGCATAGACCACAGAC	  
Gabra6	  F	   CGGTCACCCTCCTGTTTTTA	  
Gabra6	  R	   CGTTTTTCTGGCAAACCATT	  
Clec3a	  F	   CAGAGCAAGATGTGGCTTCA	  
Clec3a	  R	   GTCGGTCTGGTCCAGGAGTA	  
Klri2	  F	   CCCTCGAAGACAGACCAGAG	  
Klri2	  R	   CTATTCCTTTGCCCACATCG	  
Nhlh1	  F	   CCCTTTTGCCTAGGCCTTAC	  
Nhlh1	  R	   AGCGTAGAGAGCCCCAGTCT	  
Sequences	  in	  5’	  to	  3’	  orientation.	  
	  
Table.	  2.5.	  Primers	  to	  detect	  primary	  RNA	  transcripts;	  exon-­‐intron	  primers	  
Active	  genes	  
β-­‐actin	  F	   GATATCGCTGCGCTGGTC	  
β-­‐actin	  R	   CATCGATCCCCAAGAAAACC	  
Oct4	  F	   CACGAGTGGAAAGCAACTCA	  
Oct4	  R	   TCTAGTCCACACTGCGTCGT	  
Rpp38	  F	   TGGTAGTGACCGAGTTGCTG	  
Rpp38	  R	   GAGACCAGCCGGAAAGAAC	  
PRC-­‐repressed	  genes	   	  
Math1	  F	   GGAGAAGCTTCGTTGCACGC	  
Math1	  R	   GGGACATCGCACTGCAATGG	  
Nkx2.2	  F	   TCTACGACAGCAGCGACAACC	  
Nkx2.2	  R	   GCGGCCAAGTTTCGCTACTTA	  
Msx1	  F	   TCCTCAAGCTGCCAGAAGAT	  
Msx1	  R	   CATCCAGGGCTGGCTACTTA	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Nkx2.9	  F	   GCCACTACCTGTGTGAGTGAGC	  
Nkx2.9	  R	   CAGAGCTTCGCGCTTGC	  
Cdx2	  F	   AAACCTGTGCGAGTGGATG	  
Cdx2	  R	   CCACCTGTATTTCCCCCTTT	  
HoxA7	  F	   GACGAGGGCGTGCTTCA	  
HoxA7	  R	   CCCGCCGACCACTGAG	  
Gata4	  F	   AACCGTGTGGTGAGGTTCTC	  
Gata4	  R	   CTGGTCTCGAACACCCTGAG	  
Silent	  genes	   	  
Myf5	  F	   AACCAGAGACTCCCCAAGGT	  
Myf5	  R	   CGGCTCTTAAAGCAATGGTC	  
Gabra6	  F	   TCTCCCCTGGCTCTTCATTA	  
Gabra6	  R	   CCAGCCACACTATCCCTCTT	  
Sequences	  in	  5’	  to	  3’	  orientation.	  
	  
Table.	  2.6.	  Expression	  primers	  to	  detect	  spliced	  transcripts;	  exon-­‐exon	  primers	  
House-­‐keeping	  genes	  
β-­‐actin	  F	   TCTTTGCAGCTCCTTCGTTG	  
β-­‐actin	  R	   ACGATGGAGGGGAATACAGC	  
UBC	  F	   AGGAGGCTGATGAAGGAGCTTGA	  
UBC	  R	   TGGTTTGAATGGATACTCTGCTGGA	  
G6PD	  (5)	   CGACAGTTGATTGGAGCTCTG	  
G6PD	  (3)	   AGCCACATGAATGCCCTGCAC	  
Pluripotency	  genes	   	  
Oct4	  F	   ACCTCAGGTTGGACTGGGCCTA	  
Oct4	  R	   GCCTCGAAGCGACAGATGGT	  
Nanog	  F	   AATTCTGGGAACGCCTCAT	  
Nanog	  R	   TTGTTTGGGACTGGTAGAAGAATC	  
Sox2	  F	   CATGTGAGGGCTGGACTGCG	  
Sox2	  R	   GCTGTCGTTTCGCTGCGG	  
PRC-­‐repressed	  genes	   	  
Math1	  F	   GGAGAAGCTTCGTTGCACGC	  
Math1	  R	   GGGACATCGCACTGCAATGG	  
Nkx2.2	  F	   TGTGCAGAGCCTGCCCCTTAA	  
Nkx2.2	  R	   GCCCTGGGTCTCCTTGTCAT	  
Msx1	  F	   GCCTCTCGGCCATTTCTCAG	  
Msx1	  R	   CGGTTGGTCTTGTGCTTGCG	  
Nkx2.9	  F	   GGCCACCTCTGGACGCCTCG	  
Nkx2.9	  R	   GCCAGCTGCGACGAGTCTGC	  
Mash1	  F	   TGGAGACGCTGCGCTCGGC	  
Mash1	  R	   CGTTGCTTCAATGGAGGCAAATG	  
Cdx2	  F	   CAGCCGCCGCCACAACCTTCCC	  	  
Cdx2	  R	   TGGCTCAGCCTGGGATTGCT	  
HoxA7	  F	  	   AAGCCAGTTTCCGCATCTACC	  	  
HoxA7	  R	   GTAGCGGTTGAAATGGAATTCC	  
Gata4	  F	   GAGGCTCAGCCGCAGTTGCAG	  
Gata4	  R	   CGGCTAAAGAAGCCTAGTCCTTGCTT	  
Silent	  genes	   	  
Gata1	  F	   GTCCTCACCATCAGATTCCACAG	  
Gata1	  R	   AGTGGATACACCTGAAAGACTGGG	  
Myf5	  F	   GGAGATCCTCAGGAATGCCATCCGC	  
Myf5	  R	   GACGTGATCCGATCCACAATGCTGG	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3 Genome-­‐wide	   mapping	   of	   nascent	   RNAs	   associated	   with	   chromatin-­‐
bound	  RNA	  polymerase	  II	  	  
3.1 Introduction	  
To	  study	  in	  detail	  the	  transcriptional	  activity	  of	  RNAPII	  complexes,	  in	  particular	  the	  activity	  of	  
RNAPII	   at	   Polycomb-­‐repressed	   genes	   in	   ES	   cells,	   I	   chose	   to	   isolate	   nascent	   RNA	   bound	   to	  
RNAPII	   on	   chromatin	   from	   ES	   cells,	   using	   a	   method	   called	   RNA	   chromatin	  
immunoprecipitation	   (RNA-­‐ChIP;	   (Bittencourt	   et	   al.,	   2008)).	   The	   original	   method	   was	  
adapted	  for	  genome-­‐wide	  analysis.	  
3.1.1 RNA	  Chromatin	  Immunoprecipitation	  (RNA-­‐ChIP)	  
RNA	   Chromatin	   Immunoprecipitation	   (RNA-­‐ChIP)	   is	   a	  method	   to	   study	   association	   of	   RNA	  
with	   proteins	   of	   interest	   from	  a	   chromatin	   preparation;	   it	   has	   been	   applied	   to	   study	  RNA	  
associated	  with	  polycomb	  proteins	  (Zhao	  et	  al.,	  2010),	  a	  DNA	  methyltransferase	  (Sun	  et	  al.,	  
2006),	  and	  RNAPII	  to	  investigate	  nascent	  transcription	  and	  splicing	  in	  human	  cancer	  cell	  lines	  
and	  yeast	  (Bittencourt	  et	  al.,	  2008;	  Churchman	  and	  Weissman,	  2011)	  among	  others.	  In	  RNA-­‐
ChIP,	   cells	   are	   crosslinked	   and	   sonicated.	   After	   immunoprecipitation	   with	   antibodies	   of	  
interest,	   complexes	   are	   reverse	   crosslinked,	   associated	   RNA	   extracted	   and	   amplified	   by	  
reverse	  transcription,	  and	  analysed	  by	  RT-­‐PCR.	  It	  is	  equivalent	  to	  DNA-­‐ChIP,	  except	  that	  RNA	  
is	   extracted	   to	   find	   the	   transcripts	   associated	  with	   the	   protein	   of	   interest.	   Capturing	   RNA	  
associated	  with	  RNAPII	  at	  the	  level	  of	  chromatin	  gives	  the	  best	  chance	  of	  detecting	  the	  most	  
complete	   population	   of	   nascent	   transcripts	   in	   the	   cell,	   as	   any	   RNAs	   quickly	   degraded	  
immediately	  after	  release	  will	  be	  detected	  while	  still	  associated	  with	  RNAP.	  	  
3.1.2 RNAPII	  transcription	  at	  active	  and	  Polycomb-­‐repressed	  chromatin	  in	  ES	  cells	  
Transcription	  in	  ES	  cells	  has	  been	  interrogated	  by	  several	  approaches,	   including	  microarray	  
and	  NGS	  analyses	  of	  mRNA	  populations	  (Cloonan	  et	  al.,	  2008;	  Efroni	  et	  al.,	  2008;	  Rosenkranz	  
et	  al.,	  2008;	  Brookes	  et	  al.,	  2012;	  Marks	  et	  al.,	  2012),	   total	  RNA	  populations	   (Dinger	  et	  al.,	  
2008;	  Seila	  et	  al.,	  2008),	  miRNA	  (Calabrese	  et	  al.,	  2007)	  and	  indirectly	  by	  analysis	  of	  engaged	  
RNAPII	  (Min	  et	  al.,	  2011)	  and	  RNAPII	  phospho-­‐isoforms	  (Brookes	  et	  al.,	  2012).	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Previous	  ChIP-­‐seq	  analyses	  using	  antibodies	  against	  various	  forms	  of	  RNAPII	  phosphorylation	  
show	   that	   RNAPII-­‐S5p	   associates	  with	   promoters	   of	   active	   genes,	   extends	   through	   coding	  
regions	   and	   accumulates	   immediately	   downstream	   of	   the	   transcription	   end	   site.	   At	  
Polycomb	   target	   genes,	   RNAPII-­‐S5p	   is	   abundantly	   associated	  with	   promoters	   and	   through	  
coding	  regions	  but	  is	  not	  detected	  after	  transcription	  end	  sites.	  Sequential	  ChIP	  experiments	  
show	   that	  Polycomb	   target	  genes	  are	   simultaneously	  associated	  with	  Polycomb	  repressive	  
complexes	   (PRCs)	   and	   RNAPII-­‐S5p,	   suggesting	   that	   transcripts	   could	   be	   enriched	   by	  
immunoprecipitating	  PRC	  proteins.	   Low	   level	   transcription	  and	   splicing	  of	   first	   introns	  was	  
detected	  at	  a	  cohort	  of	  Polycomb	  target	  genes	  (Stock	  et	  al.,	  2007),	  but	  no	  additional	  detailed	  
information	  is	  available	  for	  nascent	  RNA	  associated	  with	  RNAPII	  complexes,	  present	  at	  PRC-­‐
repressed	  genes	  in	  ES	  cells.	  
	  
The	  mechanisms	  by	  which	  RNAPII	  and	  PRCs	  co-­‐exist	  and	  regulate	  repression	  in	  ES	  cells	  can	  
be	  unraveled	  by	  studying	  the	  properties	  of	  the	  associated	  transcripts	  including	  TSS	  mapping	  
by	  CAGE	  and	  transcription	  direction,	  abundance	  and	  regulatory	  transcription	  around	  protein	  
coding	  genes,	  by	  nascent	  RNA-­‐seq.	  	  
3.1.3 Aims	  
I	   set	   out	   to	   explore	   RNAPII-­‐dependent	   nascent	   transcription	   in	   ES	   cells	   using	   RNA-­‐ChIP,	   a	  
technique	   that	   captures	   RNA	   bound	   to	   chromatin	   associated	  with	   a	   protein	   of	   interest.	   I	  
chose	  to	  immunoprecipitate	  chromatin	  using	  antibodies	  that	  recognize	  RNAPII-­‐S5p,	  present	  
at	   both	   active	   and	   PRC-­‐repressed	   genes	   in	   ES	   cells,	   and	   antibodies	   against	   the	   enzymatic	  
components	   of	   Polycomb.	   This	   chapter	   first	   describes	   the	   optimization	   of	   RNA-­‐ChIP	   in	   ES	  
cells	  and	  summarises	  all	  RNA-­‐ChIP	  datasets	  produced.	  Second,	  it	  investigates	  the	  mapping	  of	  
chromatin-­‐bound	   RNAs	   associated	   with	   RNAPII-­‐S5p	   at	   active	   genes.	   The	   study	   of	   RNAs	  
detected	  at	  Polycomb	  target	  genes	  and	  results	  obtained	  with	  other	  RNA-­‐ChIP	  datasets	  are	  
discussed	  in	  Chapter	  4.	  	  
	  
Initially,	   I	   optimised	   RNA-­‐ChIP	   at	   single	   genes	   in	   ES	   cells	   by	   RT-­‐PCR,	   after	   RNA	  
immunoprecipitation	   using	   specific	   RNAPII	   antibodies	   to	   capture	   and	   enrich	   chromatin-­‐
bound	   RNA.	   Transcription	   inhibition	   with	   chemical	   inhibitors	   was	   used	   to	   confirm	   that	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transcripts	  identified	  were	  newly	  made.	  Finally,	  the	  RNA-­‐ChIP	  technique	  was	  adapted	  to	  map	  
RNA	   genome	   wide,	   using	   next-­‐generation	   sequencing	   (NGS).	   Genome-­‐wide	   mRNA	  
expression	  datasets	  were	  also	  produced	  and	  analysed	  in	  parallel.	  	  
	  
NGS	  libraries	  were	  sequenced	  at	  the	  MRC-­‐CSC	  Genomics	  Facility.	  Raw	  sequencing	  files	  were	  
processed	  and	  UCSC	  compatible	  files	  generated	  by	  A.Geiss	  (MRC	  Genomics	  Laboratory).	  All	  
bioinformatic	  analyses	  were	  performed	  by	  I.de.	  Santiago	  (our	  laboratory)	  and	  Robert	  Beagrie	  
(our	  laboratory).	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3.2.1 DNA-­‐ChIP	  using	  RNAPII	  antibodies	  at	  active,	  poised	  and	  silent	  genes	  
Before	  optimising	  the	  conditions	  for	  RNA-­‐ChIP	  using	  RNAPII	  and	  PRC	  antibodies,	  I	  started	  by	  
reproducing	  previous	  DNA-­‐ChIP	  analyses	  of	  RNAPII	  occupancy	  at	  active	  and	  PRC-­‐repressed	  
genes	   (Stock	   et	   al.,	   2007;	   Brookes	   et	   al.,	   2012).	   I	   began	   by	   using	   well-­‐characterized	  
antibodies	  against	  two	  extensively	  studied	  RNAPII	  modifications,	  S5p	  and	  S2p	  (Fig.	  3.1;	  Stock	  
et	  al.,	  2007).	  RNAPII-­‐S5p	  is	  a	  mark	  of	  transcription	  initiation,	  which	  is	  highly	  enriched	  at	  the	  
promoters	   of	   active	   and	   PRC-­‐repressed	   genes	   in	   ES	   cells,	   whereas	   RNAPII-­‐S2p	   marks	  
transcriptional	  elongation	  and	  is	  associated	  with	  the	  coding	  regions	  of	  active	  genes.	  
	  
In	  agreement	  with	  published	  data	  (Stock	  et	  al.,	  2007;	  Brookes	  et	  al.,	  2012),	  RNAPII-­‐S5p	  was	  
found	  enriched	  at	  promoters	  and	  coding	  regions	  of	  active	  and	  PRC-­‐repressed	  genes,	  while	  
absent	   at	   silent	   genes	   (Fig.	   3.1).	   Enrichment	   for	   RNAPII-­‐S5p	   at	   a	   panel	   of	   PRC-­‐repressed	  
genes	   is	   as	  high	  as	  at	   active	  genes.	  RNAPII-­‐S2p	   is	   found	  at	  active	  gene	  promoters	  with	  an	  
increased	  occupancy	  through	  coding	  regions,	  but	  not	  at	  PRC-­‐repressed	  or	  silent	  genes	  (Fig.	  
3.1).	   Mock	   ‘IgG’	   control	   IPs	   show	   no	   detectable	   enrichment	   compared	   with	   S5p	   or	   S2p	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Figure	  3.1	  RNAPII	  binding	  at	  active	  and	  PRC-­‐repressed	  genes	  in	  ES	  cells.	  Binding	  of	  different	  phosphorylated	  
forms	  of	  RNAPII	  (S5p	  and	  S2p)	  to	  active,	  PRC-­‐repressed	  and	  silent	  genes	  in	  ES-­‐OS25	  cells	  was	  assessed	  by	  DNA-­‐
ChIP	  and	  RT-­‐PCR	  at	  promoters	  (blue	  bars)	  and	  coding	  regions	  (red	  bars).	  Background	  levels	  (mean	  enrichment	  
from	  control	  antibodies	  and	  beads	  alone)	  at	  promoter	  and	  coding	  regions	  are	  shown	  as	  burgundy	  or	  light	  blue	  
bars,	  respectively.	  Active	  and	  PRC-­‐repressed	  genes	  are	  marked	  by	  RNAPII-­‐S5p	  at	  promoters	  and	  coding	  regions.	  
RNAPII-­‐S2p	  marks	  active	  genes,	  but	  not	  PRC-­‐repressed	  genes,	  at	  promoter	  regions	  with	  abundance	  increasing	  
from	   promoters	   into	   coding	   regions. Enrichment	   is	   expressed	   relative	   to	   input	   DNA	   using	   the	   same	   total	  
amount	   of	   DNA	   in	   the	   PCR.	   Mean	   and	   standard	   deviations	   are	   presented	   from	   3	   independent	   biological	  
replicates.	  
 
3.2.2 RNAPII	  RNA-­‐ChIP	  Optimisation	  
With	  the	  aim	  to	  study	  nascent	  transcription	  in	  ES	  cells,	  I	  optimised	  RNA-­‐ChIP	  to	  enrich	  for	  
chromatin-­‐bound	  RNA	  associated	  with	  RNAPII.	  RNA-­‐ChIP	  with	  RNAPII	  antibodies	  enriches	  for	  
nascent	  RNA	  from	  coding	  and	  non-­‐coding	  transcription,	  but	  may	  also	  result	  in	  the	  
immunoprecipitation	  of	  any	  structural	  RNA	  co-­‐associated	  with	  RNAPII	  bound	  at	  chromatin.	  
The	  RNAPII	  RNA-­‐ChIP	  protocol	  ( 
Figure 3.2)	   is	   similar	   to	   RNAPII	   DNA-­‐ChIP,	   with	   a	   few	  modifications,	   such	   as	   inclusion	   of	  
RNAse	   inhibitors	   to	   protect	   from	   RNA	   degradation.	   Chromatin	   is	   formaldehyde-­‐fixed	  
therefore	  crosslinking	  RNA-­‐protein	   interactions	  as	  well	  as	  DNA-­‐protein	  and	  protein-­‐protein	  
interactions.	   I	  optimised	  crucial	   steps,	   listed	   in	  Table	  3.1,	   to	  allow	  protection	  and	  efficient	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Figure	  3.2	  Flow	  diagram	  of	  RNA-­‐ChIP	  method	  to	  isolate	  chromatin-­‐bound	  RNA	  associated	  with	  a	  protein	  of	  
interest.	   	  ES-­‐OS25	  cells	  are	  fixed	  with	  formaldehyde	  followed	  by	  nuclear	   isolation	  and	  chromatin	  shearing	  by	  
sonication.	   Antibodies	   are	   used	   to	   immunoprecipitate	   chromatin	   associated	   with	   proteins	   of	   interest	   and	  
associated	  RNA.	  Reverse	  crosslinking	  and	  protein	  digestion	  are	   followed	  by	  either	  DNA	  extraction	   to	  analyse	  
binding	   regions	   of	   the	   protein	   (DNA-­‐ChIP),	   or	   RNA	   extraction	   to	   isolate	   associated	   transcripts	   (RNA-­‐ChIP).	  
Different	  extraction	  procedures	  are	  used	  for	  DNA	  and	  RNA.	  The	  RNA	  population	  is	  studied	  by	  quantitative	  RT-­‐
PCR,	  for	  single	  genes,	  or	  genome-­‐wide	  by	  RNA	  sequencing.	  	  
	  
Table	  3.1	  Optimisation	  of	  the	  RNA-­‐ChIP	  protocol.	  
	  
RNA-­‐ChIP	  conditions	  optimised	  




DNase	  treatment	  (DNA-­‐free,	  Ambion)	  
2U/rxn	  DNase,	  30min	  
4U/rxn	  DNase,	  30min	  
RNA	  Extraction	  
Phenol:Chloroform	  pH	  8.0	  
TRIzol	  pH	  4.5	  
Acid	  Phenol:Chloroform	  pH	  4.5	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An	   example	   of	   optimization	   is	   shown	   in	   Fig.	   3.3.	   After	   RNAPII-­‐S5p	   RNA-­‐ChIP,	  
immunoprecipitated	  chromatin	  was	  reverse	  crosslinked	  for	  4	  h	  or	  overnight,	  DNAse	  I	  treated	  
prior	   to	  RNA	  extraction	  and	  analysed	  by	  RT-­‐PCR.	  Active	  and	  PRC-­‐repressed	   transcripts	   are	  
detected	  more	  abundantly	  after	  4	  h	  and	  depleted	  after	  overnight	   incubation,	   likely	  due	  to	  
heat	   degradation	   (Fig	   3.3A).	   Transcripts	   detected	   by	   RNAPII	   RNA-­‐ChIP	   are	   not	   DNA	  
contaminants,	  as	  shown	  by	  no	  product	  detected	  when	  reverse	  transcription	  is	  performed	  in	  
the	   absence	  of	   enzyme	   (Fig.	   3.3B).	   Additional	   steps	   of	   optimisation	   included	   extraction	  of	  
RNA	  using	  acid	  phenol-­‐chloroform	  (pH	  4.5)	  to	  separate	  RNA	  in	  the	  aqueous	  phase	  and	  DNA	  
in	  the	  organic	  phase,	  as	  opposed	  to	  phenol-­‐chloroform	  (pH>7),	  which	  retains	  all	  nucleic	  acid	  




Figure	   3.3	   Reverse	   crosslinking	   incubation	   is	   crucial	   to	   maintain	   RNA	   integrity.	   (A)	   Reverse	   crosslinking	  
(200mM	  NaCl,	   65°C)	  was	   tested	  on	  RNAPII-­‐S5p	  RNA-­‐ChIP	   immunoprecipitates	  and	  on	   total	   chromatin	   for	  4h	  
(dark	  purple)	  or	  overnight	  (O/N,	  light	  purple).	  RNA	  was	  measured	  by	  RT-­‐PCR	  using	  primers	  at	  the	  first	  exon	  of	  
genes	   to	   detect	   total	   transcripts,	   from	   active,	   PRC-­‐repressed	   and	   a	   silent	   gene.	   Transcripts	   more	   strongly	  
detected	  at	  active	  and	  PRC-­‐repressed	  genes	  after	  4h	  incubation	  at	  65°C	  than	  O/N.	  Levels	  from	  mock	  IP	  (Control	  
Ab)	  are	  shown	  as	  dark	  grey	  bars	  and	  demonstrate	  specificity	  of	   immunoprecipitation.	  (B)	  DNA	  contamination	  
was	  assessed	  at	  an	  active	   (βactin),	  PRC-­‐repressed	  (Math1)	  and	  silent	  gene	  (Myf5)	  on	  a	  2%	  agarose	  gel.	  Total	  
chromatin	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	  products	  from	  RT-­‐PCR	  were	  run	  alongside	  reactions	  performed	  in	  parallel	  
in	   the	   absence	   of	   reverse	   transcriptase	   in	   the	   cDNA	   reaction	   prior	   to	   RT-­‐PCR	   (-­‐RT).	   No	   product	   bands	   are	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3.2.3 Chromatin-­‐bound	  RNA	  can	  be	  detected	  after	  RNA-­‐ChIP	  using	  RNAPII	  antibodies	  
To	  further	  optimize	  RNAPII	  RNA-­‐ChIP,	  I	  used	  antibodies	  specific	  for	  RNAPII-­‐S5p,	  RNAPII-­‐S2p	  
and	   8WG16;	   the	   latter	   antibody	   binds	   unphosphorylated	   S2	   residues	   of	   the	   RNAPII	   CTD	  
(Stock	  et	  al.,	  2007;	  Fig.	  2.1).	  8WG16	  is	  a	  marker	  of	  active	  genes	  but	  its	  binding	  is	  sensitive	  to	  
CTD	  phosphorylation	  (Stock	  et	  al.,	  2007).	  RNA	  purified	  after	  RNA-­‐ChIP	  was	  analysed	  by	  RT-­‐
PCR	  (Fig.	  3.4).	  To	  detect	  RNA	  molecules	  irrespectively	  of	  splicing,	  primers	  were	  designed	  at	  
the	  5’	  end	  of	  transcripts,	  excluding	  intron-­‐exon	  junctions.	  	  
	  
Control	  RNA-­‐ChIP	  experiments	   included	  RNA	  extraction	  from	  total	  chromatin,	  a	  mock	   ‘IgG’	  
IP,	   and	   performing	   RNA-­‐ChIP	   with	   chromatin	   prepared	   from	   cells	   treated	   with	   two	  
transcriptional	  inhibitors,	  flavopiridol	  or	  α-­‐amanitin.	  Flavopiridol	  inhibits	  CDK9,	  a	  kinase	  that	  
phosphorylates	  RNAPII	  S2	  residues	  as	  well	  as	  RNAPII	  pausing	  factors	  NELF	  and	  DSIF	  (Peterlin	  
and	  Price,	  2006).	  Inhibition	  of	  CDK9	  decreases	  nascent	  transcript	  levels	  measured	  by	  nuclear	  
run-­‐on	   assays	   and	   is	   thought	   to	   prevent	   RNAPII	   elongation	   (Chao	   and	   Price,	   2001).	   α-­‐
Amanitin	   binds	   the	   active	   enzymatic	   site	   of	   RNAPII	   directly	   and	   inhibits	   nucleotide	  
incorporation	   into	  the	  nascent	  transcript,	   resulting	   in	  stalling	  of	  RNAPII	  and	  recruitment	  of	  
the	   proteosome	   for	   degradation	   (Nguyen	   et	   al.,	   1996).	   Flavopiridol	   treatments	   were	  
restricted	  to	  1h,	  in	  which	  RNAPII-­‐S2p	  is	  depleted	  with	  minimal	  effect	  on	  S5p	  or	  total	  RNAPII,	  
as	  shown	  by	  western	  analysis	  (Stock	  et	  al.,	  2007).	  Treatment	  with	  α-­‐amanitin	  was	  7h,	  due	  to	  
lower	  cell	  permeability	  of	  ES	  cells	  to	  this	  drug	  as	  previously	  optimised	  (Stock	  et	  al.,	  2007).	  
	  
RNA-­‐ChIP	  with	  RNAPII-­‐S5p	  antibodies	  enriches	  for	  RNA	  from	  active	  genes	  (βactin,	  Sox2	  and	  
Oct4)	  above	  RNA	  levels	  detected	  in	  total	  chromatin	  or	  in	  mock	  ‘IgG’	  IPs	  (Fig	  3.4A,B).	  Active	  
gene	  transcripts	  are	  highly	  sensitive	  to	  transcriptional	  inhibitors	  flavopiridol	  and	  α-­‐amanitin,	  
whereas	  no	  transcripts	  were	  detected	  at	  silent	  genes	  Gabra6	  and	  Myf5	  (Fig	  3.4A,	  B).	  In	  the	  
presence	   of	   flavopiridol,	  βactin	   and	   Oct4	  RNA	   decrease	   to	   background	   levels,	   while	   Sox2	  
RNA	  is	  depleted	  by	  ~5	  fold	  but	  is	  still	  detected	  at	  higher	  levels	  than	  those	  found	  with	  total	  
chromatin	  or	  in	  the	  mock	  ‘IgG’	  IP	  (Fig.	  3.4A).	  Sox2	  is	  a	  small	  intron-­‐less	  gene,	  which	  is	  highly	  
active	   in	   ES	   cells	   and	   required	   for	   pluripotency.	   It	   is	   found	   embedded	   in	   a	   lncRNA	   intron	  
(Sox2ot)	  which	  is	  transcribed	  in	  ES	  cells,	  during	  differentiation	  and	  vertebrate	  development	  
(Amaral	  et	  al.,	  2009).	  This	  complex	  regulation	  and	  the	  presence	  of	  Sox2ot	  may	  explain	  why	  a	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stronger	   depletion	   is	   not	   observed	   with	   Sox2	   primers,	   which	   will	   also	   amplify	   RNA	   from	  
Sox2ot.	   The	   positive	   detection	   of	   RNA	   and	   their	   relative	   levels	   are	   highly	   reproducible	  
between	   independent	   replicate	   experiments.	   Sensitivity	   of	   RNA	   to	   short	   (1h)	   treatments	  
with	   flavopiridol	   suggests	   that	   the	   RNA	   extracted	   after	   RNA-­‐ChIP	   with	   RNAPII-­‐S5p	  
corresponds	   to	  RNA	   transcribed	  within	   the	   last	   hour	  before	   chromatin	   crosslinking.	   In	   the	  
presence	   of	   α-­‐amanitin,	   βactin	   RNA	   is	   also	   depleted	   to	   background	   levels	   and	   Sox2	  
decreases	  by	  ~10	  fold	  (Fig.	  3.4B).	  	  
	  
Nascent	  RNA	  detection	  after	  RNA-­‐ChIP	  was	  also	  possible	  with	  antibodies	  specific	  for	  RNAPII-­‐
S2p	   (Fig.	   3.4C)	   or	   unphosphorylated	   S2	   residues	   (8WG16;	   Fig	   3.4D).	   Enrichment	   for	  
transcripts	   from	   active	   genes,	   but	   not	   silent	   genes,	   is	   robustly	   observed	   above	   levels	  
detected	  in	  total	  chromatin	  or	  after	  mock	  IP,	  in	  accordance	  with	  presence	  of	  RNAPII-­‐S2p	  and	  
RNAPII-­‐8WG16	  at	  active	  but	  not	  silent	  genes	  in	  ES	  cells	  (Fig.	  3.1;	  Stock	  et	  al.,	  2007,	  Brookes	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Figure	   3.4	   Chromatin-­‐bound	   RNA	   is	   detected	   by	   RNAPII	   RNA-­‐ChIP	   and	   is	   sensitive	   to	   flavopiridol	   and	   α-­‐
amanitin.	  Transcripts	  associated	  with	  different	  RNAPII	  phospho-­‐isoforms	  bound	  to	  chromatin	  were	  assessed	  by	  
RNA-­‐ChIP	  and	  quantitative	  RT-­‐PCR,	  at	  active	  and	  silent	  genes.	  Levels	  of	  RNA	  from	  RNAPII-­‐S5p	  RNA-­‐ChIP,	  with	  or	  
without	   transcription	   inhibitors,	   are	   shown	   as	   white	   and	   blue	   bars,	   respectively.	   RNA	   extracted	   from	   total	  
chromatin	   is	   shown	   in	   light	   grey.	   No	   antibody	   or	  mock	   ‘IgG’	   controls	   are	   shown	   in	   dark	   grey.	   Primers	  were	  
designed	  within	  5’	  exonic	   regions	   to	  capture	   total	  RNA	  populations.	  RNA-­‐ChIP	   for	  RNAPII-­‐S5p	   (A,	  B),	   -­‐S2p	   (C)	  
and	  RNAPII-­‐8WG16	  (D)	  enriches	  for	  transcripts	  from	  active,	  but	  not	  silent	  genes,	  above	  levels	  detected	  in	  total	  
chromatin.	  Transcripts	  are	  sensitive	  to	   flavopiridol	   (A)	  and	  α-­‐amanitin	   (B).	  Mean	  and	  standard	  deviations	  are	  
presented	  from	  2-­‐3	   independent	  experiments	  for	  RNAPII-­‐S5p	  +/-­‐	  Flavopiridol	  and	  RNAPII-­‐S2p.	  RNAPII-­‐S5p	  +/-­‐	  
α-­‐amanitin	  and	  RNAPII-­‐8WG16	  are	  from	  a	  single	  experiment.	  ND	  represents	  no	  product	  detected.	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3.2.4 Adapting	  RNA-­‐ChIP	  for	  genome-­‐wide	  sequencing	  
Analysis	   at	   single	   genes	   shows	   that	   RNAPII	   RNA-­‐ChIP	   can	   capture	   nascent	   transcripts	  
associated	  with	  RNAPII	  bound	  to	  chromatin	  in	  ES	  cells	  (Figs.	  3.3,	  3.4).	  Studying	  transcription	  
and	  regulation	  at	  single	  genes	  by	  RT-­‐PCR	  requires	  prior	  knowledge	  of	  which	  genes	  and	  gene	  
regions	   to	   study.	   To	   study	   nascent	   transcription	   in	   detail	   genome-­‐wide,	   I	   applied	   next-­‐
generation	   sequencing	   (NGS)	   to	   study	   the	   RNA	   populations	   obtained	   after	   RNA-­‐ChIP	   in	  
parallel	   with	  mRNA	   expression.	   To	   prepare	   RNA	   sequencing	   libraries	   I	   used	   two	   different	  
library	   preparation	   strategies	   from	   Illumina,	   generating	   non-­‐directional	   and	   directional	  
sequencing	  libraries	  (Fig.	  3.5).	  mRNA	  library	  results	  have	  already	  been	  mined,	  validated	  and	  
confirmed	  with	  ChIP-­‐seq	  datasets	  (Brookes	  et	  al.,	  2012).	  
	  
The	   non-­‐directional	   strategy	   for	   library	   preparation	   generates	   libraries	   that	   have	   no	  
information	  regarding	  direction	  of	  transcription	  but	  can	  be	  sequenced	  from	  both	  ends	  (as	  a	  
paired-­‐end	   library),	  a	  sequencing	  strategy	  useful	   for	  studying	  splicing	  dynamics.	   I	  prepared	  
non-­‐directional	   libraries	   from	   both	   mRNA	   (rRNA-­‐,	   PolyA+;	   Brookes	   et	   al.,	   2012)	   and	   RNA	  
extracted	   after	   RNA-­‐ChIP	   with	   RNAPII-­‐S5p	   or	   Ezh2	   antibodies	   (Fig	   3.5a,	   b),	   the	   latter	   to	  
enrich	   for	   RNA	   associated	   with	   PRC2.	   One	   RNAPII-­‐S5p	   RNA-­‐ChIP	   library	   was	   prepared	  
without	   RNA	   fragmentation	   (“Intact”	   library),	   and	   another	   with	   fragmentation	  
(“Fragmented”	  library;	  Fig.	  3.5b),	  due	  to	  concerns	  about	  capturing	  long	  transcripts.	  
	  
The	  directional	  strategy	  generates	  libraries	  that	  retain	  strand-­‐specific	  information,	  but	  is	  not	  
compatible	   with	   paired	   end	   sequencing	   and	   therefore	   studies	   of	   splicing	   dynamics	   (Fig.	  
3.5c).	   The	   directional	   library	   preparation	   has	   only	   become	   available	  more	   recently,	   and	   is	  
technically	   more	   challenging.	   Optimisation	   was	   performed	   in	   collaboration	   with	   Jiannis	  
Ragoussis	  and	  Carme	  Camps	  (WTCHG,	  Oxford).	  The	  directional	   library	  preparation	  protocol	  
chosen	   had	   been	   originally	   designed	   for	   small	   RNAs	   and	  miRNA	   and	   therefore	   had	   to	   be	  
extensively	  optimised	   for	  use	  with	  RNA-­‐ChIP	  material.	   I	  prepared	  directional	   libraries	   from	  
RNA	   extracted	   after	   RNA-­‐ChIP	   with	   RNAPII-­‐S5p	   or	   Ring1B	   antibodies,	   the	   latter	   to	   enrich	  
RNA	  associated	  with	  PRC1.	   I	   also	  prepared	  directional	   RNAPII-­‐S5p	  RNA-­‐ChIP	   libraries	   from	  
chromatin	   treated	   with	   flavopiridol	   (not	   discussed	   in	   this	   thesis)	   and	   from	   conditional	  
Ring1B-­‐knockout	  cells.	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Figure	  3.5d	  represents	  all	  of	   the	  sequencing	   libraries	  prepared,	  according	  to	  each	  method.	  	  
In	   this	   Chapter,	   I	   will	   discuss	   mRNA,	   RNAPII-­‐S5p	   (Intact),	   RNAPII-­‐S5p	   (Fragmented)	   and	  
RNAPII-­‐S5p	  (Directional)	   libraries	  only.	  RNAPII-­‐S5p	  RNA-­‐ChIP	   libraries	   from	  Ring1b-­‐KD	  cells,	  
































































Figure	   3.5	   Library	   preparation	   protocols	   utilised	   to	   generate	   Illumina	   compatible	   RNA-­‐ChIP	   sequencing	  
libraries.	   (a,	   b)	   Illumina’s	   protocol	   for	   non-­‐directional	   paired-­‐end	   libraries	   was	   used	   as	   described	   to	   make	  
mRNA	  libraries,	  and	  adapted	  for	  RNA-­‐ChIP	  samples.	  Chemical	  fragmentation	  is	  followed	  by	  cDNA	  preparation	  
using	  random	  hexamers	  and	  adapter	  ligation,	  where	  directional	  information	  is	  lost.	  Libraries	  are	  size	  selected,	  
PCR	  amplified	  and	  purified.	  Ribosomal	  depletion	  and	  PolyA+	  selection	  are	  included	  to	  enrich	  for	  mRNA.	  (c)	  For	  
Directional	  RNA-­‐ChIP	  libraries	  adapters	  are	  ligated	  to	  RNA	  prior	  to	  cDNA	  synthesis	  to	  retain	  strand	  information.	  
RNA	  is	  fragmented	  and	  ends	  dephosphorylated	  with	  antarctic	  phosphatase,	  before	  polynucleotide	  kinase	  (PNK)	  
treatment	   to	   generate	   a	   5’	   phosphate	   group.	   PNK	   also	   has	   weak	   3’	   phosphatase	   activity.	   Enzymatic	   steps	  
ensure	  that	  the	  5’	  and	  3’	  ends	  of	  RNA	  are	  distinctly	  modified	  so	  that	  adapters	  ligate.	  Reverse	  transcription	  and	  
PCR	  amplification	  using	  primers	  specific	  for	  the	  adapters	  ensures	  cDNA	  conversion	  of	  only	  adapter-­‐ligated	  RNA.	  
(d)	  Sequencing	  libraries	  prepared	  by	  each	  method	  are	  listed.	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3.2.5 Fragmentation	  of	  RNA	  prior	  to	  preparation	  of	  sequencing	  libraries	  
Chemical	   fragmentation	   at	   high	   temperatures	   is	   a	   standard	   step	   in	   preparing	   RNA-­‐seq	  
libraries	  from	  mRNA	  or	  total	  RNA	  samples,	  both	  known	  to	  have	  a	  wide	  fragment	  size	  range.	  
In	   the	   case	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP,	   the	   fragment	   size	   distribution	   of	   transcripts	   was	  
unknown,	  but	  expected	  to	  contain	  long	  transcripts	  with	  unspliced	  introns.	  To	  determine	  the	  
size	   distribution	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP	   material,	   isolated	   RNA	   was	   run	   on	   an	   Agilent	  
Bioanalyser	   in	  parallel	  with	   total	   cellular	  RNA,	   total	   chromatin	  RNA,	   and	  RNA	   from	  an	   IgG	  
control	  RNA-­‐ChIP	  experiment	  (Fig.	  3.6).	  
	  
Total	  cellular	  RNA	  has	  a	  profile	  with	  two	  predominant	  peaks	  of	  ribosomal	  RNA	  (rRNA)	  that	  
represent	  18S	  and	  28S	  rRNA,	  and	  an	  abundant	  population	  of	  small	  RNA	  below	  200nt	  that	  is	  
likely	   to	   correspond	   to	   snRNAs	   and	   tRNAs.	   The	   remaining	   RNA	   profile	   represents	   mRNA,	  
unprocessed	   RNA	   and	   long	   non-­‐coding	   RNAs.	   In	   contrast,	   RNA	   extracted	   from	   total	  
chromatin,	  RNAPII-­‐S5p	  and	  IgG	  control	  RNA-­‐ChIP	  show	  an	  absence	  or	  minimal	  rRNA	  peaks.	  
Lack	   of	   rRNA	   suggests	   that	   abundant	   rRNA	   transcripts	   are	   efficiently	   selected	   against	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Figure	   3.6	   RNAPII-­‐S5p	   immunoprecipitated	   RNA	   has	   a	   broad	   size	   range.	   RNA	   immunoprecipitated	   from	  
RNAPII-­‐S5p	  RNA-­‐ChIP	  in	  ES-­‐OS25	  cells	  was	  run	  on	  an	  Agilent	  Bioanalyser	  RNA	  chip.	  Total	  RNA,	  total	  chromatin-­‐
associated	  RNA	  and	  RNA	  from	  an	  IgG	  control	  RNA-­‐ChIP,	  were	  run	  in	  parallel.	  Abundant	  peaks	  of	  rRNA	  are	  seen	  
in	  the	  total	  RNA	  population	  and	  low	  or	  absent	  in	  all	  other	  samples.	  A	  broad	  size	  range	  is	  seen	  for	  RNAPII-­‐S5p	  
RNA-­‐ChIP.	  
	  
RNA	  extracted	  from	  total	  chromatin	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	  show	  a	  broad	  range	  of	  sizes	  
including	  a	  population	  of	  small	  RNA	  (<200nt)	  similar	  to	  that	  seen	  in	  total	  cellular	  RNA.	  This	  
population	  may	   represent	   snRNAs	   abundantly	   present	   in	   the	   nucleus,	   and	   potentially	   co-­‐
immunoprecipitated	  with	  RNAPII	  antibodies,	  as	  RNAPII	  directly	   interacts	  with	  spliceosomes	  
during	   co-­‐transcriptional	   splicing	   (Proudfoot,	   2000;	  Oesterreich	  et	   al.,	   2011).	   The	  RNA	   size	  
range	   extends	   to	   ~4	   and	   ~2kb	   for	   total	   chromatin	   and	  RNAPII-­‐S5p	  RNA,	   respectively.	   Low	  
amounts	  of	  RNA	  are	   immunoprecipitated	   in	   the	   IgG	  control	  which	  also	  shows	  a	  broad	  size	  
range	  (Fig.	  3.6).	  	  
	  
The	  wide	  size	  range	  of	  RNA-­‐ChIP	  RNA	  suggests	  that	  RNA	  fragmentation	  may	  help	  capture	  the	  
full	   RNA	   population	   in	   the	   sequencing	   library,	   but	   has	   the	   potential	   of	   inducing	   loss	   of	  
smaller	  RNA	  fragments.	  Therefore,	  I	  prepared	  non-­‐directional	  libraries	  from	  both	  intact	  and	  
RNA	  fragment	  length	  (nt)
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fragmented	  RNA	  from	  RNAPII-­‐S5p	  RNA-­‐ChIP.	  Figure	  3.7	  represents	  the	  size	  distributions	  of	  
the	  RNA	  material	  used	  for	  library	  preparation	  and	  of	  the	  final	  DNA	  library	  for	  each	  sample.	  	  
	  
For	  the	  mRNA	  library	  (Brookes	  et	  al.,	  2012)	  total	  RNA	  extracted	  with	  TRIzol	  was	  depleted	  for	  
rRNA,	   selected	   for	   polyA+,	   and	   fragmented	   before	   library	   preparation	   (Fig.	   3.7A).	   Before	  
sequencing,	  fragments	  between	  200-­‐350nts	  were	  selected.	  For	  the	  non-­‐directional	  libraries,	  
RNA	  from	  RNAPII-­‐S5p	  RNA-­‐ChIP	  was	  either	  kept	  intact	  (Fig.	  3.7B)	  or	  fragmented	  (Fig.	  3.7C),	  
before	  library	  preparation.	  Irrespective	  of	  fragmentation,	  both	  approaches	  produce	  libraries	  
with	   200-­‐300nt	   in	   size,	   due	   to	   size	   selection	   and	   the	   PCR	   conditions	   in	   the	   presence	   of	  
random	   primers.	   RNA	   prepared	   using	   the	   directional	   protocol	   was	   fragmented	   prior	   to	  
adapter	  ligation	  generating	  a	  final	  library	  size	  range	  is	  100-­‐250nt	  (Fig.	  3.7D).	  The	  smaller	  size	  
of	  the	  RNA	  complement,	  compared	  to	  those	  produced	  using	  the	  non-­‐directional	  protocols,	  
may	  be	  due	  to	  the	  additional	  enzymatic	  steps	  before	  RNA	  is	  converted	  to	  cDNA,	  which	  may	  
lead	   to	   increased	   RNA	   fragmentation.	   In	   addition,	   both	   cDNA	   synthesis	   and	   PCR	  
amplification	   are	   performed	   with	   primers	   directed	   against	   adapter	   sequence.	   In	   this	  
instance,	  smaller	  RNA	  fragments	  in	  the	  library	  may	  be	  favoured.	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Figure	  3.7	  Size	  distributions	  of	  mRNA	  and	  RNA	  extracted	  after	  RNAPII-­‐S5p	  RNA-­‐ChIP	  and	  of	   corresponding	  
DNA	  libraries.	  RNA	  size	  distributions	  were	  analysed	  before	  library	  preparation	  (left	  hand	  panels;	  A-­‐D)	  and	  after	  
sequencing	   library	   preparation	   (right-­‐hand	  panels,	   A-­‐D).	   Total	   RNA	   (A)	  was	   PolyA+	   selected	   and	  depleted	   for	  
rRNA	   before	   fragmentation	   and	   library	   preparation.	   RNAPII-­‐S5p	   RNA-­‐ChIP	   RNA	   was	   kept	   intact	   (B)	   or	  
fragmented	   (C)	   prior	   to	   library	   preparation.	   RNA	   for	   the	   directional	   RNAPII-­‐S5p	   RNA-­‐ChIP	   library	   was	  
fragmented	  (D)	  prior	  to	  library	  preparation;	  a	  slight	  contamination	  of	  adapters	  at	  ~75nt	  was	  hard	  to	  avoid	  due	  
to	  purification	  of	  a	  small	  library.	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Libraries	   were	   sequenced	   at	   the	   Genomics	   Laboratory	   (MRC-­‐CSC)	   Details	   of	   read	   length,	  
total	  read	  numbers	  and	  proportion	  of	  read	  alignment	  for	  all	  libraries	  discussed	  in	  this	  thesis	  	  
are	   represented	   in	   Table	   3.2.	   Levels	   of	   mitochondrial	   RNA	   ranged	   from	   0.06-­‐0.34%,	  
consistent	   with	  minimal	   cytoplasmic	   contamination	   from	   a	   nuclear	   preparation.	   Although	  
the	  rRNA	  peaks	  were	  clearly	  depleted	  in	  the	  Bioanalyser	  profiles	  (Fig.	  3.6)	  reads	  from	  rRNA	  
still	  represent	  a	  high	  proportion	  of	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  libraries	  (34-­‐51%)	  probably	  due	  
to	   its	   high	   cellular	   abundance	   (80-­‐85%).	   Alternatively,	   it	   may	   be	   due	   to	   association	   of	  
ribosomes	   with	   RNAPII	   at	   chromatin,	   as	   shown	   in	   human	   cells	   (Iborra	   et	   al.,	   2004)	   or	  
Drosophila	   polytene	   chromosomes	   (Brogna	   et	   al.,	   2002)	   and	   by	   co-­‐immunoprecipitation	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3.2.6 RNAPII-­‐S5p	   RNA-­‐ChIP	   sequencing	   libraries	   correlate	   irrespective	   of	   library	  
preparation	  method	  
A	   first	   step	   in	   the	   analysis	   of	   the	   genome-­‐wide	   datasets	   for	   RNAPII-­‐S5p	   RNA-­‐ChIP	  was	   to	  
compare	  the	   libraries	  prepared	  according	  to	  different	  methods.	  The	  non-­‐directional	   (Intact	  
or	  Fragmented)	  and	  directional	  libraries	  were	  all	  prepared	  from	  the	  same	  starting	  chromatin	  
sample.	  	  
	  
To	  test	  for	  any	  major	  biases	  in	  RNA	  detection,	  the	  sequencing	  reads	  were	  measured	  at	  1kb-­‐
sliding	  windows	  across	  the	  genome	  and	  were	  correlated	  between	  the	  different	  libraries	  (Fig.	  
3.8).	   Irrespective	   of	   preparation	   method,	   all	   three	   libraries	   show	   good	   correlation	  
(Spearman’s	  correlation	  ranging	  from	  0.81	  to	  0.83).	  RNAPII-­‐S5p	   Intact	  and	  Fragmented	  are	  
highly	  positively	  correlated	  (left	  panel;	  r=0.83),	  showing	  that	  fragmentation	  of	  RNA	  prior	  to	  
library	  preparation	  does	  not	  appear	  to	  affect	  the	  complexity	  or	  depth	  of	  the	  sequencing	  at	  
this	   genomic	   level.	   RNAPII-­‐S5p	   Directional	   made	   using	   a	   completely	   different	   library	  
preparation	   method,	   also	   presents	   a	   high	   positive	   correlation	   with	   both	   Intact	   and	  



























































Figure	   3.8	   Different	   RNA-­‐ChIP	   library	   preparations	   correlate	   genome-­‐wide.	   For	   each	   RNAPII-­‐S5p	   RNA-­‐ChIP	  
dataset	   (Intact,	   Fragmented	  and	  Directional)	   log10	   read	  counts	   for	  each	  1kb	  window	  across	   the	  genome	  are	  
plotted.	   Spearman’s	   rank	   correlations	   are	   depicted	   in	   each	   panel	   (rs).	   There	   is	   a	   strong	   positive	   correlation	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3.2.7 Single	  gene	  profiles	  in	  ES	  cells	  
To	  begin	  exploring	  characteristics	  of	  RNAPII-­‐S5p	  RNA	  sequencing	  at	  single	  genes,	  sequenced	  
reads	   aligned	   to	   the	   reference	  murine	   genome	   (assembly	  mm9)	  were	   visualized	  using	   the	  
UCSC	  Genome	  Browser.	  Profiles	  of	  RNAPII	  occupancy	  from	  published	  RNAPII-­‐S5p	  DNA-­‐ChIP	  
sequencing	  in	  the	  same	  cell	  line	  (Brookes	  et	  al.,	  2012)	  are	  included	  for	  comparison.	  
	  
Analysis	  of	   Jarid2,	   an	  active	  gene	   in	  ES	   cells	   that	  encodes	  a	  protein	   involved	   in	  Polycomb-­‐
repression	  (Herz	  and	  Shilatifard,	  2010),	  shows	  RNAPII-­‐S5p	  occupancy	  at	  and	  upstream	  from	  
the	   transcription	   start	   site	   (TSS)	   throughout	   the	   coding	   region	   and	   after	   the	   transcription	  
end	  site	  (TES),	  as	  expected	  of	  RNAPII	  at	  active	  genes	  (Fig.	  3.9)	  	  (Anamika	  et	  al.,	  2012;	  Brookes	  
et	  al.,	  2012).	  In	  contrast,	  and	  as	  expected,	  there	  is	  no	  RNAPII-­‐S5p	  binding	  at	  the	  silent	  Gpr55	  
gene.	  Gene	  expression	  of	  Jarid2	  is	  reflected	  in	  the	  high	  level	  of	  mRNA	  detected,	  where	  reads	  
are	  confined	  to	  coding	  regions	  and	  specifically	  define	  exons.	  	  
	  
All	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  (Intact,	  Fragmented	  and	  Directional)	  show	  RNA	  detection	  
throughout	   Jarid2,	  but	  not	  at	  Gpr55	   (Fig.	  3.9).	  The	  specific	  detection	  of	  RNA	   isolated	  after	  
RNA-­‐ChIP	   at	   active	   but	   not	   silent	   genes	   suggests	   that	   any	   DNA	   contamination	   is	   below	  
detection	   levels,	   confirming	   the	   results	   obtained	   by	   RT-­‐PCR	   analyses	   of	   RNA	   from	   single	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Figure	  3.9	  Single	  gene	  profiles	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  sequencing.	  	  Profiles	  at	  an	  active	  (Jarid2)	  and	  a	  silent	  
(Gpr55)	  gene	  of	  RNAPII-­‐S5p	  occupancy,	  RNAs	   isolated	  after	  RNAPII-­‐S5p	  RNA-­‐ChIP	  and	  mRNA	   in	  ES-­‐OS25	  cells	  
are	  visualized	  in	  the	  UCSC	  genome	  browser.	  RNA	  is	  detected	  throughout	  Jarid2	  for	  all	  three	  RNAPII-­‐S5p	  RNA-­‐
ChIP	  datasets,	  but	  not	  for	  Gpr55.	  Detection	  of	  transcripts	   in	   intronic	  regions	  and	  outside	  of	  the	  Jarid2	  coding	  
region	  is	  apparent.	  Arrows	  indicate	  gene	  start	  and	  transcription	  direction.	  	  Sequencing	  reads	  were	  mapped	  to	  
the	  murine	  genome	  (mm9)	  and	  UCSC	  compatible	  files	  generated	  by	  I.de	  Santiago	  and	  A.	  Geiss.	  	  
	  
The	  RNA	  profiles	  obtained	  after	  RNAPII-­‐S5p	  RNA-­‐ChIP	  are	  strikingly	  similar	  regardless	  of	  the	  
different	   library	   preparations	   (Intact	   and	   Fragmented).	   Detection	   of	   intron	   transcripts,	   in	  
contrast	  to	  mRNA,	  suggests	  that	  RNA-­‐ChIP	  is	  able	  to	  pick	  up	  nascent	  transcripts.	  Sequencing	  
reads	   in	   exons	   are	   more	   abundant	   in	   all	   datasets	   then	   at	   introns,	   suggestive	   of	   co-­‐
transcriptional	  splicing.	  RNA	  signals	  are	  not	  confined	  to	  the	  coding	  region	  of	  Jarid2	  but	  also	  
detected	   downstream	   of	   the	   transcription	   end	   site	   (TES)	   in	   all	   RNAPII-­‐S5p	   RNA-­‐ChIP	   seq	  
datasets.	  The	  RNAPII-­‐S5p	  RNA	  directional	  library	  shows	  transcription	  of	  Jarid2	  occurs	  in	  the	  
correct	  orientation	  (+	  strand)	  and	  that	  the	  low-­‐level	  transcription	  occurring	  after	  the	  TES	  is	  
mainly	  on	  the	  +	  strand,	  with	   low	  level	  antisense	  transcription.	   Importantly,	  RNA	  signal	  was	  
detected	   throughout	   the	   long	   192kb	   Jarid2	   gene,	   regardless	   of	   whether	   the	   RNA	   was	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fragmented	   before	   library	   preparation	   (Fragmented)	   or	   not	   (Intact),	   suggesting	   that	   these	  
methods	  are	  able	  to	  detect	  RNA	  along	  the	  entire	  length	  of	  a	  gene	  independent	  of	  length.	  
	  
Housekeeping	   gene	  β-­‐actin	   (Fig.	   3.10)	   is	   highly	   active	   in	   ES	   cells	   as	   seen	   by	   high	   levels	   of	  
mRNA	   and	   is	   abundantly	   occupied	   by	   RNAPII-­‐S5p	   in	   particular	   at	   its	   promoter	   and	  
immediately	  downstream	  of	  the	  TES.	  RNAPII-­‐S5p	  RNA-­‐ChIP	  transcripts	  are	  seen	  throughout	  
the	  gene	  and	  enriched	  at	  exons	  across	  all	  RNA-­‐ChIP	  datasets	  with	  similar	  features	  as	  those	  
seen	   for	   Jarid2.	   Zooming	   in	   on	   specific	   regions	   of	   the	   β-­‐actin	   gene	   reveals	   additional	  
characteristics	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  in	  comparison	  to	  mRNA.	  For	  example,	  transcription	  is	  
seen	  at	  low	  levels	  upstream	  of	  the	  TSS	  in	  an	  antisense	  orientation,	  which	  is	  also	  detected	  at	  
low	   levels	   in	   the	   mRNA	   (Fig.	   3.10i).	   Presence	   of	   these	   non-­‐coding	   transcripts	   in	   mRNA	  
suggests	  the	  transcripts	  may	  be	  polyadenylated	  in	  some	  instances	  (Preker	  et	  al.,	  2011).	  At	  an	  
exon-­‐intron	   junction,	   transcripts	   have	   similar	   depth	   across	   the	   boundary,	   in	   contrast	   to	  
mRNA	  (Fig.	  3.10ii),	  demonstrating	  detection	  of	  nascent	  transcripts	  from	  βactin	  using	  RNAPII-­‐
S5p	   RNA-­‐ChIP.	   Downstream	   from	   the	   TES,	   RNA	   is	   in	   the	   sense	   orientation	   in	   RNAPII-­‐S5p	  
RNA-­‐ChIP	   datasets	   as	   opposed	   to	   mRNA	   datasets,	   where	   RNA	   is	   minimally	   detected	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Figure	  3.10	  Features	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  at	  an	  active	  gene.	  Single	  gene	  profiles	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP,	  
mRNA	  and	  RNAPII-­‐S5p	  DNA-­‐ChIP	  are	  represented	  for	  active	  gene	  β-­‐actin.	  Regions	  of	  interest	  including	  the	  TSS	  
(i),	  an	  exon-­‐intron	  boundary	  (ii)	  and	  the	  TES	  (iii)	  are	  depicted	  as	  zoomed	  images.	  Transcription	  upstream	  of	  the	  
TSS,	   within	   introns	   and	   downstream	   of	   the	   TES	   is	   seen	   for	   all	   RNAPII-­‐S5p	   RNA-­‐ChIP	   datasets.	   Transcripts	  
upstream	  of	   the	  TSS	  are	  antisense	  and	  detected	   in	   the	  mRNA.	  Transcripts	  downstream	  of	   the	  TES	  are	   in	   the	  
sense	  orientation	  and	  not	  present	  in	  mRNA.	  	  	  
	  
Pluripotency	  genes,	  Nanog	  and	  Oct4,	   act	   together	   in	   concert	  with	  Sox2	   to	   tightly	   regulate	  
many	  active	  and	  inactive	  genes	  in	  ES	  cells	  as	  well	  as	  being	  intimately	  linked	  with	  each	  other	  
in	  autoregulatory	  networks	  (Boyer	  et	  al.,	  2005;	  Loh	  et	  al.,	  2006).	  These	  critical	  pluripotency	  
genes	  possess	  interesting	  features	  of	  transcription	  in	  the	  RNAPII-­‐ChIP	  datasets	  (Fig.	  3.11A).	  
Both	  Nanog	  and	  Oct4	  are	  highly	  expressed,	  as	  seen	  by	  the	  high	  levels	  of	  mRNA,	  as	  expected	  
in	  ES	  cells.	  Nanog	  appears	  to	  have	  an	  additional	  exon	  at	  the	  gene’s	  3’	  end,	  not	  annotated	  in	  
the	   UCSC	   Genome	   Browser.	   Transcription	   occurs	   throughout	   the	   two	   genes,	   as	   well	   as	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upstream	   of	   the	   TSS	   and	   downstream	   from	   the	   TES,	   in	   antisense	   and	   sense	   orientation’s	  
relative	   to	   the	  gene,	   respectively.	  Presence	  of	  antisense	   transcription	  upstream	  of	   the	  TSS	  
has	  been	   suggested	   to	  be	  marker	  of	  highly	  active	  genes	  and	   thought	   to	  be	  a	   sign	  of	  gene	  
regulation	  (Core	  et	  al.,	  2008;	  Preker	  et	  al.,	  2008;	  Seila	  et	  al.,	  2008).	  	  
	  
Interestingly,	  Nanog	  presents	  RNAPII-­‐S5p	  binding	  at	  its	  enhancer	  which	  was	  described	  to	  be	  
~5kb	  upstream	  of	  the	  TSS	  (Loh	  et	  al.,	  2006).	  It	  is	  apparent	  from	  RNAPII-­‐S5p	  RNA	  profiles	  that	  
this	  enhancer	   is	  transcribed	  at	  a	   low	  level.	  Features	  include	  bidirectional	  transcription	  (NB-­‐
only	   antisense	   RNA	   is	   seen	   due	   to	   scaling)	   and	   a	   lack	   of	   polyadenylation	   as	   shown	   by	   its	  
absence	   in	  mRNA,	   even	  when	   zoomed	   in	   on	   the	   x-­‐axis	   (not	   shown).	   These	   features	   along	  
with	   high	   levels	   of	  Nanog	  mRNA	   correlate	  with	   known	   features	   of	   enhancer	   RNA	   (eRNA)	  
described	  genome-­‐wide	  in	  mouse	  cortical	  neurons	  (Kim	  et	  al.,	  2010).	  	  
	  
As	  with	   Jarid2	   and	  βactin,	   both	  Nanog	  and	  Oct4	   show	  pronounced	   intron	   RNA	   signal	   not	  
seen	  in	  mRNA	  that	  appears	  as	  a	  ‘saw-­‐tooth’	  pattern	  such	  that	  the	  signal	   is	  higher	  at	  the	  5’	  
than	  at	  the	  3’	  ends	  of	  the	  intron	  indicative	  of	  co-­‐transcriptional	  splicing	  (Wada	  et	  al.,	  2009;	  
Ameur	  et	   al.,	   2011).	   Interestingly,	   RNA	   signal	   at	   introns	  of	  Oct4	   can	  occur	   in	   an	  antisense	  
direction	   to	   the	   coding	   sequence,	   especially	   apparent	   in	   the	   first	   intron.	   Introns	   encode	  a	  
number	  of	  regulatory	  non-­‐coding	  RNAs	  including	  snoRNA	  and	  miRNA,	  (Mattick	  and	  Makunin,	  
2005).	   Presence	   of	  Oct4	  antisense	   transcripts	  within	   introns	  may	   suggest	   the	   presence	   of	  
regulatory	  non-­‐coding	  RNA. 
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Figure	  3.11	  Profiles	  of	  pluripotency	  and	  non-­‐coding	  genes.	  (A)	  Images	  of	  pluripotency	  genes,	  Nanog	  and	  Oct4,	  
and	   (B)	   ncRNA	   genes	   Kcnq1ot1	   and	  Malat1,	   are	   depicted	   for	   all	   RNAPII-­‐S5p	   RNA-­‐ChIP	   datasets,	   mRNA	   and	  
RNAPII-­‐S5p	  protein.	  All	  genes	  are	  active	  in	  ES-­‐OS25	  cells	  as	  shown	  by	  high	  read	  depth	  in	  RNAPII-­‐S5p	  RNA-­‐ChIP	  
and	  mRNA.	  Non-­‐coding	   transcription	   is	   detected	   at	   the	  Nanog	  enhancer	   along	  with	  RNAPII-­‐S5p	   (depicted	   in	  
image).	  Antisense	  transcription	  occurs	   in	  an	  Oct4	   intron	  and	  promoter-­‐associated	  antisense	  transcription	   is	  a	  
feature	  Nanog,	  Oct4	  and	  Malat1.	  	  Sequencing	  reads	  from	  each	  dataset	  was	  mapped	  to	  the	  genome	  (mm9)	  and	  
visualized	  in	  the	  UCSC	  genome	  browser.	  
	  
In	   addition	   to	   protein	   coding	   genes,	   RNAPII-­‐S5p	   RNA-­‐ChIP	   is	   able	   to	   detect	   transcription	  
from	   non-­‐coding	   genes,	   for	   example,	   Kcnq1ot1	   and	  Malat1	   (Fig.	   3.11B).	  Non-­‐coding	   RNA	  
Kcnq1ot1	   is	   embedded	  within	  and	   involved	   in	   the	   regulation	  of	   the	   imprinted	  Kcnq1	   gene	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(Kanduri,	  2011).	  Kcnq1ot1	  is	  transcribed	  in	  the	  opposite	  orientation	  to	  the	  coding	  gene,	  and	  
polyadenylated	   as	   shown	   by	   its	   presence	   in	   RNAPII-­‐S5p	   RNA-­‐ChIP	   and	  mRNA	   datasets.	   A	  
proportion	  of	  non-­‐coding	  RNAs	  are	  known	  to	  be	  polyadenylated	  (Harrow	  et	  al.,	  2012).	  In	  	  
addition	  in	  the	  directional	  RNA	  dataset,	  Kcnq1	  shows	  low	  level	  transcription	  that	   is	  seen	  in	  
the	  mRNA,	  which	  may	  be	  due	  to	  allelic	  differences.	  Malat1	  is	  a	  long	  non-­‐coding	  RNA	  with	  a	  
role	  in	  pre-­‐mRNA	  processing	  (Tripathi	  et	  al.,	  2010)	  and	  implications	  in	  cancer	  (Ji	  et	  al.,	  2003).	  
In	  ES	  cells,	  RNAPII-­‐S5p	  is	  bound	  throughout	  the	  gene	  and	  active,	  as	  shown	  by	  the	  high	  level	  
of	   mRNA.	   Antisense	   transcription	   occurs	   upstream	   of	   the	   TSS	   as	   already	   seen	   for	   highly	  
active	  genes	  (Core	  et	  al.,	  2008;	  Preker	  et	  al.,	  2008;	  Seila	  et	  al.,	  2008).	  A	  prominent	  peak	  of	  
transcription	   immediately	  downstream	  of	   the	  Malat1	  promoter	   that	   is	  present	  also	   in	   the	  
RNAPII-­‐S5p	  binding	  profile	  may	  suggest	  alternative	  promoters.	  	  
3.2.8 Transcriptome	  coverage	  of	  RNAPII-­‐S5p	  RNA	  sequencing	  across	  the	  ES	  cell	  genome	  
Protein	  coding	  genes	  make	  up	  around	  1.2%	  of	  the	  genome.	  However,	  recent	  genome-­‐wide	  
studies	  in	  a	  range	  of	  systems	  reveal	  a	  much	  more	  complex	  picture	  where	  the	  vast	  majority	  of	  
the	  genome	  is	  pervasively	  transcribed	  (Carninci	  et	  al.,	  2005;	  Katayama	  et	  al.,	  2005;	  Birney	  et	  
al.,	   2007;	  Djebali	   et	   al.,	   2012).	   Previous	   studies	   in	   ES	   cells	   revealed	  a	  hyperactive	   genome	  
(Efroni	  et	  al.,	  2008)	  with	  31-­‐37%	  transcription	  occuring	  outside	  known	  or	  predicted	  protein	  
coding	  exons	  in	  mRNA	  data	  (Cloonan	  et	  al.,	  2008).	  	  
	  
Studying	  RNAPII-­‐S5p	  RNA-­‐ChIP	  profiles	   at	   single	   genes	   reveals	   that	   this	   approach	  not	  only	  
detects	  RNA	  confined	  to	  protein-­‐coding	  exons	  but	  also	  RNA	  in	  introns,	  non-­‐coding	  genes,	  up-­‐	  
and	   downstream	   of	   the	   coding	   sequence	   and	   at	   intergenic	   regions,	   as	   is	   the	   case	   of	   the	  
Nanog	  enhancer.	  To	  reveal	  the	  overall	  distribution	  of	  RNA	  sequencing	  reads	  genome-­‐wide,	  
we	  measured	  the	  total	  number	  of	  reads	  mapping	  to	  annotated	  RefSeq	  genes,	  discriminated	  
at	  regions	  of	  interest:	  (i)	  transcript	  exons,	  (ii)	  transcript	  introns,	  (iii)	  within	  2kb	  upstream	  of	  
the	   TSS	   (i.e.	   -­‐2000	   to	   0	   nucleotides),	   (iv)	   2kb	   downstream	   of	   the	   TES	   (i.e.	   0	   to	   +2000	  
nucleotides),	   (v)	  non-­‐RefSeq	   (i.e.	  UCSC	  Known	  Genes	   that	  are	  not	   substantiated	  by	  a	  NCBI	  
RefSeq	  transcript	  but	  are	  supported	  by	  at	   least	  one	  GenBank	  RNA	  sequence	  and	  a	  Uniprot	  
protein),	  and	  (vi)	  intergenic	  (all	  other	  mapped	  reads).	  A	  summary	  of	  the	  read	  distribution	  in	  
mRNA	  and	  each	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  is	  depicted	  in	  Figs.	  3.12.	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A	   striking	  difference	  between	  mRNA	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	   is	   the	  percentage	  of	   reads	  
mapping	   to	   exons	   versus	   introns.	   Protein	   coding	   exon	   reads	  make	   up	   the	  majority	   of	   the	  
mRNA	   dataset	   (78.6%)	   alongside	   a	   minority	   of	   intron	   reads	   (10.4%),	   likely	   due	   to	   intron	  
retention.	   In	   contrast,	   RNAPII-­‐S5p	   RNA-­‐ChIP	   from	   Intact,	   Fragmented	   (Fig.	   3.12A)	   or	  
Directional	  (Fig	  3.12B)	  comprise	  relatively	  equal	  proportions	  of	  exon	  (42.7,	  44.8	  and	  43.8%,	  
respectively)	   and	   intron	   RNA	   (34.4,	   32.1	   and	   33.8%	   respectively)	   reads,	   suggestive	   of	  
genome-­‐wide	  nascent	  transcription.	  The	  high	  percentage	  of	  reads	  from	  all	  datasets	  including	  
mRNA	  that	  overlap	  RefSeq	  UCSC	  Known	  protein	  coding	  genes	  (>75%	  reads	  for	  all	  datasets)	  
demonstrates	  a	  high	  representation	  of	  the	  RefSeq	  transcriptome	  in	  ES	  cells.	  Transcripts	  from	  
intergenic	  regions	  represent	  a	  small	  but	   important	  proportion	  of	   the	  transcriptome.	  10.3%	  
of	   transcripts	  map	   to	   intergenic	   regions	  of	   the	   genome	   in	   the	  RNA-­‐ChIP	   (Fragmented	   and	  
Intact)	  as	  opposed	  to	  half	  (5.1%)	  in	  the	  mRNA.	  The	  common	  intergenic	  population	  in	  mRNA	  
and	  RNA-­‐ChIP	  likely	  represents	  ncRNA	  that	  are	  polyadenylated.	  	  	  	  
	  
Reads	  mapping	  upstream	  of	  the	  TSS	  (-­‐2	  to	  0kb)	  can	  be	  detected	  in	  all	  the	  RNA-­‐ChIP	  datasets	  
(1.6-­‐3.2%)	  and,	  although	  low,	  is	  at	  least	  double	  the	  percentage	  detected	  in	  mRNA	  (0.6%),	  in	  
keeping	  with	  these	  transcripts	  being	  non-­‐coding	  and	  targeted	  by	  the	  exosome	  (Preker	  et	  al.,	  
2008).	  In	  contrast,	  downstream	  transcription	  from	  the	  TES	  is	  similarly	  detected	  in	  RNA-­‐ChIP	  
and	   mRNA,	   which	   may	   indicate	   alternative	   polyadenylation	   sites	   or	   3’	   end	   annotation	  
discrepancies	   genome-­‐wide.	   Non-­‐RefSeq	   genes	   show	   double	   the	   percentage	   of	   reads	  
mapping	  in	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  (10.3%	  in	  both	  Intact	  and	  Fragmented)	  compared	  
to	  mRNA	  (5.1%),	  some	  of	  which	  may	  represent	  pseudo-­‐genes.	  Non-­‐RefSeq	  genes	  are	  UCSC	  
genes	  that	  show	  minimal	  evidence	  for	  protein	  coding	  capacity	  and	  therefore	  in	  many	  cases	  
may	  not	  go	  on	  to	  form	  a	  polyadenylated	  mRNA,	  or	  may	  produce	  non-­‐coding	  RNA.	  	  
	  
Directional	   RNA-­‐ChIP	   (Fig.	   3.12B)	   recapitulates	   that	   seen	   with	   the	   RNAPII-­‐S5p	   Intact	   and	  
Fragmented	   datasets,	   although	   the	   percentage	   of	   reads	   mapping	   to	   intergenic	   regions	   is	  
more	  similar	  to	  mRNA.	  Transcription	  upstream	  of	  the	  TSS	  in	  the	  vast	  majority	  of	  genes	  across	  
the	  genome	  is	  antisense	  to	  the	  gene,	  in	  keeping	  with	  published	  results	  (Fig.	  3.12B)	  (Core	  et	  
al.,	  2008;	  Preker	  et	  al.,	  2008;	  Seila	  et	  al.,	  2008).	  As	  expected,	  exons	  and	   introns	  of	  RefSeq	  
genes	  transcribe	  in	  the	  sense	  orientation	  although	  there	  is	  a	  small	  percentage	  of	  antisense	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transcription	   notably	   in	   introns.	   Transcripts	   downstream	   of	   the	   TES	   show	   relatively	   equal	  
mapping	  in	  the	  sense	  (54.2%)	  and	  antisense	  (45.8%)	  orientation.	  	  
RNAPII-­‐S5p	  
(Directional)


















































Figure	   3.12	   Distribution	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP	   sequencing	   reads	   across	   the	   genome.	   (A)	   Reads	   from	  
RNAPII-­‐S5p	   RNA-­‐ChIP	   and	  mRNA	  datasets	  were	  mapped	   to	   regions	   of	   the	   RefSeq	   genome	   (-­‐2kb	   TSS,	   exons,	  
introns,	  +2kb	  TES),	  Non-­‐Refeq	  genes	  and	  the	  rest	  of	  the	  genome	  (Intergenic).	  Percentage	  of	  reads	  from	  each	  
dataset	  mapping	  to	  each	  regions	  are	  depicted.	  RefSeq	  genes	  are	  highly	  represented	  for	  all	  3	  datasets.	  RefSeq	  
exon	  reads	  account	  for	  the	  majority	  of	  mRNA	  while	  an	  equal	  distribution	  of	  exon	  and	  intron	  reads	  is	  seen	  for	  
RNAPII-­‐S5p	   Intact	  and	  Fragmented.	  Percentage	  of	  reads	  for	  Non-­‐RefSeq	  and	   intergenic	  regions	   in	  RNAPII-­‐S5p	  
RNA	  is	  twice	  that	  mapped	  in	  mRNA.	  (B)	  Reads	  from	  RNAPII-­‐S5p	  RNA-­‐ChIP	  (Directional)	  were	  mapped	  to	  regions	  
of	  the	  RefSeq	  genome	  as	  in	  (A).	  Percentage	  of	  reads	  from	  each	  dataset	  mapping	  to	  each	  regions	  are	  depicted	  
for	  the	  combined	  read	  dataset.	  Reads	  mapping	  to	  RefSeq	  regions	  were	  further	  categorised	  into	  %	  of	  sense	  or	  
antisense	   reads	   based	   on	   RefSeq	   gene	   orientation.	   The	   majority	   of	   reads	   map	   to	   RefSeq	   gene	   exons	   and	  
introns.	  Bionformatic	  analysis	  performed	  by	  I.D	  Santiago.	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3.2.9 Average	  RNAPII-­‐S5p	  RNA-­‐ChIP	  profiles	  at	  active	  and	  silent	  genes	  
To	  assess	  whether	  the	  profiles	  we	  see	  at	  single	  genes	  in	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  
are	  general	   features	  observed	  genome-­‐wide,	  we	  selected	  two	  groups	  of	  genes	   (Active	  and	  
Silent)	   that	   are	   not	   targets	   for	   Polycomb	   repression	   and	   present	   the	   most	   extreme	  
expression	   levels	   (highest	   20%	   and	   lowest	   20%	   expressed	   genes)	   based	   on	   FPKM	   mRNA	  
expression	   level	   (Fig.	   3.13).	   FPKM	   (‘fragments	   per	   kilobase	   of	   exon	   model	   per	   million	  
mapped	   reads’)	   is	   a	  measurement	   used	   to	   caluclate	   expression	   levels	   genome-­‐wide	   from	  
sequencing	  data,	  whereby	  read	  depth	  in	  exons	  and	  across	  exon-­‐exon	  junctions	  is	  calculated	  
and	  normalised	  to	  gene	  size.	  Features	  of	  the	  3,772	  genes	  in	  each	  group	  are	  represented	  in	  
Fig.	  3.13	  and	   include	  mRNA	  signal	   through	  coding	  regions,	  and	  occupancy	  of	  RNAPII-­‐S5p,	   -­‐
S7p	  and	  -­‐S2p	  across	  TSS	  and	  TES	  regions	  (±5kb)	  for	  all	  non-­‐overlapping	  RefSeq	  genes	  (mm9	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Figure	  3.13	  Properties	  of	  genes	  assigned	  to	  Active	  and	  Silent	  gene	  groups.	  Previous	  data	  from	  Brookes	  et	  al.,	  
(2012)	  investigated	  RNAPII	  and	  PRC	  occupancy	  across	  the	  genome.	  Genes	  were	  divided	  into	  PRC-­‐positive	  (PRC+,	  
n=5628)	   and	  PRC-­‐negative	   (PRC-­‐,	   n=9776)	   and	  ordered	  based	  on	  mRNA	  FPKM	   levels	   in	   gene	   coding	   regions.	  
Read	  depth	  is	  shown	  over	  windows	  covering	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb)	  and	  log(signal/threshold)	  was	  plotted	  
on	   a	   colour	   scale	   (blue,	   low;	   yellow,	   high).	   For	   analysis	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP	   datasets	   the	   20%	   highest	  
expressed	  genes	  (green,	  n=3772;	  Active	  group)	  and	  20%	  lowest	  expressed	  genes	  (grey,	  n=3772;	  Silent	  group)	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To	   further	   summarise	   the	   characteristics	   of	   the	   two	   groups	   of	   genes,	   Active	   and	   Silent,	   I	  
compared	  levels	  of	  interesting	  markers	  in	  box-­‐plots,	  including	  mRNA,	  RNAPII	  (S5p,	  S2p,	  S7p)	  
and	  histone	  marks	  associated	  with	  activity	  (H3K4me3,	  H3K36me3;	  Fig.	  3.14;	  Brookes	  et	  al.,	  
2012).	   Expression	   levels	   for	   the	   two	   groups	   show	   a	   clear	   distinction	   as	   expected.	   This	   is	  
mirrored	   in	   the	   levels	   of	   RNAPII-­‐S5p,	   S7p,	   S2p	   and	   active	   histone	   marks	   H3K4me3	   and	  





Figure	  3.14	  Properties	  of	  active	  and	  silent	  genes	  in	  ES	  cells.	  Using	  previous	  published	  datasets	  produced	  in	  the	  
laboratory	  using	  the	  ES-­‐OS25	  cell	   line	   (Brookes	  et	  al.,	  2012)	  we	  assessed	   levels	  of	  RNAPII	  modifications	   (S5p,	  
S2p,	   S7p)	   and	  mRNA	   along	  with	   active	   histone	  marks	   H3K4me3	   and	   H3K36me3.	   Active	   genes	   (20%	   highest	  
expressed	  genes;	  n=3772)	  and	  Silent	  genes	  (20%	  lowest	  expressed	  genes;	  n=3772)	  are	  depicted.	  Average	  depth	  
was	  calculated	  per	  nucleotide	  in	  2kb	  promoter	  windows	  around	  the	  TSS	  or	  in	  the	  case	  of	  RNAPII-­‐S2p,	  2kb	  after	  
the	  TES	  and	  H3K36me3,	  2kb	  before	  the	  end	  of	  the	  gene.	  FPKM	  was	  calculated	  for	  mRNA.	  Active	  genes	  possess	  
all	  active	  marks	  and	  express	  high	  levels	  of	  mRNA	  in	  comparison	  to	  low	  levels	  from	  silent	  genes.	  Bioinformatic	  
analysis	  performed	  by	  I.de	  Santiago.	  
	  
To	   further	   compare	   the	   different	   RNA-­‐ChIP	   datasets	   produced	   using	   different	   library	  
preparation	   strategies,	   we	   represented	   the	   average	   distribution	   profiles	   of	   RNA-­‐ChIP	   and	  
mRNA	  reads	  around	  the	  TSS	  and	  TES	  regions,	   for	  the	  Active	  and	  Silent	  groups	  (Fig.	  3.15A).	  
Average	  mRNA	  profiles	  show	  high	  and	  equal	  read	  depth	  at	  the	  TSS	  and	  TES	  indicative	  of	  full-­‐
length	   transcripts;	   depletion	   in	   the	   intervening	   region	   is	   due	   to	   the	   splicing	   of	   intronic	  
sequences	   that	   map	   at	   different	   coordinates	   downstream	   of	   the	   TSS	   and	   have	   different	  
lengths.	  The	  sharp	  promoter	  peak	  decreases	  dramatically	  into	  coding	  regions,	  suggestive	  of	  
splicing	  of	  the	  first	  exon-­‐intron	  boundary,	  as	  expected.	  Levels	  of	  mRNA	  increase	  immediately	  
before	  the	  TES	  indicative	  of	  the	  last	  exon,	  and	  have	  a	  sharp	  and	  precise	  diminishment	  after	  
the	  TES,	  as	  expected	  from	  mRNA	  of	  protein-­‐coding	  genes.	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RNAPII-­‐S5p	  Intact	  and	  Fragmented	  RNA-­‐ChIP	  datasets	  have	  similar	  profiles	  with	  detection	  of	  
RNA	   throughout	   coding	   regions	  of	   the	   top	  20%	  expressed	  genes	  and	  no	   signal	  at	   the	  20%	  
least	  expressed	  genes.	  In	  contrast	  to	  mRNA,	  sequencing	  depth	  is	  higher	  at	  the	  TSS	  than	  the	  
TES	   resulting	   in	   a	   gradient	   effect	   throughout	   the	   genes	   suggestive	   of	   capturing	   nascent	  
transcription	   where	   the	   5’	   sequences	   are	   represented	  more	   than	   the	   3’	   (Fig.	   3.15B).	   The	  
ratio	  of	  TSS	  signal	  to	  TES	  is	  more	  pronounced	  in	  the	  Fragmented	  RNA-­‐ChIP	  relative	  to	  Intact,	  
which	  may	   indicate	   the	   advantage	   of	   fragmentation	   in	   capturing	   longer	   transcripts	   across	  
the	  genome.	  Interestingly,	  this	  is	  the	  first	  difference	  detected	  between	  the	  two	  datasets.	  A	  
sharp	   peak	   at	   the	   TSS,	   which	   decreases	   dramatically	   in	   coding	   regions,	   similar	   to	   mRNA,	  
suggests	   detection	   of	   co-­‐transcriptional	   splicing.	   There	   is	   an	   increase	   in	   RNA	   signal	   just	  
before	   the	   TES	   possibly	   a	   result	   of	   terminal	   exon	   splicing	   or	   RNAPII	   exon	   stalling	   (Carrillo	  
Oesterreich	  et	  al.,	  2010).	  As	  opposed	  to	  mRNA,	  an	  appreciable	  level	  of	  transcription	  can	  be	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Figure	  3.15	  Average	  genome-­‐wide	  profiles	  of	  mRNA	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	  at	  active	  and	  silent	  genes.	  (A)	  
Distribution	   of	   mRNA	   and	   RNAPII-­‐S5p	   RNA	   was	   assessed	   at	   the	   20%	   highest	   (green)	   and	   lowest	   (grey)	  
expressed	  genes.	  Average	  depth	  of	  sequencing	  reads	  per	  nucleotide,	  was	  analysed	  in	  windows	  around	  the	  TSS	  
and	  TES	   (-­‐5	   to	  +5kb).	  Average	   transcript	   levels	  are	   similar	  at	   the	  TSS	  and	  TES	   for	  mRNA	  while	   there	   is	   lower	  
signal	  at	  the	  TES	  in	  the	  RNA-­‐ChIP	  datasets	  from	  non-­‐directional	  libraries	  (Intact	  and	  Fragmented).	  Non-­‐coding	  
transcripts	  are	  detected	  upstream	  of	  the	  promoter	  and	  downstream	  of	  the	  TES	  in	  all	  RNAPII-­‐S5p	  RNA	  datasets,	  
above	  levels	  observed	  in	  mRNA.	  Directional	  RNAP-­‐S5p	  RNA-­‐ChIP	  library	  fails	  to	  detect	  the	  RNA	  peak	  at	  the	  5’	  
end	  of	  genes,	  but	  demonstrates	  that	  non-­‐coding	  transcripts	  upstream	  of	  the	  promoter	  are	  mostly	  antisense	  to	  
the	   average	   gene,	   whereas	   transcripts	   downstream	   of	   the	   TES	   are	   mostly	   coded	   in	   the	   sense	   strand.	  
Bioinformatic	   analyses	   performed	   by	   I.de	   Santiago.	   (B)	   Cartoon	   depiction	   of	   RNAPII	   transcription	   and	   RNA	  
produced	  through	  the	  average	  active	  gene.	  RNAPII	  (grey)	  produces	  transcripts	  where	  introns	  (blue)	  are	  spliced	  
and	  exons	  (red)	  remain	  associated.	  Non-­‐coding	  transcripts	  are	  shown	  in	  grey	  and	  black.	  	  
	  
Transcription	  of	  the	  top	  20%	  expressed	  genes	  occurs	  in	  the	  correct	  orientation,	  as	  shown	  in	  
the	  directional	  dataset.	  However,	  an	  absence	  of	  a	  sharp	  promoter	  peak	  indicates	  a	  potential	  
bias	   in	   this	   dataset.	   Library	   preparation	   is	   significantly	   different	   to	   the	   non-­‐directional	  
libraries	  (Intact	  and	  Fragmented),	  the	  main	  difference	  being	  ligation	  of	  adapters	  to	  the	  RNA	  
(Fig.	  3.5C).	  Biases	   in	  adapter	   ligation	  (Hafner	  et	  al.,	  2011)	  and	  absence	  of	  a	  5’	  Cap	  removal	  
step	  may	  account	  for	  the	  lack	  of	  signal	  at	  5’	  ends	  of	  the	  transcripts	  mapped	  with	  directional	  
libraries.	  In	  addition,	  the	  conversion	  of	  adapter-­‐ligated	  RNAs	  to	  cDNA	  using	  primers	  specific	  
for	   the	  adapters	   (as	  opposed	   to	   random	  hexamers	   in	   the	  case	  of	  non-­‐directional	   libraries)	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may	   lead	   to	  exclusion	  of	   longer	  RNA	   fragments	   thereby	  depleting	  5’	   transcript	   sequences.	  
Although	   an	   absence	   of	   transcripts	   at	   the	   TSS	   prevents	   the	   use	   of	   this	   library	   to	   assess	  
transcript	   levels	   at	   5’	   regions	   of	   promoters,	   it	   nevertheless	   gives	   us	   valuable	   information	  
about	   direction	   of	   transcription	   upstream,	   through	   and	   downstream	   of	   coding	   regions.	  
Strikingly,	  the	  directional	  library	  shows	  that	  the	  transcription	  upstream	  of	  the	  TSS	  detected	  
in	   all	   RNA-­‐ChIP	   datasets	   and	   absent	   in	   mRNA,	   is	   antisense	   to	   protein-­‐coding	   genes,	  
recapitulating	  results	  seen	  across	  the	  genome	  (Fig.	  3.12B).	  Transcription	  downstream	  from	  
the	  TES	  occurs	   in	  the	  sense	  orientation	  to	  the	  protein	  coding	  gene,	  which	  may	  account	  for	  
nascent	   non-­‐coding	   RNA	  produced	   during	   transcriptional	   termination	   of	   RNAPII	   (Campbell	  
and	  Street,	  2004;	  West	  et	  al.,	  2004;	  Gromak	  et	  al.,	  2006;	  Rondón	  et	  al.,	  2009)	   reflected	   in	  
RNAPII	  binding	  profiles	  at	  single	  genes	  (Fig.	  3.9,	  3.10,	  3.11)	  and	  at	  the	  20%	  highest	  expressed	  
genes	  in	  ES	  cells	  (Brookes	  et	  al.,	  2012).	  
3.2.10 Transcription	  and	  splicing	  through	  coding	  regions	  
To	   investigate	  whether	  RNAPII-­‐S5p	  RNA-­‐ChIP	   is	  able	   to	  detect	  nascent	   transcription	  within	  
the	  gene	  body	  of	  the	  highest	  and	  lowest	  20%	  expressed	  genes,	  profiles	  were	  generated	  for	  
the	  average	  depth	  at	   all	   introns	   combined,	   all	   exons	   combined,	   as	  well	   as	   the	   sum	  of	   the	  
exons	  (cDNA)	  using	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets	  and	  mRNA	  (Fig.	  3.16).	  	  
	  
Profiles	  of	  exons	  in	  mRNA	  show	  high	  depth	  with	  an	  even	  profile,	  as	  expected,	  demonstrating	  
equal	   representation	   across	   the	   coding	   region.	   In	   the	   RNAPII-­‐S5p	   RNA-­‐ChIP	   datasets	   high	  
exon	   depth	   followed	   by	   signal	   depletion	   at	   5’	   and	   3’	   ends	   may	   indicate	   un-­‐annotated	  
alternative	   splice	   sites.	   RNAPII-­‐S5p	   protein	   occupancy	   is	   detected	   evenly	   throughout	   the	  
average	  exon	  profile,	  suggesting	  the	  depletion	  of	  RNA	  is	  not	  due	  to	  lack	  of	  RNAPII.	  Antisense	  
transcription	   is	   detected	   at	   extremely	   low	   levels,	   although	   above	   background	   seen	   at	   the	  
lowest	  20%	  expressed	  genes.	  
	  
Intron	  profiles	  of	  mRNA	  have	  extremely	  low	  depth	  relative	  to	  exons	  and	  present	  a	  flat	  even	  
distribution,	   as	   expected	   from	   spliced	   transcripts.	   Intron	   retention	   likely	   accounts	   for	  
minimal	  detection.	  In	  contrast,	  intron	  profiles	  from	  RNAPII-­‐S5p	  Intact	  and	  Fragmented	  RNA-­‐
ChIP	   reveal	   a	   striking	   gradient	   with	   higher	   signal	   at	   5’	   compared	   to	   the	   3’	   end.	   This	   is	   a	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typical	  pattern	  seen	  in	  nascent	  transcripts	  that	  undergo	  co-­‐transcriptional	  splicing	  (Wada	  et	  
al.,	   2009;	  Ameur	   et	   al.,	   2011).	  A	  minimal	   gradient	   in	   the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  Directional	  
dataset	  is	  present,	  although	  not	  striking	  and	  not	  due	  to	  antisense	  transcription.	  
	  
To	   further	   investigate	   the	   RNA-­‐ChIP	   datasets	   for	   evidence	   of	   nascent	   transcription	   we	  
analysed	   average	   sequencing	   depth	   through	   the	   exonic	   gene	   length	   (i.e.	   cDNA).	  mRNA	   is	  
characterised	  by	  high	  depth	   similarly	  distributed	  across	   all	   exons	  with	   a	   slight	  decrease	   in	  
signal	  at	  the	  extreme	  5’	  and	  3’	  exons.	  Reverse	  transcription	  of	  RNA	  with	  random	  hexamers	  is	  
expected	   to	   yield	   such	   a	   profile	   due	   to	   presence	   of	   a	   PolyA+	   tail,	   which	   hinders	   random	  
hexamer	   priming	   causing	   under-­‐representation	   of	   the	   extreme	   ends	   of	   the	   transcript.	  
Transcription	  of	  the	  entire	  coding	  region	  of	  the	  20%	  highest	  expressed	  genes	  is	  seen	  in	  the	  
Intact	  and	  Directional	  datasets	  with	  higher	  exon	  depth	  at	  the	  5’	  end	  of	  the	  transcript.	  Again	  
there	   is	  minimal	   antisense	   transcription.	   Strikingly,	   fragmented	   RNAPII-­‐S5p	   RNA	   reveals	   a	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Figure	   3.16	   Average	   genome-­‐wide	   profiles	   of	   mRNA	   andRNAPII-­‐S5p	   RNA-­‐ChIP	   and	   RNAPII-­‐S5p	   DNA-­‐ChIP	  
through	  coding	   regions	  of	  Active	  and	  Silent	  genes.	  Distribution	  of	  mRNA,	  RNAPII-­‐S5p	  RNA-­‐ChIP	  and	  RNAPII-­‐
S5p	  DNA-­‐ChIP	  was	  assessed	  at	  the	  20%	  highest	  (green)	  and	  lowest	  (grey)	  expressed	  genes	  throughout	  exons,	  
introns	  and	  coding	  regions.	  Average	  depth	  of	  sequenced	  reads	  per	  nucleotide	  were	  calculated	  across	  all	  RefSeq	  
exons,	  introns	  and	  coding	  (cDNA).	  Read	  density	  was	  normalised	  to	  length	  of	  the	  analysed	  region.	  	  RNAPII-­‐S5p	  
occupancy	   is	   included	   for	   comparison	   (bottom	  panel).	  Exons	  and	   introns	  of	  mRNA	  have	  high	  and	   low	  depth,	  
respectively	  (note	  difference	  in	  scale)	  and	  relatively	  even	  coverage	  across	  the	  cDNA.	  Depletion	  is	  apparent	  at	  
the	  5’	  and	  3’	  due	   to	  cDNA	  preparation	  with	   random	  hexamers.	  RNAPII-­‐S5p	  RNA-­‐ChIP	  Fragmented	  and	   Intact	  
have	   high	   exon	   depth	  with	   a	   profile	   through	   introns	   suggestive	   of	   co-­‐transcriptional	   splicing.	   Profiles	   across	  
cDNA	  show	  a	  5’	  to	  3’	  gradient,	  expected	  for	  nascent	  transcription.	  Transcription	  occurs	  in	  the	  sense	  orientation	  
as	   only	   very	   low	   signal	   is	   detected	   in	   the	   antisense	   direction.	   Bioinformatic	   analyses	   performed	   by	   I.de	  
Santiago.	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Average	  profiles	  of	   introns	   irrespective	  of	  where	   the	   intron	   is	  within	   the	  gene	  show	  decay	  
from	   5’	   to	   3’	   consistent	   with	   the	   occurence	   of	   co-­‐transcriptional	   splicing.	   To	   understand	  
whether	   splicing	   can	   be	   detected	   throughout	   the	   transcript	   length,	   average	   profiles	  were	  
made	  for	  the	  first	  and	   last	   introns	  of	  the	  top	  and	  bottom	  20%	  expressed	  genes	  (Fig.	  3.17).	  
Only	   genes	   that	   have	   three	   of	   more	   introns	   were	   considered	   meaning	   that	   the	   top	   and	  
bottom	  20%	  genes	  included	  in	  this	  analysis	  contain	  3,371	  and	  1,782	  genes,	  respectively.	  	  
	  
As	   expected,	   mRNA	   intron	   detection	   is	   low	   and	   shows	   a	   flat	   distribution	   across	   intronic	  
sequences.	  A	  gradient	  across	  the	  first	  and	  last	  intron	  in	  the	  Intact	  and	  Fragmented	  datasets	  
is	   indicative	   of	   co-­‐transcriptional	   splicing	   across	   the	   entire	   gene	   length.	   Last	   intron	  
transcripts	   in	   the	   Intact	  RNA-­‐ChIP	  dataset	  appear	   to	  have	  a	   sharper	  gradient	   compared	   to	  
the	  fragmented	  dataset.	  However,	  as	  mentioned	  previously	  the	  latter	  appears	  to	  capture	  5’	  
transcription	  more	  readily	  explaining	  why	  the	  last	  intron	  appears	  less	  represented,	  although	  
apparently	   still	   spliced.	   First	   and	   last	   intron	   transcription	   occurs	   primarily	   in	   the	   correct	  
orientation	  with	  low	  level	  antisense	  transcription,	  although	  the	  directional	  dataset	  does	  not	  
present	  the	  same	  gradient	  seen	  for	  Intact	  and	  Fragmented.	  
	  
The	  analyses	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  average	  profiles	  overall	  suggests	  that	  the	  Fragmented	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Figure	  3.17	  Average	  first	  and	  last	  intron	  profiles	  show	  evidence	  for	  co-­‐transcriptional	  splicing	  in	  the	  RNAPII-­‐
S5p	  RNA-­‐ChIP	  datasets.	  Distribution	  of	  mRNA	  and	  RNAPII-­‐S5p	  RNA	  was	  assessed	  at	   the	  20%	  highest	   (green,	  
n=3371)	   and	   lowest	   (grey,	   n=1782)	   expressed	   genes	   at	   first	   and	   last	   introns	   of	   genes.	   Average	   depth	   of	  
sequencing	   reads	   per	   nucleotide	   were	   calculated	   and	   normalized	   to	   average	   intron	   length.	   	   Genes	   with	  ≥3	  
introns	  were	  included	  in	  the	  analysis.	  Low	  intron	  depth	  is	  seen	  in	  mRNA	  with	  a	  flat	  distribution	  as	  expected.	  In	  
contrast,	  RNAPII-­‐S5p	   Intact	  and	  Fragmented	  RNA	  show	  patterns	  of	   co-­‐transcriptional	   splicing	  of	   the	   first	  and	  
last	   introns.	   Directional	   datasets	   do	   not	   show	   signs	   of	   splicing	   but	   confirm	   the	   correct	   orientation	   of	  
transcription.	  Bioinformatic	  analyses	  performed	  by	  I.de	  Santiago.	  
 
3.2.11 RNAPII-­‐S5p	  RNA-­‐ChIP	  transcripts	  correlate	  with	  RNAPII-­‐S5p	  occupancy	  
In	   this	   chapter	   I	   have	   performed	   RNA-­‐ChIP	   after	   IP	   with	   RNAPII-­‐S5p	   antibodies.	   To	  
investigate	   the	   relationship	   between	   levels	   of	   RNAPII-­‐S5p	   binding	   within	   protein	   coding	  
genes	   and	   transcriptional	   output	   at	   the	   level	   of	   nascent	   transcription	   by	   RNA-­‐ChIP	   we	  
correlated	  read	  depth	  across	  exons	  genome-­‐wide	  for	  all	  RefSeq	  genes	  (Fig.	  3.18).	  Reads	  from	  
the	   20%	   highest	   and	   lowest	   expressing	   genes	   are	   depicted	   in	   the	   correlation	   graphs.	   A	  
positive	  correlation	  between	  mRNA	  expression	  and	  RNAPII-­‐S5p	  protein	  at	  all	  RefSeq	  genes	  
(r=0.69)	  is	  suggestive	  that	  RNAPII-­‐S5p	  levels	  are	  a	  good	  predictor	  of	  expression.	  RNAPII-­‐S5p	  
RNA-­‐ChIP	   from	   the	   three	   library	   preparations	   also	   show	   strong	   positive	   correlations	   with	  
RNAPII-­‐S5p	  binding	  for	  all	  RefSeq	  genes	  (range	  from	  r=0.65-­‐0.74).	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Figure	   3.18	  Nascent	   RNA	   correlates	  with	  RNAPII-­‐S5p	  binding	   genome-­‐wide.	   For	   each	  RNAPII-­‐S5p	  RNA-­‐ChIP	  
dataset	   (Intact,	  Fragmented	  and	  Directional)	   log10	  read	  counts	   for	  each	  exon	  across	  the	  genome	  are	  plotted	  
alongside	  RNAPII-­‐S5p	  binding.	  Spearman’s	  rank	  correlations	  are	  depicted	  for	  all	  genes	  in	  each	  panel	  (rs).	  There	  
is	   a	   strong	  positive	   correlation	  between	  all	   sequencing	   library	  preparations	  and	  RNAPII-­‐S5p	  binding.	  Top20%	  
active	  (green)	  and	  lowest	  20%	  active	  (grey)	  are	  depicted	  among	  the	  population	  and	  represent	  the	  extremes.	  
 
3.2.12 RNAPII-­‐S5p	   RNA-­‐ChIP	   transcript	   detection	   at	   chromatin	   correlates	   with	   mRNA	  
expression	  
Regulation	   of	   gene	   expression	   is	   complex	   and	   can	   occur	   at	   many	   stages	   including	   at	   the	  
transcriptional,	   post-­‐transcriptional	   and	   translational	   levels.	   We	   aimed	   to	   investigate	   the	  
role	   of	   transcriptional	   regulation	   and	   whether	   the	   RNA	   detected	   at	   the	   chromatin	   level	  
associated	  with	  RNAPII-­‐S5p	  in	  RNA-­‐ChIP	  correlates	  with	  final	  mRNA	  expression.	  To	  this	  end,	  
we	  correlated	  read	  depth	  in	  exons	  of	  all	  genes	  between	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  and	  mRNA	  
datasets	  (Fig.	  3.19).	  Correlations	  of	  all	  genes	  between	  mRNA	  and	  the	  Intact,	  Fragmented	  and	  
Directional	  RNA-­‐S5p	  datasets	  are	  highly	  positive	  with	  Spearman’s	  correlations	  of	  0.93,	  0.94	  
and	  0.94,	  respectively.	  Analysis	  suggests	  that	  in	  general	  if	  a	  gene	  is	  transcribed	  as	  detected	  
in	   the	   RNA-­‐ChIP	   experiment	   then	   it	   will	   also	   be	   expressed	   as	   mRNA.	   For	   this	   general	  
genome-­‐wide	  analysis	  of	  exons	  only	  at	  the	  highest	  and	   lowest	  expressed	  genes,	   it	  appears	  
that	  transcriptional	  regulation	  resulting	  in	  gene	  repression	  does	  not	  play	  a	  major	  role	  in	  ES	  
cells.	  This	  analysis	   is	  a	  view	  of	   the	  extreme	  ends	  of	   the	   transcriptional	  population	   (highest	  
20%	  or	   lowest	  20%	  expressed	  genes)	  and	  shows	  that	  high	  transcription	  activity	  yields	  high	  
expression	  levels.	  Such	  coincidence	  between	  RNA	  associated	  with	  RNAPII	  and	  mRNA	  may	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not	   be	   the	   case	   for	   groups	  of	   genes	  where	   transcriptional	   priming	   and	   regulation	  may	  be	  
crucial	  for	  expression	  yield	  such	  as	  PRC-­‐repressed	  genes	  (Brookes	  and	  Pombo,	  2009).	  
	  
	  
Figure	   3.19	   Nascent	   RNA	   correlates	   with	   mRNA	   expression	   genome-­‐wide.	   For	   each	   RNAPII-­‐S5p	   RNA-­‐ChIP	  
dataset	   (Intact,	  Fragmented	  and	  Directional)	   log10	  read	  counts	   for	  each	  exon	  across	  the	  genome	  are	  plotted	  
alongside	  mRNA.	  Spearman’s	  rank	  correlations	  are	  depicted	   for	  all	  genes	   in	  each	  panel	   (rs).	  There	   is	  a	  strong	  
positive	  correlation	  between	  all	  RNA-­‐ChIP	   library	  preparations	  and	  mRNA	  expression.	  Top	  20%	  active	  (green)	  
and	  lowest	  20%	  active	  (grey)	  are	  depicted	  among	  the	  population	  and	  represent	  the	  extremes.	  	  
 
3.2.13 Transcripts	  detected	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  undergo	  co-­‐transcriptional	  splicing	  
Nascent	   RNAs	   associated	   with	   RNAPII-­‐S5p	   are	   detected	   with	   RNA-­‐ChIP.	   Evidence	   from	  
average	   profiles	   at	   the	   TSS	   (Fig.	   3.15)	   and	   through	   introns	   (Figs.	   3.16,	   3.17)	   suggests	   co-­‐
transcriptional	   splicing	   of	   transcripts	   associated	   with	   RNAPII	   bound	   to	   chromatin.	   To	  
specifically	   ask	   whether	   we	   can	   detect	   co-­‐transcriptional	   splicing	   by	   RNA-­‐ChIP	   we	   took	  
advantage	  of	   the	  RNAPII-­‐S5p	   (Fragmented)	   library	  which	  had	  been	  sequenced	   ‘paired-­‐end’	  
for	  use	  in	  additional	  projects	  in	  the	  lab	  investigating	  splicing	  fidelity.	  Paired-­‐end	  sequencing	  
is	  where	  the	  same	  fragment	  in	  the	  library	  is	  sequenced	  from	  both	  ends	  to	  produce	  a	  pair	  of	  
related	   reads.	   These	   are	   then	  aligned	   together	  back	   to	   the	   genome	  and	  when	  both	   reads	  
align	   to	   different	   exons,	   or	   across	   exon-­‐exon	   junctions	   they	   are	   called	   as	   ‘spliced’.	  
Sequencing	  pairs	   that	  align	  to	  an	  exon	  and	  an	   intron	  or	  across	  exon-­‐intron	  boundaries	  are	  
called	  as	   ‘unspliced’.	   I	   compared	   the	  percentage	  of	   spliced	   reads	  and	  unspliced	   reads	   that	  
were	  sequenced	   in	  RefSeq	  genes	  for	  the	  mRNA	  and	  RNAPII-­‐S5p	  (Fragmented)	  dataset	   (Fig.	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3.20).	   Spliced	   reads	   dominate	   the	   mRNA	   dataset	   (75%)	   as	   expected,	   while	   there	   is	   a	  
proportion	   of	   unspliced	   reads	   (25%).	   In	   contrast,	   RNAPII-­‐S5p	   RNA-­‐ChIP	   is	   comprised	   of	   a	  
comparable	  percentage	  of	  spliced	  (45%)	  and	  unspliced	  (55%)	  reads.	  Detection	  of	  high	  levels	  
of	  unspliced	  reads,	  which	  is	  double	  the	  number	  in	  mRNA,	  demonstrates	  the	  ability	  of	  RNA-­‐
ChIP	  with	  RNAPII-­‐S5p	   to	   detect	   nascent	   transcription	   associated	  with	   chromatin.	   The	  high	  
percentage	  of	  spliced	  reads	  also	  confirms	  that	  co-­‐transcriptional	  splicing	  can	  be	  detected	  by	  





Figure	  3.20	  Nascent	   transcripts	  detected	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	   show	  co-­‐transcriptional	   splicing.	  RNAPII-­‐
S5p	  RNA-­‐ChIP	  (Fragmented)	  and	  mRNA	  were	  sequenced	  as	  ‘paired	  end’	  libraries	  where	  each	  library	  fragment	  is	  
sequenced	  from	  each	  end,	  creating	  a	  ‘pair’.	  Paired	  reads	  were	  aligned	  to	  the	  genome	  using	  TopHat.	  A	  pair	  of	  
reads	  that	  occur	   in	  exons	  or	  across	  an	  exon	  junction	  within	  a	  gene	  are	  called	  ‘spliced’.	  Reads	  that	  align	  to	  an	  
exon	   and	   intron	   or	   across	   an	   exon-­‐intron	   boundary	   are	   called	   ‘unspliced’.	   The	   proportion	   of	   spliced	   and	  
unspliced	  reads	  were	  calculated	  for	  each	  dataset.	  Spliced	  reads	  predominate	  in	  mRNA	  but	  are	  also	  substantially	  
detected	  in	  RNAPII-­‐S5p	  RNA-­‐ChIP.	  Unspliced	  RNAs	  are	  detected	  more	  readily	  in	  RNAPII-­‐S5p	  compared	  to	  mRNA	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3.3.1 RNAPII	  RNA-­‐ChIP	  
RNA	   chromatin	   immunoprecipitation	   is	   a	  method	   to	   evaluate	   association	   of	   proteins	  with	  
RNA	   still	   coupled	   to	   chromatin.	   It	   has	   been	   used	   successfully	   to	   study	   co-­‐transcriptional	  
splicing	   of	   oestrogen	   responsive	   genes	   at	   the	   level	   of	   single	   genes	   in	   human	   cells,	   by	  
immunoprecipitating	   RNAPII-­‐S5p	   (Bittencourt	   et	   al.,	   2008).	   However,	   application	   of	   RNA-­‐
ChIP	   to	   look	  at	  RNAPII	   transcription	  genome-­‐wide	  has	  not	  been	  demonstrated	  before,	  but	  
with	  the	  advent	  of	  NGS	  it	  became	  a	  reachable	  goal.	  ES	  cells	  have	  complex	  gene	  expression	  
regulation	  and	  the	  association	  of	  PRC	  and	  RNAPII	  at	  PRC-­‐repressed	  genes	  led	  to	  the	  question	  
of	  whether	  transcriptional	  regulation	  plays	  a	  role	  in	  repressing	  expression	  from	  these	  genes.	  
In	  this	  chapter,	  I	  aimed	  to	  optimize	  RNA-­‐ChIP,	  which	  was	  then	  used	  to	  study	  transcription	  at	  
PRC-­‐repressed	  genes	  in	  ES	  cells	  (Chapter	  4).	  RNA-­‐ChIP	  gives	  the	  best	  chance	  of	  capturing	  the	  
earliest	   stages	   of	   transcription	   and	   immunoprecipitating	   proteins	   of	   interest	   allows	  
specificity	  in	  the	  RNA	  populations	  extracted.	  	  	  
	  
Optimisation	  of	  RNA-­‐ChIP	   in	  ES-­‐OS25	  cells	  with	  RNAPII	   antibodies	  against	  different	  RNAPII	  
CTD	  modifications	  in	  the	  presence	  of	  transcription	  inhibitors	  demonstrated	  that	  RNAPII	  RNA-­‐
ChIP	   can	  be	  used	   successfully	   to	  enrich	  newly-­‐made	   transcripts	   from	  active	   (Figs.	  3.3,	  3.4)	  
and	  PRC-­‐repressed	  genes	  (Fig.	  3.3)	  over	  the	  total	  population	  of	  RNA	  by	  single	  gene	  analysis.	  
In	   chapter	   4,	   I	   also	   used	   PRC	   antibodies	   to	   immunoprecipitate	   transcripts	   from	   PRC-­‐
repressed	  genes	   in	  ES	  cells	   (Fig.	  4.5).	   I	   then	  went	  on	  to	  optimize	  the	  RNA-­‐ChIP	  method	  for	  
NGS	  using	  RNAPII-­‐S5p	  antibodies.	  Detection	  of	  transcripts	  at	  active	  genes	  allowed	  a	  positive	  
control	  to	  help	  assess	  the	  quality	  of	  RNA-­‐ChIP-­‐seq	  datasets	  produced	  and	  to	  help	  determine	  
the	   best	   library	   preparation	  method.	   It	   also	   gave	   us	   the	   opportunity	   to	   study	   features	   of	  
transcription	   at	   active	   genes	   in	   ES	   cells	   in	   parallel	   with	   mRNA	   and	   RNAPII	   occupancy	  
datasets.	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3.3.2 Fragmented	   sequencing	   library	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP	   best	   represents	  
transcription	  in	  ES	  cells	  
NGS	  library	  preparation	  and	  sequencing	  of	  RNA-­‐ChIP	  samples	  had	  not	  been	  done	  previously	  
therefore	  requiring	  optimisation.	  I	  prepared	  RNAPII-­‐S5p	  RNA-­‐ChIP	  libraries	  using	  Illumina	  
kits	  that	  do	  not	  provide	  information	  about	  transcription	  direction	  but	  are	  a	  robust	  method	  
to	  prepare	  mRNA	  NGS	   libraries.	  This	  approach	  was	  used	   to	  make	   two	  kinds	  of	  RNAPII-­‐S5p	  
RNA-­‐ChIP	  libraries:	  Fragmented	  and	  Intact	  (Fig.	  3.6).	  Regulation	  of	  gene	  expression	  is	  known	  
to	   involve	   antisense	   transcription	   (Katayama	   et	   al.,	   2005;	   Core	   et	   al.,	   2008;	   Preker	   et	   al.,	  
2008;	   Seila	   et	   al.,	   2008),	   and	   was	   hypothesized	   as	   a	   mechanism	   of	   regulation	   at	   PRC-­‐
repressed	  genes.	  Therefore,	  I	  also	  prepared	  RNAPII-­‐S5p	  RNA-­‐ChIP	  Directional	  libraries	  using	  
a	   library	  preparation	  kit	  originally	  designed	  by	  Illumina	  for	  miRNA	  profiling,	  which	  required	  
some	  optimization	  for	  use	  with	  RNA-­‐ChIP	  samples.	  Optimisation	  was	  done	   in	  collaboration	  
with	  Jiannis	  Ragoussis	  and	  Carme	  Camps	  (WTCHG,	  Oxford).	  
	  
Reads	  from	  each	  of	  the	  sequencing	  libraries	  (Intact,	  Fragmented	  and	  Directional)	  correlated	  
across	  the	  genome	  (Fig.	  3.9)	  and	  gave	  good	  depth	  of	  signal	  over	  entire	  coding	  regions	  of	  long	  
genes	   in	   ES	   cells	   (Fig.	   3.10).	   Mapping	   to	   regions	   across	   the	   genome	   saw	   comparatively	  
similar	  results	  for	  all	  three	  preparations	  (Fig.	  3.13)	  although	  the	  Directional	  library	  had	  some	  
important	  shortcomings.	  	  
	  
Genome-­‐wide	  analysis	  at	  two	  robust	  groups	  of	  genes,	  characterized	  by	  absence	  of	  Polycomb	  
and	   being	   the	   20%	   most	   active	   or	   20%	   least	   active	   genes,	   demonstrated	   that	   all	   library	  
preparations	  could	  detect	  transcripts	  at	  TSS,	  through	  coding	  regions	  and	  at	  TES	  (Figs.	  3.16,	  
3.17).	  However,	  the	  Directional	   library	  did	  not	  detect	  the	  characteristic	  enrichment	  of	  RNA	  
at	  the	  5’	  ends	  of	  transcripts	  (Fig.	  3.16),	  likely	  the	  result	  of	  technical	  aspects	  of	  the	  method,	  
namely	  possibly	  inhibition	  of	  primer	  ligation	  at	  5’	  ends	  in	  the	  presence	  of	  capping.	  Therefore	  
the	   Directional	   RNAPII-­‐S5p	   RNA-­‐ChIP	   library	   was	   only	   used	   for	   specific	   questions	   that	  
concerned	  direction	  of	  transcription.	  Further	  optimization	  would	  be	  required	  to	  improve	  the	  
Directional	   method,	   including	   a	   5’	   cap	   removal	   step,	   which	  may	   enhance	   5’	   detection	   of	  
RNA.	  Additional	  protocols	  are	  also	  now	  available	  which	  could	  be	  used	  if	  deemed	  necessary	  in	  
the	  future.	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The	  Fragmented	  library	  detected	  5’	  transcripts	  more	  readily	  than	  the	  Intact	  library	  although	  
both	  presented	  a	  5’	  to	  3’	  gradient	  of	  RNA	  expected	  from	  RNAPII	  transcription	  through	  a	  gene	  
(Wada	  et	  al.,	  2009).	  This	  result	  suggests	  that	  the	  Fragmented	  library	  is	  currently	  the	  best	  	  
representation	  of	  nascent	   transcription	  where	   transcripts	  are	  more	  abundant	  at	  5’	   than	  3’	  
ends	  of	  coding	  regions,	  as	  RNAPII	   traverses	   the	  gene	   length,	  compared	  to	  mRNA	  where	  5’	  
and	  3’	  ends	  of	  transcripts	  should	  be	  equally	  represented.	  Average	  intron	  profiles	  reveal	  that	  
both	  Intact	  and	  Fragmented	  libraries	  can	  detect	  co-­‐transcriptional	  splicing	  (Fig.	  3.17;	  (Ameur	  
et	  al.,	  2011;	  Khodor	  et	  al.,	  2011)).	  However,	   the	  Fragmented	   library	  captures	   transcription	  
throughout	  coding	  regions	  with	  a	  more	  defined	  pattern	  suggestive	  of	  nascent	  transcription	  
(Wada	  et	  al.,	  2009)	  than	  the	  Intact	  library	  (Fig.	  3.17).	  All	  the	  analyses	  performed	  point	  to	  the	  
non-­‐directional	   Fragmented	   RNAPII-­‐S5p	   RNA-­‐ChIP	   library	   as	   the	   most	   representative	   of	  
RNAPII	  transcription	  genome-­‐wide.	  For	  simplicity,	  it	  was	  therefore	  used	  for	  the	  subsequent	  
analyses	  of	   transcription	  at	  PRC-­‐repressed	  genes	   in	  Chapter	  4,	   alongside	  RNAPII-­‐S5p	  DNA-­‐
ChIP	  and	  Ring1B	  RNA-­‐ChIP	  Directional	  dataset	  to	  ask	  specific	  questions.	  
3.3.3 Transcription	  at	  active	  genes	  in	  ES	  cells	  
Nascent	  transcripts	  can	  be	  detected	  from	  active	  genes	  in	  ES	  cells	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  by	  
single	  gene	  analysis	   (Fig.	  3.5).	  Transcription	   from	  highly	  expressed	  genes	   in	  ES	  cells	  can	  be	  
detected	  genome-­‐wide	  (Figs.	  3.15,	  3.16,	  3.17)	  with	  some	  interesting	  features.	  	  
	  
Promoter	  associated	  antisense	   transcription	   is	   readily	  detected	   in	  all	  RNAPII-­‐S5p	  RNA-­‐ChIP	  
datasets,	  a	  feature	  already	  described	  in	  yeast,	  mouse	  and	  human	  (Core	  et	  al.,	  2008;	  Preker	  
et	  al.,	  2008;	  Seila	  et	  al.,	  2008;	  Neil	  et	  al.,	  2009).	  Anti-­‐sense	  transcription	  is	  thought	  to	  be	  non-­‐
coding	   and	   to	   have	   regulatory	   roles	   in	   the	   expression	   of	   associated	   protein-­‐coding	   genes,	  
although	   the	   mechanism	   is	   not	   known.	   Unstable	   antisense	   transcription	   has	   so	   far	   been	  
identified	  using	  GRO-­‐seq,	  an	  in	  vitro	  assay	  to	  assess	  engaged	  RNAPII	  that	  can	  elongate	  after	  
nuclear	   isolation,	   and	   exosome	   depletion,	   in	  mouse	   and	   human	   respectively	   (Core	   et	   al.,	  
2008;	   Preker	   et	   al.,	   2008).	   Here,	   robust	   detection	   of	   antisense	   transcription	   in	   ES	   cells	   by	  
RNAPII-­‐S5p	  RNA-­‐ChIP	  demonstrates	   the	   sensitivity	  of	   this	  method	   to	  detect	  unstable	  non-­‐
coding	  transcription.	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RNAPII	  elongation	  carries	  on	  over	   long	  distances	  from	  the	  TES	  at	  active	  genes	   in	  mammals	  
(Richard	  and	  Manley,	  2009).	  After	  transcript	  cleavage,	  exonuclease	  Xrn2	  facilitates	  	  
	  
termination	   and	   promotes	   RNAPII	   dissociation	   from	   the	   template	   by	   degrading	   the	   post-­‐
cleavage	  transcript	  (West	  et	  al.,	  2004).	  The	  extent	  of	  RNAPII-­‐S2p	  levels	  detected	  immediately	  
after	  the	  TES	  is	  the	  best	  predictor	  of	  mRNA	  expression	  (Brookes	  et	  al.,	  2012)	  suggesting	  that	  
this	   process	   is	   highly	   important	   for	   RNA	   maturation	   through	   co-­‐transcriptional	  
polyadenylation	   (Proudfoot	   et	   al.,	   2002).	   Termination	   associated	   transcription	   is	   robustly	  
detected	  by	  RNAPII	  RNA-­‐ChIP	  at	  active	  genes	  (Figs.	  3.10,	  3.12,	  3.15)	  further	  demonstrating	  
the	   sensitivity	   of	   the	   technique	   to	   identify	   readily	   degraded	   transcripts,	   as	   well	   as	   the	  
identification	  of	  termination	  associated	  transcription	  as	  a	  general	  feature	  of	  active	  genes	  in	  
ES	   cells.	   Future	   studies	  may	   explore	   the	   extent	   of	   post-­‐cleavage	   transcription	   and	   how	   it	  
relates	  with	  genomic	  and	  epigenetic	  features.	  
	  
A	  number	  of	  results	  from	  this	  chapter	  lead	  to	  the	  conclusion	  that	  co-­‐transcriptional	  splicing	  
can	  be	  detected	  by	  RNA-­‐ChIP	  and	   is	  general	  phenomenon	  at	  active	  genes	   in	  ES	  cells	   (Figs.	  
3.15,	  3.16,	  3.17,	  3.20).	  Co-­‐transcriptional	  splicing	  can	  be	  inferred	  by	  specific	  intron	  patterns	  
showing	   5’	   to	   3’	   gradients	   (Ameur	   et	   al.,	   2011)	  which	   can	   be	   detected	   in	   RNA-­‐ChIP	   (Figs.	  
3.16,	  3.17).	  We	  also	   show	  direct	  evidence	   that	   co-­‐transcriptional	   splicing	  occurs	  at	  RefSeq	  
protein-­‐coding	   genes	   in	   ES	   cells	   (Fig.	   3.20),	   confirming	   the	   connection	   between	   RNAPII,	  
chromatin	  and	  RNA	  processing.	  Recent	   reports	   from	   the	  ENCODE	  consortium	  also	   confirm	  
the	  presence	  of	  co-­‐transcriptional	  splicing	  in	  a	  number	  of	  cell	  lines	  (Djebali	  et	  al.,	  2012).	  	  
	  
In	   conclusion,	   RNAPII	   RNA-­‐ChIP	   is	   a	   method	   that	   can	   be	   used	   genome-­‐wide	   to	   study	  
transcription	  at	  groups	  of	  genes	  and	  possible	  mechanisms	  of	  regulation	  including	  non-­‐coding	  
transcription,	  splicing	  and	  transcript	  coverage	  through	  genes.	  Analyses	  of	  RNAPII	  RNA-­‐ChIP	  
samples	   after	   transcription	   inhibition	   with	   CDK9	   inhibitor	   flavopiridol	   are	   ongoing	   to	  
understand	   the	  extent	  of	  nascent	   transcription	  over	   the	  detection	  of	   stable	  RNA	   that	  may	  
associate	  with	  RNAPII	  bound	  chromatin,	  or	  be	  carried	  over	  during	  ChIP.	  Inclusion	  of	  control	  
IP	  RNA	  sequencing	  may	  also	  help	  interpret	  levels	  of	  RNA	  carry	  over	  in	  the	  chromatin	  sample.	  
Interestingly,	   specific	   inhibitors	   can	   also	   be	   used	   to	   study	   transcription	   dynamics,	   and	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flavopiridol	   in	   particular	   affects	   the	   elongation	   phase	   of	   transcription.	   Importantly,	  
numerous	  lines	  of	  evidence	  in	  this	  chapter	  support	  the	  idea	  that	  RNA-­‐ChIP	  is	  able	  to	  detect	  
transcription	   in	   ES	   cells.	   After	   analysis	   of	   different	   sequencing	   library	   preparations,	   it	  was	  
concluded	   that	   the	   Fragmented	   non-­‐directional	   library	   gives	   the	   most	   accurate	   view	   of	  
RNAPII	  transcription.	   
Chapter	  4	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4 Transcription	  at	  Polycomb-­‐repressed	  genes	  
4.1 Introduction	  
4.1.1 Polycomb	  complexes	  associate	  with	  an	  unusual	  RNAPII	  variant	  in	  ES	  cells	  
Polycomb	   repressor	   complexes	   (PRCs)	   are	   critical	   in	   repressing	   developmental	   regulator	  
genes	   in	  ES	   cells.	   In	   their	   silent	   state,	  PRC-­‐repressed	  genes	  are	  associated	  with	  Polycomb-­‐
mediated	   histone	  modifications	   	   (H2Aub1+,	   H3K27me3+;	   Fig.	   4.1)	   and	   an	   unusual	   form	   of	  
‘poised’	  RNAPII	  (RNAPII-­‐S5p+S2p-­‐8WG16-­‐;	  Figs.	  1.5,	  4.1)	  that	  is	  incompatible	  with	  expression	  


























































































































































































Figure	  4.1	  RNAPII	  complexes	  phosphorylated	  on	  S5	  residues	  are	  present	  at	  promoter	  and	  coding	  regions	  of	  
PRC-­‐repressed	  genes.	   (A)	  Genome-­‐wide	  ChIP-­‐seq	  analyses	   in	  murine	  ES	  cells	  of	  RNAPII-­‐S5p	  and	   -­‐S2p,	  and	  of	  
Polycomb	   marks	   H3K27me3	   and	   H2Aub1	   show	   that	   RNAPII-­‐S5p	   and	   Polycomb	   have	   similar	   average	  
distributions	  at	  PRC-­‐repressed	  genes	  (adapted	  from	  Brookes	  et	  al.,	  2012).	  (B)	  Transcript	  level	  analysis	  in	  ES	  cells	  
treated	   in	   the	   absence	   (-­‐)	   or	   presence	   (+)	   of	   α-­‐amanitin	   identify	   low	   levels	   transcription	   from	   Polycomb-­‐
repressed	   genes	   (Cdx2,	   Msx1,	   Nkx2.2,	   Gata4),	   in	   comparison	   with	   active	   gene	   Oct4	   or	   silent	   gene	   Myf5	  
(adapted	   from	   Stock	   et	   al.,	   2007).	   Total	   transcripts	   are	   detected	   with	   primers	   at	   the	   first	   exon	   after	  
amplification	  of	  total	  RNA	  with	  random	  hexamers.	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Lack	   of	   RNAPII	   recruitment	   is	   therefore	   not	   the	   major	   step	   in	   repressing	   the	   activity	   of	  
Polycomb	   target	   genes,	   but	   steps	   subsequent	   to	   transcription	   initiation	   are	   likely	   to	   be	  
involved.	  Although	  not	  expressed	  at	   the	  mRNA	   level,	   transcription	  can	  be	  detected	  at	   low	  
level,	  at	  a	  panel	  of	  PRC-­‐repressed	  genes	  (Stock	  et	  al.,	  2007;	  Fig.	  4.1B).	  	  	  
	  
Genome-­‐wide	   analyses	   show	   that	   RNAPII-­‐S5p	   extends	   through	   coding	   regions	   of	   PRC-­‐
repressed	   genes	   in	   the	   absence	   of	   elongation	   associated	   S2p,	   and	   histone	   modification	  
H3K36me3	   (Brookes	   et	   al.,	   2012).	   Lack	   of	   marks	   that	   signify	   productive	   transcription	  
prompts	   the	   question	   of	   whether	   transcript	   processing	   including	   splicing	   and	  
polyadenylation	  are	   compromised	  at	  PRC	   targets	  due	   to	   the	  absence	  of	   S2p	   (Brookes	  and	  
Pombo,	   2009).	   More	   recent	   analyses	   also	   show	   that	   S7p	   is	   extremely	   low	   at	   Polycomb	  
targets	  (Brookes	  et	  al.,	  2012),	  a	  modification	  important	  for	  the	  transition	  between	  S5p	  and	  
S2p.	  	  
	  
RNAPII-­‐S5p	   extends	   through	   the	   entire	   coding	   region	   reaching	   the	   TES	   at	   many	   PRC-­‐
repressed	   genes	   (Brookes	   et	   al.,	   2012).	   Interestingly,	   PRC	   binding	   and	   associated	   histone	  
modifications	   mirror	   RNAPII	   distribution	   genome-­‐wide.	   Sequential	   ChIP	   at	   a	   panel	   of	  
Polycomb	  target	  genes	  shows	  that	  the	  catalytic	  subunits	  of	  PRC2	  and	  PRC1,	  Ezh2	  and	  Ring1B	  
respectively,	  both	  simultaneously	  co-­‐associate	  with	  RNAPII	  (Brookes	  et	  al.,	  2012),	  suggesting	  
regulatory	   interplay	   between	   the	   three	   complexes.	   How	   co-­‐occupancy	   of	   PRC	   and	   RNAPII	  
affects	   transcription	   at	   these	   genes	   is	   unknown.	   Investigating	  how	   this	   interplay	   regulates	  
transcriptional	   output	   from	   PRC-­‐repressed	   genes	   is	   important	   to	   gain	   insight	   into	  
mechanisms	   of	   gene	   regulation	   not	   only	   in	   ES	   cells,	   but	   potentially	   other	   systems	   where	  
PRCs	  are	  critical	  for	  gene	  regulation.	  	  	  
4.1.2 Transcription	  at	  PRC-­‐repressed	  genes	  
Low	   level	  of	   transcriptional	   activity	  has	  been	  detected	  at	  PRC-­‐target	  genes	   (Breiling	  et	   al.,	  
2004;	  Bracken	  et	  al.,	  2006;	  Tolhuis	  et	  al.,	  2006;	  Stock	  et	  al.,	  2007;	  Carter	  et	  al.,	  2009;	  Chopra	  
et	  al.,	  2009;	  Kanhere	  et	  al.,	  2010;	  Min	  et	  al.,	  2011),	  although	  the	  properties	  of	  the	  nascent	  
transcripts	  produced	  have	  not	  been	  studied.	  Single	  gene	  analyses	  of	  total	  RNA	  using	  primers	  
at	  the	  first	  exon	  or	  across	  the	  first	  splice	  junction	  show	  that	  transcription	  and	  splicing	  occur	  
(Stock	  et	  al.,	  2007),	  even	  though	  these	  genes	  are	  silent	  at	  both	  the	  mRNA	  and	  protein	  levels	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in	  ES	  cells	  (Guenther	  et	  al.,	  2007;	  Mikkelsen	  et	  al.,	  2007;	  Brookes	  et	  al.,	  2012).	  Presence	  of	  
appreciable	  occupancy	  of	  RNAPII-­‐S5p	  at	  PRC-­‐repressed	  genes,	  which	  produces	  only	  low-­‐level	  
transcripts,	   suggests	   that	   Polycomb	   regulation	   may	   act	   at	   the	   level	   of	   transcription	  
elongation	   and	   maturation	   of	   nascent	   transcripts.	   The	   presence	   of	   RNAPII	   alongside	  
Polycomb	   complexes	   adds	   unexplored	   layers	   of	   complexity	   to	   Polycomb	   repression.	   The	  
interplay	  between	  these	  two	  complexes	  in	  the	  regulation	  of	  transcription	  has	  not	  yet	  been	  
investigated.	  	  
4.1.3 Aims	  
My	  aim	  was	   to	   investigate	   the	  properties	  of	   transcription	  at	  PRC-­‐repressed	  genes,	   to	  shed	  
light	  on	  mechanisms	  of	  Polycomb	  repression	  and	  RNAPII	  regulation	  in	  ES	  cells.	  To	  this	  end,	  I	  
used	  RNA-­‐ChIP	   as	   a	  method	   to	   isolate	  nascent	  RNA	  associated	  with	  RNAPII	   at	   both	  active	  
and	  PRC-­‐repressed	  genes,	  followed	  by	  transcript	  detection	  by	  single-­‐gene	  and	  genome-­‐wide	  
analyses.	   I	   began	   by	   identifying	   nascent	   transcripts	   by	   RNA-­‐ChIP	   using	   antibodies	   against	  
RNAPII-­‐S5p,	   followed	   by	   Ring1B	   and	   Ezh2,	   the	   catalytic	   component	   of	   PRC1	   and	   PRC2,	  
respectively.	   Inclusion	   of	   transcriptional	   inhibitors	   demonstrated	   the	   detection	   of	   nascent	  
transcription.	   From	  RNAPII-­‐S5p	  RNA-­‐ChIP	   genome-­‐wide	   datasets,	   I	   explored	  whether	   PRC-­‐
repressed	   genes	   are	   transcribed	   and	   the	   features	   of	   the	   nascent	   transcripts.	   We	   asked	  
whether	   the	   relationship	   between	   RNAPII	   and	   PRC	   occupancy	   at	   PRC-­‐repressed	   genes	  
affected	   transcriptional	   output.	  Using	   a	   conditional	   Ring1B-­‐knockout	   ES	   cell	   line,	   I	   studied	  
the	  effect	  of	  PRC1	  removal	  on	  RNAPII	  transcription;	   in	  these	  cells	  PRC2	  remains	  associated	  
with	  PRC	  target	  genes	  (Stock	  et	  al.,	  2007).	  Cap	  analysis	  of	  gene	  expression	  (CAGE)	  allowed	  
me	   to	   explore	  whether	   PRC-­‐repressed	   transcripts	   are	   capped,	   and	   transcription	   promoter	  
usage	  at	  PRC-­‐target	  genes.	  	  
	  
Raw	  sequencing	  files	  were	  processed,	  and	  UCSC	  compatible	  files	  generated	  by	  A.Geiss	  (MRC	  
Genomics	   Laboratory).	   All	   bioinformatic	   analyses	   in	   this	   chapter	   were	   performed	   by	   I.de	  
Santiago	   (our	   laboratory),	   and	   N	   Harmston	   (Computational	   Regulatory	   Genomics	   Group,	  
MRC-­‐CSC).	  	  




4.2.1 Strategy	  to	  detect	  nascent	  transcripts	  from	  PRC	  target	  genes	  in	  ES	  cells	  
PRC-­‐repressed	   genes	   present	   an	   unexpected	   combination	   of	   histone	   marks,	   PRCs,	   and	  
RNAPII	   modifications,	   which	   distinguish	   them	   from	   active	   and	   silent	   genes	   across	   the	  
genome	  in	  ES	  cells	   (Fig.	  4.2A).	   In	  order	  to	  detect	  chromatin-­‐bound	  nascent	  RNA	  from	  PRC-­‐
repressed	  genes,	   I	   took	  advantage	  of	   their	  unique	  chromatin	  configuration	  and	  performed	  
RNA-­‐ChIP	  with	  RNAPII-­‐S5p	  and	  PRC-­‐directed	  antibodies	  followed	  by	  single	  gene	  analysis	  by	  
RT-­‐PCR	  or	  genome-­‐wide	  by	  NGS	  (Fig.	  4.2B).	  	  
	  
Figure	  4.2	  Strategy	  to	  enrich	  nascent	  transcripts	  from	  PRC-­‐repressed	  genes	  in	  ES	  cells.	  PRC-­‐repressed	  genes	  
present	   a	   novel	   occupancy	   profile	   of	   RNAPII-­‐S5p+S2p-­‐	   and	   PRCs	   in	   comparison	   to	   active	   genes,	   which	   have	  
RNAPII-­‐S5p+S2p+,	  in	  the	  absence	  of	  PRC.	  RNA-­‐ChIP	  with	  antibodies	  against	  S5p	  will	  enrich	  for	  transcripts	  from	  
both	  active	   and	  PRC-­‐repressed	  genes.	   Transcriptional	   inhibitors	   are	   included	   to	  dissect	  nascent	   transcription	  
from	  stable	  RNA	  pools.	  Ring1b	  and	  Ezh2	  RNA-­‐ChIP	  will	  enrich	  for	  transcripts	  from	  PRC-­‐repressed	  genes.	  	  	  	  
	  
In	   the	   case	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP,	   RNA	   from	   all	   active	   genes	   as	   well	   as	   PRC-­‐repressed	  
genes	  will	  be	  enriched	  from	  the	  population.	  Inclusion	  of	  transcriptional	  inhibitors	  will	  allow	  
discrimination	  between	  nascent	  and	   stable	  populations	  of	  RNA.	  With	   the	  aim	  of	  enriching	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for	  PRC-­‐repressed	  transcripts	  specifically,	  I	  also	  performed	  RNA-­‐ChIP	  with	  antibodies	  against	  
Ring1B	  and	  Ezh2,	  components	  of	  PRC1	  and	  PRC2,	  respectively.	  
4.2.2 Nascent	   transcripts	   from	  PRC-­‐repressed	   genes	   are	   detected	   after	   RNA-­‐ChIP	  with	  
RNAPII-­‐S5p	  antibodies	  
To	  begin	  investigating	  the	  possibility	  that	  PRC-­‐repressed	  genes	  are	  transcribed,	  I	  used	  RNA-­‐
ChIP	   with	   antibodies	   against	   RNAPII-­‐S5p,	   initially	   for	   single	   gene	   analysis	   using	   RT-­‐PCR.	  
Abundant	   RNAPII-­‐S5p	   associates	   with	   PRC-­‐repressed	   genes	   (Fig.	   3.1;	   Stock	   et	   al.,	   2007;	  
Brookes	   et	   al.,	   2012).	   RNA-­‐ChIP	   was	   performed	   with	   ES	   cells	   grown	   in	   the	   presence	   or	  
absence	   of	   transcriptional	   inhibitors	   flavopiridol	   and	   α-­‐amanitin,	   to	   test	   whether	   RNA	  
detected	  were	  newly	  made.	  Other	  controls	  included	  RNA	  extracted	  from	  total	  chromatin	  as	  
well	   as	   a	  mock	   IgG	   IP.	   Primers	   designed	   in	   the	   5’	   of	   coding	   regions,	   excluding	   annotated	  
intron-­‐exon	  boundaries,	  were	  used	  to	  detect	  total	  transcripts	  independently	  of	  splicing,	  from	  
a	   panel	   of	   eight	   previously	   well	   characterized	   PRC-­‐repressed	   genes	   (Azuara	   et	   al.,	   2006;	  
Stock	  et	  al.,	  2007;	  Brookes	  et	  al.,	  2012).	  Silent	  genes	  were	  also	  analysed	  for	  comparison.	  
	  
Transcripts	  from	  PRC-­‐repressed	  genes	  are	  enriched	  above	  RNA	  levels	  from	  total	  chromatin,	  
mock	  IP	  and	  transcriptional	  inhibitors	  (Fig.	  4.3).	  Short	  (1h)	  treatment	  with	  the	  CDK9	  inhibitor	  
flavopiridol	   reveals	   depletion	   of	   transcripts	   from	   PRC-­‐repressed	   genes.	   Sensitivity	   to	   the	  
short	   duration	   of	   flavopiridol	   treatment	   suggests	   that	   nascent	   transcription	   from	   PRC-­‐
repressed	  genes	  occurred	  within	  the	  1h	  period	  prior	  to	  cell	  crosslinking.	  Transcripts	  detected	  
are	   therefore	   not	   stable	   RNA	  pools,	   but	   recently	   transcribed.	   Absence	   of	   RNA	   from	   silent	  
genes	  Myf5	  and	  Gabra6	  demonstrate	  specificity	  of	  immunoprecipitation,	  as	  these	  two	  genes	  
are	  not	  associated	  with	  RNAPII-­‐S5p	  (Myf5;	  Fig.	  3.1,	  Gabra6;	  not	  shown),	  and	  absence	  of	  DNA	  
contamination	   in	   the	  RNA	  extraction	  after	   IP.	   Low	   levels	  of	  Nmur2	  RNA	  detection	  appears	  
insensitive	   or	   to	   flavopiridol	   treatment.	   Treatment	   with	   a	   separate	   inhibitor,	  α-­‐amanitin,	  
which	   targets	   RNAPII	   directly,	   recapitulates	   results	   seen	   with	   flavopiridol	   (Fig.	   4.3).	   PRC-­‐
repressed	  transcripts	  are	  all	  highly	  sensitive	   to	  α-­‐amanitin	  with	  ≥50%	  transcript	  depletion.	  
There	  is	  no	  detection	  of	  RNA	  from	  silent	  genes	  Myf5,	  Gabra6,	  and	  low	  levels	  of	  Nmur2	  RNA	  
are	  detected	  and	  only	  partially	  sensitive	  to	  α-­‐amanitin.	  	  
	  







































































Figure	   4.3	   Nascent	   PRC-­‐repressed	   transcripts	   are	   detected	   by	   RNA-­‐ChIP	   bound	   to	   chromatin.	   Transcripts	  
associated	  with	  RNAPII-­‐S5p	  bound	  to	  chromatin	  were	  assessed	  by	  RNA-­‐ChIP	  and	  quantitative	  RT-­‐PCR,	  at	  PRC-­‐
repressed	   and	   silent	   genes	   in	   ES-­‐OS25	   cells.	   Levels	   of	   RNA	   from	   RNAPII-­‐S5p	   RNA-­‐ChIP	   with	   or	   without	  
transcription	  inhibitors	  are	  shown	  as	  white	  and	  blue	  bars,	  respectively.	  RNA	  extracted	  from	  total	  chromatin	  is	  
shown	   in	   light	  grey	  and	  no	  antibody	  control	   in	  dark	  grey.	  Primers	  were	  designed	  within	  5’	  exonic	   regions	   to	  
capture	  total	  RNA	  populations.	  RNA-­‐ChIP	  for	  RNAPII-­‐S5p	  enriches	  for	  PRC-­‐repressed,	  but	  not	  silent	  transcripts	  
(Gabra6,	  Myf5)	  above	  levels	  detected	  in	  total	  chromatin	  and	  mock	  IP.	  PRC-­‐repressed	  transcripts	  are	  sensitive	  to	  
flavopiridol	   and	   α-­‐amanitin.	   Mean	   and	   standard	   deviations	   are	   presented	   from	   3	   independent	   biological	  
replicates	   in	   the	   case	   of	   flavopiridol	   and	   a	   single	   matched	   experiment	   with	   α-­‐amanitin.	   ND	   labeled	   genes	  
represent	  “Not	  Detected”.	  
	  
It	  is	  worth	  noting	  that	  levels	  of	  transcripts	  from	  PRC-­‐repressed	  genes	  detected	  by	  RT-­‐PCR	  at	  
single	  genes,	  after	  RNAPII-­‐S5p	  RNA-­‐ChIP,	  are	  approximately	  100-­‐1000	  times	  lower	  than	  from	  
active	  genes	  (Fig.	  3.4),	  but	  robustly	  detected	  across	  biological	  replicates.	  However,	  levels	  of	  
RNAPII-­‐S5p	  detected	  at	  PRC-­‐repressed	  genes	  can	  be	  as	  high	  as	  at	  active	  genes	   (Fig.	  3.1),	  a	  
characteristic	  also	  seen	  genome-­‐wide	  after	  ChIP-­‐seq	  (Brookes	  et	  al.,	  2012).	  The	  discrepancy	  
between	   the	   high	   amounts	   of	   RNAPII-­‐S5p	  occupancy	   and	   the	   amount	   of	   RNA	  detected	   at	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PRC-­‐repressed	   genes	   suggests	   that	   PRC	   repression	   may	   be	   intimately	   associated	   with	  
regulation	  of	  transcription	  or	  RNA	  stability.	  
4.2.3 Ring1B	  and	  Ezh2	  RNA-­‐ChIP	  enrich	  PRC-­‐repressed	  transcripts	  
Nascent	   transcripts	   from	  PRC-­‐repressed	  genes	   can	  be	   successfully	  detected	  by	  RNAPII-­‐S5p	  
RNA-­‐ChIP.	  Sequential	  ChIP	  shows	  that	  RNAPII-­‐S5p	  and	  PRCs	  simultaneously	  associate	  at	  PRC-­‐
repressed	  genes.	  Therefore,	  to	  test	  whether	  PRC-­‐bound	  chromatin	  is	  indeed	  associated	  with	  
nascent	   transcripts	   from	   PRC-­‐repressed	   genes,	   I	   performed	   RNA-­‐ChIP	   with	   antibodies	  
against	   Ring1b	   and	   Ezh2,	   components	   of	   PRC1	   and	   PRC2,	   respectively.	   This	   strategy,	   if	  
successful,	   would	   also	   have	   the	   advantage	   of	   more	   specifically	   enriching	   for	   these	   low	  
abundant	  transcripts	  and	  allow	  for	  more	  robust	  detection.	  
	  
In	  the	  first	  instance,	  I	  performed	  DNA-­‐ChIP	  to	  confirm	  the	  presence	  of	  both	  proteins	  at	  PRC-­‐
repressed	  genes	  by	  RT-­‐PCR	  at	  single	  genes	  (Fig.	  4.4).	  As	  expected,	  Ring1B	  and	  Ezh2	  associate	  
abundantly	  with	   PRC-­‐repressed	   promoters	   and	   extended	   into	   coding	   regions	   (Stock	   et	   al.,	  
2007;	   Brookes	   et	   al.,	   2012).	   Detection	   of	   Ring1B	   at	   active	   genes	   is	   detected	   but	   at	   lower	  
levels	  than	  found	  at	  PRC-­‐repressed	  genes,	  and	  absent	  with	  Ezh2	  DNA-­‐ChIP,	  while	  there	  is	  no	  
binding	  at	  silent	  genes.	  Unpublished	  work	  in	  the	  laboratory,	  where	  we	  mapped	  Ring1B	  in	  ES-­‐
ERT2	  cells	  after	  Ring1B	  knockdown,	  suggests	  that	  the	  current	  stock	  of	  Ring1B	  antibody	  may	  
have	  cross-­‐reactivity	  to	  a	  protein	  that	  binds	  to	  active	  promoters.	  
	  























































































Figure	  4.4	  Ring1b	  and	  Ezh2	  associate	  with	  PRC-­‐repressed	  genes	  in	  ES	  cells.	  Binding	  of	  Ring1B	  (PRC1)	  and	  Ezh2	  
(PRC2)	   at	   active,	   PRC-­‐repressed	   and	   silent	   genes	   in	   ES-­‐OS25	   cells	  was	   assessed	   by	   DNA-­‐ChIP	   and	   RT-­‐PCR	   at	  
promoters	   (red	   bars)	   and	   coding	   regions	   (blue	   bars).	   Background	   levels	   (mean	   enrichment	   from	   control	  
antibodies	   or	   beads	   alone)	   at	   promoter	   and	   coding	   regions	   are	   shown	   as	   burgundy	   or	   light	   blue	   bars,	  
respectively.	  Enrichment	  is	  expressed	  relative	  to	  input	  DNA	  using	  the	  same	  amount	  of	  DNA	  in	  the	  PCR.	  Mean	  
and	  standard	  deviations	  are	  presented	  from	  3	  independent	  biological	  replicates	  in	  the	  case	  of	  Ezh2	  and	  1	  single	  
matched	  replicate	  for	  Ring1B.	  NA	  labeled	  genes	  were	  not	  tested.	  
	  
I	   then	   performed	  RNA-­‐ChIP	  with	   Ring1B	   or	   Ezh2	   at	   the	   same	   panel	   of	   PRC-­‐repressed	   and	  
active	  genes	   (Fig.	  4.5).	   	  Controls	   included	  RNA	  extracted	   from	  total	  chromatin	  and	  a	  mock	  
IgG	  IP	  for	  Ring1B,	  and	  a	  no-­‐antibody	  control	  for	  Ezh2.	  Transcripts	  from	  PRC-­‐repressed	  genes	  
are	   detected	   associated	   with	   Ring1B-­‐bound	   chromatin,	   at	   levels	   enriched	   over	   total	  
chromatin	  and	  mock	  IP	  control.	  RNA-­‐ChIP	  with	  Ezh2	  antibodies	  also	  enriches	  PRC-­‐repressed	  
transcripts	   for	   the	   six	   genes	   tested	  over	   total	   chromatin	   and	   control	  mock	   IP.	   Enrichment	  
using	  PRC	  antibodies	  confirms	  the	  presence	  of	  transcripts	  at	  PRC-­‐repressed	  genes	  previously	  
identified	  with	  RNAPII-­‐S5p	  RNA-­‐ChIP.	  Unexpectedly,	   transcripts	   from	  active	  genes	  are	  also	  
detected	  after	  RNA-­‐ChIP	  with	  Ring1B	  and	  Ezh2	  antibodies,	  at	  levels	  that	  are	  comparable	  to	  
the	   RNA	   purified	   from	   total	   chromatin,	   which	   therefore	   can	   be	   interpreted	   as	   chromatin	  
carryover	  in	  the	  Polycomb	  ChIP.	  Taken	  together,	  the	  low	  level	  detection	  of	  Ring1B	  protein	  at	  
active	  genes	  by	  DNA-­‐ChIP	  (Fig.	  4.4)	  and	  the	  detection	  of	  lower	  transcript	  levels	  from	  active	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genes	  after	  RNA-­‐ChIP	  with	  Polycomb	  than	  with	  RNAPII-­‐S5p	  antibodies	  (Fig.	  3.4),	  suggest	  that	  
the	  RNA	  detected	  at	  active	  genes	  after	  Polycomb	  RNA-­‐ChIP	  may	  be	  explained	  by	  non-­‐specific	  









































































































































Figure	   4.5	   Transcripts	   from	   PRC-­‐repressed	   genes	   are	   associated	   with	   Ring1B	   and	   Ezh2	   at	   the	   level	   of	  
chromatin.	  Transcripts	  associated	  with	  Ring1B	  and	  Ezh2	  bound	  to	  chromatin	  were	  assessed	  by	  RNA-­‐ChIP	  and	  
quantitative	  RT-­‐PCR,	  at	  active,	  PRC-­‐repressed	  and	  silent	  genes.	  Levels	  of	  RNA	  from	  Ring1B	  and	  Ezh2	  RNA-­‐ChIP	  
are	   shown	   as	   red	   bars.	   RNA	   extracted	   from	   total	   chromatin	   is	   shown	   in	   light	   grey	   and	  Mock	   IgG	   IP	   or	   no	  
antibody	  control	   for	  Ring1B	  and	  Ezh2,	   respectively,	  are	   in	  dark	  grey.	  Primers	  were	  designed	  within	  5’	  exonic	  
regions	  to	  capture	  total	  RNA	  populations.	  RNA-­‐ChIP	  for	  Ring1b	  and	  Ezh2	  enriches	  for	  PRC-­‐repressed,	  but	  not	  
silent	  transcripts	  (Gabra6,	  Myf5)	  above	  levels	  detected	  in	  total	  chromatin	  and	  mock	  IP.	  Active	  gene	  transcripts	  
are	   detected	   at	   levels	   comparable	   to	   total	   chromatin.	  Mean	   and	   standard	   deviations	   are	   presented	   from	   3	  
independent	   biological	   replicates	   experiments	   for	   Ring1B.	   A	   single	   replicate	   was	   performed	   for	   Ezh2.	   ND	  
represents	  genes	  where	  RNA	  was	  ‘Not	  Detected’.	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4.2.4 Genome-­‐wide	  analyses	  of	  nascent	  transcripts	  at	  PRC-­‐repressed	  genes;	  Single	  gene	  
profiles	  
The	   detection	   of	   nascent	   RNA	   at	   single	   PRC-­‐repressed	   genes	   by	   RT-­‐PCR	   prompted	   our	  
interest	   in	  mining	   the	  genome-­‐wide	  RNA-­‐ChIP	  datasets	  described	   in	  Chapter	  3,	   to	  explore	  
the	  presence	  and	  distribution	  of	  nascent	   transcripts	   at	  PRC-­‐repressed	  genes	   (Fig.	   4.6).	   For	  
comparison,	   I	  also	  represented	  the	  occupancy	  of	  RNAPII-­‐S5p	  and	  Polycomb	  proteins	  (Ezh2,	  
Ring1B)	  and	  associated	  histone	  marks	  (H3K27me3,	  H2Aub1)	  previously	  determined	  by	  ChIP-­‐
seq	   (Brookes	   et	   al.,	   2012;Ku	   et	   al.,	   2008–	   for	   Ezh2).	   Note	   that	   the	   same	   ES	   cell	   line	   and	  
antibody	  clones	  were	  used	   in	   the	  published	  DNA-­‐ChIP-­‐seq	  and	  the	  RNA-­‐ChIP	  produced	   for	  
RNAPII	   and	   Ring1B.	   Ezh2	   ChIP-­‐seq	   from	   Ku	   et	   al.,	   (2008)	   used	   an	   Ezh2	   clone	   from	   Active	  
Motif	   (39013),	  whereas	   in	  the	  RNA-­‐ChIP	  experiments	  shown	  here,	   I	  used	  an	  Ezh2	  antibody	  
from	  Diagenode	  (39050).	  	  
	  
Although	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  dataset	  mined	  throughout	  this	  chapter	  is	  the	  same	  NGS	  
library	  analysed	  in	  detail	  in	  Chapter	  3	  (RNAPII-­‐S5p	  RNA-­‐ChIP,	  Fragmented),	  in	  Fig.	  4.6	  only,	  I	  
have	  used	   the	  original	   data	   together	  with	   an	   additional	   lane	  of	   sequencing	  data	   from	   the	  
same	   library,	   re-­‐sequenced	   more	   recently	   for	   higher	   depth,	   using	   an	   Illumina	   HiSEQ	  
machine.	  This	  sequencing	  was	  performed	  late	   in	  the	  project	  so	  all	  RNA-­‐ChIP	  mining	  results	  
shown	   in	   the	   rest	   of	   this	   chapter	   were	   obtained	   from	   earlier	   analyses	   of	   the	   lower-­‐
sequencing	   depth	   RNAPII-­‐S5p	   RNA-­‐ChIP	   dataset	   presented	   in	   Chapter	   3.	   Analyses	   will	   be	  
repeated	  in	  the	  future	  with	  the	  higher	  sequencing	  dataset.	  
	  	  
As	  shown	  previously	  (Brookes	  et	  al.,	  2012),	  PRC-­‐repressed	  (Nkx2-­‐9,	  Msx1)	  and	  active	  (βactin)	  
genes	   are	   associated	   with	   RNAPII-­‐S5p,	   but	   not	   silent	   gene	  Gabra6	   (Fig.	   4.6A).	   Polycomb-­‐
repressed	  genes	  associate	  with	  abundant	  Polycomb	  proteins	  and	  histone	  marks	  across	   the	  
entire	  gene.	  Gabra6	  shows	  no	  detectable	  binding	  of	  RNAPII	  or	  Polycomb,	  as	  expected.	  	  
	  
Transcripts	   from	   PRC-­‐repressed	   genes	   are	   detected	   after	   RNA-­‐ChIP	   with	   antibodies	   for	  
RNAPII-­‐S5p	   and	   for	   Polycomb	   (Ring1B,	   Ezh2;	   Fig.	   4.6B),	   in	   agreement	   with	   single	   gene	  
analysis	   by	   RT-­‐PCR	   shown	   earlier	   (Figs.	   4.3,	   4.5).	   Transcripts	   are	   detected	   throughout	   the	  
coding	   region	  of	  Nkx2-­‐9	  and	  Msx1	   for	  both	  RNAPII-­‐S5p	  and	  Ezh2,	   showing	   that	   transcripts	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from	  PRC-­‐repressed	  genes	  can	  be	  detected	  by	  RNA-­‐ChIP.	   It	   is	  worthwhile	  noticing	  that	  the	  
apparent	  difference	  in	  RNAPII-­‐S5p	  RNA-­‐ChIP	  sequencing	  read	  enrichment	  at	  the	  active	  and	  
PRC-­‐repressed	  genes	  considered	  here	  is	  ~100	  fold	  lower,	  whereas	  the	  abundance	  of	  RNAPII-­‐
S5p	  at	  the	  two	  kinds	  of	  gene	  is	  different	  by	  ~2	  fold;	  this	  could	  be	  explained,	  for	  example,	  by	  
more	   abundant	   S5	   phosphorylation	   at	   the	   many	   CTD	   repeats	   in	   the	   Polycomb-­‐repressed	  
chromatin,	   or	   by	   co-­‐transcriptional	   degradation	   of	   RNAs	   transcribed	   by	   RNAPII-­‐S5p	   at	   the	  
PRC-­‐repressed	   genes.	  Msx1	   RNA	   is	   confined	   to	   the	   coding	   region,	   while	   Nkx2-­‐9	   RNA	   is	  
detected	   outside	   the	   gene	   boundary,	   also	   seen	   at	   very	   low-­‐levels	   in	   the	   mRNA	   dataset.	  
Transcripts	   from	  Polycomb-­‐repressed	  genes	  can	  also	  be	  detected	   in	  the	  Directional	  Ring1B	  
RNA-­‐ChIP	  datasets,	  in	  the	  coding	  orientation,	  with	  very	  low	  RNA	  detection	  for	  Msx1	  (please	  
recall	  that	  directional	  datasets	  fail	  to	  detect	  abundance	  nascent	  RNA	  present	  at	  the	  5’	  coding	  
regions;	  Fig.	  3.15).	  	  
	  
Transcripts	   from	   active	   gene,	   βactin,	   are	   highly	   enriched	   after	   RNAPII-­‐S5p	   RNA-­‐ChIP,	   as	  
demonstrated	   previously	   (Fig.	   3.12),	   and	   display	   the	   distribution	   expected	   for	   nascent	  
transcripts	   with	   higher	   detection	   of	   5’	   than	   3’	   RNA	   across	   the	   coding	   region.	   βactin	  
transcripts	  are	  also	  detected	  after	  Ring1B	  and	  Ezh2	  RNA-­‐ChIP	  experiments,	  although	  these	  
proteins	  are	  not	  present	  at	   the	  coding	  region.	   Interestingly	   this	   lower	   level	  detection	  does	  
not	  display	  the	  appropriate	  5’	  to	  3’	  slope	  typical	  of	  nascent	  transcripts,	  and	  may	  therefore	  be	  
due	   to	   background	   carry-­‐over	   of	   this	   abundant	   RNA.	   Detection	   of	   active	   gene	   transcripts	  
after	  RNA-­‐ChIP	  with	  Polycomb	  antibodies	  was	  already	  observed	  in	  the	  single	  gene	  RNA-­‐ChIP	  
analyses	   (Fig.	   4.5),	   where	   it	   is	   important	   to	   notice	   that	   the	   RNA	   levels	   detected	   are	   not	  
enriched	  above	   levels	  seen	   in	  total	  chromatin.	  The	  observation	  of	  some	  background	  carry-­‐
over	   RNA	   after	   RNA-­‐ChIP	   with	   Polycomb	   antibodies	   poses	   some	   challenges	   in	   the	  
interpretation	  of	  these	  RNA-­‐ChIP-­‐seq	  datasets	  in	  the	  absence	  of	  a	  mock	  (or	  Input)	  RNA-­‐ChIP-­‐
seq	  dataset	  for	  background	  comparison.	  
	  




Figure	  4.6	  Single	  gene	  profiles	  of	  DNA	  and	  RNA-­‐ChIP	  for	  RNAPII	  and	  Polycomb	  at	  PRC-­‐repressed,	  active	  and	  
silent	   genes.	   	   (A)	   Profiles	   at	   PRC-­‐repressed	   (Nkx2-­‐9,	   Msx1),	   an	   active	   (Actb)	   and	   silent	   (Gabra6)	   genes	   are	  
shown	   for	   published	   DNA	   ChIP-­‐seq	   (RNAPII-­‐S5p,	   Ezh2,	   H2Aub1,	   H3K27me3;	   Brookes	   et	   al.,	   2012,	   Ku	   et	   al.,	  
2008)	  and	  unpublished	   (Ring1B).	   (B)	  RNA-­‐ChIP	  datasets	   (RNAPII-­‐S5p,	  Ezh2,	  Ring1B)	  and	  mRNA	  are	  shown	   for	  
the	  same	  genes.	  A	  different	  antibody	  was	  used	  in	  the	  published	  genome-­‐wide	  Ezh2	  dataset	  than	  in	  the	  RNA-­‐
ChIP	  dataset.	  PRC-­‐repressed	  genes	  are	  bound	  by	  RNAPII-­‐S5p	  and	  Polycomb,	  while	  Active	  gene,	  Actb,	  is	  bound	  
by	  RNAPII-­‐S5p	   in	   the	  absence	  of	  Polycomb.	  Transcripts	   from	  PRC-­‐repressed	  genes	  are	  detected	  with	  RNAPII-­‐
S5p	  and	  Polycomb	  RNA-­‐ChIP	  throughout	  the	  gene	  at	   low	  levels.	  Actb	  RNA	  is	  abundant	  with	  RNAPII-­‐S5p	  RNA-­‐
ChIP,	  but	  also	  detected	  at	  low	  levels	  in	  Polycomb	  RNA-­‐ChIP	  datasets,	  albeit	  with	  a	  different	  distribution	  across	  
the	  coding	  region.Silent	  gene	  Gabra6	  show	  no	  enrichment	  for	  any	  of	  the	  markers	  studied.	  Arrows	  indicate	  gene	  
start	  and	  transcription	  direction. 
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4.2.5 Characterization	  of	  PRC-­‐repressed	  genes	  chosen	  for	  genome-­‐wide	  analyses	  
To	  study	  the	  average	  properties	  of	  transcription	  at	  active	  and	  silent	  genes	  genome-­‐wide	  in	  
Chapter	  3,	  we	  had	  worked	  with	  two	  groups	  of	  genes	  with	  the	  20%	  highest	  and	  20%	  lowest	  
mRNA	   expression	   values,	   which	   were	   not	   Polycomb	   targets	   (Fig.	   3.14).	   In	   Brookes	   et	   al.	  
(2012),	  we	  have	  shown	  that	  many	  PRC-­‐target	  genes	  are	  also	  expressed	  at	   the	  mRNA	   level	  
and	   associated	   with	   active	   RNAPII	   complexes;	   we	   showed	   that	   these	   genes	   are	   likely	   to	  
fluctuate	  between	  PRC-­‐repression	  (in	  the	  presence	  of	  RNAPII-­‐S5p+S2p-­‐	  and	  epigenetic	  marks	  
H3K4me3+K36me3-­‐,	   H2Aub+	   and	   H3K27me3+)	   and	   ‘normal’	   activity	   (in	   the	   presence	   of	  
RNAPII-­‐S5p+S2p+	  and	  absence	  of	  H2Aub	  and	  H3K27me3).	  To	  investigate	  transcription	  at	  PRC-­‐
repressed	  genes,	  we	  now	  focused	  on	  a	  group	  of	  Polycomb-­‐target	  genes	  which	  are	  associated	  
with	  RNAPII-­‐S5p	  only	  but	  not	  with	  any	  of	  the	  other	  active	  marks	  of	  RNAPII,	  i.e.	  we	  identified	  
all	   the	   genes	   that	   are	   RNAPII-­‐S5p+S2p-­‐	   8WG16-­‐,	   H2Aub1+	   and	   H3K27me3+;	   this	   group	   of	  
1,065	  genes	  are	  hereafter	  called	  PRC-­‐repressed	  and	  that	  do	  not	  have	  detectable	  features	  of	  
active	  expression.	  
	  
General	   properties	   of	   the	   1,065	   PRC-­‐repressed	   genes	   chosen	   for	   further	   analyses	   are	  
represented	   in	   Fig.	   4.7,	   including	   mRNA	   signal	   through	   coding	   regions,	   histone	   marks	  
associated	  with	  Polycomb	  (H2Aub1+	  and	  H3K27me3+)	  at	  TSS	  region	  and	  RNAPII-­‐S5p	  and	  S2p	  
across	   TSS	   and	   TES	   regions	   for	   all	   non-­‐overlapping	   RefSeq	   genes	   (mm9	   mouse	   genome	  
assembly).	  PRC-­‐repressed	  genes	  are	  marked	  by	  Polycomb	  and	  associated	  with	  RNAPII-­‐S5p,	  in	  
the	  absence	  of	  RNAPII-­‐S2p	  (Brookes	  et	  al.,	  2012).	  




Figure	  4.7	  Classification	  of	  the	  group	  of	  PRC-­‐repressed	  genes	  (H2Aub1+	  and	  H3K27me3+)	  bound	  by	  RNAPII-­‐
S5p+S2p-­‐	   further	   studied	   in	   this	   chapter.	  Previous	  work	   from	  Brookes	  et	  al.	   (2012)	   studied	  RNAPII	   and	  PRC	  
occupancy	   across	   the	   genome.	   RefSeq	   genes	   (separated	   by	   >2kb	   from	   the	   TSS	   or	   TES	   of	   other	   genes)	  were	  
divided	  into	  PRC-­‐positive	  (PRC+,	  n=5628)	  and	  PRC-­‐negative	  (PRC-­‐,	  n=9776)	  and	  ordered	  based	  on	  mRNA	  levels	  
(FPKM)	  in	  gene	  coding	  regions.	  Read	  depth	  was	  assessed	  over	  windows	  covering	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb)	  
and	   the	   values	   of	   log	   (signal/threshold)	   plotted	   on	   a	   colour	   scale	   (blue,	   low;	   yellow,	   high).	   A	   group	   of	   PRC-­‐
repressed	  genes	  (n=1065)	  was	  identified	  for	  further	  analyses	  based	  on	  being	  PRC-­‐positive	  (PRC+;	  H2Aub1+	  and	  
H3K27me3+)	   and	   presence	   of	   RNAPII-­‐S5p+S2p-­‐8WG16-­‐.	   PRC-­‐repressed	   genes	   identified	   according	   to	   these	  
criteria	  are	  labeled	  (right	  panel,	  dark	  pink)	  alongside	  the	  20%	  highest	  (green)	  and	  20%	  lowest	  (grey)	  expressed	  
genes.	  Figure	  adapted	  from	  Brookes	  et	  al.	  (2012).	  
	  
To	   further	   summarise	   the	   properties	   of	   the	   three	   groups	   of	   genes	   chosen	   for	   further	  
analyses	   (Active,	   PRC-­‐repressed	   and	   Silent),	   we	   measured	   the	   distribution	   of	   levels	   of	  
markers	  across	  the	  genes	   in	  each	  group,	   including	   levels	  of	  RNAPII	  modification,	  Polycomb	  
proteins	   and	   associated	  histone	  marks	   at	   TSS	   or	   TES	   regions	   of	   interest,	   as	  well	   as	  mRNA	  
expression	   values	   across	   the	   coding	   region	   (Fig.	   4.8);	   data	   was	  measured	   from	   published	  
ChIP-­‐seq	  and	  mRNA	  datasets	   (Brookes	  et	  al.,	  2012).	  As	  expected,	  PRC-­‐repressed	  genes	  are	  
associated	   with	   higher	   levels	   of	   Polycomb	   proteins	   and	   respective	   marks,	   than	   Active	   or	  
Silent	  genes.	  The	  PRC-­‐repressed	  cohort	  has	   relatively	  high	   levels	  of	  RNAPII-­‐S5p,	  within	   the	  
range	  found	  at	  Active	  genes.	  RNAPII-­‐S2p	  and	  RNAPII-­‐8WG16	  levels	  at	  PRC-­‐repressed	  genes	  
are	  as	  low	  as	  at	  Silent	  genes.	  mRNA	  levels	  (shown	  in	  log10	  scale)	  are	  below	  the	  levels	  seen	  at	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Active	   genes,	   but	   slightly	   higher	   than	   at	   Silent	   genes,	   as	   expected	   (Guenther	   et	   al.,	   2007;	  
Brookes	  et	  al.,	  2012).	  	  
	  
Figure	  4.8	  Properties	  of	   the	  cohort	  of	  genes	  chosen	   for	   further	  analyses.	  Using	  previous	  published	  datasets	  
produced	  in	  our	  laboratory	  from	  the	  ES-­‐OS25	  cell	  line	  (Brookes	  et	  al.,	  2012),	  we	  assessed	  levels	  of	  PRC1	  subunit	  
Ring1B	  and	  its	  histone	  mark	  H2Aub1,	  PRC2	  associated	  H3K27me3,	  RNAPII	  modifications	  (S5p,	  S2p,	  8WG16)	  and	  
mRNA	   for	   the	  Active,	  PRC-­‐repressed	  and	  Silent	  gene	  groups.	  Active	  genes,	  20%	  highest	  expressed	  genes	  not	  
associated	  with	   PRC	   (n=3772);	   Silent	   genes,	   20%	   lowest	   expressed	   genes	   not	   associated	  with	   PRC	   (n=3772);	  
and,	  PRC-­‐repressed	  genes	  (S5p+8WG16-­‐S2p-­‐,	  H2Aub+	  and	  H3K27me3+;	  n=1065).	  Average	  depth	  was	  calculated	  
per	  nucleotide	  in	  2kb	  windows	  around	  the	  TSS	  or	  in	  the	  case	  of	  RNAPII-­‐S2p,	  2kb	  after	  the	  end	  of	  the	  gene	  (i.e.	  0	  
to	  2kb	  downstream	  of	  the	  TES).	  PRC-­‐repressed	  genes	  show	  high	  levels	  of	  all	  PRC	  marks	  and	  RNAPII-­‐S5p	  in	  the	  
absence	   of	   RNAPII-­‐S2p	   and	   RNAPII-­‐8WG16	   or	   mRNA	   expression.	   Bioinformatic	   analysis	   performed	   by	   I.de	  
Santiago.	  
	  
4.2.6 PRC-­‐repressed	  gene	  transcription	  is	  detected	  genome-­‐wide	  
To	   investigate	   PRC-­‐repressed	   gene	   transcription	   genome-­‐wide,	   I	   focused	   on	   analysing	   the	  
RNAPII-­‐S5p	   RNA-­‐ChIP	   (Fragmented)	   sequencing	   dataset	   and	   the	   Ring1B	   RNA-­‐ChIP	  
(Directional);	   bioinformatics	   analyses	   of	   Ezh2	   RNA-­‐ChIP	   (Fragmented)	   dataset	   will	   be	  
performed	  in	  the	  future.	  	  
	  
Transcripts	   from	  PRC-­‐repressed	   genes	   can	  be	   detected	   at	   single	   gene	   level	  with	   the	  RNA-­‐
ChIP	  approaches	  optimized	  here	  both	  by	  RT-­‐PCR	   (Fig.	  4.3)	  and	   lllumina	   library	  preparation	  
(Fig.	   4.6).	   In	   Chapter	   3,	   I	   showed	   that	   the	   Fragmented	   non-­‐directional	   library	   preparation	  
method	   gives	   the	  most	   robust	   representation	   of	   nascent	   transcription	   as	   opposed	   to	   the	  
directional	  protocol	  used.	  For	  this	  reason	  the	  Directional	  protocols	  are	  only	  used	  to	  assess	  
directionality	   of	   transcription,	   and	   not	   to	   represent	   the	   distribution	   of	   nascent	   transcripts	  
across	   coding	   regions.	   Ring1B	   RNA-­‐ChIP	   sequencing	   libraries	   were	   prepared	   using	   the	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directional	   protocol,	   prior	   to	   complete	   knowledge	   of	   biases	   identified	   in	   the	   previous	  
chapter	  for	  RNAPII-­‐S5p	  RNA-­‐ChIP;	  it	  will	  also	  only	  be	  used	  here	  to	  address	  directionality.	  The	  
Ezh2	   RNA-­‐ChIP	   (Fragmented)	   dataset	   was	   produced	   very	   recently	   and	   bioinformatics	  
analyses	  have	  not	  yet	  been	  performed	  other	  than	  producing	  the	  genomic	  profiles	  that	  can	  
be	  visualized	  at	  the	  UCSC	  Genome	  Browser	  (Fig.	  4.6).	  	  
	  
To	  further	  explore	  the	  extent	  of	  transcription	  at	  PRC-­‐repressed	  genes	  genome-­‐wide,	  average	  
profiles	  were	  generated	  for	  TSS	  and	  TES	  regions	  from	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  Fragmented	  
dataset	   (Fig.	   4.9)	   for	   the	   three	   groups	   of	   genes	   considered	   earlier:	   Active	   (H3K27me3-­‐,	  
H2Aub1-­‐,	  20%	  most	  expressed),	  PRC-­‐repressed	  (H3K27me3+	  and	  H2Aub1-­‐,	  S5p+S2p-­‐8WG16-­‐)	  
and	   Silent	   (H3K27me3-­‐,	   H2Aub1-­‐,	   20%	   least	   expressed).	   RNAPII-­‐S5p	   and	   Ring1B	   RNA-­‐ChIP	  
Directional	   datasets	   are	   also	   included	   in	   this	   comparison	   to	   highlight	   the	   direction	   of	  
transcription,	  and	  mRNA-­‐seq	  as	  a	  measure	  of	  mRNA	  levels	  for	  each	  group	  of	  gene.	  	  
	  
In	  keeping	  with	  published	  evidence	  that	  PRC-­‐repressed	  genes	  are	  not	  expressed	  (Guenther	  
et	  al.,	  2007;	  Brookes	  et	  al.,	  2012),	   the	  average	  profiles	  of	  mRNA-­‐seq	  at	   the	  PRC-­‐repressed	  
cohort	   show	   very	   low	   level	  mRNA	   detection,	   just	   above	   background	   levels	   seen	   at	   Silent	  
genes	  (Fig	  4.9B).	  The	  mRNA	  average	  profiles	  at	  PRC-­‐repressed	  genes	  show	  equal	  proportion	  
of	  reads	  at	  the	  5’	  and	  3’	  regions,	  as	  expected	  for	  mRNA	  expression,	  similar	  to	  that	  seen	  at	  
Active	  genes	  (Fig.	  4.9A),	  albeit	  at	  a	  much	  lower	  level.	  	  
	  
In	  contrast	   to	  mRNA,	   transcripts	  detected	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  are	  over-­‐representated	  
around	  the	  TSS	  compared	  to	  that	  at	  the	  3’	  TES,	  indicative	  of	  nascent	  transcription.	  Average	  
profiles	   for	   RNAPII-­‐S5p	   RNA-­‐ChIP	   across	   PRC-­‐repressed	   genes	   reveal	   detection	   of	   nascent	  
transcription	  above	  detection	  at	  silent	  genes	  (Fig.	  4.8B).	  A	  sharp	  peak	  of	  signal	  at	  the	  TSS	  is	  
observed	  with	  the	  Fragmented	  library,	  suggesting	  that	  transcription	  at	  PRC-­‐repressed	  genes	  
may	  begin	  relatively	  precisely	  from	  the	  annotated	  TSS.	  PRC-­‐repressed	  genes	  are	  transcribed	  
in	  the	  correct	  orientation	  as	  seen	  in	  the	  directional	  RNA-­‐ChIP	  datasets.	  
	  
Transcripts	  from	  PRC-­‐repressed	  genes	  are	  also	  detected	  at	  low	  levels	  in	  the	  Ring1B	  RNA-­‐ChIP	  
(Directional)	   dataset	   (Fig	   4.6B),	   confirming	   genome-­‐wide	   the	   presence	   of	   transcripts	   from	  
PRC-­‐repressed	   genes,	   also	   identified	   with	   RNAPII-­‐S5p	   RNA-­‐ChIP.	   There	   is	   no	   detectable	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antisense	  transcription	  at,	  or	  around	  the	  TSS,	  in	  contrast	  to	  active	  genes	  (compare	  Figs.	  4.9B	  
with	   3.15).	   RNAPII	   is	   able	   to	   transcribe	   the	   entire	   length	   of	   PRC-­‐repressed	   genes,	   as	  
demonstrated	  by	  presence	  of	  transcripts	  until	  the	  TES	  above	  that	  seen	  for	  the	  Silent	  genes.	  	  
Average	   profile	   analysis	   however	   does	   not	   distinguish	   the	   proportion	   of	   genes	   at	   which	  
transcription	   extends	   to	   the	  3’	   end	  of	   the	   gene.	  One	   interesting	   feature	  of	   PRC-­‐repressed	  
genes	   is	   that	   RNAPII-­‐S5p	   is	   detected	   up	   to	   the	   TES,	   but	   not	   immediately	   after,	   in	   a	  
proportion	  of	  genes	  (Brookes	  et	  al.,	  2012),	  the	  latter	  a	  noticeable	  feature	  of	  Active	  genes.	  It	  
is	  difficult	   to	  assess	   simply	  with	   the	  current	  analyses	  whether	   the	  amount	  of	   transcription	  
detected	  immediately	  after	  the	  TES	  (which	  accompanies	  RNAPII	  termination	  at	  Active	  genes)	  
occurs	  to	  lower	  extent	  at	  PRC-­‐repressed	  genes.	  	  
	  
Splicing	  of	  at	  least	  the	  first	  intron	  has	  been	  demonstrated	  previously	  for	  a	  panel	  of	  four	  PRC-­‐
repressed	  genes	  by	  RT-­‐PCR	  from	  total	  RNA	  (Stock	  et	  al.,	  2007).	  A	  sharp	  decrease	  in	  transcript	  
depth	   is	   detected	   immediately	   downstream	   of	   the	   TSS	   at	   both	   Active	   and	   PRC-­‐repressed	  
genes,	  suggesting	  that	  co-­‐transcriptional	  splicing	  may	  occur	  at	  both	  kinds	  of	  gene.	  However,	  
it	  is	  not	  yet	  clear	  whether	  the	  extent	  of	  processing	  of	  nascent	  RNAs	  at	  PRC-­‐repressed	  genes	  
would	  occur	  to	  the	  same	  extent	  as	  at	  Active	  genes,	  the	  former	  in	  the	  absence	  of	  RNAPII-­‐S2p	  
(Fig.	   4.1;	   Brookes	   et	   al.,	   2012)	   and	   H3K36me3	   (Brookes,	   unpublished).	   More	   detailed	  
bioinformatics	  analyses	  are	  required	  to	  specifically	  investigate	  this	  topic.	  	  




Figure	  4.9	  Average	  profiles	  detect	  transcription	  genome-­‐wide	  at	  PRC-­‐repressed	  genes.	  Distribution	  of	  mRNA,	  
RNAPII-­‐S5p	   RNA-­‐ChIP	   and	   Ring1B	   RNA-­‐ChIP	   was	   assessed	   at	   Active	   (green),	   PRC-­‐repressed	   (dark	   pink)	   and	  
Silent	  genes	  (grey).	  (A)	  Transcripts	  from	  Active,	  but	  not	  Silent,	  genes	  are	  detected	  in	  the	  mRNA	  and	  RNAPII-­‐S5p	  
RNA-­‐ChIP	   with	   patterns	   consistent	   of	   mature	   and	   nascent	   transcription,	   respectively.	   Average	   depth	   of	  
sequencing	  reads	  per	  nucleotide	  was	  measured	  in	  windows	  around	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb).	  (B)	  Transcripts	  
from	  PRC-­‐repressed	  genes	  are	  detected	  in	  the	  mRNA-­‐seq	  dataset	  at	  very	  low	  levels,	  with	  similar	  enrichment	  at	  
TSS	   and	   TES,	   consistent	   with	   detection	   of	   low	   levels	   mature	   mRNA	   (Guenther	   et	   al.,	   2007).	   The	   RNA-­‐ChIP	  
datasets	  from	  the	  non-­‐directional	  fragmented	  library	  show	  higher	  RNA	  signal	  at	  the	  5’	  than	  3’	  coding	  regions,	  
which	  is	  a	  trait	  of	  nascent	  transcription.	  Directional	  RNAP-­‐S5p	  and	  Ring1B	  RNA-­‐ChIP	  libraries	  fail	  to	  detect	  the	  
RNA	   peak	   at	   the	   5’	   end	   of	   genes,	   but	   demonstrate	   that	   PRC-­‐repressed	   genes	   are	   transcribed	   in	   the	   sense	  
orientation.	  Non-­‐coding	  transcription	  is	  absent	  upstream	  of	  the	  promoter	  and	  is	  low	  downstream	  of	  the	  TES	  at	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4.2.7 Evidence	   for	   nascent	   transcription	   through	   coding	   regions	   and	   splicing	   at	   PRC-­‐
repressed	  genes	  
To	   investigate	   in	  more	  detail	   the	  progression	  of	  transcription	  through	  the	  coding	  region	  of	  
PRC-­‐repressed	  genes,	  we	  generated	  average	  profiles	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  across	  exons,	  
introns	   or	   the	   sum	   of	   the	   exons	   (cDNA)	   (Fig.	   4.10).	   The	   equivalent	   average	   profiles	   are	  
shown	  for	  Active	  genes	  for	  comparison	  (Fig.	  3.15,	  4.10A).	  	  
	  
The	  patterns	  of	  enrichment	  across	  the	  three	  regions	  (Exons,	  Introns	  and	  cDNA	  sequence)	  are	  
similar	  between	  Active	  and	  PRC-­‐repressed	  genes	  for	  both	  mRNA	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	  
(Fragmented)	  datasets,	  except	  that	   levels	  of	  detection	  are	  extremely	   low	  at	  PRC	  repressed	  
genes,	  in	  comparison	  with	  Active	  genes	  genes,	  but	  in	  both	  cases	  above	  the	  levels	  detected	  at	  
Silent	  genes.	  	  	  
	  
RNAPII-­‐S5p	  RNA-­‐ChIP	   (Fragmented;	   Fig.	   4.10B)	  presents	   a	   slight	  depletion	  at	   the	  5’	   and	  3’	  
ends	  of	  exons	  which	  may	   suggest	  alternate	  or	   imprecise	   splicing	   that	   is	   regulated	  prior	   to	  
mRNA	  expression,	  a	  feature	  seen	  at	  active	  genes	  (Fig.	  4.10A).	  Intron	  depth	  at	  PRC-­‐repressed	  
genes	   is	   lower	   than	   at	   exons	   with	   a	   slight	   5’	   to	   3’	   gradient	   in	   the	   average	   intron	   signal	  
indicating	  the	  presence	  of	  co-­‐transcriptional	  splicing,	  although	  the	  proportion	  of	  genes	  and	  
efficiency	  of	  splicing	  cannot	  be	  inferred	  from	  these	  analyses.	  Evidence	  that	  we	  are	  detecting	  
nascent	   transcription	   at	   PRC-­‐repressed	   chromatin	   is	   enforced	   by	   the	   clear	   decrease	   in	  
transcript	   detection	   over	   the	   exonic	   length	   (Sum	   of	   exons)	   where	   5’	   exons	   are	   over-­‐
represented	   as	   opposed	  more	   distal	   exons,	  mirroring	   the	   profile	   of	   RNAPII-­‐S5p	   traversing	  
PRC-­‐repressed	   genes	   (RNAPII-­‐S5p;	   bottom	   panel).	   Transcription	   across	   exons,	   introns	   and	  
the	   exonic	   length	   occurs	   in	   the	   sense	   orientation	   only	   (RNAPII-­‐S5p	   Directional).	   No	  
transcription	  above	  background	  is	  detected	  in	  the	  antisense	  orientation.	  	  
	  




Figure	  4.10	  Transcription	  and	  splicing	  through	  coding	  regions	  of	  PRC-­‐repressed	  genes.	  Average	  distributions	  
of	  mRNA	  and	  RNAPII-­‐S5p	  RNA-­‐ChIP	  enrichments	  were	  assessed	  through	  coding	  regions	  of	  Active	  (green),	  PRC-­‐
repressed	  (dark	  pink)	  and	  Silent	  genes	  (grey).	  Active	  gene	  (green)	  profiles	  were	  also	  shown	  in	  Fig.	  3.16,	  and	  also	  
included	   here	   for	   comparison.	   Average	   profiles	   of	   RNAPII-­‐S5p	   protein	   binding	   	   were	   also	   included	   (bottom	  
row).	  Average	  depth	  per	  nucleotide	  was	  calculated	  for	  average	  exon,	  and	  intron	  length	  as	  well	  as	  the	  sum	  of	  
exons	   (cDNA).	  mRNA	   from	  PRC-­‐repressed	  genes	   is	  detected	  at	   low	   level.	  RNAPII-­‐S5p	  RNA-­‐ChIP	   (Fragmented)	  
signal	   at	   exons	   and	   introns	   is	   above	   Silent	   genes.	   A	   slight	   5’	   to	   3’	   bias	   at	   introns	   is	   suggestive	   of	   low	   level	  
splicing.	  Along	   the	  coding	   region	  of	   the	  gene	   (sum	  of	  exons),	   transcripts	  are	  detected	  more	   readily	  at	   the	  5’	  
end,	   in	   parallel	   with	   RNAPII-­‐S5p	   binding,	   indicating	   detection	   of	   nascent	   transcription	   from	   PRC-­‐repressed	  
genes.	  No	  antisense	  transcription	  is	  detected	  at	  PRC-­‐repressed	  genes.	  Bioinformatic	  analyses	  performed	  by	  I.de	  
Santiago.	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4.2.8 PRC-­‐repressed	  genes	  transcribe	  at	  a	  range	  of	  levels	  genome-­‐wide	  
Analysis	  of	  nascent	  transcription	  from	  PRC-­‐repressed	  genes	  so	  far	  indicates	  that	  they	  are	  on	  
average	  transcribed	  at	  low	  levels	  in	  the	  correct	  orientation	  (Figs.	  4.6,	  4.9),	  with	  evidence	  for	  
low	   level	   splicing	   (Fig.	  4.10),	  but	  no	  antisense	   transcription.	   	  Average	  profiles	  of	  RNA	  from	  
PRC-­‐repressed	  genes	  demonstrate	  detection	  of	  RNA	  until	  the	  TES,	  at	  least	  for	  a	  proportion	  of	  
genes	   (Fig.	   4.9).	   	   PRC-­‐repressed	   genes	   also	   lack	   detectable	   antisense	   transcription	   from	  
promoters	  or	  sense	  transcription	  past	  the	  TES,	  in	  contrast	  to	  active	  genes	  adding	  to	  the	  idea	  
that	  there	  have	  regulatory	  constraints	  different	  from	  active	  genes.	  	  
	  
To	  further	  dissect	  the	  features	  of	  PRC-­‐repressed	  gene	  transcription	  genome-­‐wide,	  I	  started	  
by	  looking	  at	  the	  range	  of	  levels	  of	  nascent	  transcription	  of	  PRC-­‐repressed	  genes	  in	  parallel	  
with	  mRNA	  (Fig.	  4.11).	  RNAPII-­‐S5p	  RNA-­‐ChIP	  shows	  a	  wide	  range	  of	  transcript	  levels	  at	  PRC-­‐
repressed	  genes,	  with	  some	  values	  as	  low	  as	  at	  Silent	  genes	  while	  a	  proportion	  have	  as	  high	  
transcript	   level	   as	   that	   seen	   at	   the	   most	   active	   genes.	   PRC-­‐repressed	   mRNA	   also	   shows	  
broad	   levels	  with	  a	  proportion	  overlapping	  with	   the	  20%	   lowest	  expressed	  genes,	  but	  not	  
the	   active	   genes.	   Therefore,	   it	   appears	   that	   RNAs	   from	   PRC-­‐repressed	   genes	   are	   more	  
promptly	  detected	  in	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  dataset	  than	  in	  the	  mRNA	  dataset,	  consistent	  
with	  a	  role	  in	  RNA	  degradation	  that	  may	  be	  essential	  for	  PRC-­‐repression	  mechanisms.	  
	  
Figure	  4.11	  PRC-­‐repressed	  transcriptional	  activity	  covers	  a	  wide	  range.	  To	  investigate	  levels	  of	  transcription	  at	  
PRC-­‐repressed	  genes,	  we	  assessed	  their	  average	  depth	  per	  nucleotide	  over	  the	  gene	  length	  or	  FPKM	  for	  PRC-­‐
repressed	   genes	   (n=1,065)	   alongside	   the	   highest	   (Active)	   and	   lowest	   (Silent)	   20%	   expressed	   genes	  
(n=3,772/group).	   Transcript	   levels	   in	   RNAPII-­‐S5p	   RNA-­‐ChIP	   at	   PRC-­‐repressed	   genes	   covers	   a	   wide	   range,	   in	  
which	  many	  genes	  are	  transcribed	  at	  similar	  levels	  to	  highly	  active	  genes,	  while	  others	  have	  very	  low	  levels	  in	  
the	   range	   of	   the	   lowest	   20%.	   mRNA	   levels	   are	   similar	   showing	   a	   wide	   range	   of	   transcript	   levels	   for	   PRC-­‐
repressed	  genes.	  
Chapter	  4	   	  	  	  	  	  	  	  	  	  	  	  Transcription	  at	  Polycomb-­‐repressed	  genes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
131	  
To	  explore	  the	  relationship	  between	  different	  levels	  of	  transcription	  at	  PRC-­‐repressed	  genes	  
and	  whether	  occupancy	  with	  Polycomb	  and	  RNAPII-­‐S5p-­‐S2p	  alters	  accordingly,	  we	  began	  by	  
ordering	  PRC-­‐repressed	   genes	  based	  on	   levels	   of	   RNA	  detected	   in	   the	   last	   intron	  by	  RNA-­‐
ChIP.	   Introns	  were	   chosen	   as	   they	   best	   represent	   the	   nascent	   RNA	   population	  within	   the	  
dataset.	  Genes	  were	   then	  divided	   into	  3	  groups	   (Q1,	  Q2,	  Q3;	  Table	  4.1)	  where	  RNA	   levels	  
increase	   from	   Q1-­‐Q3.	   Only	   genes	   that	   have	   two	   or	   more	   introns	   were	   included	   in	   the	  
analysis,	   generating	   a	   PRC-­‐repressed	   gene	   group	   of	   735	   genes.	  Q1	   represents	   the	   highest	  
number	  of	  genes	   in	   the	  PRC-­‐repressed	  group	  due	  to	  absence	  of	  any	  RNA	  signal	  at	   the	   last	  
intron	  for	  a	  large	  number	  of	  genes.	  This	  does	  not	  necessarily	  reflect	  a	  lack	  of	  transcription	  at	  
genes	  in	  the	  group,	  where	  transcription	  may	  still	  be	  present	  nearer	  the	  promoter.	  	  
	  
Table	   4.1	  Groups	   of	   PRC-­‐repressed	   genes	   based	   on	   RNA	  depth	   from	  RNAPII-­‐S5p	   RNA-­‐ChIP	  within	   the	   last	  
intron.	   PRC-­‐repressed	   genes	   were	   divided	   into	   three	   groups	   (Quantile	   1	   to	   Quantile	   3).	   All	   ‘zero’	   values	  
identified	   in	  Q2	  were	  moved	   to	  Q1,	   yielding	   three	  groups	  of	   genes.	   In	  Q1,	  we	  have	  all	   PRC-­‐repressed	  genes	  










Average	   profiles	   and	   boxplots,	   representing	   nascent	   transcripts	   from	   each	   group,	   confirm	  
increasing	   transcript	   levels	   at	   the	   end	  of	   the	   genes	   from	  groups	  Q1	   to	  Q3	   (Fig.	   4.12A,	   B).	  	  
Even	  though	  a	  proportion	  of	  PRC-­‐repressed	  genes	  do	  not	  have	  detectable	  transcripts	  at	  the	  
last	  intron	  (Q1),	  they	  still	  transcribe,	  as	  shown	  by	  signal	  at	  the	  TSS	  that	  extends	  until	  at	  least	  
1kb	   downstream	   (Fig.	   4.12A).	   Genes	   from	   Q2,	   where	   transcripts	   are	   detected	   in	   the	   last	  
intron,	  have	  similar	  levels	  of	  RNA	  at	  the	  TSS	  to	  Q3	  but	  considerably	  lower	  levels	  that	  extend	  
to	   the	  TES,	   indicative	  of	   regulation	  prior	   to	   the	   termination	   site	   (Fig.	  4.12A).	  These	   results	  
show	  that	  a	  number	  of	  PRC-­‐repressed	  genes	  are	  able	  to	  transcribe	  the	  whole	  gene	  while	  a	  
proportion	  elongate	   into	   coding	   regions	  but	  RNA	   is	  not	  detected	  at	   the	  TES,	   as	  previously	  
suggested	  based	  on	  RNAPII-­‐S5p	  profiles	  (Brookes	  et	  al.,	  2012).	  Higher	  levels	  of	  transcription	  
detected	  at	  the	  last	  intron	  results	  in	  a	  minimal	  increase	  in	  mRNA	  produced	  from	  those	  PRC-­‐
repressed	  genes,	  which	  does	  not	  reach	  levels	  seen	  at	  active	  genes	  (Fig.	  4.12B;	  right	  boxplot).	  




Figure	  4.12	  Characterisation	  of	  three	  groups	  of	  PRC-­‐repressed	  genes	  based	  on	  the	  RNA	  signal	  detected	  at	  the	  
last	   intron	   in	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets.	   (A)	  Distribution	  of	  nascent	  RNA	   from	  RNAPII-­‐S5p	  RNA-­‐ChIP	   for	  
the	  3	  groups	  (Q1-­‐Q3)	  was	  analysed	  by	  taking	  the	  depth	  of	  sequencing	  per	  nucleotide,	  across	  the	  TSS	  and	  TES	  (-­‐
5	  to	  +5kb)	  of	  PRC-­‐repressed	  genes.	  Transcripts	  are	  detected	  at	  the	  TSS	  for	  all	  3	  groups,	  while	  Q3	  have	  signal	  
throughout	   coding	   regions	   to	   the	   TES.	   (B)	   Levels	   of	   RNA	   were	   assessed	   by	   taking	   the	   average	   depth	   per	  
nucleotide	   at	   the	   last	   intron	   or	   calculating	   the	   Log10	   FPKM	   for	   RNAPII-­‐S5p	   RNA-­‐ChIP	   or	  mRNA,	   respectively.	  
PRC-­‐repressed	   genes	   in	   Q3	   show	   transcript	   levels	   similar	   to	   some	   highly	   active	   genes	   which	   is	   not	   seen	   in	  
mRNA.	  Transcript	   levels	   increase	  across	   the	  groups	   (Q1-­‐Q3).	  There	   is	  a	   smaller	   increase	   in	  mRNA	  expression	  
between	  the	  groups.	  	  
4.2.9 RNAPII-­‐S2p	  is	  not	  associated	  with	  PRC-­‐repressed	  genes	  that	  transcribe	  to	  the	  TES	  
To	  understand	  the	  nature	  of	  RNAPII	  at	  PRC-­‐repressed	  genes	  that	  transcribe	  to	  the	  TES,	  we	  
made	  average	  profiles	  of	  RNAPII-­‐S5p	  and	  RNAPII-­‐S2p	  protein	  binding	  around	  the	  TSS	  and	  TES	  
for	  the	  3	  groups	  (Fig.	  4.13A).	  In	  particular,	  the	  analyses	  of	  RNAPII-­‐S2p	  at	  this	  selected	  groups	  
of	  genes,	  would	  help	  explore	  the	  possibility	  that	  low	  level	  transcription	  detected	  through	  the	  
coding	  regions	  of	  a	  subset	  of	  PRC-­‐repressed	  genes,	  might	  constitute	  bonafide	  transcription	  
by	  RNAPII	  complexes	  weakly	  phosphorylated	  on	  S2.	  Levels	  of	  RNAPII	  binding	  around	  these	  
regions	  were	  also	  compared	   in	  boxplots	   to	  better	   represent	   the	  overall	   levels	  of	  detection	  
across	  the	  whole	  population	  of	  genes,	  in	  parallel	  with	  the	  Active	  and	  Silent	  genes	  (Fig.	  4.13B,	  
D).	  	  
	  
Interestingly,	   these	   analyses	   show	   that	   the	   levels	   of	   RNAPII-­‐S5p	   occupancy	   at	   the	   TSS	   is	  
indistinguishable	  between	  the	  different	  groups	  of	  PRC-­‐repressed	  genes	  (Q1	  to	  Q3)	  both	  seen	  
in	  average	  profiles	  across	  TSS	  and	  TES	   regions	   (±5kb;	   Fig.	   4.13A)	  or	   in	   the	   range	  of	   values	  
detected	  in	  each	  population	  and	  represented	  in	  boxplots	  (Fig.	  4.13B).	  TES	  binding	  of	  RNAPII-­‐
S5p	  is	  slightly	  more	  abundant	  at	  Q3	  genes	  (genes	  with	  more	  RNA	  in	  the	  last	  intron)	  relative	  
to	  the	  other	  groups	  (Q1,	  Q2;	  Fig.	  4.13A,B).	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Importantly,	  RNAPII-­‐S2p	   is	  not	  detected	  at	  PRC-­‐repressed	  genes,	   irrespectively	  of	  whether	  
nascent	  RNA	  is	  detected	  through	  coding	  regions	  (Fig.	  4.13C).	  S2p	  levels	  are	  similar	  for	  Q1	  to	  
Q3	  groups	  of	  genes,	  and	  comparable	  to	  levels	  detected	  at	  Silent	  genes	  (Fig.	  4.13D).	  Absence	  
of	  RNAPII-­‐S2p	  even	  at	  PRC-­‐repressed	  genes	  where	  more	  nascent	  RNA	  is	  detected	  shows	  that	  
RNAPII	  at	  these	  genes	  is	  able	  to	  elongate	  and	  transcribe	  to	  the	  TES,	  in	  the	  absence	  of	  RNAPII	  
elongation	  associated	  modifications.	  	  
	  
Figure	  4.13	  Higher	  transcript	  levels	  at	  the	  Q3	  group	  of	  PRC-­‐repressed	  genes	  are	  not	  accompanied	  by	  RNAPII-­‐
S2p.	  Distribution	  of	  RNAPII-­‐S5p	   (A)	   and	   -­‐S2p	   (C)	   binding	   for	   the	  3	   groups	   (Q1-­‐3)	  was	   analysed	  by	   taking	   the	  
depth	  of	  sequencing	  per	  nucleotide,	  across	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb)	  of	  PRC-­‐repressed	  genes.	  Similar	  levels	  
of	  occupancy	  of	  the	  S5p	  and	  S2p	  modifications	  of	  RNAPII	  are	  seen	  at	  the	  TSS	  and	  TES	  for	  all	  3	  groups.	  Levels	  of	  
binding	   were	   assessed	   by	   taking	   the	   average	   depth	   per	   nucleotide	   at	   the	   TSS	   (+/-­‐1kb)	   and	   TES	   (2-­‐0kb)	   for	  
RNAPII-­‐S5p	  (B)	  and	  -­‐S2p	  (D).	  Genes	  from	  the	  3	  groups	  have	  similar	  levels	  of	  RNAPII-­‐S5p	  that	  is	  as	  high	  as	  active	  
genes,	  of	  similar	  levels	  of	  RNAPII-­‐S2p	  as	  low	  as	  Silent	  genes.	  Levels	  of	  binding	  were	  assessed	  at	  the	  TES	  (2-­‐0kb)	  
for	  RNAPII-­‐S2p.	  
 
4.2.10 RNAPII	  transcribes	  PRC-­‐repressed	  genes	  in	  the	  presence	  of	  Polycomb	  
To	  investigate	  whether	  RNAPII-­‐S5p	  transcribes	  PRC-­‐repressed	  genes	  at	  higher	  or	  lower	  levels	  
while	  in	  the	  presence	  of	  Polycomb,	  we	  plotted	  average	  profiles	  of	  Polycomb	  catalytic	  histone	  
marks	  H3K27me3	  and	  H2Aub1	  for	  the	  three	  gene	  groups	  (Q1-­‐Q3;	  Fig.	  4.14).	  Profiles	  of	  both	  
H3K27me3	   and	  H2Aub1	   are	   strikingly	   similar	   to	   RNAPII-­‐S5p	   (Fig.	   4.13A),	   as	   demonstrated	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from	  previous	  analysis	  at	  PRC-­‐repressed	  genes	   (Brookes	  et	  al.,	  2012).	   Interestingly,	   the	  Q3	  
group	  of	  genes,	   characterized	  by	  higher	   levels	  of	  nascent	  RNA	  before	   the	  TES	  also	  show	  a	  
slight	   increase	   in	  H3K27me3	  occupancy	  before	  the	  TES	  (Fig	  4.14A);	  distribution	  of	   levels	  of	  
K27me3	  across	  Q1-­‐Q3	  are	  above	  both	  Silent	  and	  Active	  genes	  (Fig.	  4.14B).	  Binding	  patterns	  
of	  H2Aub1	  for	  the	  three	  groups	  are	  the	  same	  at	  the	  TSS	  and	  TES	  (Fig.	  4.14C,	  D).	  Importantly,	  
levels	  of	  Polycomb	  marks	  do	  not	  decrease	  with	  increasing	  levels	  of	  nascent	  RNA	  through	  PRC	  
repressed	  genes,	  which	  together	  with	   lack	  of	  S2p	  detection	   (Fig.	  4.13C,D)	  shows	  that	  PRC-­‐
repressed	  genes	  can	  be	  transcribed	  by	  RNAPII-­‐S5p+S2p-­‐,	  in	  the	  presence	  of	  Polycomb	  which	  
mirrors	  RNAPII	  binding	  throughout	  genes.	  
	  
Figure	   4.14	   RNAPII-­‐S5p+S2p-­‐	   transcribes	   PRC-­‐repressed	   genes	   in	   the	   presence	   of	   Polycomb	   marks.	  
Distribution	  of	   PRC2	   and	  PRC1	  modifications	  H3K27me3	   (A)	   and	  H2Aub1	   (C),	   respectively,	  were	   analysed	  by	  
taking	   the	   depth	   of	   sequencing	   per	   nucleotide,	   across	   the	   TSS	   and	   TES	   (-­‐5	   to	   +5kb)	   of	   PRC-­‐repressed	   genes	  
from	  the	  groups	  Q1,	  Q2	  and	  Q3.	  Similar	  profiles	  of	  H3K27me3	  and	  H2Aub	  at	  the	  TSS	  are	  seen	  for	  the	  3	  groups.	  
H3K27me3	  increases	  minimally	  at	  the	  TES	  from	  Q1-­‐Q3	  while	  H2Aub	  remains	  the	  same.	  Levels	  of	  binding	  were	  
assessed	  by	  taking	  the	  average	  depth	  per	  nucleotide	  at	  the	  TSS	  (+/-­‐1kb)	  and	  TES	  (2-­‐0kb)	  for	  H3K27me3	  (B)	  and	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4.2.11 RNAPII	  at	  the	  TES	  of	  PRC-­‐repressed	  genes	  correlates	  with	  transcription	  but	  not	  an	  
increase	  in	  mRNA	  expression	  
Analysis	   of	   RNAPII	   and	   Polycomb	   binding	   patterns	   has	   so	   far	   been	   based	   on	   identifying	  
groups	  of	  PRC-­‐repressed	  genes	  with	  different	  levels	  of	  RNA	  detection	  at	  the	  end	  of	  genes,	  in	  
particular	   at	   the	   last	   intron	   to	   avoid	   quantifying	   any	   low	   levels	   of	   mature	   RNA.	   At	   a	  
proportion	  of	  PRC-­‐repressed	  genes,	  RNAPII-­‐S5p	  is	  detected	  through	  the	  entire	  coding	  region	  
to	  the	  TES	  (Brookes	  et	  al.,	  2012).	  At	  these	  genes	  RNAPII-­‐S5p	  does	  not	  traverse	  past	  the	  TES	  
at	  PRC-­‐repressed	  genes,	  unlike	  at	  Active	  genes,	  suggesting	  a	  termination	  control	  mechanism.	  	  
	  
To	  investigate	  the	  relationship	  between	  RNAPII-­‐S5p	  and	  Polycomb	  occupancy	  at	  the	  ends	  of	  
PRC-­‐target	  genes	  and	  the	  amount	  of	  RNA	  detected	  in	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets,	  we	  
re-­‐grouped	  the	  cohort	  of	  PRC-­‐repressed	  genes	  according	  to	  whether	  RNAPII-­‐S5p	  is	  detected	  
immediately	  upstream	  the	  TES	  (-­‐2	  to	  0kb;	  RNAPII-­‐S5pEnd+)	  or	  not	  (RNAPII-­‐S5pEnd-­‐)	  (Brookes	  
et	   al.,	   2012).	   Classifications	   for	   these	   two	   sub-­‐groups	   of	   PRC-­‐repressed	   genes	   are	  
summarized	  in	  Table	  4.2.	  
	  
Table	  4.2	  Classification	  of	  RNAPII-­‐S5p	  at	  the	  TES	  (-­‐2	  to	  0kb)	  of	  PRC-­‐repressed	  genes	  
	  
	  
RNAPII-­‐S5p	  elongates	  all	  the	  way	  to	  the	  TES	  at	  a	  number	  of	  PRC-­‐repressed	  genes	  (Brookes	  et	  
al.;	  2012).	  This	  is	  not	  solely	  due	  to	  gene	  length,	  as	  60%	  of	  RNAPII-­‐S5p⁺	  genes	  are	  more	  than	  
5kb	   long	   (Brookes	   et	   al.,	   2012).	   Even	   though	   RNAPII-­‐S5p	   is	   not	   detected	   at	   end	   of	   the	  
majority	   of	   PRC-­‐repressed	   genes,	   in	   most	   cases	   it	   elongates	   well	   into	   coding	   regions.	   To	  
understand	  how	  the	  detection	  of	  RNAPII-­‐S5p	  immediately	  before	  the	  TES	  of	  PRC-­‐repressed	  
genes	  relates	  with	  RNA	  detection	  in	  the	  same	  region	  in	  the	  RNAPII-­‐S5p	  RNA-­‐ChIP	  datasets,	  
we	   plotted	   the	   latter	   datasets	   for	   genes	   classified	   as	   RNAPII-­‐S5pEnd-­‐	   and	   -­‐S5pEnd+	   (Fig.	  
4.15).	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This	  analysis	  produced	  interesting	  results.	  At	  genes	  classified	  as	  RNAPII-­‐S5pEnd-­‐,	  transcripts	  
from	  RNAPII-­‐S5p	  RNA-­‐ChIP	  peak	  sharply	  at	  promoters	  and	  decrease	  into	  coding	  regions	  with	  
minimal	  detection	  at	  the	  TES	  (Fig.	  4.15A),	  where	  there	  is	  no	  RNAPII-­‐S5p	  binding.	  In	  contrast,	  
RNAPII-­‐S5pEnd+	  gene	  transcripts	  are	  detected	  at	  the	  TSS,	  although	  at	  a	   lower	   level	  than	  at	  
RNAPII-­‐S5pEnd-­‐	   genes,	   and	   are	   robustly	   detected	   throughout	   the	   entire	   coding	   region,	  
peaking	  prior	   to	   the	   TES	  with	   similar	   depth	   as	   that	   seen	   at	   the	   TSS.	  However,	   there	   is	   no	  
transcription	  past	  the	  TES	  or	  upstream	  of	  the	  TSS,	  both	  typical	  of	  active	  genes.	  Levels	  of	  RNA	  
detected	   in	   RNAPII-­‐S5p	   RNA-­‐ChIP	   dataset	   at	   the	   last	   intron	   of	   each	   gene	   recapitulate	   the	  
differences	   between	   gene	   groups	   seen	   at	   average	   gene	   profiles	   (Fig.	   4.15B),	   with	   more	  
transcript	  detection	   in	  the	  RNAPII-­‐S5pEnd+	  group	  than	  RNAPII-­‐S5pEnd-­‐.	  Levels	  of	  RNA	  from	  
RNA-­‐ChIP,	  at	  a	  proportion	  of	  RNAPII-­‐S5pEnd+	  genes,	  are	  as	  high	  as	  that	  seen	  for	  highly	  Active	  
genes	   (Fig.	   4.15B).	   There	   are	   also	   similar	   levels	   of	  mRNA	   detected	   at	   RNAPII-­‐S5pEnd-­‐	   and	  
RNAPII-­‐S5pEnd,	  suggesting	  that	  even	  though	  RNAPII	  and	  transcription	  reach	  the	  end	  of	  the	  
gene,	   there	   is	   a	  block	  on	  mRNA	  expression,	   consistent	  with	  absence	  of	  detectable	   S2p.	   In	  
contrast,	  genes	  with	  RNAPII-­‐S5p	  that	  do	  not	  reach	  the	  TES	  present	  transcripts	  that	  elongate	  
past	  the	  promoter	  but	  regulation	  appears	  to	  occur	  at	  an	  earlier	  point.	  
	  
Figure	   4.15	   Transcription	   occurs	   throughout	   PRC-­‐repressed	   genes	   bound	   by	   RNAPII-­‐S5p	   at	   the	   TES.	   (A)	  
Distribution	  of	  RNA	  from	  RNAPII-­‐S5p	  RNA-­‐ChIP	  were	  plotted	  by	  taking	  the	  depth	  of	  sequencing	  per	  nucleotide,	  
across	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb)	  of	  PRC-­‐repressed	  genes	  from	  the	  groups	  RNAPII-­‐S5p+	  and	  RNAPII-­‐S5p-­‐.	  (B)	  
Levels	  of	  binding	  were	  assessed	  by	  taking	  the	  average	  depth	  per	  nucleotide	  at	  the	  TSS	  (+/-­‐1kb)	  and	  TES	  (2-­‐0kb)	  
for	  RNAPII-­‐S5p	  RNA	   in	  the	   last	   intron	  and	  by	  using	  FPKM	  for	  mRNA.	  PRC-­‐repressed	  genes	  with	  RNAPII	   to	  the	  
TES	  (RNAPII-­‐S5p+)	  have	  a	  smaller	  promoter	  peak	  of	  RNA	  compared	  to	  RNAPII-­‐S5p-­‐	  which	  extends	  into	  coding	  
regions,	  peaking	  before	  the	  TES.	  No	  transcription	  is	  seen	  after	  the	  TES.	  RNAPII-­‐S5p-­‐	  genes	  have	  a	  high	  promoter	  
peak	  of	  nascent	  RNA	  that	  extends	   into	  coding	   regions	  with	  no	  detection	  at	   the	  TES.	  RNAPII-­‐S5p+	  have	  more	  
RNA	   in	   the	   last	   intron	  which	  can	  be	  as	  high	  as	  active	  genes.	  Levels	  of	  mRNA	  are	   largely	  unchanged	  between	  
S5p+	  and	  S5p-­‐	  genes	  and	  are	  as	  low	  as	  silent	  genes	  but	  not	  as	  high	  as	  active.	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4.2.12 RNAPII-­‐S5pEnd+	   PRC-­‐repressed	   genes	   transcribe	   to	   the	   TES	   in	   the	   absence	   of	   S2	  
phosphorylation	  
RNAPII	   can	  elongate	   through	   coding	   regions	  producing	  PRC-­‐repressed	   transcripts	   until	   the	  
TES.	  Average	  profiles	  confirm	  that	  RNAPII-­‐S5p	  elongates	  to	  the	  TES	  where	  it	  peaks,	  but	  does	  
not	  extend	  further	  at	  RNAPII-­‐S5pEnd+	  genes	  (Fig.	  4.16A)	  in	  contrast	  to	  Active	  genes	  (Brookes	  
et	   al.,	   2012).	   Levels	   of	   RNAPII-­‐S5p	   at	   the	   TSS	   are	   slightly	   elevated	   in	   the	   RNAPII-­‐S5pEnd+	  
compared	  to	  RNAPII-­‐S5pEnd-­‐	  groups,	  seen	  by	  average	  profiles	  and	  boxplots	   (Fig.	  4.16A,	  B).	  
Levels	  for	  both	  groups	  at	  the	  TSS	  are	  as	  high	  as	  at	  the	  20%	  most	  active	  genes.	  Intriguingly,	  at	  
the	   TES,	   levels	   for	   the	   RNAPII-­‐S5pEnd+	   group	   are	   slightly	   higher	   than	   at	   the	   Active	   gene	  
cohort,	  although	  the	  levels	  of	  transcription	  at	  the	  last	  intron	  is	  lower	  (Fig.	  4.15B),	  which	  may	  
suggest	  accumulation	  or	  stalling	  of	  RNAPII	  prior	  to	  termination,	  a	  process	  known	  to	  occur	  in	  
yeast	  and	  linked	  to	  splicing	  efficiency	  (Carrillo	  Oesterreich	  et	  al.,	  2010).	  Even	  though	  RNAPII-­‐
S5p	  is	  not	  detected	  at	  the	  TES	  at	  a	  group	  of	  genes	  (RNAPII-­‐S5pEnd-­‐),	  it	  is	  still	  able	  to	  elongate	  








Figure	  4.16	  RNAPII-­‐S5p	  can	  elongate	  through	  PRC-­‐repressed	  genes	  to	  the	  TES	  in	  the	  absence	  of	  RNAPII-­‐S2p.	  
Distribution	  of	   	   RNAPII-­‐S5p	   (A)	   and	  RNAPII-­‐S2p	   (C)	   binding	   for	   the	   groups	  RNAPII-­‐S5p+	   and	  RNAPII-­‐S5p-­‐	  was	  
analysed	   by	   taking	   the	   depth	   of	   sequencing	   per	   nucleotide,	   across	   the	   TSS	   and	   TES	   (-­‐5	   to	   +5kb)	   of	   PRC-­‐
repressed	   genes.	   RNAPII-­‐S5p	   associates	   with	   RNAPII-­‐S5p+	   genes	   until	   the	   TES.	   In	   contrast	   RNAPII-­‐S5p	   is	  
associated	  with	  the	  TSS	  but	  does	  not	  elongate	  to	  the	  TES	  at	  RNAPII-­‐S5p-­‐	  PRC-­‐repressed	  genes.	  Levels	  of	  binding	  
were	  assessed	  by	  taking	  the	  average	  depth	  per	  nucleotide	  at	  the	  TSS	  (+/-­‐1kb)	  and	  TES	  (2-­‐0kb)	  for	  RNAPII-­‐S5p	  
(B)	  and	  TES	  (2-­‐0kb)	  for	  RNAPII-­‐S2p	  (D).	  Both	  groups	  associate	  with	  RNAPII-­‐S5p	  at	  the	  TSS	  at	  levels	  comparable	  
to	  active	  genes.	  In	  contrast	  RNAPII-­‐S2p	  binding	  is	  as	  low	  as	  the	  20%	  lowest	  expressed	  genes.	  
	  
In	   both	   instances,	   where	   RNAPII	   transcribes	   the	   entire	   gene	   length	   or	   not,	   there	   is	   no	  
detection	  of	  appreciable	  RNAPII-­‐S2p	  at	  the	  TSS	  or	  TES	  (Fig.	  4.16C).	  Levels	  at	  the	  TES	  are	  as	  
low	  as	   that	  seen	   for	   the	  Silent	  gene	  cohort	   (Fig.	  4.16D).	  These	  data	  demonstrate	   that	  at	  a	  
group	  of	  PRC-­‐repressed	  genes,	  RNAPII-­‐S5p	  elongates	  to,	  but	  not	  past	  the	  TES	  and	  transcribes	  
throughout	   the	   entire	   gene	   detectable	   by	   RNA-­‐ChIP.	   This	   phenomenon	   occurs	   in	   the	  
absence	  of	  the	  elongating	  associated	  RNAPII-­‐S2p.	  
 
4.2.13 RNAPII-­‐S5pEnd+	   transcribe	   the	   whole	   gene	   in	   the	   presence	   of	   high	   levels	   of	  
Polycomb	  marks	  
Polycomb	   binding	   mirrors	   that	   of	   RNAPII-­‐S5p	   genome-­‐wide	   (Brookes	   et	   al.,	   2012).	   To	  
investigate	  whether	  this	   is	  the	  case	  at	  both	  RNAPII-­‐S5pEnd+	  and	  RNAPII-­‐S5pEnd-­‐	  genes,	  we	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plotted	   average	   profiles	   for	   Polycomb	   marks	   H3K27me3	   and	   H2Aub1	   (Fig.	   4.17A,	   B)	   and	  
PRC2	  component	  Ezh2,	  the	  catalyst	  of	  H3K27me3	  (Fig.	  4.17C).	  Binding	  of	  all	  Polycomb	  marks	  
at	   the	   two	   groups	   (RNAPII-­‐S5pEnd+,	   -­‐S5pEnd-­‐)	   is	   nearly	   identical	   to	   RNAPII-­‐S5p	   occupancy	  
(Fig.	  4.16A).	  All	  PRC	  marks	  peak	  at	  promoters	  and,	  for	  RNAPII-­‐S5pEnd+	  genes,	  also	  just	  before	  
the	  TES.	  At	  RNAPII-­‐S5pEnd-­‐	  genes,	  PRC	  peaks	  at	  promoters	  and	  extends	  into	  coding	  regions	  
by	  the	  same	  margin	  as	  RNAPII-­‐S5p	  (Fig.	  4.16A).	  
	  
Figure	   4.17	   Polycomb	   binding	   mirrors	   RNAPII-­‐S5p	   at	   PRC-­‐repressed	   genes.	   Distribution	   of	   H3K27me3	   (A),	  
H2Aub1	  (B)	  and	  Ezh2	  (C)	  binding	  for	  RNAPII-­‐S5pEnd+	  and	  RNAPII-­‐S5pEnd-­‐	  PRC-­‐repressed	  genes	  was	  plotted	  by	  
taking	  the	  depth	  of	  sequencing	  per	  nucleotide,	  across	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb).	  All	  Polycomb	  components	  
bind	   through	   coding	   regions	   up	   to	   the	   TES	   at	   RNAPII-­‐S5pEnd+	   genes.	   At	   RNAPII-­‐S5pEnd-­‐	   genes,	   Polycomb	  
primarily	  associates	  with	  the	  promoter	  extending	  slightly	  into	  coding	  regions.	  Binding	  mirrors	  RNAPII-­‐S5p	  (Fig.	  
4.16).	  	  
 
4.2.14 De-­‐repression	  of	  PRC-­‐repressed	  genes	  in	  Ring1B-­‐conditional	  knockouts	  
Interplay	   between	   RNAPII	   and	   PRC	   is	   crucial	   for	   regulation	   of	   PRC-­‐repressed	   genes	   and	  
Ring1B	   activity	   restrains	   RNAPII	   at	   PRC-­‐repressed	   genes	   (Stock	   et	   al.,	   2007).	   Removal	   of	  
Ring1B	  in	  an	  inducible	  knockout	  ES	  cell	  line	  that	  is	  also	  Ring1A	  null,	  results	  in	  de-­‐repression	  
of	  PRC-­‐repressed	  genes	  in	  a	  total	  cellular	  RNA	  preparation,	  depicted	  here	  in	  Figure	  4.18	  and	  
also	  in	  published	  data	  (Stock	  et	  al.,	  2007;	  Brookes	  et	  al.,	  2012).	  RT-­‐PCR	  at	  a	  panel	  of	  genes	  in	  
Ert2-­‐ES	  cells	  after	  Ring1B	  removal	  demonstrates	  de-­‐repression	  of	  total	  RNA	  transcripts	  (Fig.	  
4.18).	   At	   this	   panel	   of	   genes	   expression	   of	   PRC-­‐repressed	   genes	   occurs	   in	   the	   absence	   of	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elongation	  associated	  RNAPII-­‐S2p	   (Stock	  et	  al.,	  2007)	  and	  H3K36me3	  (E.	  Brookes,	  personal	  
communication).	  	  
	  
Figure	  4.18	  Ring1B	  activity	  is	  important	  in	  silencing	  PRC-­‐repressed	  gene	  mRNA	  expression.	  (A)	  Schematic	  of	  
the	   effects	   of	   Ring1B	   removal	   on	   PRC-­‐repressed	   genes.	   Ring1B	   knockout	   results	   in	   loss	   of	   H2Aub1	   and	   de-­‐
repression	  of	  PRC-­‐repressed	  genes	  in	  the	  absence	  of	  RNAPII-­‐S2p.	  (B)	  Effects	  on	  active,	  PRC-­‐repressed	  and	  silent	  
gene	  transcripts	  from	  total	  RNA	  were	  assessed	  by	  quantitative	  RT-­‐PCR	  after	  0	  (white),	  24	  (light	  grey)	  and	  48h	  
(dark	   grey)	   tamoxifen	   treatment	   of	   ES-­‐ERT2	   cells	   to	   excise	   the	  Ring1B	   gene.	  Primers	   in	   the	   5’	   exonic	   region	  
were	  used	  to	  capture	  total	  transcripts.	  Active	  gene	  transcripts	  (βactin,	  Oct4)	  remain	  unchanged	  after	  treatment	  
with	  tamoxifen	  (+TMX)	  at	  24	  and	  48	  h.	  PRC-­‐repressed	  transcripts	  increase	  at	  24	  h	  and	  again	  at	  48	  h.	  Low	  levels	  
of	   increase	   are	   seen	   at	  Gata4	   and	   no	   change	   at	   silent	   genes	   (Myf5,	   Gabra6).	   Levels	   were	   normalized	   to	   3	  
housekeeping	  genes	   (βactin,	  UBC,	  G6PD)	  and	  plotted	  relative	   to	   levels	   in	  untreated	  ES	  cells.	  Experiment	  was	  
from	  1	  biological	  replicate	  (see	  also	  Stock	  et	  al.,	  2007).	  
	  
What	   happens	   to	   transcription	   at	   the	   level	   of	   chromatin	   after	   Ring1B	   removal	   and	   de-­‐
repression	  is	  not	  known.	  In	  the	  previous	  sections	  of	  this	  chapter,	  I	  have	  described	  genome-­‐
wide	  features	  of	  PRC-­‐repressed	  RNAPII	  transcription.	  However,	  it	  is	  not	  clear	  whether	  upon	  
removal	   of	   PRC	   these	   genes	   are	   de-­‐repressed	   in	   a	  manner	  where	   transcription	   resembles	  
active	  genes	  or	  is	  still	  compromised.	  
4.2.15 Ring1B	   knockout	   results	   in	   de-­‐repression	   of	   PRC-­‐repressed	   genes	   at	   the	   level	   of	  
chromatin	  
To	  understand	  the	  features	  of	  transcription	  at	  PRC-­‐repressed	  genes	  after	  Ring1B	  removal,	  I	  
made	   use	   of	   Ert2-­‐ES	   cells	   to	   study	   transcription	   after	   RNAPII-­‐S5p	   RNA-­‐ChIP,	   isolating	  
chromatin	   bound	   transcripts	   at	   single	   genes	   and	   genome-­‐wide.	   As	   well	   as	   investigating	  
Ring1B	  removal	  on	  transcription,	  these	  cells	  also	  provide	  biological	  replicates	  of	  RNAPII-­‐S5p	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RNA-­‐ChIP	  at	  PRC-­‐repressed	  genes	  in	  a	  separate	  ES	  cell	  line	  to	  that	  used	  in	  Chapters	  3	  and	  4.	  
RNAPII-­‐S5p	   RNA-­‐ChIP	   was	   performed	   in	   cells	   that	   were	   either	   untreated	   or	   tamoxifen	  
treated	   for	   24	   or	   48h	   (Fig.	   4.19).	   Primers	   against	   5’	   regions	   of	   PRC-­‐repressed,	   active	   and	  
silent	   genes	   were	   used	   in	   RT-­‐PCR	   for	   single	   genes,	   detecting	   all	   transcripts.	   	   Complete	  
removal	  of	  Ring1B	  protein	  is	  seen	  by	  48h	  (Stock	  et	  al.,	  2007).	  	  
	  
PRC-­‐repressed	  transcripts	  are	  enriched	  in	  the	  untreated	  RNAPII-­‐S5p	  RNA-­‐ChIP,	  as	  seen	  in	  ES-­‐
OS25	   cells	   (Fig.	   4.3).	   Upon	   Ring1B	   knockout	   PRC-­‐repressed	   transcript	   levels	   increase	  
suggesting	  that	  PRC	  could	  have	  a	  direct	  role	  in	  regulating	  RNAPII	  transcription	  and	  not	  mRNA	  
stability.	  At	  the	  panel	  of	  six	  PRC-­‐repressed	  genes	  all	  show	  an	  increase	  in	  transcription	  apart	  
from	  Gata4,	  which	  is	  detected	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  but	  not	  affected	  by	  Ring1B	  removal	  
(Fig.	   4.19),	   recapitulating	   that	   seen	   in	   total	   RNA	   (Fig.	   4.18).	   Transcripts	   for	   active	   genes	  
βactin	   and	  Oct4	   are	   enriched	   in	   RNAPII-­‐S5p	   RNA-­‐ChIP	   for	   all	   timepoints	   of	   treatment	   as	  
expected	   for	   active	   genes,	   but	   importantly	   enrichment	   does	   not	   change	   with	   Ring1B	  

























































































































Figure	   4.19	   PRC-­‐repressed	   transcripts	   are	   de-­‐repressed	   at	   the	   level	   of	   transcription.	   Transcripts	   associated	  
with	  RNAPII-­‐S5p	  were	  assessed	  by	  RNA-­‐ChIP	  and	  quantitative	  RT-­‐PCR,	  at	  active,	  PRC-­‐repressed	  and	  silent	  genes	  
after	  0	   (light	  grey),	  24	   (dark	  grey)	  and	  48h	   (black)	   tamoxifen	  treatment	  of	  ES-­‐ERT2	  cells	   to	  excise	   the	  Ring1B	  
gene.	  An	  untreated	  control	  mock	   IgG	  antibody	  was	   included	   (white).	  Primers	  were	  designed	  within	  5’	  exonic	  
regions	   to	   capture	   total	   RNA	   populations.	   PRC-­‐repressed	   transcripts	   are	   de-­‐repressed	   upon	   Ring1B	   removal	  
whereas	   active	   and	   silent	   genes	   remain	   unchanged.	   Levels	   were	   normalized	   to	   total	   chromatin	   transcripts	  
(Input).	  Mean	  and	  standard	  deviations	  are	  presented	  from	  3	  independent	  biological	  replicates	  experiments.	  
 
4.2.16 Transcripts	  detected	  at	  PRC-­‐repressed	  genes	  increase	  upon	  Ring1B	  knockdown	  
To	  investigate	  characteristics	  of	  transcription	  of	  PRC-­‐repressed	  genes	  associated	  with	  Ring1B	  
removal,	  I	  made	  sequencing	  libraries	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  RNA	  in	  Ring1B+	  and	  Ring1B-­‐	  ES	  
cells	   to	   study	   de-­‐repression	   at	   the	   level	   of	   chromatin,	   genome-­‐wide.	   RNAPII-­‐S5p	   RNA	  
libraries	  (Ring1B+	  and	  Ring1B-­‐)	  were	  prepared	  using	  the	  directional	  protocol.	  A	   list	  of	  read	  
numbers	   and	   alignments	   are	   shown	   in	   Chapter	   3,	   Table	   3.2.	   Average	   profiles	   of	   PRC-­‐
repressed	  and	   the	  20%	   lowest	  expressing	  genes	  were	  made	   (Fig.	  4.20)	   in	  parallel	  with	   the	  
20%	   highest	   expressed	   genes	   (not	   shown).	   Importantly,	   no	   differences	   were	   detected	   in	  
depth	  or	  profile	  of	  transcription	  at	  highly	  active	  genes	  after	  Ring1B	  removal.	  	  	  
	  
Transcripts	   are	   detected	   genome-­‐wide	   from	   average	   profiles	   of	   PRC-­‐repressed	   genes	   in	  
Ring1B+	  (-­‐Tmx)	  cells,	  in	  accordance	  with	  results	  seen	  in	  ES-­‐OS25	  cells	  (Fig.	  4.8).	  In	  agreement	  
with	   previous	   results,	   transcription	   occurs	   in	   the	   sense	   orientation	   of	   the	   PRC-­‐repressed	  
genes	   and	   there	   is	   no	   detectable	   antisense	   transcription	   at	   promoter	   regions.	   Low	   level	  
transcription	  is	  seen	  after	  the	  TES.	  Upon	  Ring1B	  knockdown	  (+Tmx	  48h),	  there	  is	  an	  increase	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in	  transcription	  of	  PRC-­‐repressed	  genes	  relative	  to	  the	  background	  levels	  detected	  at	  Silent	  
genes.	   Interestingly,	  promoter	  associated	  antisense	   transcription	  and	   transcription	  beyond	  
the	   TES	   becomes	   more	   appararent	   after	   Ring1B	   knockout,	   suggesting	   some	   unexpected	  
interplay	  between	  Polycomb	  presence	  at	  PRC-­‐repressed	  chromatin	  and	  the	  unusual	  state	  of	  
RNAPII	  at	  this	  group	  of	  genes.	  
	  
Figure	   4.20	  Average	  profiles	   reveal	   transcription	   reminiscent	   of	   active	   transcription	  upon	  Ring1B	   removal.	  
Distribution	  of	  RNAPII-­‐S5p	  RNA	  in	  Ring1B+	  and	  Ring1B-­‐	  cells	  (ES-­‐Ert2,	  -­‐/+	  Tmx)	  was	  assessed	  at	  PRC-­‐repressed	  
(dark	  pink)	  and	  20%	  least	  active	  (grey)	  genes.	  Average	  depth	  of	  sequencing	  reads	  per	  nucleotide,	  was	  analysed	  
in	   windows	   around	   the	   TSS	   and	   TES	   (-­‐5	   to	   +5kb).	   PRC-­‐repressed	   transcripts	   are	   detected	   genome-­‐wide	   in	  
Ring1b+	  cells,	  with	  no	  antisense	  transcription.	  Upon	  Ring1b	  removal	  (Ring1B-­‐,	  +Tmx)	  transcript	  levels	  increase	  
relative	   to	   20%	   least	   active	   genes.	   Antisense	   transcription	   is	   detected	   upstream	   from	   the	   TSS.Bioinformatic	  
analyses	  performed	  by	  I.de	  Santiago.	  
 
4.2.17 RNA	  processing	  at	  PRC-­‐repressed	  genes;	  low	  level	  Capping	  
The	  S5p	  modification	  of	  RNAPII	  has	  been	  linked	  to	  the	  recruitment	  of	  capping	  machinery	  to	  
transcribing	   genes	   (McCracken	   et	   al.,	   1997;	   Ho	   and	   Shuman,	   1999;	   Cowling,	   2010)	   and	  
association	  with	  RNAPII-­‐S5p	  enhances	  guanylyltransferase	  activity	  (Ho	  and	  Shuman,	  1999).	  	  
	  
Transcription	   of	   PRC-­‐repressed	   genes	   occurs	   genome-­‐wide.	   However,	   this	   occurs	   in	   the	  
absence	  of	  S2p	  but	   in	  the	  presence	  of	  abundant	  RNAPII-­‐S5p	  and	  PRCs.	  Whether	  Polycomb	  
repression	   affects	   recruitment	   of	   capping	   enzymes	   or	   the	   enzymatic	   process	   of	   transcript	  
capping,	  even	  in	  the	  presence	  of	  abundant	  RNAPII-­‐S5p	  is	  not	  known.	  To	  determine	  whether	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PRC-­‐repressed	   transcripts	   are	   capped,	   we	   mined	   CAGE	   sequencing	   datasets,	   which	   I	  
prepared	   from	   the	   same	   cell	   line	   used	   throughout	   this	   thesis	   (ES-­‐OS25	   cells).	   Total	   RNA	  
samples	  that	  will	  encompass	  the	  whole	  RNA	  complement	  included	  that	  in	  mRNA	  and	  RNA-­‐
ChIP	   RNA,	   were	   extracted	   and	   sent	   for	   library	   preparation	   and	   sequencing	   at	   Riken	   OSC	  
(Japan).	  CAGE	  is	  a	  method	  to	  annotate	  TSS	  usage	  with	  nucleotide	  precision	  as	  well	  as	  being	  a	  
measure	  of	  gene	  expression	  (Takahashi	  et	  al.,	  2012).	  However,	  CAGE	  relies	  on	  the	  presence	  
of	  a	  7-­‐methyl-­‐guanosine	  ‘cap’	  structure	  at	  the	  5’	  end	  of	  genes.	  Transcripts	  that	  do	  possess	  a	  
cap	  will	  be	   incorporated	   into	   the	  sequencing	   library	  while	   those	  that	  do	  not	  have	  a	  5’	  cap	  
will	  not.	  Previous	  analysis	  of	  RNAPII-­‐S5p	  RNA-­‐ChIP	  in	  this	  chapter	  demonstrates	  that	  we	  are	  
able	   to	   detect	   PRC-­‐repressed	   transcripts	   by	   genome-­‐wide	   sequencing	   (Fig.	   4.9).	   For	   CAGE	  
analysis	  we	  used	   the	   three	  gene	  groups	  used	  previously	   (20%	  Active,	  20%	  Silent	  and	  PRC-­‐
repressed	  genes)	  and	  generated	  average	  profiles	  of	  CAGE	  sequencing	  tags	  (Fig.	  4.21).	  
	  
The	   20%	  most	   active	   genes	   have	   a	   sharp	   peak	   precisely	   at	   the	   TSS	   showing	   transcription	  
from	   these	   genes	  mostly	   begins	   from	   the	   annotated	   TSS.	   There	   is	   a	   small	   distribution	   of	  
promoter	  usage	  upstream	  and	  downstream	  of	  the	  TSS.	  Antisense	  transcription	  upstream	  of	  
active	  gene	  promoters	  occurs	  at	  low	  level	  with	  broad	  promoter	  usage	  up	  to	  0.5kb	  away	  from	  
the	  annotated	  TSS.	  Presence	  of	  antisense	   transcripts	   in	   this	   sequencing	   library	  means	   that	  










Figure	  4.21	  Low-­‐level	  capping	  of	  PRC-­‐repressed	  transcripts.	  Total	  RNA	  was	  extracted	  from	  ES-­‐OS25	  cells	  and	  
sent	  for	  CAGE	  sequencing.	  (Riken	  OSC,	  Japan).	  Average	  tags	  per	  million	  were	  calculated	  across	  the	  TSS	  and	  TES	  
(-­‐1	  to	  +1kb)	  for	  sense	  and	  antisense	  reads	  and	  average	  profiles	  of	  active	  (20%	  most	  expressed),	  PRC-­‐repressed	  
and	   silent	   (20%	   least	   active	   made.	   Active	   genes	   are	   capped	   and	   have	   precise	   TSS	   usage	   as	   well	   as	   broad	  
antisense	   transcription.	   PRC-­‐repressed	   genes	   have	   low	   level	   capping	   and	   those	   transcripts	   that	   are	   capped	  
transcribe	  from	  the	  annotated	  TSS.	  There	  is	  low	  level	  usage	  of	  promoter	  start	  sites	  into	  the	  body	  of	  the	  gene	  
with	  no	  detectable	  antisense	  transcription.	  	  
	  
Capping	   of	   PRC-­‐repressed	   genes	   is	   also	   detected	   above	   that	   seen	   for	   the	   20%	   lowest	  
expressed	  genes	  (Fig.	  4.21)	  in	  keeping	  with	  results	  seen	  for	  RNAPII-­‐S5p	  RNA-­‐ChIP	  that	  PRC-­‐
repressed	   genes	   are	   transcribed	   but	   are	   detected	   at	   considerably	   lower	   level	   than	   active	  
genes,	   even	   in	   the	   presence	   of	   abundant	   S5p	   (Fig	   4.9).	   PRC-­‐repressed	   genes	   detected	  
transcribe	  mainly	   from	   the	   annotated	   TSS.	   Interestingly	   there	   are	   a	   number	   of	   transcripts	  
that	  show	  promoter	  usage	  into	  the	  body	  of	  the	  gene,	  in	  the	  absence	  of	  antisense	  transcripts,	  
suggesting	   a	   difference	   in	   transcription	   initiation	   and	   promoter	   usage	   at	   PRC-­‐repressed	  
genes	   in	   ES	   cells.	   In	   keeping	   with	   RNA-­‐ChIP	   sequencing	   (Fig	   4.9)	   there	   is	   no	   detectable	  
antisense	  transcription	  from	  these	  genes.	  
	  
Levels	  of	  PRC-­‐repressed	  capped	  transcripts	  are	   low	  but	  show	  a	  broad	  range	  (Fig.	  4.22A).	  A	  
small	  proportion	  show	  capped	  transcript	  levels	  similar	  to	  that	  at	  the	  20%	  most	  active	  genes.	  
Intriguingly,	   within	   this	   broad	   range	   two	   populations	   of	   PRC-­‐repressed	   genes	   are	   evident	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(Fig.	   4.22B).	   One	   population	   have	  minimal	   detection	   of	   capping	   in	   line	   with	   silent	   genes,	  
while	  the	  other	  population	  have	  higher	  levels	  of	  capping	  that	  is	  more	  within	  range	  of	  active	  
genes.	  This	  preliminary	  analysis	  demonstrates	  that	  PRC-­‐repressed	  transcripts	  are	  capable	  of	  
being	   capped.	   Interestingly,	   presence	   of	   two	   populations	   suggests	   there	  may	   be	   different	  
mechanisms	  of	  regulation	  of	  which	  may	  be	  integral	  to	  5’	  processing.	  	  Numbers	  of	  genes	  and	  
the	  relationship	  between	  level	  of	  transcription	  in	  RNA-­‐ChIP	  datasets,	  RNAPII	  and	  Polycomb	  
binding	  with	  capping	  is	  not	  known.	  Further	  analysis	  is	  ongoing	  to	  investigate	  the	  number	  and	  
features	  of	  PRC-­‐repressed	  genes	  that	  have	  detectable,	  capped	  transcripts.	  
 
Figure	   4.22	   PRC-­‐repressed	   genes	   have	   low	   level	   capping.	   CAGE	   data	   was	   assessed	   to	   look	   at	   the	   level	   of	  
capped	   transcripts	   detected	   for	   20%	   highest	   and	   lowest	   expressed	   and	   PRC-­‐repressed	   genes.	   (A)	   Levels	   of	  
binding	   were	   assessed	   by	   taking	   the	   sum	   of	   the	   tags	   per	   million	   (TPM)	   at	   the	   TSS	   (+/-­‐1kb).	   (B)	   Bean	   plots	  
present	   the	   distribution	   of	   the	   data.	   Active	   genes	   have	   high	   levels	   of	   capped	   transcripts.	   PRC-­‐repressed	  
transcripts	  have	  low	  level	  capping	  within	  the	  levels	  of	  the	  20%	  lowest	  expressed	  genes.	  Bioinformatic	  analysis	  
performed	  by	  N.Harmston.	  	  
	  
4.2.18 Ring1B	  knockout	  results	  in	  increased	  5’	  capped	  transcripts	  
PRC-­‐target	   genes	   are	   de-­‐repressed	   upon	   PRC1	   knockout	   induced	   by	   tamoxifen	   treatment,	  
with	  changes	  in	  the	  RNA-­‐ChIP	  transcript	  profiles	  which	  become	  reminiscent	  of	  profiles	  seen	  
at	  active	  genes	  (Figs.	  4.20).	  To	  understand	  whether	  transcripts	  become	  capped	  upon	  PRC1	  
knockout,	   CAGE	   sequencing	   libraries	   were	   produced	   for	   Ring1A-­‐Ring1B+	   and	   for	   Ring1A-­‐
Ring1B-­‐	  cells	  (Fig.	  4.23A,	  B).	  Ring1B	  knockout	  does	  not	  affect	  capping	  or	  transcript	  expression	  
levels	  in	  the	  Silent	  or	  Active	  gene	  group,	  as	  expected	  for	  genes	  that	  are	  not	  PRC1	  regulated.	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However,	  there	  is	  a	  significant	  effect	  at	  PRC-­‐repressed	  genes	  of	  increased	  capped	  transcript	  
detection.	   Again,	   two	   populations	   are	   apparent	   within	   the	   PRC-­‐repressed	   gene	   group,	   as	  
well	   as	   the	   silent	   (Fig.	   4.23B).	  Upon	   PRC1	   knockout	   capped	   transcripts	   that	   are	  minimally	  
detected	   significantly	   increase	   (permutation	   t-­‐test	   p-­‐value>2.2x10-­‐16).	   Silent	   genes	   show	   a	  
small	  change	  that	  is	  barely	  significant	  (p-­‐value>0.494).	  These	  results	  suggest	  that	  Polycomb	  
regulates	  RNAPII	  transcription	  and	  possibly	  5’	  capping	  of	  transcripts.	  	  
	  
Figure	  4.23	  Detection	  of	  capped	  PRC-­‐repressed	  transcripts	   increases	  with	  Ring1B	  knockout.	  CAGE	  data	  was	  
assessed	  to	   look	  at	   the	   level	  of	  capped	  transcripts	  detected	   for	  20%	  highest	   (Active)	  and	  20%	   lowest	   (Silent)	  
expressed	   and	   PRC-­‐repressed	   genes	   in	   Ring1A-­‐Ring1B+	   and	   Ring1A-­‐Ring1B-­‐	   cells.	   (A)	   Levels	   of	   binding	   were	  
assessed	   by	   taking	   the	   log,	   sum	   of	   tags	   per	  million	   (TPM)	   at	   the	   TSS	   (+/-­‐1kb).	   (B)	   Bean	   plots	   represent	   the	  
distribution	  of	  genes.	  Active	  genes	  have	  high	   levels	  of	   capped	   transcripts	   that	  do	  not	  alter	   in	  Ring1A-­‐Ring1B-­‐	  
cells.	   PRC-­‐repressed	   transcripts	   are	   low	   level	   and	   are	   de-­‐repressed	   and	   capped	   in	   Ring1A-­‐Ring1B-­‐	   cells.	  















The	  aim	  of	   this	   chapter	  was	   to	   investigate	   the	   interplay	  between	  RNAPII	   and	  PRC	  at	   PRC-­‐
repressed	   genes	   in	   terms	  of	  RNAPII	   transcription.	   Transcripts	  were	   isolated	   at	   the	   earliest	  
stages	   of	   transcription	   using	   RNA-­‐ChIP	   to	   extract	   RNA	   from	   chromatin.	   PRC-­‐repressed	  
transcripts	   were	   isolated	   associated	   with	   chromatin-­‐bound	   RNAPII-­‐S5p	   or	   PRCs	   (Figs.	   4.3,	  
4.5)	   and	   demonstrated	   to	   correspond	   to	   newly-­‐made	  RNA	   for	   a	   panel	   of	   genes	   (Fig.	   4.3).	  
Consistent	   with	   single	   gene	   studies,	   PRC-­‐repressed	   genes	   are	   seen	   to	   be	   transcribed	  
genome-­‐wide	   in	   two	   separate	   ES	   cell	   lines	   (Figs.	   4.9,	   4.20).	   	   Transcription	   profiles	   show	  
similarities	  as	  well	   as	  differences	   relative	   to	  active	  genes	   (Figs.	  4.9,	  4.10)	  but	   the	  disparity	  
between	   high	   levels	   of	   RNAPII-­‐S5p	   and	   low-­‐level	   RNA	   suggest	   that	   PRC-­‐dependent	  
mechanisms	  of	  repression	  may	  occur	  at	  the	  level	  of	  transcription.	   Interestingly,	  there	  is	  no	  
antisense	  transcription	  from	  the	  promoters	  of	  PRC-­‐repressed	  genes	  (Fig.	  4.9).	  There	  is	  some	  
evidence	  of	  splicing	  (Figs.	  4.9,	  4.10)	  at	  PRC-­‐repressed	  genes,	  although	  a	  more	  direct	  analysis	  
would	   be	   required	   to	   confirm	   these	   observations.	   Levels	   of	   transcription	   among	   the	   PRC-­‐
repressed	  group	  are	  broad	   (Figs.	  4.11)	  and	   transcription	  can	  occur	   throughout	  entire	  gene	  
coding	  regions	  (Figs.	  4.9,	  4.10,	  4.12,	  4.15).	  Interestingly,	  PRC-­‐target	  genes	  with	  higher	  levels	  
of	  transcript	  detection	  at	  the	  end	  of	  genes	  (Fig.	  4.12)	  elongate	  in	  the	  absence	  of	  RNAPII-­‐S2p	  
but	  remain	  associated	  with	  high	  levels	  of	  S5p	  and	  PRCs	  (Figs.	  4.13,	  4.14).	  For	  the	  population	  
of	  PRC-­‐repressed	  genes	   in	  which	  RNAPII-­‐S5p	   is	  detected	   immediately	  upstream	  of	   the	  TES	  
(RNAPIIS5pEnd+),	   transcription	   occurs	   in	   the	   presence	   of	   PRC	   and	   absence	   of	   RNAPII-­‐S2p	  
(Fig.	  4.15,	  4.16,	  4.17).	  Ring1B	   is	   instrumental	   in	   restraining	  RNAPII	  at	  PRC-­‐repressed	  genes	  
and	   its	   deletion	   causes	   de-­‐repression	   and	   an	   increase	   in	   mRNA	   expression	   of	   PRC-­‐target	  
genes	   (Stock	   et	   al.,	   2007).	   This	   de-­‐repression	   occurs	   at	   the	   level	   of	   chromatin	   (Fig.	   4.19)	  
implying	  that	  regulation	  is	  not	  at	  the	  level	  of	  mRNA	  stability	  or	  translation,	  but	  is	  integral	  to	  
RNAPII	   transcription.	   Transcripts	   at	   PRC-­‐repressed	   genes	   after	   Ring1B	   knockout	   show	  
identical	   features	   to	   those	   of	   an	   active	   gene	   (Fig.	   4.20),	   including	   antisense	   transcription	  
from	  promoters	   (a	   feature	  not	  observed	   in	  the	  PRC-­‐repressed	  state),	  suggesting	  that	  PRC1	  
may	   have	   a	   direct	   role	   in	   inhibiting	   transcription	   possibly	   via	   processing	   recruitment	   and	  
function,	  or	  RNAPII	  processivity	  through	  the	  gene.	  The	  well	  established	  relationship	  between	  
the	   presence	   of	   S5p	   modification	   and	   capping	   at	   active	   genes,	   together	   with	   abundant	  
detection	  of	  RNAPII-­‐S5p	  at	  PRC-­‐repressed	  genes,	  might	  suggest	  that	  PRC-­‐transcripts	  should	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be	   capped	   (McCracken	   et	   al.,	   1997;	   Ho	   and	   Shuman,	   1999).	   Unexpectedly,	   only	   low	   level	  
capping	   at	   a	   population	   of	   PRC-­‐repressed	   genes	   is	   detected	   (Figs.	   4.22,	   4.23),	   raising	   the	  
possibility	   that	   the	   recruitment	  of	   the	  capping	  machinery	   to	  chromatin	  may	  be,	  at	   least	   in	  
part,	  compromised	  at	  PRC-­‐target	  genes.	  The	  minor	  detection	  of	  CAGE	  tags	  shows	  precise	  TSS	  
usage	   from	   the	   promoters	   in	   the	   sense	   direction,	   confirms	   the	   absence	   of	   antisense	  
transcription	  at	  PRC	  targets	  (Fig.	  4.21).	  Interestingly,	  low	  capping	  of	  nascent	  transcripts	  from	  
PRC-­‐repressed	   genes	   would	   constitute	   a	   mechanism	   to	   repress	   downstream	   expression	  
through	  compromised	  RNA	  stability	  and	  translation	  mechanisms.	  
4.3.1 PRC-­‐repressed	  genes	  transcribe	  genome-­‐wide	  in	  the	  presence	  of	  abundant	  RNAPII-­‐
S5p	  
Transcription	  from	  PRC-­‐repressed	  genes	   is	  detected	  genome-­‐wide	  by	  RNAPII-­‐S5p	  RNA-­‐ChIP	  
in	  two	  separate	  ES	  cell	  lines	  (Figs.	  4.9,	  4.20),	  consistent	  with	  the	  detection	  of	  RNAPII-­‐S5p	  at	  
the	   same	  genes.	   Transcript	   levels	   show	  a	  broad	   range	  with	   the	  majority	  of	   PRC-­‐repressed	  
genes	   showing	   low-­‐level	   transcripts,	   and	   a	   small	   proportion	   showing	   levels	   as	   high	   as	   the	  
20%	  most	  active	  genes	   in	  ES	   cells	   (Fig.	   4.11).	   Inhibition	  of	   transcription	  with	   two	   separate	  
drugs	  (flavopiridol	  and	  α-­‐amanitin)	  demonstrates	  that	  transcripts	  from	  PRC-­‐repressed	  genes	  
are	   newly	  made	   and	   detection	   is	   not	   the	   result	   of	   stable	   RNA	   pools	   (Fig.	   4.3).	   As	  well	   as	  
RNAPII-­‐S5p,	   PRC-­‐repressed	   transcripts	   are	   also	   detected	   associated	   with	   PRC-­‐bound	  
chromatin	   (Figs.	   4.5,	   4.6).	   ES	   cells	   in	   culture	   are	   known	   to	   be	   heterogeneous,	   expressing	  
variable	   levels	   of	   pluripotency	   factors	   including	   Nanog	   (Chambers	   et	   al.,	   2007),	   while	  
showing	   differing	   propensities	   to	   differentiate,	   reminiscient	   of	   the	   blastocyst	   in	   vivo.	   Co-­‐
occupancy	   of	   RNAPII-­‐S5p	   and	   PRC	   (Brookes	   et	   al.,	   2012)	   alongside	   detection	   of	   PRC-­‐
repressed	  transcripts	  associated	  with	  PRC	  components	  in	  RNA-­‐ChIP	  suggests	  that	  transcripts	  
identified	  here	  are	  not	  from	  those	  few	  cells	  in	  the	  population	  that	  are	  differentiating	  and	  are	  
in	  fact	  from	  cells	  undergoing	  Polycomb	  repression.	  	  	  
	  
Previous	   reports	   have	   shown	   detection	   of	   transcription	   at	   inactive	   genes	   in	   ES	   cells	  
(Guenther	   et	   al.,	   2007),	   with	   the	   suggestion	   that	   elongation	   would	   not	   occur	   based	   on	  
absence	  of	  H3K36me3,	  and	  that	  regulation	  occurs	  during	  transcription	  initiation.	  In	  contrast,	  
we	   demonstrate	   that	   transcription	   of	   PRC-­‐repressed	   genes	   can	   be	   detected	   throughout	  
coding	   regions	   (Figs.	   4.9,	   4.10,	   4.12,	   4.15)	   in	   parallel	   with	   the	   presence	   of	   RNAPII-­‐S5p	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(Brookes	  et	  al.,	  2012).	  Not	  all	  PRC-­‐repressed	  genes	   transcribe	  the	  entire	  gene	   length	   (Figs.	  
4.12,	   4.15)	   but	   the	  majority	   extend	   at	   least	   1kb	   downstream	   of	   their	   TSS	   suggesting	   that	  
there	  may	   be	  more	   than	   one	   level	   of	   regulation	   important	   to	   keep	   PRC-­‐repressed	   genes	  
silent.	   Transcription	   however	   does	   occur	   in	   the	   correct	   orientation	   to	   the	   gene	   (Fig.	   4.9)	  
ruling	  out	  the	  possibility	  that	  the	  genes	  are	  kept	  silent	  in	  a	  poised	  conformation	  through	  the	  
production	  of	  antisense	  transcripts,	  that	  would	  not	  code	  for	  protein.	  
	  
PRC-­‐repressed	   genes	   are	   associated	   with	   abundant	   RNAPII-­‐S5p	   that	   can	   be	   as	   high,	   or	  
higher,	   than	   at	   active	   genes	   (Stock	   et	   al.,	   2007;	   Brookes	   et	   al.,	   2012).	   Expression	   of	   PRC-­‐
repressed	  genes	  as	  mRNA	   is	  minimal	   (Fig.	  4.11)	  and	  total	   levels	  of	  nascent	  PRC-­‐transcripts	  
are	   also	   low	   for	   a	   panel	   of	   genes	   (Stock	   et	   al.,	   2007).	   Even	   in	   the	   presence	   of	   high	   S5p	  
binding,	   levels	   of	   PRC-­‐repressed	   gene	   transcripts	   are	   low	   when	   isolated	   from	   chromatin	  
(Figs.	  4.9,	  4.11)	  relative	  to	  active	  genes.	  The	  disparity	  between	  S5p	  abundance	  and	  low-­‐level	  
transcript	   detection	   suggests	   that	   PRC-­‐repression	   is	   intimately	   linked	   with	   transcription.	  
Presence	   of	   repressive	   histone	  marks	   (H3K27me3,	   H2Aub1)	   in	   the	   absence	   of	   elongation	  
associated	  RNAPII-­‐S2p	  and	  H3K36me3	  may	  affect	  processivity	  and	  elongation	  rates	  of	  RNAPII	  
resulting	   in	   lower	   transcript	   output.	   Repressive	   histone	   marks	   may	   affect	   the	   ability	   of	  
RNAPII	   to	   traverse	   the	   DNA	   template	   due	   to	   a	   role	   in	   chromatin	   compaction.	   However,	  
chromatin	   modification	   can	   also	   affect	   RNAPII	   elongation	   rates	   and	   splicing	   efficiency	  
(Oesterreich	   et	   al.,	   2011).	   Elongating	   RNAPII	   plays	   crucial	   roles	   in	   recruiting	   chromatin	  
remodelers	  that	  aid	  efficient	  elongation	  through	  the	  chromatin	  template	  (Simic	  et	  al.,	  2003).	  
Recruitment	  of	  specific	  chromatin	  remodelers	  affect	  nucleosome	  positioning	  and	  release	  of	  
RNAPII	  into	  elongation	  and	  in	  certain	  instances	  are	  dependent	  on	  RNAPII	  CTD	  modifications	  
for	  recruitment	  (Morillon	  et	  al.,	  2003).	  Absence	  of	  RNAPII-­‐S2p	  at	  PRC-­‐repressed	  genes	  may	  
disrupt	   co-­‐transcriptional	   recruitment	   of	   RNA	   processing	   machineries	   and	   H3K36me3	  
modification	   and	   negatively	   affect	   elongation,	   resulting	   in	   low	   transcriptional	   output.	   In	  
these	   instances,	   S5p	  detected	   throughout	   coding	   regions	  of	  PRC-­‐repressed	  genes	  may	  not	  
reflect	   a	   high	   density	   of	   RNAPII	   molecules	   but	   may	   reflect	   fewer	   RNAPII	   molecules	   with	  
abundant	  S5p	  modification	  if	  present	  at	  higher	  number	  of	  CTD	  repeats,	  compared	  to	  active	  
genes	   where	   many	   RNAPII	   molecules	   may	   exist	   on	   the	   chromatin	   template	   with	   faster	  
elongation	   rates	   and	   lower	   levels	   of	   S5p.	   Measuring	   elongation	   rates	   of	   RNAPII	   at	   PRC-­‐
repressed	   genes	   may	   be	   possible	   using	   the	   RNAPII-­‐S5p	   RNA-­‐ChIP	   datasets,	   and	   will	   be	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explored	  in	  future	  analyses.	  Assessing	  RNAPII	  abundance	  independently	  of	  CTD	  modification	  
would	  allow	  us	  to	  understand	  how	  RNAPII	  transcription	  rates	  are	  affected	  at	  PRC-­‐repressed	  
genes.	   Presence	   of	   PRC	   complexes	   on	   the	   same	   chromatin	   as	   RNAPII	   and	   their	   effects	   on	  
processivity	  of	  RNAPII	  have	  not	  been	  investigated	  and	  may	  affect	  RNAPII	  elongation	  in	  an	  as	  
yet	  unknown	  way.	  
4.3.2 PRC-­‐repressed	  gene	  RNA	  processing	  in	  the	  absence	  of	  RNAPII-­‐S2p	  
At	   active	   genes,	   S2p	   recruits	   the	   H3K36	   HMT	   as	   well	   as	   splicing	   and	   polyadenylation	  
machinery	   (Fig.	   1.2).	   Lack	   of	   detectable	   S2p	   at	   PRC-­‐repressed	   genes	   may	   indicate	   that	  
splicing,	   or	   cleavage	   and	   polyadenylation	   factors	   may	   not	   be	   recruited,	   resulting	   in	  
improperly	  processed	  transcripts	  liable	  to	  degradation	  (Fig.	  4.24).	  In	  macrophages,	  inducible	  
genes	  are	  bound	  by	  RNAPII-­‐S5p	  and	   transcribe	   low-­‐level	  unspliced	   transcripts	   that	   in	   their	  
basal	   state	   fail	   to	  make	  mRNA.	   Induction	   is	   regulated	   at	   the	   level	   of	   elongation	   and	   RNA	  
processing	  (Hargreaves	  et	  al.,	  2009).	  Presence	  of	  S5p	  and	  transcription	  at	  PRC	  genes	  indicate	  
that	  this	  may	  also	  be	  the	  case	  at	  PRC-­‐repressed	  genes,	  although	  there	  are	   indications	  that	  
splicing	  can	  occur	  to	  some	  extent	  from	  average	  genome-­‐wide	  profiles	  of	  PRC-­‐repressed	  gene	  
transcripts	  (Figs.	  4.9,	  4.10),	  and	  splicing	  of	  the	  first	  exon	  has	  been	  demonstrated	  at	  a	  panel	  
of	  genes	  (Stock	  et	  al.,	  2007).	  It	  is	  not	  known	  to	  what	  extent	  and	  how	  efficient	  splicing	  occurs	  
at	  these	  genes,	  and	  how	  much	  of	  it	  occurs	  co-­‐transcriptionally.	  Recruitment	  of	  U1	  snRNP	  to	  
RNAPII	  occurs	  through	  interaction	  with	  S2p	  (Das	  et	  al.,	  2007),	  and	  begins	  a	  chain	  of	  events	  
recruiting	  the	  rest	  of	  the	  spliceosome	  complex	  which	  is	  thought	  to	  be	  independent	  of	  RNAPII	  
and	  more	  dependent	  on	  gene	   structure	   and	   intron	  presence	   (Oesterreich	  et	   al.,	   2011).	  At	  
PRC-­‐repressed	   genes,	   the	   lack	   of	   S2p	  may	   hinder	   splicing	   factor	   recruitment	   but	   not	   fully	  
inhibit	   spliceosome	  assembly.	   Further	  analysis	  of	  RNA-­‐ChIP	  datasets	  and	   investigation	   into	  
splicing	   factor	   binding	   at	   PRC-­‐repressed	   genes	   is	   required	   to	   understand	   the	   level	   and	  
efficiency	  of	  splicing.	  	  
	  





Figure	   4.24	   Configuration	   of	   RNAPII	   at	   PRC-­‐repressed	   genes	   may	   disrupt	   RNA	   processing.	   RNAPII	   CTD	  
modifications	  recruit	  RNA	  processing	  and	  histone	  modifiers	  to	  chromatin.	  RNAPII-­‐S5p	  occupies	  PRC-­‐repressed	  
genes	  at	  promoters	   and	   into	   coding	   regions	   in	   the	  absence	  of	   S2p	  and	  mRNA	  expression.	   S5p	   recruits	  H3K4	  
HMT’s	   and	   possibly	   capping	  machinery	  while	   lack	   of	   S2p	   is	  marked	   by	   H3K36me3	   absence	   and	  may	   inhibit	  
recruitment	   of	   splicing	   and	   polyadenylation	   machinery.	   Production	   of	   improperly	   processed	   transcripts	   can	  
lead	  to	  degradation	  by	  exonucleases	  such	  as	  the	  exosome.	  	  
	  
Transcription	   downstream	   of	   the	   TES	   of	   PRC-­‐repressed	   genes	   is	   absent	   or	   minimally	  
detected	   (Fig.	  4.9,	  4.20),	   in	  agreement	  with	  RNAPII-­‐S5p	  profiles	   (Brookes	  et	  al.,	  2012),	  but	  
unlike	   the	   typical	   distributions	   seen	   at	   active	   genes	   from	   RNAPII-­‐S5p	   RNA-­‐	   and	   DNA-­‐ChIP	  
datasets.	  At	   the	  majority	  of	  PRC-­‐target	  genes	  where	  RNAPII-­‐S5p	  does	  not	  extend	  until	   the	  
TES	  (Table.	  4.2)	  or	  transcripts	  are	  not	  detected	  until	  the	  last	  intron	  (Fig.	  4.12),	  repression	  is	  
likely	  to	  occur	  at	  an	  earlier	  stage	  of	  elongation,	  for	  example	  if	  co-­‐transcriptional	  degradation	  
caused	  elongating	  complexes	  to	  terminate,	  as	  is	  thought	  to	  occur	  at	  active	  genes	  beyond	  the	  
TES.	  However,	   RNAPII-­‐S5p	   at	   a	   number	   of	   genes	   extends	   to	   and	   accumulates	   prior	   to	   the	  
TES,	  in	  contrast	  to	  active	  genes	  (Brookes	  et	  al.,	  2012),	  where	  termination	  in	  mammalian	  cells	  
can	  occur	  up	  to	  1.5kb	  downstream	  (Richard	  and	  Manley,	  2009).	  Accumulation	  of	  RNAPII	  (Fig.	  
4.16)	  and	   transcripts	   (Fig.	  4.15)	  prior	   to	   the	  TES	  could	  be	  due	   to	  defects	  or	   inefficiency	  of	  
termination.	   Cleavage	   and	  polyadenylation	  machinery	   recruitment	   is	   intimately	   associated	  
with	  S2p	  (Neugebauer,	  2002)	  although	  3’	  processing	  factors	  can	  also	  associate	  with	  initiating	  
RNAPII	  (Glover-­‐Cutter	  et	  al.,	  2010).	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Occupancy	  of	  RNAPII-­‐S5p	  at	  PRC-­‐repressed	  genes	  and	  the	  role	  of	  S5p	  in	  recruitment	  of	  the	  
capping	   enzyme	  at	   active	   genes	   suggest	   that	   5’	   capping	  of	   transcripts	   is	   likely	   to	   occur	   at	  
PRC-­‐repressed	  genes,	  unless	  active	  regulatory	  steps	  are	  employed	  to	  inhibit	   it.	   Intriguingly,	  
de-­‐capping	   of	   nascent	   transcripts	   at	   promoters	   has	   been	   shown	   to	   regulate	   transcription	  
elongation	   in	  HeLa	   cells	   (Brannan	  et	   al.,	   2012).	   CAGE	  experiments	  will	   only	   enrich	   capped	  
RNA	  from	  the	  total	  population	  (Takahashi	  et	  al.,	  2012)	  and	  so	  can	  be	  used	  to	  ask	  whether	  
transcripts	   are	   capped.	   Its	   sensitivity	   also	   allows	   analysis	   of	   promoter	   usage	   at	   nucleotide	  
resolution.	  CAGE	   tags	  are	  detected	  at	  PRC-­‐repressed	  genes	   (Figs.	  4.21,	  4.22)	  at	   low	   levels;	  
approximately	  half	  of	  all	  PRC-­‐repressed	  genes	  show	  CAGE	  tag	  density	  to	  levels	  similar	  to	  the	  
lowest	  expressed	  Active	  genes	  (Fig.	  4.22).	  Interestingly,	  whereas	  the	  distribution	  of	  RNAPII-­‐
S5p	   closely	  matches	   the	  detection	  of	   CAGE	   tags	   aligned	   at	   TSS	  of	   active	   genes,	   the	  broad	  
distribution	  of	  S5p	  at	  PRC-­‐repressed	  genes	  is	  slightly	  delocalized	  downstream	  of	  the	  TSS	  (Fig.	  
4.1;	  Brookes	  et	  al	  2012),	  a	  feature	  not	  seen	  at	  the	  detected	  CAGE	  tags	  (Fig.	  4.21).	  Although	  it	  
is	  clear	  that	  low	  level	  capping	  occurs	  at	  PRC-­‐repressed	  genes,	  it	  remains	  unclear	  whether	  the	  
bulk	  of	   the	  RNAPII-­‐S5p	  complexes	  detected	  at	  PRC-­‐repressed	  genes	   in	  a	  wider	  distribution	  
that	   reflects	   CpG	   islands	   produce	   a	   population	   of	   uncapped	   RNAs,	   invisible	   in	   the	   CAGE	  
protocol.	  Whether	  processing	  is	  efficient	  is	  unknown	  and	  more	  detailed	  analysis	  of	  the	  PRC-­‐
repressed	   genes	   that	   demonstrate	   capped	   transcripts	   and	   their	   relationship	   with	   RNAPII	  
modifications	   and	   PRC	   is	   ongoing.	   Populations	   of	   PRC-­‐repressed	   genes	   show	   differing	  
profiles	  of	  transcription	   including	  some	  that	  transcribe	  to	  the	  TES	  and	  some	  that	  are	  more	  
promoter	   enriched,	   but	   do	   still	   elongate	   (Figs.	   4.12.	   4.15).	   	   It	   would	   be	   interesting	   to	  
determine	   whether	   capped	   transcripts	   shared	   common	   features	   of	   transcription	   and	  
whether	  more	  promoter	  enriched	  transcripts	  were	  under	  cap	  processing	  control.	  
	  
Finally,	  with	  CAGE	  datasets	  those	  PRC-­‐transcripts	  that	  are	  detected	  do	  transcribe	  from	  the	  
annotated	  TSS	  with	  little	  deviation,	  even	  though	  PRC-­‐repressed	  gene	  promoters	  are	  CpG	  rich	  
and	   associated	   with	   broad	   promoter	   usage	   (Carninci	   et	   al.,	   2006).	   Regulation	   of	   PRC-­‐
repressed	  genes	  detected	  in	  this	  analysis	  is	  unlikely	  to	  be	  due	  to	  alternative	  promoter	  usage,	  
resulting	   in	   non-­‐coding	   transcript	   production.	   Profiles	   differ	   from	   active	   genes	   that	   show	  
symmetrical	   TSS	   usage	   to	   TSS	   usage	   more	   biased	   towards	   to	   protein-­‐coding	   region,	  
suggesting	  possible	  inhibition	  of	  upstream	  transcription	  in	  the	  presence	  of	  PRC.	  There	  is	  also	  
Chapter	  4	   	  	  	  	  	  	  	  	  	  	  	  Transcription	  at	  Polycomb-­‐repressed	  genes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
154	  
a	  lack	  of	  appreciable	  antisense	  transcription	  at	  PRC-­‐repressed	  genes	  detected	  by	  CAGE	  (Fig.	  
4.21)	  in	  agreement	  with	  RNAPII-­‐S5p	  RNA-­‐ChIP	  (Fig.	  4.9,	  4.20). 
4.3.3 Antisense	  transcription	  is	  absent	  at	  PRC-­‐repressed	  genes	  
Promoter-­‐associated	   antisense	   transcription	   occurs	   across	   species,	   including	   Drosophila,	  
yeast,	  human	  and	  mouse,	  suggesting	   important	  conserved	  regulatory	  roles	   in	  transcription	  
(Core	  et	  al.,	  2008;	  Preker	  et	  al.,	  2008;	  Seila	  et	  al.,	  2008;	  Neil	  et	  al.,	  2009).	  It	  is	  not	  known	  if	  
the	  process	  of	  transcription	  or	  the	  transcript	  itself	  has	  a	  function,	  or	  whether	  its	  effects	  on	  
protein-­‐coding	  gene	  expression	  are	  positive	  or	  negative.	  Interestingly,	  PRC-­‐repressed	  genes	  
do	  not	  show	  antisense	  transcription	  from	  promoters	  (Figs.	  4.9,	  4.20)	  even	  though	  they	  are	  
CpG	   rich,	   and	   present	   H3K4me3	   and	   RNAPII	   binding	   (Brookes	   et	   al.,	   2012),	   all	   of	   which	  
positively	   correlate	   with	   antisense	   transcription	   (Core	   et	   al.,	   2008;	   Seila	   et	   al.,	   2008).	   Bi-­‐
directional	   promoters	   have	   been	   suggested	   to	   be	   a	   reservoir	   of	   primed	   RNAPII	   ready	   for	  
transcription	   and	   keeping	   the	   chromatin	   environment	   accessible.	   If	   this	  was	   the	   case	   it	   is	  
intriguing	  why	  occupancy	  of	  ‘poised’	  RNAPII	  at	  promoters	  of	  PRC-­‐repressed	  genes	  does	  not	  
result	  in	  more	  extensive	  antisense	  transcription.	  Suggestions	  that	  bi-­‐directional	  transcription	  
is	  due	  to	  negative	  supercoiling	  in	  the	  wake	  of	  RNAPII	  elongation	  into	  protein	  coding	  regions	  
of	  highly	  active	  genes	  have	  also	  been	  put	  forward.	  In	  light	  of	  this	  possibility,	  lack	  of	  antisense	  
transcription	  at	  PRC-­‐repressed	  genes	  could	  indirectly	  be	  the	  result	  of	  low	  RNAPII	  processivity	  
due	  to	  excessive	  negative	  supercoiling.	  In	  general,	  antisense	  transcript	  levels	  correlate	  with	  
increasing	  gene	  activity,	  although	  a	  number	  of	  silent	  genes	  have	  antisense	  transcripts	  (Seila	  
et	  al.,	  2008).	   In	  ES	  cells,	  genes	  with	  antisense	  transcripts	  were	  depleted	  for	  binding	  of	  PRC	  
component	   Suz12	   (Seila	   et	   al.,	   2008)	   opening	   up	   the	   possibility	   that	   PRC	   may	   somehow	  
inhibit	  antisense	  transcription.	  	  
4.3.4 Transcription	   elongation	   at	   PRC-­‐repressed	   genes	   in	   the	   presence	   of	   PRC	   and	  
absence	  of	  RNAPII-­‐S2p	  
In	  a	  scenario	  where	  PRC	  mechanisms	  of	  repression	  include	  restraining	  RNAPII	  processivity,	  it	  
would	  be	  intuitive	  to	  think	  that	  higher	  levels	  of	  transcription	  at	  PRC-­‐repressed	  genes	  would	  
be	  accompanied	  by	  lower	  levels	  of	  PRC	  occupancy	  and	  the	  appearance	  of	  low	  levels	  of	  S2p,	  
leading	  to	  detection	  of	   low	  level	  mRNAs.	   In	  contrast,	  we	  find	  that	  PRC-­‐target	  genes	  where	  
transcription	   is	   detected	  at	   higher	   levels	   (which	   can	  be	  as	  high	   as	   some	  active	   genes;	   Fig.	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4.12B),	  RNAPII-­‐S5p	  can	  extend	  to	  the	  TES	  in	  the	  presence	  of	  high	  levels	  of	  PRC	  and	  absence	  
of	  S2p	  (Figs.	  4.13,	  4.14),	   implicating	  co-­‐transcriptional	  RNA	  degradation	  and	  termination	  as	  
likely	  regulatory	  steps	  at	  many	  PRC-­‐repressed	  genes.	  	  
	  
At	   PRC-­‐repressed	   genes	  where	   S5p	   is	   detected	  up	   to	   TES	   (Fig.	   4.16),	   RNA-­‐ChIP	   transcripts	  
mirror	  RNAPII	  occupancy	  but	  are	  not	  detected	  after	  the	  TES	  (Fig.	  4.15),	  suggesting	  regulation	  
of	   termination	   different	   from	   that	   seen	   at	   active	   genes.	   PRC-­‐repressed	   genes	   where	   S5p	  
does	  not	  reach	  the	  TES	  (Fig.	  4.16)	  still	  elongate	  into	  coding	  regions	  although	  transcription	  is	  
detected	   at	   higher	   levels	   at	   promoter	   regions	   (Fig.	   4.15).	   Further	   analyses	   of	   these	   two	  
groups	   of	   genes	   may	   help	   understand	   whether	   there	   are	   different	   mechanisms	   of	   PRC	  
repression	  that	  act	  downstream	  of	  transcript	  initiation.	  Preventing	  RNAPII-­‐S5p	  reaching	  the	  
3’	   end,	   or	   by	   promoting	   efficient	   termination	   prior	   to	   TES,	   could	   possibly	   uncouple	  
termination	   from	   polyadenylation,	   which	   is	   thought	   to	   occur	   dependently	   of	   RNAPII	  
complexes	   that	   continue	   to	   transcribe	  downstream	  of	   the	  TES.	   In	  Drosophila,	   inhibition	  of	  
PTEFb	   (S2p	   kinase)	   activity	   does	   not	   prevent	   RNAPII	   elongation	   but	   causes	   3’	   processing	  
defects	  at	  heat	  shock	  genes	  where	  transcripts	  remain	  tethered	  to	  the	  chromatin	  template	  as	  
a	   result	   of	   cleavage	   inhibition	   (Ni	   et	   al.,	   2004).	   Although	   S2p	   is	   not	   detectable	   at	   PRC-­‐
repressed	   genes,	   PTEFb	   component	   CDK9	   is	   recruited	   to	   these	   genes	   (J.K	   Stock,	   personal	  
communication).	   At	   genes	   where	   S5p	   reaches	   the	   TES	   it	   could	   be	   envisaged	   that	  
accumulation	  of	  transcripts	  may	  be	  the	  result	  of	  a	  defect	  in	  3’	  processing	  due	  to	  absence	  of	  
S2p	   (and	   H3K36me3)	   resulting	   in	   transcripts	   that	   cannot	   be	   cleaved	   (Fig.	   4.25A).	   Those	  
where	   S5p	   does	   not	   elongate	   to	   the	   TES	   accumulate	   transcripts	   earlier	   in	   elongation	   and	  
may	  be	  under	  other	   regulatory	   restraints	  such	  as	  capping	  or	  splicing	   inhibition	   (Fig	  4.25B).	  
Capping	   is	   intimately	   associated	   with	   elongation	   and	   splicing	   so	   defects	   in	   capping	   may	  
prevent	   efficient	   	   RNAPII	   transcription	   elongation	   (Görnemann	   et	   al.,	   2005).	   Interestingly,	  
when	   S5p	   reaches	   the	   TES,	   the	   extent	   of	   mRNA	   de-­‐repression	   is	   greater	   after	   Ring1B	  
knockout	   compared	   to	   genes	   where	   S5p	   is	   more	   proximal	   to	   promoters	   suggesting	   the	  
presence	  of	  Polycomb	  through	  coding	  regions	  is	  essential	  to	  silence	  RNAPII	  complexes	  that	  
are	  able	  to	  extend	  further	  into	  coding	  regions	  (Brookes	  et	  al.,	  2012).	  Detection	  of	  low	  level	  
polyadenylated	   transcripts	   from	   three	  PRC-­‐repressed	  genes	   (Chapter	  5,	   Fig.	  5.12)	   suggests	  
that	   polyadenylation	   can	   occur	   in	   some	   instances	   although	   from	   average	   profiles	   of	  
transcription	  that	  do	  not	  extend	  past	  the	  TES	  this	  seems	  unlikely	  to	  be	  efficient.	  	  




Figure	   4.25	   Dissecting	   possible	   RNA-­‐processing	   defects	   from	   differing	   transcript	   profiles	   at	   PRC-­‐repressed	  
genes.	  Where	  RNAPII	   and	   transcripts	   are	  detected	   throughout	   coding	   regions	  and	  accumulating	  prior	   to	   the	  
TES	   (RNAPII-­‐S5pEnd+),	   it	   could	   be	   envisaged	   that	   cleavage	   and	   termination	   are	   disrupting	   in	   the	   absence	  of	  
S2p.	  (B)	  PRC-­‐repressed	  genes	  where	  RNAPII	  and	  transcripts	  are	  more	  confined	  to	  the	  TSS	  (RNAPII-­‐S5pEnd-­‐)	  may	  
undergo	  regulation	  such	  as	  cap	  inhibition	  that	  prevents	  efficient	  elongation.	  
 
4.3.5 Ring1B	   knockout	   results	   in	   de-­‐repression	   of	   PRC-­‐repressed	   genes	   at	   the	  
transcriptional	  level	  
RNAPII	  at	  PRC-­‐repressed	  genes	   is	   restrained	  by	  H2Aub1	  of	  Ring1B,	  and	   removal	  of	  Ring1A	  
and	   Ring1B	   results	   in	   de-­‐repression	   (Stock	   et	   al.,	   2007;	   Endoh	   et	   al.,	   2012).	   Upon	   Ring1B	  
knockout,	  de-­‐repression	  is	  detected	  at	  the	  level	  of	  RNAPII	  transcription	  of	  the	  DNA	  template	  
(Fig.	  4.19,	  4.20)	  suggesting	  PRC	  function	  primarily	   to	  regulate	  RNAPII	   transcription	  and	  not	  
through	  RNA	   stability.	   The	   profile	   of	   transcripts	   detected	   after	   Ring1A	   and	  Ring1B	   double	  
knockout	   (Fig.	   4.20)	   is	   reminiscent	   of	   that	   seen	   at	   active	   genes	   genome-­‐wide	   with	  
appearance	  of	  promoter	  associated	  antisense	   transcription	  and	   transcripts	  downstream	  of	  
the	  TES,	   suggestive	  of	  efficient	   termination.	  However,	  detection	  of	  S2p	   is	  not	  enhanced	  at	  
Polycomb	   targets	   after	   PRC1	   loss	   (Stock	   et	   al.,	   2007),	   to	   which	   RNA	   cleavage	   and	  
polyadenylation	  factors	  are	  recruited	  (Neugebauer,	  2002).	  Elongation	  associated	  H3K36me3	  
is	   also	   minimally	   detected	   (E.	   Brookes	   personal	   communication)	   suggesting	   that	  
transcription	   elongation	   can	   occur	   without	   detectable	   S2p	   and	   H3K36me3.	   In	   some	  
instances	  cleavage	  and	  polyadenylation	  can	  occur	  in	  the	  absence	  of	  S2p,	  for	  example,	  after	  
induction	   of	   p21	   (Gomes	   et	   al.,	   2006).	   In	   contrast,	   at	   heat	   shock	   genes,	   absence	   of	   S2p	  
results	   in	   RNAPII	   elongation	   with	   3’	   processing	   defects	   (Ni	   et	   al.,	   2004).	   Other	   CTD	  
modifications	  are	  affected	  after	  Ring1B	  knockout	  including	  S7p	  which	  increases	  (E.	  Brookes	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personal	   communication)	   and	   is	   known	   to	   enhance	   PTEFb	   activity.	   Additional	   CTD	  
modifications	  may	  also	  be	  affected	  with	  known	  roles	  in	  elongation	  and	  3’	  processing	  such	  as	  
T4p	  and	  Y1p	  (Hintermair	  et	  al.,	  2012;	  Mayer	  et	  al.,	  2012)	  that	  may	  result	  in	  the	  patterns	  of	  
transcription	  reminicient	  of	  active	  genes	  that	  are	  detected	  upon	  PRC1	  removal,	  although	  this	  
has	  not	  been	  tested.	  
	  
Loss	   of	   the	   PRC1	   mark,	   H2Aub1,	   does	   not	   result	   in	   loss	   of	   PRC2	   protein	   Ezh2	   and	   its	  
associated	   histone	  modification,	   H3K27me3	   (Stock	   et	   al.,	   2007),	   yet	   transcription	   profiles	  
appear	   identical	   to	   active	   genes	   suggesting	   mechanisms	   of	   repression	   occur	   other	   than	  
chromatin	  compaction.	  PRC2	  knockouts	   (Eed-­‐/-­‐,	  Suz12-­‐/-­‐)	  also	  show	  gene	  de-­‐repression	  at	  
the	  level	  of	  expression	  (Azuara	  et	  al.,	  2006)	  although	  effects	  on	  transcription	  are	  not	  known.	  
This	  suggests	  that	  PRC	  complexes	  may	  show	  redundancy	  or	  co-­‐regulation	  that	  requires	  both	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5 The	  role	  of	  RNA	  degradation	  at	  PRC-­‐repressed	  genes	  
5.1 Introduction	  
ES	   cell	   chromatin	   is	   globally	   decondensed,	   enriched	   for	   active	   histone	   modifications	   and	  
thought	  to	  be	  transcriptionally	  hyperactive	  (Meshorer	  and	  Misteli,	  2006;	  Efroni	  et	  al.,	  2008).	  
Maintenance	   of	   ES	   cell	   pluripotency	   while	   remaining	   primed	   for	   differentiation	   requires	  
complex	   gene	   regulation.	   Transcriptional	   regulation	  occurs	   at	  many	   levels	   and	  one	   critical	  
mechanism	   is	   the	   degradation	   of	   unwanted	   or	   improperly	   processed	   RNA,	   co-­‐	   and	   post-­‐
transcriptionally.	   Vital	   exonucleases	   that	   perform	   this	   task	   include	   Xrn2	   and	   the	   exosome	  
complex.	  	  
	  
Xrn2	   is	   a	   well	   known	   nuclear	   5’	   to	   3’	   exonuclease	   involved	   in	   RNAPII	   transcription	  
termination	  in	  yeast	  and	  mammals	  (Kim	  et	  al.,	  2004;	  West	  et	  al.,	  2004;	  Gromak	  et	  al.,	  2006).	  
According	  to	  the	  torpedo	  model,	  uncapped	  RNA	  produced	  after	  cleavage	  at	  the	  termination	  
site	  prior	  to	  polyadenylation	  is	  bound	  by	  Xrn2.	  As	  the	  polymerase	  continues	  to	  elongate	  past	  
the	  termination	  site,	  Xrn2	  exonuclease	  activity	  degrades	  the	  nascent	  RNA,	  until	  it	  meets	  the	  
RNAPII	  promoting	   its	  destabilization.	  More	   recently,	  Xrn2	  has	  been	  shown	  to	  be	  a	  general	  
co-­‐transcriptional	   RNA	   surveillance	   mechanism	   controlling	   transcription	   elongation	   in	  
mammals	  (Brannan	  et	  al.,	  2012;	  Davidson	  et	  al.,	  2012).	  	  
	  
The	  exosome	   is	   a	  highly	   conserved	   complex	  which	   is	   active	   in	   the	  nucleus	  and	   cytoplasm,	  
with	   3’	   to	   5’	   exo-­‐	   and	   endonuclease	   activity.	   Mammalian	   exosome	   consists	   of	   eleven	  
subunits	  (Fig.	  5.1),	  nine	  of	  which	  form	  a	  structural	  core	  (Exosc1-­‐9),	  through	  which	  the	  RNA	  
travels	   (Malet	   and	   Lorentzen,	   2011),	   while	   the	   remaining	   two	   (Exosc10	   and	   Dis3)	   have	  
catalytic	  activity.	  The	  exosome	  is	  involved	  in	  general	  RNA	  surveillance	  preventing	  expression	  
of	   inappropriate	   transcripts	   (Tomecki	   et	   al.,	   2010;	   Kiss	   and	   Andrulis,	   2011),	   but	   has	   been	  
revealed	  as	  crucial	  for	  specific	  functions	  including	  heterochromatic	  gene	  silencing	  (Vasiljeva	  
et	  al.,	  2008)	  and	  regulation	  of	  antisense	  transcription	  from	  active	  human	  promoters	  (Preker	  
et	  al.,	  2008).	  In	  Drosophila	  and	  human	  cells,	  the	  exosome	  has	  been	  shown	  to	  be	  recruited	  to	  
chromatin	   at	   the	   site	   of	   RNAPII	   transcription	   suggesting	   a	   direct	   role	   in	   co-­‐transcriptional	  
regulation	   (Andrulis	  et	  al.,	  2002;	  de	  Almeida	  et	  al.,	  2010).	   In	  ES	  cells,	   its	   role	  has	  not	  been	  
explored.	  






Figure	  5.1	  Structure	  of	  the	  eukaryotic	  exosome.	  The	  exosome	  consists	  of	  9	  core	  subunits	  devoid	  of	  catalytic	  
activity	   that	   form	   a	   core	   ring	   structure	   (Exosc1-­‐9).	   Two	   exonucleases,	   Dis3	   and	   Exosc10	   associate	   and	   are	  
responsible	  for	  degradation	  of	  RNA,	  as	  it	  passes	  through	  the	  ring	  structure.	  Dis3	  also	  has	  endonuclease	  activity.	  
	  
5.1.1 Aims	  
I	  set	  out	  to	  explore	  whether	  RNA	  degradation	  is	  a	  mechanism	  of	  regulation	  occurring	  at	  PRC-­‐
repressed	  genes	  in	  ES	  cells,	  maintaining	  gene	  silencing	  in	  the	  presence	  of	  abundant	  RNAPII-­‐
S5p.	  I	  used	  a	  siRNA	  knockdown	  strategy	  to	  test	  whether	  candidate	  proteins	  play	  a	  role	  in	  the	  
repression	  of	  a	  small	  cohort	  of	  PRC-­‐target	  genes.	  Promising	  siRNAs	  were	  further	  analysed	  by	  
genome-­‐wide	   microarray	   expression	   studies,	   with	   an	   interest	   in	   studying	   effects	   at	   PRC-­‐
target	  genes.	  I	  also	  analysed	  whether	  the	  exosome	  is	  recruited	  PRC-­‐repressed	  genes	  by	  DNA-­‐
ChIP	  to	  understand	  whether	  it	  plays	  a	  role	  in	  RNA	  surveillance	  at	  the	  level	  of	  chromatin	  in	  ES	  
cells.	  
 




5.2.1 Expression	  of	  exosome	  components	  decreases	  during	  differentiation	  
I	  started	  by	  testing	  whether	  the	  expression	  of	  Xrn2	  and	  Exosome	  proteins	  change	  during	  ES	  
differentiation	   using	   published	   expression	   microarray	   datasets	   (Shen	   et	   al.,	   2009);	  
bioinformatics	   analyses	   were	   kindly	   performed	   by	   Tom	   Carroll	   (MRC-­‐CSC).	   The	   mRNA	  
expression	   levels	  are	  strikingly	  decreased	  upon	  LIF	  removal	   from	  ES	  cell	  culture	  for	  several	  
components	   of	   the	   exosome	   complex	   (Fig.	   5.2),	   whereas	   Xrn2	   remains	   unaltered.	   	   This	  
intriguing	  finding	  suggests	  that	  the	  exosome	  may	  be	  particularly	   important	  for	  maintaining	  
pluripotency	  by	  regulating	  transcription.	  
 
	  
Figure	   5.2	   Expression	   of	   exosome,	   but	   not	   Xrn2,	   changes	   through	   ES	   cell	   differentiation.	   Analysis	   of	  
microarray	  expression	  data	  for	  ES	  cell	  differentiation	  after	  LIF	  withdrawal	  (Shen	  et	  al.,	  2009)	  focusing	  on	  two	  
well	   known	   exonuclease	   complexes,	   Xrn2	   and	   the	   exosome	   complex	   (Exosc2,	   4,	   5,	   7-­‐9).	   Red/green	   colors	  
represent	  expression	  changes	  relative	  to	  the	  mean	  across	  the	  gene	  group	  represented.	  Exosome	  expression	  is	  
downregulated	  during	  ES	  differentiation.	  Xrn2	  expression	  does	  not	  change	  throughout	  differentiation.	  
 
5.2.2 Strategy	  to	  study	  the	  effect	  of	  exosome	  on	  PRC-­‐repressed	  transcription	  
In	  order	  to	  study	  a	  role	  of	  RNA	  degradation	  in	  the	  mechanisms	  of	  PRC	  repression	  in	  ES	  cells,	  I	  
knocked	  down	  exosome	  subunits	  and	  Xrn2	  in	  mouse	  ES-­‐OS25	  cells	  using	  commercial	  siRNAs	  
(Fig.	   5.3).	   The	   extent	   of	   knockdown	   was	   validated	   by	   measuring	   expression	   levels	   by	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quantitative	  RT-­‐PCR	  and,	  when	  available,	  using	  specific	  antibodies	  by	  western	  blotting.	  The	  
effects	  of	  siRNA	  knockdown	  were	  assessed	  at	  the	  transcript	  level	  at	  a	  panel	  active,	  silent	  and	  
PRC-­‐repressed	  genes	  after	   total	  RNA	  amplification	  with	  random	  primers,	  and	  measured	  by	  
RT-­‐PCR.	  For	  promising	  protein	  candidates,	  I	  then	  sought	  to	  study	  the	  effect	  of	  the	  protein’s	  
knockdown	  on	  ES	  cell	  transcription	  genome-­‐wide	  by	  microarrays	  and	  CAGE	  analyses.	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Figure	  5.3	  Strategy	  to	  identify	  the	  role	  of	  exonuclease	  proteins	  in	  PRC-­‐repressed	  gene	  regulation.	  ES	  cells	  are	  
targeted	   with	   siRNAs	   against	   proteins	   of	   interest	   and	   knockdown	   success	   assessed	   at	   the	   RNA	   and	   protein	  
level.	  After	  knockdown,	  transcript	  levels	  of	  active,	  PRC-­‐repressed	  and	  silent	  genes	  are	  analysed	  by	  RT-­‐PCR	  at	  a	  
panel	  of	  PRC-­‐repressed	  genes.	  If	  knockdown	  results	  in	  interesting	  changes	  in	  transcript	  levels	  of	  PRC-­‐repressed	  
genes,	  changes	  in	  gene	  expression	  were	  then	  performed	  genome-­‐wide	  by	  microarray	  and	  CAGE	  analyses.	  
	  
Commercial	   siRNAs	   were	   chosen	   to	   target	   Xrn2	   and	   specific	   subunits	   of	   the	   exosome	   as	  
summarized	  in	  Table	  5.1.	  I	  started	  by	  knocking	  down	  two	  structural	  subunits	  of	  the	  exosome	  
(Exosc3	  and	  5;	  Fig.	  5.1)	  that	  have	  been	  successfully	  targeted	  to	  study	  antisense	  transcription	  
from	  active	  promoters	  in	  HeLa	  cells	  (Preker	  et	  al.,	  2008).	  I	  subsequently	  went	  on	  to	  further	  
this	  analysis	  by	   targeting	   the	  catalytic	  components	  of	   the	  exosome,	  Dis3	  and	  Exosc10	   (Fig.	  
5.1).	  Association	  of	  these	  subunits	  with	  the	  exosome	  core	  complex	  is	   less	  well	  defined	  and	  
there	   are	   suggestions	   they	   can	   act	   independently	   (Kiss	   and	   Andrulis,	   2011).	   Studies	   that	  
knockout	   different	   subunits	   of	   the	   exosome	   can	   show	   varying	   results	   in	   different	   systems	  
(Kiss	   and	   Andrulis,	   2011).	   With	   this	   in	   mind,	   by	   targeting	   multiple	   subunits	   within	   the	  
exosome,	   I	   aimed	   to	   uncover	   possible	   roles	   in	   regulation	   of	   PRC-­‐repressed	   gene	  
transcription.	  	  	  	  
	  
Table	  5.1	  Proteins	  targeted	  by	  siRNA	  knockdown	  in	  ES	  cells	  
Candidate	  protein	   Role	  in	  complex	   Cellular	  Function	  
Xrn2	   -­‐	   Transcription	  termination,	  nuclear	  RNA	  regulation	  
Exosc3	   Structural	  core	  
Exosome	  complex,	  nuclear	  and	  cytoplasmic	  RNA	  regulation	  Exosc5	   Structural	  core	  
Exosc10	   Exoribonuclease	  
Dis3	   Exoribonuclease	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5.2.3 Xrn2	  depletion	  does	  not	  affect	  PRC-­‐repressed	  gene	  transcription	  
To	  investigate	  a	  possible	  role	  for	  Xrn2	  in	  regulation	  of	  gene	  expression	  in	  ES	  cells,	  I	  used	  two	  
independent	  siRNA	  sequences	  to	  target	  Xrn2	  transcripts	  in	  ES-­‐OS25	  cells.	  Cells	  were	  treated	  
for	  48	  and	  72	  h	  with	  each	  siRNA	  before	  analysis	  of	  total	  RNA	  and	  protein	  (Fig.	  5.4).	  Controls	  
included	  ES-­‐OS25	  cells	  grown	  in	  normal	  media	  conditions	  as	  well	  as	  cells	  treated	  with	  a	  non-­‐
specific	  siRNA	  conjugated	  to	  GFP	  (scrambled	  siRNA).	  The	  scrambled	  siRNA	  was	  used	  to	  track	  
incorporation	  of	  siRNA	  into	  cells	  and	  to	  monitor	  non-­‐specific	  effects	  of	  transfection	  on	  RNA	  
expression.	   Cells	  were	  monitored	   by	   fluorescence	  microscopy	   to	   confirm	   incorporation	   of	  
siRNA	   into	   rapidly	   dividing	   ES	   cells	   that	   form	   dense	   colonies	   (not	   shown)	   before	   further	  
analysis.	   Efficient	   transfection	   of	   ES	   cells	   is	   performed	   in	   cell	   suspension	   prior	   to	   plating	  
ensuring	   targeting	   of	   the	   vast	   majority	   of	   cells	   (Methods,	   2.12).	   This	   is	   opposed	   to	  
transfecting	   plated	   ES	   cells	   that	   form	   large	   dense	   colonies,	   and	   would	   result	   in	   the	  
transfection	  of	  only	  peripherally	  located	  cells.	  	  
	  
RNA	   validation	   of	   Xrn2	   knockdown	   shows	   that	   spliced	   transcripts	   are	   depleted	   over	   50%	  
with	  both	  siRNA	  sequences	  (1	  and	  2)	  at	  48	  h,	  while	  there	  is	  no	  change	  in	  cells	  treated	  with	  
the	   scrambled	   non-­‐specific	   siRNA	   (Fig.	   5.4A).	   Depletion	   is	   still	   apparent	   at	   72	   h,	   although	  
levels	   of	   spliced	  RNA	  are	   slightly	   higher	   showing	   a	   less	   effective	   knockdown.	  Xrn2	  protein	  
levels	  are	  also	  depleted	  by	  48	  h	  compared	   to	   the	  untreated	  sample,	  and	  no	  effect	   is	   seen	  
using	   the	   scrambled	   siRNA	   (Fig.	   5.4B).	   The	   Xrn2	   antibody	   detects	   three	   separate	   bands,	  
which	  may	  be	  due	  to	  non-­‐specific	  detection	  by	  the	  antibody	  or	  variants	  of	  Xrn2	  protein.	  The	  
band	   depicting	   the	   full-­‐length	   annotated	   protein	   is	   at	   109kDa	   although	   all	   three	   bands	  






















































































































































Figure	  5.4	  Xrn2	  siRNA	  knockdown	  in	  ES	  cells	  results	   in	  depletion	  of	  Xrn2	  RNA	  and	  protein.	  (A)	  Extraction	  of	  
total	  RNA	  after	  siRNA	  treatment	  with	  two	  separate	  siRNAs	  against	  Xrn2	  (1	  and	  2)	  and	  a	  scrambled	  siRNA,	  was	  
followed	  by	  analysis	  of	  spliced	  Xrn2	  RNA	  levels	  by	  qRT-­‐PCR	  using	  exon-­‐exon	  primers.	  Treatment	  were	  carried	  
out	  for	  48	  and	  72	  h.	  RNA	  levels	  were	  normalised	  to	  three	  housekeeping	  genes	  (βactin,	  UBC,	  G6PD),	  that	  remain	  
unchanged	  during	  siRNA	  treatment,	  and	  normalised	  to	  levels	  of	  Xrn2	  in	  untreated	  ES	  cells.	  Both	  siRNAs	  deplete	  
Xrn2	  RNA	  levels	  over	  50%	  by	  48	  h.	  By	  72	  h,	  Xrn2	  RNA	  is	  depleted	  although	  less	  than	  at	  48	  h.	  Mean	  and	  SD	  were	  
calculated	  from	  2	  independent	  experiments.	  (B)	  Protein	  levels	  of	  Xrn2	  after	  siRNA	  treatment	  were	  determined	  
by	  western	  blot	  of	  a	  48h	  whole	  cell	  extract.	  Extracts	   from	  untreated	  ES	  cells	  were	   loaded	   in	  a	   serial	  dilution	  
(1:2).	  PCNA	  used	  as	  a	  loading	  control.	  Xrn2	  protein	  levels	  are	  depleted	  by	  approximately	  50%	  with	  both	  siRNAs.	  
Multiple	   bands	   detected	   with	   the	   Xrn2	   antibody	   are	   either	   splice	   variants	   or	   may	   be	   due	   to	   non-­‐specific	  
binding.	  
	  
Xrn2	  RNA	  and	  protein	  levels	  are	  substantially	  reduced	  in	  the	  siRNA	  knockdown,	  although	  not	  
completely	  depleted.	  To	  investigate	  any	  effects	  of	  Xrn2	  depletion	  on	  the	  extent	  of	  Polycomb	  
repression	   in	   ES	   cells,	   I	   measured	   the	   levels	   of	   transcripts	   from	   a	   panel	   of	   active,	   PRC-­‐
repressed	   and	   silent	   genes	   by	   quantitative	   RT-­‐PCR	   (Fig.	   5.5).	   Using	   primers	   that	   detect	  
spliced	  transcripts	  from	  active	  pluripotency	  genes,	  Nanog,	  Oct4	  and	  Sox2	  (Fig.	  5.5;	  left	  panel)	  
showed	  no	  effect	  of	  the	  Xrn2	  knockdown	  after	  48	  or	  72	  h,	  suggesting	  that	  Xrn2	  may	  not	  play	  
a	   significant	   role	   in	   regulating	  pluripotency	   genes;	   however,	   Xrn2	  depletion	  may	  not	  have	  
been	  sufficient	  to	  detect	  an	  effect.	  RNA	  levels	  measured	  using	  primers	  that	  amplify	  exonic	  5’	  
RNA	  to	  capture	  the	  whole	  population	  of	  transcripts	  from	  active	  genes	  βactin	  and	  Oct4	  and	  a	  
panel	  of	  six	  PRC-­‐repressed	  genes	  also	  showed	  no	  clear	  effect	  upon	  Xrn2	  knockdown	  at	  48	  or	  
72	  h,	  suggesting	  that	  Xrn2	  does	  not	  regulate	  transcription	  from	  this	  panel	  of	  PRC-­‐repressed	  
genes.	  However,	  the	  lack	  of	  detectable	  effect	  may	  be	  due	  to	  the	  incomplete	  knockdown	  of	  
Xrn2	  (Fig.	  5.4)	  so	  that	  Xrn2	  levels	  after	  knockdown	  are	  still	  sufficient	  to	  maintain	  correct	  and	  
stable	   function	  within	   the	   cell.	  More	   extensive	   optimisation	   of	   knockdown	   and	   analysis	   is	  
required	  to	  fully	  demonstrate	  the	  lack	  of	  effect	  of	  Xrn2	  on	  transcriptional	  regulation	  at	  PRC-­‐
repressed	  genes.	  	  	  	  

































































































































































Figure	  5.5	  Xrn2	  depletion	  has	  no	  effect	  on	  PRC-­‐repressed	  gene	   transcription	  at	   single	  genes.	  ES-­‐OS25	   total	  
RNA	  was	  extracted	  from	  untreated,	  scrambled	  siRNA	  and	  two	  Xrn2	  siRNA	  (1	  and	  2)	  treated	  cells	  at	  48	  and	  72	  h	  
time	  points.	  Samples	  were	  converted	  to	  cDNA	  using	  random	  primers	  and	  analysed	  by	  RT-­‐PCR	  at	  single	  genes.	  
Primers	  at	  the	  5’	  end	  of	  the	  gene	  were	  used	  to	  detect	  total	  RNA	  independent	  of	  splicing	  for	  all	  genes	  except	  
pluripotency	   markers	  Oct4,	   Nanog	   and	   Sox2	   (left	   panel)	   where	   spliced	   primers	   across	   exon	   junctions	   were	  
used.	   	  Knockdown	  of	  Xrn2	  was	  verified	  prior	   to	  analysis.	  A	  panel	  of	  PRC-­‐repressed	  transcripts	  were	  analysed	  
alongside	   active	   genes	   (βactin,	   Oct4)	   and	   silent	   gene	   (Myf5).	   RNA	   levels	   were	   normalised	   to	   3	   individual	  
housekeeping	  genes	  (βactin,	  UBC,	  G6PD),	  that	  remain	  unchanged	  during	  siRNA	  treatment,	  and	  normalised	  to	  
levels	  of	  Xrn2	   in	  untreated	  ES	  cells	   (Untreated;	  =1).	  There	   is	  no	  effect	  on	   levels	  of	  pluripotency	  genes	   (Oct4,	  
Nanog	  and	  Sox2)	  or	  5’	  transcripts	  for	  active,	  PRC-­‐repressed	  or	  silent	  genes	  upon	  Xrn2	  siRNA	  treatment	  at	  48	  or	  
72	  h.	  Mean	  and	  SD	  are	  from	  2	  independent	  experiments.	  ND	  is	  not	  detected	  where	  no	  RNA	  was	  present.	  
 
5.2.4 Knockdown	  of	  four	  separate	  exosome	  subunits	  
To	   test	   whether	   the	   exosome	   may	   prevent	   aberrant	   expression	   of	   PRC-­‐repressed	  
developmental	   genes,	   I	   began	   by	   using	   siRNA	   against	   two	   structural	   subunits	   Exosc3	   and	  
Exosc5,	  followed	  later	  by	  targeting	  of	  two	  catalytic	  exonuclease	  subunits,	  Dis3	  and	  Exosc10.	  I	  
first	  validated	  the	  efficiency	  of	  knockdown	  of	  the	  four	  subunits	  by	  analysing	  RNA	  expression	  
from	  total	  RNA	  extractions	  after	  knockdown	  at	  48	  and	  72	  h,	  using	  primers	  that	  detect	  spliced	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transcripts	  (Fig.	  5.6).	  Exosc3	  spliced	  RNA	  levels	  are	  depleted	  by	  >70%	  at	  48	  h	  with	  the	  Exosc3	  
siRNA,	  while	  at	  72	  h	  knockdown	  is	  around	  50%	  (Fig.	  5.6A).	  Exosc5	  siRNA	  does	  not	  have	  any	  
effect	   on	   levels	   of	  Exosc3	   RNA	   at	   any	   time	   point	   showing	   that	   knockdown	   is	   specific	   and	  
depletion	   of	   one	   exosome	   subunit	   does	   not	   lead	   to	   reduced	   expression	   of	   another.	   In	  
accordance,	  knockdown	  with	  Exosc5	  siRNA	  results	   in	  dramatically	   reduced	   levels	  of	  Exosc5	  
spliced	  transcripts	  (Fig.	  5.6B)	  at	  48	  and	  72	  h	  by	  >70%.	  There	  is	  no	  effect	  on	  Exosc5	  RNA	  when	  
Exosc3	  siRNA	  is	  used.	  
	  
Exosc10	   is	   successfully	  depleted	  with	  both	  siRNA	  at	  48	  and	  72	  h,	  while	  at	  48	  h	  one	  of	   the	  
siRNAs	  for	  Exosc10	  (1)	  shows	  a	  better	  knockdown	  than	  the	  other	  (2;	  Fig.	  5.6C).	  Spliced	  Dis3	  
transcripts	  are	  also	  depleted	  >50%	  at	  72	  h	  with	  two	  independent	  siRNAs,	  while	  at	  48	  h	  only	  
Dis3	  (1)	  depletes	  transcript	   levels.	  These	  analyses	  show	  that	  all	   four	  Exosc	  subunits	  can	  be	  
substantially	   depleted	   at	   the	   level	   of	   RNA	  expression.	   Structural	   subunits	   (Exosc3,	   Exosc5)	  
are	  more	  efficiently	  depleted	  at	  48	  h	  while	  the	  catalytic	  subunits	  show	  increased	  knockdown	  






















































































































Figure	   5.6	   Knockdown	   of	   four	   separate	   exosome	   subunits	   by	   siRNA.	   Extraction	   of	   total	   RNA	   after	   siRNA	  
treatment	  with	  was	   followed	  by	   analysis	   of	   spliced	   transcript	   levels	   by	   RT-­‐PCR	  using	   exon-­‐exon	   primers.	   (A)	  
Exosc3	   and	   (B)	   Exosc5	   were	   targeted	   with	   one	   siRNA	   each	   and	   both	   subunits	   monitored	   by	   RT-­‐PCR	   to	  
determine	  knockdown	  efficiency	  and	  any	  potential	  off-­‐target	  effects.	   (C)	  Exosc10	  and	  (D)	  Dis3	  were	  targeted	  
with	  two	  separate	  siRNA.	  Treatment	  with	  siRNA	  including	  a	  non-­‐specific	  siRNA	  (scrambled)	  was	  carried	  out	  for	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48	  and	  72	  h.	  RNA	  levels	  were	  normalised	  to	  3	  individual	  housekeeping	  genes	  (βactin,	  UBC,	  G6PD),	  that	  remain	  
unchanged	  during	  siRNA	  treatment.	  Results	  were	  normalised	  to	  levels	  of	  each	  exosome	  subunit	  in	  untreated	  ES	  
cells.	  All	  siRNAs	  deplete	  their	  respective	  exosome	  subunits	  over	  50%	  at	  48	  h.	  By	  72	  h	  depletion	  is	  maintained	  
although	  to	  a	  lesser	  extent	  for	  Exosc3.	  (A,	  B)	  Mean	  and	  SD	  were	  calculated	  from	  3	  independent	  experiments	  for	  
Exosc3	  and	  Exosc5.	  (C,	  D)	  A	  single	  replicate	  was	  performed	  for	  Exosc10	  and	  Dis3	  siRNA.	  
	  
Protein	   levels	   of	   three	   of	   the	   exosome	   subunits	   (Exosc3,	   5	   and	   10)	   are	   also	   substantially	  
depleted	   after	   knockdown	   with	   specific	   siRNAs,	   without	   detectable	   effect	   in	   the	   control	  
samples	  of	  untreated	  ES	  cells	  or	  treatment	  with	  scrambled	  siRNA	  (Fig.	  5.7).	  Dis3	  protein	  was	  
not	  tested	  due	  to	  lack	  of	  any	  available	  commercial	  antibodies	  at	  the	  time.	  Exosc5	  protein	  is	  
substantially	   reduced	   at	   48	  h	   of	   treatment	  with	   Exosc5	   siRNA	   compared	   to	   the	  untreated	  
sample	  or	  treatment	  with	  Exosc3	  siRNA	  (Fig.	  5.7A).	  However,	  levels	  of	  Exosc5	  protein	  appear	  
to	  be	  slightly	  reduced	  after	  72	  h	  treatment	  with	  Exosc3	  and	  Exosc5	  siRNAs,	  suggesting	  that	  
removal	  of	  one	  subunit	  over	  a	  prolonged	  period	  may	  destabilize	  the	  exosome	  complex	  and	  
result	   in	  proteosome	  degradation	  of	  other	   subunits.	  The	  effect	  of	  Exosc3	  siRNA	  on	  Exosc5	  
protein	   is	   unlikely	   to	   result	   from	   off	   target	   effects	   of	   the	   Exosc3	   siRNA,	   as	   there	   was	   no	  
detectable	   effect	   at	   the	  RNA	   level	   (Fig.	   5.6B).	   Exosc3	  protein	   levels	   are	   reduced	  after	   48h	  
siRNA	   treatment	   with	   both	   Exosc3	   and	   Exosc5	   siRNAs	   (Fig.	   5.7B).	   Again	   this	   is	   not	  
recapitulated	   at	   the	  RNA	   level	   (Fig.	   5.6A)	   suggesting	   the	   structure	  of	   the	   exosome	   core	   is	  
affected	  after	  disruption	  of	  one	  subunit	  possibly	  resulting	  in	  degradation	  of	  others.	  Exosc10	  
protein	  levels	  are	  depleted	  using	  both	  Exosc10	  siRNAs	  at	  48	  and	  72	  h	  time	  points	  (Fig.	  5.7C);	  
the	  effects	  of	  the	  Exosc3	  and	  5	  siRNAs	  on	  Exosc10	  protein	  were	  not	  tested.	  
 




































































































































































































































































































Figure	  5.7	  Protein	  levels	  after	  exosome	  knockdown	  by	  siRNA.	  Protein	  levels	  of	  Exosome	  subunits	  Exosc5	  (A),	  
Exosc3	   (B)	   and	   Exosc10	   (C)	   after	   siRNA	   treatment	   were	   determined	   by	   western	   blot	   at	   48	   h	   (all)	   and	   72	   h	  
(Exosc5	  and	  Exosc10)	  using	  ES	  whole	  cell	  extracts.	  Equal	  amounts	  of	  protein	  were	  loaded	  and	  PCNA	  used	  as	  a	  
loading	  control.	  All	  three	  subunits	  are	  depleted	  after	  treatment	  with	  their	  respective	  siRNA.	  	  
 
5.2.5 De-­‐repression	   at	   a	   panel	   of	   PRC-­‐repressed	   genes	   upon	   Exosc3	   and	   Exosc5	  
knockdown	  by	  siRNAs	  
Efficient	  knockdown	  of	  exosome	  proteins	  allowed	  further	  analysis	  of	  the	  effect	  the	  complex	  
may	  play	  on	  PRC-­‐repressed	  gene	  transcription.	  I	  began	  by	  analysing	  transcription	  effects	   in	  
the	   Exosc3	   and	   Exosc5	   knockdowns	   (Exosc3	   KD	   and	   Exosc5	   KD,	   respectively).	   Transcript	  
levels	   from	  a	  panel	  of	  active,	  PRC-­‐repressed	  and	  silent	  genes	  were	  tested	  by	  RT-­‐PCR	  using	  
primers	  for	  total	   transcripts	  after	  total	  RNA	  extraction	  from	  ES-­‐OS25	  cells	   that	  were	  either	  
untreated	  or	  treated	  with	  scrambled,	  Exosc3	  or	  Exosc5	  siRNAs,	  at	  48	  and	  72	  h	  time	  points	  
(Fig.	  5.8).	  
	  
Treatment	  with	  scrambled	  or	  Exosc3	  siRNAs	  has	  no	  detectable	  effect	  on	  the	  levels	  of	  mature	  
transcripts	   from	   pluripotency	   genes	   Nanog,	   Oct4	   and	   Sox2	   at	   48	   and	   72	   h	   (Fig.	   5.8A),	  
showing	   ES	   cells	   retain	   pluripotency	   markers	   and	   suggesting	   exosome	   does	   not	   play	   an	  
important	   role	   in	   their	   transcriptional	   regulation.	   Total	   transcript	   levels	   for	   active	   genes,	  
Chapter	  5	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  role	  of	  RNA	  degradation	  at	  PRC-­‐repressed	  genes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 
168	  
βactin	  and	  Oct4,	  also	  do	  not	  change	  at	  either	  time	  point	  when	  analysing	  using	  primers	  in	  the	  
5’	   end	   of	   the	   gene.	   Strikingly,	   total	   transcripts	   from	   three	   of	   the	   six	   PRC-­‐repressed	   genes	  
(Nkx2-­‐2,	   Nkx2-­‐9,	   Math1)	   analysed	   increase	   substantially	   after	   48	   h.	   There	   is	   a	   minimal	  
increase	  in	  RNA	  from	  Cdx2	  and	  no	  change	  in	  transcript	   level	  from	  HoxA7	  or	  Gata4	  at	  48	  h.	  
After	  72	  h,	   the	  de-­‐repression	   from	   the	   three	  affected	  genes	   is	  maintained	  although	   lower	  
upregulation	  of	  Nkx2-­‐2	   is	  detected.	  Active	  genes	  remain	  unchanged	  at	  72	  h	  and	  transcripts	  
from	  silent	  genes	  Myf5	  and	  Gabra6	  are	  not	  detected	  at	  any	  time	  point.	  
	  
Interestingly,	  these	  results	  are	  closely	  recapitulated	  in	  the	  Exosc5	  KD	  treatments	  (Fig.	  5.8B).	  
Pluripotency	  markers	  do	  not	  alter	  when	  detecting	  spliced	  transcripts	  (Nanog,	  Oct4,	  Sox2)	  or	  
total	  transcripts	  (Oct4).	  Three	  of	  the	  six	  PRC-­‐repressed	  genes	  (Nkx2-­‐2,	  Nkx2-­‐9,	  Math1)	  show	  
an	  increase	  in	  total	  transcript	  detection	  in	  Exosc5	  KD	  cells	  although	  to	  a	  lesser	  extent	  than	  in	  
the	  Exosc3	  KD.	  This	  is	  slightly	  diminished	  by	  72	  h	  treatment.	  	  	  


































































































































































































































Figure	  5.8	  De-­‐repression	  of	  PRC-­‐repressed	  genes	  upon	  Exosc3	  and	  Exosc5	  siRNA	  knockdown.	  Total	  RNA	  was	  
extracted	  from	  untreated	  ES-­‐OS25	  cells	  or	  from	  cells	  treated	  with	  scrambled	  siRNA	  and	  Exosc3	  (A)	  and	  Exosc5	  
(B)	  at	  48	  and	  72	  h.	  Samples	  were	  converted	  to	  cDNA	  using	  random	  primers	  and	  analysed	  by	  RT-­‐PCR	  at	  single	  
genes.	  Primers	  across	  exon	  junctions	  were	  used	  to	  detect	  expression	  of	  pluripotency	  markers	  Oct4,	  Nanog	  and	  
Sox2	   (left	   panels).	   Primers	   at	   5’	   ends	  were	   used	   to	   detect	   total	   RNA	   independent	   of	   splicing	   (right	   panels).	  	  
Knockdowns	  of	  Exosc3	  and	  Exocs5	  RNA	  were	  verified	  prior	  to	  this	  analysis	  in	  the	  same	  RNA	  samples	  (Figs.	  5.6,	  
5.7).	  A	  panel	  of	  PRC-­‐repressed	  transcripts	  were	  analysed	  alongside	  active	  genes	  (βactin,	  Oct4)	  and	  silent	  genes	  
(Myf5,	   Gabra6).	   RNA	   levels	   were	   normalised	   to	   3	   individual	   housekeeping	   genes	   (βactin,	   UBC,	   G6PD),	   that	  
remain	   unchanged	   during	   siRNA	   treatment,	   and	   depicted	   relative	   to	   RNA	   levels	   in	   untreated	   ES	   cells.	   No	  
detectable	  effect	  is	  seen	  on	  levels	  of	  pluripotency	  genes	  (Oct4,	  Nanog	  and	  Sox2)	  or	  5’	  transcripts	  for	  active	  or	  
silent	  genes	  at	  48	  or	  72	  h	  with	  either	  Exosc3	  or	  Exosc5	  siRNA.	  PRC-­‐repressed	  genes	  increase	  transcript	  levels	  at	  
three	  (Nkx2-­‐2,	  Nkx2-­‐9,	  Math1)	  of	  six	  genes	  by	  a	  high	  degree.	  Small	  changes	  are	  seen	  at	  Cdx2	  and	  no	  change	  at	  
HoxA7	  or	  Gata4.	  	  Mean	  and	  SD	  are	  from	  3	  independent	  experiments.	  ND	  represents	  no	  detection	  of	  cDNA.	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It	  is	  apparent	  from	  quantitative	  RT-­‐PCR	  of	  gene	  expression	  that	  exosome	  depleted	  cells	  are	  
still	  pluripotent	  as	  shown	  by	  the	  maintenance	  of	  pluripotency	  genes	  (Fig.	  5.8).	  However,	  as	  
an	  independent	  verification,	  I	  performed	  alkaline	  phosphatase	  staining	  (Fig.	  5.9),	  as	  alkaline	  
phosphatase	   is	   highly	   expressed	   in	   ES	   cells.	   Untreated	   cells	   were	   stained	   alongside	   cells	  
treated	   with	   scrambled,	   Exosc3	   and	   Exosc5	   siRNAs	   at	   48	   h.	   All	   cells	   show	   high	   alkaline	  
phosphatase	  expression.	  Even	   though	  cells	  are	  put	   through	  a	  harsh	  staining	  procedure	  we	  
can	  see	  that	  Exosc3	  and	  Exosc5	  treated	  cells	  have	  smaller,	   less	  uniform	  colonies	  compared	  
to	  untreated	  and	  scrambled	  suggesting	  there	   is	  some	  effect	  on	  the	  biology	  of	   the	  ES	  cells.	  
This	  effect	  is	  seen	  when	  the	  cells	  are	  still	  growing	  before	  fixation	  (not	  shown)	  and	  is	  not	  the	  
result	   of	   the	   experimental	   procedure.	   The	   changes	   in	  morphology	   suggest	   that	   cells	  may	  
have	  difficulty	  in	  forming	  colonies	  and	  may	  have	  higher	  levels	  of	  differentiating	  cells	  at	  the	  
colony	  periphery.	  Staining	  with	  early	  differentiation	  markers,	  Gata4	  and	  Gata6,	  would	  help	  
elucidate	  whether	  the	  changes	  in	  colony	  morphology	  are	  due	  to	  early	  differentiation	  or	  have	  
other	  causes.	  ES	  cells	   treated	  with	  scrambled	  siRNA	  show	  a	  green	  outline,	  due	   to	   the	  GFP	  
expression	  that	  marks	  efficient	  transfection.	  
 
	  
Figure	  5.9	  Exosc3	  knockouts	   retain	  alkaline	  phosphatase	  activity.	  Untreated	  ES	  cells	  and	  those	   treated	  with	  
scrambled	   or	   Exosc3,	   Exosc5	   siRNA	   were	   stained	   for	   alkaline	   phosphatase	   activity	   and	   visualised	   by	   light	  
microscopy.	  Pictures	  were	  captured	  at	  the	  same	  magnification	  for	  each	  treatment.	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5.2.6 De-­‐repression	   at	   a	   panel	   of	   PRC-­‐repressed	   genes	   after	   knockdown	   of	   exosome	  
catalytic	  subunits,	  Exosc10	  and	  Dis3	  
Depletion	   of	   both	   structural	   components	   of	   the	   exosome	   yield	   strikingly	   similar	   results	  
across	  a	  panel	  of	  genes	  in	  ES	  cells	  (Fig.	  5.8).	  To	  support	  this	  finding,	  I	  also	  analysed	  the	  same	  
panel	   of	   active,	   PRC-­‐repressed	   and	   silent	   genes	   in	   the	   Exosc10	   and	   Dis3	   knockouts	   for	  
transcript	  levels	  by	  RT-­‐PCR	  (Fig.	  5.10).	  
	  
As	  with	  the	  structural	  subunits,	  pluripotency	  genes	  are	  still	  expressed	  upon	  Dis3	  (Fig.	  5.10A)	  
and	   Exosc10	   (Fig.	   5.10B)	   knockdown	  when	   detected	   with	   primers	   across	   splice	   junctions.	  
There	  is	  a	  slight	  reduction	  in	  Oct4	  and	  Sox2	  expression	  upon	  Exosc10	  KD	  at	  48	  h.	  However,	  
the	  Oct4	  depletion	  is	  not	  reflected	  in	  the	  level	  of	  total	  Oct4	  RNA	  detected	  with	  5’	  primers,	  
capturing	   the	   total	   population.	   When	   detecting	   the	   total	   population	   of	   transcripts	   it	   is	  
apparent	   βactin	   levels	   increase	   slightly	   at	   72	   h	   with	   both	   knockdowns,	   suggesting	   the	  
exosome	  plays	  a	  role	   in	  regulating	  active	  gene	  transcription	  akin	  to	   its	  role	  as	  a	  pre-­‐mRNA	  
surveillance	  mechanism	  (Isken	  and	  Maquat,	  2007).	  There	  is	  no	  detection	  of	  RNA	  from	  silent	  
genes	  Myf5	  and	  Gabra6.	  	  
	  
Encouragingly,	   de-­‐repression	   of	   the	   same	   three	   PRC-­‐repressed	   genes	   (Nkx2-­‐2,	   Nkx2-­‐9,	  
Math1)	   in	  both	  the	  Dis3	  and	  Exosc3	  knockdowns	   is	  detected	  at	  48	  h.	  Similarly,	   there	   is	  no	  
effect	  at	  HoxA7	  and	  Gata4.	   In	  contrast	  to	  knockdowns	  with	  Exosc3	  and	  Exosc5	  siRNAs	  (Fig.	  
5.8),	  the	  extent	  of	  de-­‐repression	  in	  the	  Dis3	  knockout	  is	  more	  enhanced	  by	  72	  h	  for	  Nkx2-­‐2	  
and	   Math1,	   while	   Nkx2-­‐9	   levels	   stay	   the	   same	   (Fig.	   5.10A).	   There	   is	   a	   slight	   increase	   in	  
transcription	   apparent	   for	   HoxA7	   after	   72	   h	   of	   siRNA	   treatment	   for	   both	   exonuclease	  
subunits.	  These	  experiments	  were	  only	  performed	  once,	  requiring	  further	  validation	  by	  the	  
analyses	  of	  additional	  biological	  replicates.	  
	  























































































































































































































































































































































Figure	  5.10	  De-­‐repression	  of	  PRC-­‐repressed	  genes	  upon	  siRNA	  knockdown	  of	  exonuclease	  components	  of	  the	  
exosome.	   ES-­‐OS25	   total	   RNA	  was	   extracted	   from	   untreated,	   scrambled	   siRNA	   and	  Dis3	   (A)	   and	   Exosc10	   (B)	  
siRNA	  treated	  cells	  at	  48	  and	  72	  h.	  Samples	  were	  converted	  to	  cDNA	  using	  random	  primers	  and	  analysed	  by	  RT-­‐
PCR	  at	   single	   genes.	   Primers	  across	  exon	   junctions	  were	  used	   to	  detect	  expression	  of	   	   pluripotency	  markers	  
Oct4,	  Nanog	  and	  Sox2	  (left	  panels).	  Primers	  at	  5’	  ends	  were	  used	  to	  detect	  total	  RNA	  independent	  of	  splicing	  
(right	   panels).	   	   Knockdown	   of	   Dis3	   and	   Exosc10	   was	   verified	   prior	   to	   analysis.	   A	   panel	   of	   PRC-­‐repressed	  
transcripts	   were	   analysed	   alongside	   active	   genes	   (βactin,	   Oct4)	   and	   silent	   gene	   (Myf5,	   Gabra6).	   RNA	   levels	  
were	  normalised	  to	  3	  individual	  housekeeping	  genes	  (βactin,	  UBC,	  G6PD),	  that	  remain	  unchanged	  during	  siRNA	  
treatment,	  and	  depicted	  relative	  to	  levels	  in	  untreated	  cells.	  There	  is	  no	  effect	  on	  levels	  of	  pluripotency	  genes	  
(Oct4,	  Nanog	   and	  Sox2)	  or	  5’	   transcripts	   for	  active	  or	   silent	  genes	  at	  48	  or	  72	  h	  with	  either	  Dis3	  or	  Exosc10	  
siRNA.	  PRC-­‐repressed	  genes	  increase	  transcript	  levels	  at	  three	  (Nkx2-­‐2,	  Nkx2-­‐9,	  Math1)	  of	  five	  genes	  to	  a	  high	  
degree.	   Small	   changes	   are	   seen	   at	  HoxA7	   and	   no	   change	   at	  Gata4.	   ND	   is	   not	   detected	  where	   no	   RNA	  was	  
present.	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5.2.7 De-­‐repressed	  transcripts	  can	  undergo	  splicing	  and	  polyadenylation	  
Consistent	   and	   robust	   de-­‐repression	   of	   three	   PRC-­‐repressed	   genes	   is	   detected	   after	  
depletion	  of	  four	  separate	  subunits	  of	  the	  exosome	  by	  siRNA	  treatments.	  Transcripts	  were	  
detected	  by	  RT-­‐PCR	  using	  primers	  at	  the	  5’	  ends	  of	  genes	  that	  detect	  transcripts	  irrespective	  
of	   processing	   by	   splicing	   and	  polyadenylation.	   To	   gain	   further	   insights	   about	   the	   effect	   of	  
exosome	   activity	   on	   PRC-­‐repression,	   I	   also	   measured	   the	   effects	   of	   exosome	   knockdown	  
(Exosc3	   and	   Exosc5	   KD)	   on	   primary	   transcripts,	   using	   primers	   across	   exon-­‐intron,	   and	   the	  
effect	   on	   transcripts	   that	   mature	   at	   the	   level	   of	   splicing	   using	   primers	   at	   exon-­‐exon	  
boundaries	   (Fig	   5.11).	   Transcripts	   upon	   exosome	   depletion	   were	   also	   analysed	   for	  
polyadenylated	   transcripts,	  by	  performing	  cDNA	  conversion	  with	  OligodT	  primers	   followed	  
by	  amplification	  using	  primers	  at	  the	  exonic	  5’	  ends	  of	  genes	  (Fig.	  5.12).	  
	  
Exosome	  knockdown	  does	  not	  change	  the	  level	  of	  primary	  transcripts	  detected	  from	  active	  
genes	   βactin	   and	   Oct4.	   Levels	   of	   primary	   transcripts	   from	   PRC-­‐repressed	   genes,	  Math1,	  
Nkx2-­‐2	  and	  Nkx2-­‐9,	  increase	  upon	  Exosc3	  and	  Exosc5	  KD	  showing	  an	  effect	  on	  the	  regulation	  
of	  nascent	  transcripts	  and	  not	  simply	  an	  effect	  on	  mRNA	  stability.	  No	  effects	  are	  detected	  at	  
HoxA7	  or	  Gata4	  genes,	  and	  no	  RNA	  is	  detected	  from	  silent	  Myf5	  and	  Gabra6.	  Similar	  results	  
were	  obtained	  for	  the	  analyses	  for	  spliced	  transcripts	  (Fig.	  5.11),	  where	  Nkx2-­‐2	  and	  Nkx2-­‐9	  
transcripts	   increase	   after	   knockdown.	   Low	   levels	   of	   spliced	   transcripts	   from	   HoxA7	   and	  
Gata4	  are	  produced	   recapitulating	  published	  data	   (Stock	  et	   al.,	   2007)	  but	  do	  not	   increase	  








































































































































Figure	  5.11	  Primary	  and	  spliced	  transcripts	  at	  PRC-­‐repressed	  genes	  increase	  in	  exosome	  knockouts.	  Total	  RNA	  
was	  extracted	  from	  untreated	  ES-­‐OS25	  cells	  and	  from	  cells	  treated	  for	  48	  h	  with	  scrambled,	  Exosc3	  or	  Exosc5	  
siRNAs.	   RNA	   was	   converted	   to	   cDNA	   using	   random	   primers	   and	   analysed	   by	   quantitative	   RT-­‐PCR	   at	   single	  
genes.	   Primers	   spanning	   exon-­‐intron	   or	   exon-­‐exon	   junctions	  were	   used	   to	   detect	   primary	   and	   spliced	   RNA,	  
respectively.	   Knockdown	   of	   Exosc3	   and	   Exosc5	   mRNA	   with	   the	   respective	   siRNAs	   was	   verified	   prior	   to	   this	  
analysis.	  A	  panel	  of	  PRC-­‐repressed	   transcripts	  were	  analysed	  alongside	  active	  genes	   (βactin,	  Oct4)	  and	  silent	  
genes	   (Myf5,	  Gabra6).	   RNA	   levels	  were	  normalised	   to	  3	   individual	  housekeeping	  genes	   (βactin,	  UBC,	  G6PD),	  
that	  remain	  unchanged	  during	  siRNA	  treatment,	  and	  depicted	  relative	  to	  levels	  in	  Untreated	  cells.	  There	  is	  no	  
effect	   on	   primary	   or	   spliced	   active	   or	   silent	   genes.	   An	   increase	   in	   nascent	   and	   spliced	   transcripts	   is	   seen	   at	  
three	   PRC-­‐repressed	   genes	   (Nkx2-­‐2,	   Nkx2-­‐9,	  Math1).	   No	   changes	   are	   detected	   at	  HoxA7	  or	  Gata4.	   ND,	   not	  
detected	  (no	  PCR	  amplification	  could	  be	  measured).	  *Math1	  was	  not	  tested	  with	  exon-­‐exon	  primers.	  Mean	  and	  
SD	  are	  from	  3	  biological	  replicates.	  
	  
The	   increase	   in	   transcription	   of	   some	   PRC-­‐repressed	   genes	   upon	   exosome	   depletion,	  
observed	  after	  measuring	  total	  and	  primary	  transcript	  levels,	  does	  not	  necessarily	  imply	  that	  
the	  RNAs	  become	   fully	  mature	  and	   the	  genes	   fully	  de-­‐repressed.	  To	  examine	  whether	   the	  
exosome-­‐dependent	   derepression	   was	   observed	   at	   the	   level	   of	   mRNA,	   I	   selected	   polyA+	  
RNAs	  with	  OligosT	  primers	  during	  cDNA	  conversion	  and	  prior	  to	  quantitative	  RT-­‐PCR	  for	  the	  
genes	  of	   interest	   (Fig.	  5.12).	  PolyA+	   transcripts	  are	   readily	  detectable	  at	  active	  gene	  βactin	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but	   not	   substantially	   elevated	   upon	   exosome	   knockdown.	   Strikingly,	   the	   PRC-­‐repressed	  
genes	  that	  became	  the	  most	  de-­‐repressed	  in	  previous	  analysis	  (Figs.	  5.8,	  5.10,	  5.11)	  are	  also	  
abundantly	   up-­‐regulated	   to	   a	   similar	   extent	   at	   the	   level	   of	  mature	   (polyadenylated)	   RNAs	  
(Fig.	  5.12).	  The	  similar	  fold	  changes	  raise	  the	  intriguing	  possibility	  that	  the	  exosome	  may	  act	  
to	   synergise	  with	  Polycomb	  repression,	  at	   least	   for	   some	  PRC-­‐target	  genes,	  at	   the	   level	  of	  
primary	  transcription.	  This	  would	  be	  consistent	  with	  ample	  detection	  of	  RNAPII	  at	  PRC-­‐target	  




Figure	  5.12	  Detection	  of	  polyadenylated	  transcripts	  from	  some	  PRC-­‐target	  genes	  after	  exosome	  knockdown.	  
ES-­‐OS25	  total	  RNA	  was	  extracted	  from	  untreated,	  scrambled	  siRNA	  and	  Exosc3	  and	  Exosc5	  siRNA	  treated	  cells	  
at	  48	  h	  time	  points.	  Samples	  were	  converted	  to	  cDNA	  using	  Oligo(dT)primers	  and	  analysed	  by	  RT-­‐PCR	  at	  single	  
genes.	   Knockdown	  of	   Exosc3	   and	  Exosc5	  was	   verified	  prior	   to	   analysis.	   A	  panel	   of	   PRC-­‐repressed	   transcripts	  
were	   analysed	   alongside	   active	   gene	   (βactin)	   and	   silent	   gene	   (Myf5).	   RNA	   levels	   were	   normalised	   to	   3	  
individual	  housekeeping	  genes	  (βactin,	  UBC,	  G6PD),	  that	  remain	  unchanged	  during	  siRNA	  treatment,	  relative	  to	  
levels	  in	  Untreated	  cells.	  There	  is	  a	  minimal	  effect	  on	  levels	  of	  polyA+	  at	  active	  gene	  βactin	  at	  48	  h.	  An	  increase	  
in	  polyA+	  PRC-­‐repressed	  transcripts	  is	  seen	  at	  three	  genes	  (Nkx2-­‐2,	  Nkx2-­‐9,	  Math1).	  Minimal	  changes	  detected	  
at	  HoxA7.	  ND	  is	  not	  detected	  where	  no	  RNA	  was	  present.	  Mean	  and	  SD	  are	  from	  3	  independent	  experiments.	  	  
 
5.2.8 Genome-­‐wide	  analysis	  of	  Exosc3	  knockdown	  by	  microarray	  
Analysis	  of	  transcription	  deregulation	  by	  the	  exosome	  showed	  promising	  effects	  on	  a	  small	  
number	   of	   Polycomb-­‐repressed	   genes,	   which	   suggested	   that	   exosome	   activity	   might	  
contribute	  to	  Polycomb	  silencing	  mechanisms.	  To	  understand	  the	  role	  of	  the	  exosome	  in	  PRC	  
repression	  and	  more	  broadly	  on	  gene	  regulation	   in	  ES,	   I	  performed	  microarray	  analysis	  on	  
RNA	   after	   knocking	   down	  exosome	   subunits	   using	   siRNAs.	   Previous	   results	   in	   this	   chapter	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show	  that	  knockdown	  of	  any	  one	  of	  four	  exosome	  subunits	  (Exosc3,	  5,	  10	  or	  Dis3)	  results	  in	  
upregulation	  of	  some,	  but	  not	  all,	  PRC-­‐target	  genes	  tested.	  I	  chose	  to	  use	  Exosc3	  knockdown	  
for	   the	  microarray	   analyses,	   as	   it	   gave	  more	   reproducible	   and	   robust	   effects	   than	   Exosc5,	  
and	  at	  the	  time	  I	  had	  not	  performed	  knockdown	  of	  catalytic	  subunits	  (Exosc10	  and	  Dis3).	  
	  
A	   workflow	   of	   the	   microarray	   experimental	   plan	   is	   represented	   in	   Fig.	   5.13.	   Microarray	  
expression	   analysis	   is	   a	   well-­‐established	   technique	   for	   measuring	   transcriptional	   changes	  
between	   samples	   of	   interest.	   The	  microarray	   chosen	   (GeneChIP	  Mouse	  Gene	  1.0ST	  Array,	  
Affymetrix)	  covers	  the	  entire	  mouse	  genome	  with	  multiple	  probes	  per	  gene.	  
	  
Total	  RNA	  samples
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Figure	  5.13	  Workflow	  for	  microarray	  analysis	  of	  Exosc3	  knockdown.	  Total	  RNA	  was	  extracted	  from	  ES-­‐OS25	  
cells	  treated	  in	  the	  absence	  or	  presence	  of	  scrambled	  or	  Exosc3	  siRNAs	  for	  48	  h,	  for	  4	  independent	  replicates.	  
Sample	   preparation	   for	  microarray	   hybridisation	   used	   the	   Ambion	  WT	   expression	   kit	   to	   prepare	   compatible	  
double	  strand	  cDNA	  ready	  for	   labelling	  with	  the	  Affymetrix	  Terminal	   labelling	  kit.	  The	  Ambion	  WT	  expression	  
kit	  ensures	  removal	  of	  ribosomal	  RNA.	  Labelled	  samples	  were	  hybridised	  to	  a	  Mouse	  Gene	  1.0	  ST	  array.	  Array	  
contains	  750,000	  25-­‐mer	  oligonucleotides	  with	  28,853	  gene	  level	  probesets	  based	  on	  annotations	  from	  UCSC	  
mouse	  genome	  build	  mm8,	  RefSeq,	  UCSC	  and	  Ensembl.	  Samples	  were	  hybridised	  and	  scanned	  by	  the	  MRC	  CSC	  
genomics	  facility.	  Bioinformatic	  analyses	  were	  performed	  by	  G. Dharmalingam	  (MRC-­‐CSC).	  
	  
	  
Total	  RNA	  for	  four	  biological	  replicates	  of	  untreated	  ES-­‐OS25	  cells	  and	  cells	  treated	  with	  the	  
scrambled	   or	   Exosc3	   siRNA	   were	   produced.	   RNA	   samples	   were	   verified	   for	   efficient	  
knockdown	  of	  Exosc3	  mRNA	  prior	  to	  microarray	  analysis	  (not	  shown).	  In	  parallel,	  I	  prepared	  
matched	   RNA	   samples	   for	   CAGE	   analysis,	   performed	   at	   RIKEN	   Institute	   (FANTOM5	  
consortium),	  discussed	  later	  in	  the	  chapter.	  	  	  
	  
Principle	  Component	  Analysis	  (PCA)	  is	  an	  unbiased	  primary	  step	  in	  microarray	  analysis	  (Fig.	  
5.14).	  PCA	  clusters	  RNA	  samples	  and	  can	  be	  used	  to	   illustrate	  the	  greatest	  variance	  within	  
the	   data,	   based	   on	   probe	   intensities	   and	   independent	   of	   sample	   identity.	   Batch	  
normalisation	  corrects	   for	  minimal	  non-­‐biological	  differences	   in	  the	  data	  that	  occur	  due	  to	  
experimental	  procedure,	  such	  as	  not	  being	  able	  to	  process	  all	  samples	  simultaneously.	  Batch	  
correction	   was	   performed	   using	   ComBat	   to	   correct	   for	   differences	   in	   data	   due	   to	   RNA	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extraction	  on	  different	  days	  and	  those	  samples	  that	  came	  from	  a	  separate	  stock	  of	  ES-­‐OS25	  
cells	  (Fig.	  5.14).	  	  
	  
	  
Figure	  5.14	  Principle	  component	  analysis	  (PCA)	  of	  microarray	  samples.	  PCA	  analysis	  and	  visual	  representation	  
of	   the	  most	  significant	  sources	  of	  variation	   in	  microarray	  data	   for	  Untreated	  ES-­‐OS25	  cells	  and	  those	  treated	  
with	  Scrambled	  or	  Exosc3	  siRNAs.	  Samples	  cluster	  according	  to	  presence	  or	  absence	  of	  exosome.	  Clustering	  of	  
biological	   replicates	   is	   delineated	   by	   coloured	   ovals.	   Samples	   from	   different	   extraction	   and	   cell	   batches	   are	  
denoted	   in	  the	   legend.	  Batch	  correction	  was	  applied	  to	  normalize	  for	  these	  differences	  prior	  to	  PCA	  plotting.	  
PCA	  analysis	  performed	  by	  G.	  Dharmalingam	  (MRC,	  CSC).	  
	  
PCA	  demonstrates	   that	   the	  Exosc3	   siRNA	  expression	  datasets	   are	   clearly	   distinct	   from	   the	  
untreated	  and	  scrambled	  siRNA	  treated	  cells,	  whereas	  the	  two	  control	  samples	  are	  similar	  to	  
each	  other.	  Differences	  between	  cell	  batches	  are	  observed,	  but	  the	  effect	  of	  Exosc3	  siRNA	  
seems	   conserved	   across	   independent	   biological	   replicates.	   The	  minimal	   variance	   between	  
untreated	  and	  scrambled	  shows	  that	  the	  process	  of	  siRNA	  transfection	  has	  minor	  effects	  on	  
genome-­‐wide	  gene	  expression.	  The	  greatest	  variance	  appears	  between	  Exosc3	  KD	  and	  both	  
controls	  (Untreated,	  Scrambled).	  In	  general,	  this	  suggests	  that	  exosome	  knockout	  results	  in	  
genome-­‐wide	  gene	  transcription	  changes.	  
	  
Subsequent	   analysis	   was	   performed	   to	   look	   at	   the	   numbers	   of	   upregulated	   and	  
downregulated	   genes.	   Initial	   analysis	   of	   probesets,	   of	   which	   there	   are	  multiple	   per	   gene,	  
verified	  minimal	  changes	  between	  untreated	  and	  scrambled	  siRNA	  samples	  (Table.	  5.2).	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Similar	   changes	   in	   probesets	   are	   detected	   between	   the	   untreated	   and	   Exosc3,	   and	   the	  
Scrambled	  and	  Exosc3,	   reinforcing	  the	  results	  of	   the	  PCA	  analysis	   that	  control	  samples	  are	  
remarkably	  similar.	  Once	  we	  were	  confident	  that	  controls	  were	  showing	  minimal	  variation,	  
the	  next	  step	  was	  to	  analyse	  gene	  transcriptional	  changes	  between	  untreated	  and	  Exosc3	  KD	  
samples	   (Log2FC,	   adjusted	  p-­‐value	  <0.05;	   Table	  5.3).	   	  Overall,	   there	  are	  a	   large	  number	  of	  
deregulated	  genes	  when	  no	  fold	  change	  threshold	   is	  applied.	  There	   is	  a	  tendency	  for	  gene	  
upregulation	   upon	   exosome	   removal	   as	   fold	   change	   thresholds	   are	   applied,	   as	   expected	  
when	   an	  RNA	  degradation	  mechanism	   is	   lost.	  However,	   the	   effect	   is	   subtle	  with	   only	   201	  
genes	   out	   of	   the	   20,745	  on	   the	   array	   showing	   a	   log2-­‐fold	   change	   greater	   than	   1.	   The	   low	  
number	   of	   downregulated	   genes	   (Log2FC≥0.7;	   n=46)	   may	   be	   the	   result	   of	   regulatory	  
feedback	   loops	   from	   deregulation	   of	   a	   protein	   that	   has	   a	   repressive	   role	   in	   ES	   cells.	  
Encouragingly,	  Exosc3	  is	  downregulated	  with	  a	  fold	  change	  of	  1.54	  (adj.	  p-­‐value=	  1.0810-­‐6).	  
	  
Table	  5.3	  Percentage	  of	  differentially	  regulated	  genes	  
	  




% Downregulated genes% Upregulated genes
	  
5.2.9 Deregulation	  of	  gene	  groups	  in	  ES	  cells	  
A	  main	  focus	  of	  this	  study	  is	  to	  determine	  the	  genome-­‐wide	  effects	  of	  exosome	  depletion	  on	  
PRC-­‐repressed	   genes.	   However,	   microarray	   data	   also	   allows	   us	   to	   look	   across	   the	   ES	   cell	  
genome	   and	   ask	   more	   general	   questions	   about	   the	   role	   of	   exosome	   on	   transcription,	   a	  
mechanism	  not	  studied	  in	  this	  cell	  type.	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Previous	   work	   from	   our	   laboratory	   comprehensively	   studied	   the	   ES	   cell	   protein-­‐coding	  
genome,	  mapping	  RNAPII	  and	  PRC	  occupancy	  genome-­‐wide	  and	  revealing	  gene	  groups	  with	  
differing	   combinations	   of	   RNAPII	   and	   PRC	   binding	   which	   relate	   with	   alternate	   expression	  
states.	   Hierarchical	   clustering	   of	   15,404	   non-­‐overlapping	   RefSeq	   genes	   was	   used	   as	   an	  
unbiased	  approach	  to	  classify	  genes	  according	  to	  RNAPII	  and	  PRC	  binding	  profiles	  in	  ES	  cells	  
genome-­‐wide	  (Brookes	  et	  al.,	  2012).	  Clustering	  was	  based	  on	  presence	  or	  absence	  of	  RNAPII	  
and	  PRC	  modifications	  and	  resulted	  in	  a	  robust	  classification	  of	  6	  gene	  groups	  in	  ES	  cells	  (Fig.	  
5.15).	   Relating	   gene	  groups	   and	  mRNA	  expression	  data,	  which	  was	  not	  used	   in	   clustering,	  
demonstrated	  that	  combinations	  of	  RNAPII	  and	  PRC	  could	  dictate	  final	  expression	  state	  in	  ES	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Figure	  5.15	  Differing	  regulatory	  gene	  groups	  across	  the	  ES	  cell	  genome.	  Hierarchical	  clustering	  was	  performed	  
for	  RNAPII	  and	  PRC	  modifications	  for	  15,404	  non-­‐overlapping	  RefSeq	  genes	  (see	  Brookes	  et	  al.,	  2012	  for	  details	  
of	  method).	  Four	  major	  groups	  of	  PRC-­‐target	  genes	  were	  identified:	  PRConly,	  PRCrepressed,	  PRCintermediate,	  
and	   PRCactive.	   Remaining	   genes	   were	   classified	   as	   Active	   or	   Inactive.	   Levels	   of	   mRNA	   are	   presented	   for	  
comparison	  (lower	  panel),	  but	  were	  not	  used	  as	  clustering	  variable.	  Figure	  adapted	  from	  (Brookes	  et	  al.,	  2012).	  
	  
To	  begin	  exploring	  whether	  exosome	  plays	  a	  specific	  role	  at	  protein-­‐coding	  genes	  genome-­‐
wide	   in	  ES	   cells,	  we	  used	   the	  gene	   lists	   for	   the	   six	   groups	  previously	   classified	   for	  ES	   cells	  
according	  to	  RNAPII	  and	  Polycomb	  occupancy.	  At	  this	  early	  exploratory	  stage,	  all	  genes	  that	  
are	  up-­‐	  or	  downregulated	  with	  a	  Log2FC	  ≥0.7	  were	  considered	  irrespectively	  of	  whether	  the	  
associated	  p-­‐value	  was	  considered	  significant;	  we	  were	  concerned	  in	  particular	  in	  excluding	  
genes	  that	  may	  have	  small	  changes	  in	  expression.	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Figure	   5.16	   Exosc3	   siRNA	   knockdown	   deregulates	   primarily	   active	   genes,	   including	   a	   subset	   of	   Polycomb-­‐
target	  genes	  in	  ES	  cells.	  Changes	  in	  gene	  expression	  measured	  by	  microarray	  analyses	  after	  Exosc3	  microarray	  
analyses	  were	  determined	  for	  different	  groups	  of	  genes	  described	  in	  (Brookes	  et	  al.,	  2012)	  according	  to	  their	  
chromatin	  properties	  .	  Genes	  with	  a	  Log2FC>0.7	  were	  included	  in	  analysis	  of	  up	  and	  downregulated	  genes	  from	  
each	  group.	  Genes	  assigned	  ‘No	  Group’	  are	  those	  that	  were	  excluded	  from	  original	  clustering	  analysis	  due	  to	  
genomic	   proximity.	   	   Number	   of	   genes	   for	   each	   group	   that	   are	   up	   or	   downregulated	   were	   plotted	   (A,	   C).	  
Percentage	  (%)	  of	  genes	  within	  the	  group	  that	  were	  up	  or	  downregulated	  were	  also	  plotted	  (B,	  D).	  Numbers	  for	  
each	  group	  present	  on	  the	  microarray	  as	  opposed	  to	  numbers	  in	  Fig.	  5.15	  are:	  Active	  (n=5028),	  PRCa	  (n=1101),	  
PRCi	   (n=646),	   PRCr	   (n=1493),	   PRCo	   (n=719),	   Inactive	   (n=4192),	   No	   group	   (n=7566).	   Active	   have	   the	   highest	  
number	   of	   genes	   up	   and	   downregulated	   but	   a	   low	   %	   within	   the	   group.	   PRC	   bound	   genes	   show	   up	   and	  
downregulation	   at	   different	   levels	   with	   higher	   %	   within	   the	   group	   compared	   to	   active	   and	   inactive	   genes.	  
Bioinformatic	  analysis	  performed	  by	  G.	  Dharmalingam	  (MRC,	  CSC).	  
	  
The	  active	  gene	  group	  has	  the	  highest	  overall	  number	  of	  upregulated	  genes	  (Log2FC≥0.7;	  Fig.	  
5.16A)	   excluding	   ‘No	   Group’.	   Active	   genes	   associate	   with	   RNAPII-­‐S5p+S7p+S2p+8WG16+,	  
active	   histone	   modification	   H3K4me3,	   and	   mRNA	   expression.	   However,	   this	   group	   is	  
especially	  large	  (n=5707;	  5028	  on	  microarray)	  and	  the	  percentage	  within	  the	  group	  that	  are	  
upregulated	  is	  quite	  low	  (1.9%;	  Fig.5.16B).	   In	  general,	  changes	  as	  a	  percentage	  within	  each	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of	   the	   six	   gene	  groups	  are	   low,	   likely	   reflective	  of	   the	   low	  number	  of	   total	   genes	   that	  are	  
deregulated	  upon	  exosome	  depletion	  and	  demonstrating	  that	  exosome	  regulates	  more	  than	  
one	  group	  of	  genes	  in	  ES	  cells.	  Results	  of	  upregulated	  active	  genes	  are	  recapitulated	  in	  the	  
number	  of	  downregulated	  genes,	  where	  active	  have	  the	  highest	  number	  changing	  but	  a	  low	  
proportion	  (Fig.	  5.16C,	  D).	  	  
	  	  
PRCactive	   (PRCa;	   n=1227)	   are	   PRC	   regulated	   genes	   that	   are	   able	   to	   switch	   between	  
repressed	  and	  active	  states	  in	  the	  ES	  cell	  population.	  They	  are	  enriched	  for	  metabolic	  genes	  
and	  characterised	  by	  association	  with	  either	  RNAPII	  with	  all	  active	  modifications,	  along	  with	  
mRNA	  expression	  or	  PRC	  binding	  with	  RNAPII-­‐S5p.	  Upon	  exosome	  knockdown,	  a	  number	  of	  
PRCa	  genes	  are	  upregulated,	   the	  highest	   from	  all	   the	  PRC	  groups.	   Interestingly,	   they	  show	  
the	   highest	   percentage	   of	   upregulated	   genes,	   above	   active	   and	   all	   other	   PRC	   groups	   (Fig.	  
5.16B).	   These	   results	   also	   recapitulate	   that	   seen	   in	   the	   downregulated	   portion	   of	   the	  
genome	  (Fig.	  5.16C,D).	  
	  
The	   remaining	  groups	  of	  PRC-­‐target	  genes,	  PRCo,	  PRCi	  and	  PRCr,	   are	   classified	  as	   silent	   in	  
terms	  of	  mRNA	  expression	  but	  are	  associated	  with	  PRC	  and	  RNAPII,	  with	   the	  exception	  of	  
PRConly	   (PRCo).	   PRCintermediate	   (PRCi)	   associate	   with	   RNAPII-­‐S5p+S7p+8WG16+	   while	  
PRCrepressed	   (PRCr)	  associate	  with	  RNAPII	   (-­‐S5p	  only)	  and	  PRCo	  have	  no	  RNAPII	   and	  only	  
H3K27me3.	  	  Exosome	  knockdown	  experiments	  result	  in	  upregulation	  of	  genes	  from	  PRCi	  and	  
PRCr	  (Fig.	  3.16A)	  suggesting	  that	  they	  are	  transcriptionally	  primed	  and	  regulated	  in	  part	  by	  
the	  exosome.	  Surprisingly,	  only	  a	  small	  number	  of	  PRC-­‐repressed	  genes	  are	  upregulated	   in	  
the	  Exosc3	  KD	  even	  though	  at	  single	  genes	  3	  out	  of	  6	  genes	  tested	  were	  highly	  affected	  (Fig.	  
5.8).	   PRCo	  have	   the	   lowest	   number	   and	  proportion	  of	   upregulated	   genes	   compared	   to	   all	  
other	   groups,	   consistent	  with	   the	   fact	   that	   they	   are	   not	   associated	  with	   RNAPII.	   The	   few	  
genes	  that	  do	  change	  may	  be	  the	  result	  of	  low	  levels	  of	  RNAPII	  binding	  that	  was	  classified	  as	  
negative	  in	  clustering	  but	  are	  still	  receptive	  to	  exosome	  depletion.	  Downregulated	  genes	  are	  
fewer	   in	   number	   for	   PRCi	   and	   PRCr	   (Fig.	   5.16C,	   D)	   but	   the	   trends	   compared	   to	   the	   other	  
groups	  is	  the	  same	  as	  that	  seen	  for	  upregulated	  genes.	  
	  
Inactive	   genes	   are	   the	   remaining	   RefSeq	   genes	   that	   are	   not	   bound	   by	   PRC	   and	   are	   not	  
expressed.	   This	   large	   group	   of	   genes	   (n=5296,	   4129	   on	  microarray)	   show	   some	   change	   in	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response	  to	  Exosc3	  KD	  although	  once	  again	  the	  percentage	  change	  within	  the	  group	  is	  the	  
second	   lowest	  of	   the	  groups	   (0.98%)	  after	  PRCo.	  A	  number	  of	   inactive	  genes	  appear	   to	  be	  
associated	  with	  some	  form	  of	  RNAPII	  (Fig.	  5.15)	  and	  these	  genes	  may	  be	  responsible	  for	  the	  
effect	  we	  see	  upon	  exosome	  depletion.	  	  Finally,	  genes	  labelled	  ‘No	  Group’	  are	  those	  present	  
on	   the	   microarray	   that	   are	   not	   classified	   into	   any	   of	   the	   six	   groups;	   they	   correspond	   to	  	  
genes	   proximal	   in	   the	   linear	   genomic	   sequence	   which	   were	   	   not	   included	   in	   hierarchical	  
clustering	  analysis,	  or	  may	  also	  result	  from	  annotation	  differences	  as	  the	  microarray	  is	  based	  
on	  genome	  build	  mm8	  as	  opposed	  to	  mm9	  used	  in	  Brookes	  et	  al	  (2012).	  This	  group	  is	  large	  in	  
number	  (n=7566)	  and	  there	  is	  deregulation	  upon	  exosome	  knockout.	  Further	  analysis	  of	  this	  
group	  would	  be	  required	  to	  understand	  whether	  there	  are	  any	  common	  features	  of	  genes	  
that	  are	   regulated	  by	   the	  exosome.	  However,	  overlapping	  genes	   from	  other	  groups	  would	  
complicate	  analysis.	  
5.2.10 Validation	  of	  microarray	  analysis	  by	  single	  gene	  analysis	  
To	   confirm	  and	   verify	   the	  deregulation	  of	   genes	   detected	  by	  microarray	   in	   the	   Exosc3	  KD	  
cells,	   I	  tested	  a	  panel	  of	  genes	  by	  quantitative	  RT-­‐PCR	  (Fig.	  5.17).	   I	   focused	  on	  upregulated	  
genes	  with	  the	  view	  that	  these	  were	  more	   likely	  to	  be	  direct	  targets	  of	  the	  exosome.	  RNA	  
samples	  were	  the	  same	  as	  those	  used	  for	  the	  microarray	  analysis.	  A	  panel	  of	  genes	  that	  were	  
upregulated	   according	   to	   the	   microarray	   were	   chosen	   among	   the	   active,	   PRCa	   and	   PRCr	  
gene	   groups.	   I	   aimed	   to	   chose	   three	   genes	   that	   were	   upregulated	   to	   different	   extents	  
(Log2FC	  >2,	  ≥1,	  <1),	  and	  three	  that	  showed	  no	  change	  upon	  exosome	  depletion	  from	  each	  
group.	  For	  the	  inactive	  group,	  I	  chose	  three	  genes	  that	  had	  no	  change	  by	  microarray.	  
	  
In	   general,	   all	   genes	   from	   each	   group	   that	   show	   an	   upregulation	   by	   microarray	   can	   be	  
verified	  by	  single-­‐gene	  analysis	  (Fig.	  5.17).	  The	  range	  of	  upregulation	  is	  also	  seen	  by	  RT-­‐PCR;	  
for	  example	  active	  gene	  Btg2	  had	  a	  high	  fold	  change	  of	  2.4	  by	  microarray,	  Slc19a2	  slightly	  
lower	  (1.42)	  and	  Tmem19	  had	  the	  lowest	  change	  (0.94).	  This	  pattern	  is	  also	  true	  for	  the	  PRCa	  
and	  PRCr	  genes	  that	  show	  upregulation.	  However,	  there	  are	  discrepancies,	  namely	  inactive	  
gene	  Nhlh1	   and	   PRC-­‐repressed	   gene	  Gata5,	   which	   show	   a	   substantial	   upregulation	   upon	  
Exosc3	   KD	   by	   single	   gene	   analysis	   but	   no	   change	   by	   microarray	   (Log2FC=0.04,	   0.05	  
respectively).	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Figure	  5.17	  Validation	  of	  Exosc3	  microarray	  results	  at	  single	  genes	  by	  qRT-­‐PCR.	  Total	  RNA	  samples	  from	  ES-­‐
OS25	  stem	  cells	  (untreated,	  scrambled	  siRNA	  and	  Exosc3)	  were	  the	  same	  as	  those	  used	  in	  microarray	  analysis	  
from	  a	   48	  h	   treatment.	   Samples	  were	   converted	   to	   cDNA	  using	   random	  primers	   and	   analysed	  by	  RT-­‐PCR	   at	  
single	  genes.	  Primers	  at	  the	  5’	  end	  of	  the	  gene	  were	  used	  to	  detect	  total	  RNA	  independent	  of	  splicing	  for	  all	  
genes.	  Knockdown	  of	  Exosc3	  was	  verified	  prior	   to	  analysis.	  A	  panel	  of	   active,	  PRC-­‐active,	  PRC-­‐repressed	  and	  
inactive	   transcripts	  were	   analysed.	   RNA	   levels	  were	   normalised	   to	   3	   individual	   housekeeping	   genes	   (βactin,	  
UBC,	  G6PD),	  that	  remain	  unchanged	  during	  siRNA	  treatment,	  and	  depicted	  relative	  to	  levels	  in	  Untreated	  cells.	  
Analysis	  by	  RT-­‐PCR	   in	  general	  verifies	   results	  seen	  by	  microarray	  with	  a	  couple	  of	  exceptions	   (Gata5,	  Nhlh1).	  
Mean	  and	  SD	  are	  from	  4	  biological	  replicates.	  
	  
	  
To	  understand	  whether	   the	   three	  PRC-­‐repressed	   genes	   that	   I	   had	  previously	   shown	   to	  be	  
sensitive	   to	  Exosc3	  knockdown,	  by	  single	  gene	  RT-­‐PCR	   (Fig.	  5.8),	  were	  also	  deregulated	  by	  
microarray	  analysis,	  I	  re-­‐analysed	  the	  original	  panel	  of	  PRC-­‐repressed	  genes	  by	  RT-­‐PCR	  in	  the	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samples	  that	  went	  onto	  the	  microarray	  (Fig.	  5.18)	  and	  compared	  the	  fold	  enrichment	  to	  that	  
seen	  in	  the	  microarray	  results	  (Table	  5.4).	  	  	  	  
	  
RT-­‐PCR	  results	  recapitulate	  those	  seen	  previously	  (Fig.	  5.8)	  with	  three	  PRC-­‐repressed	  genes	  
being	  upregulated	  upon	  exosome	  depletion	  (Math1,	  Nkx2-­‐9,	  Nkx2-­‐2).	  	  However,	  microarray	  
results	  do	  not	  all	  show	  the	  same	  trend	  as	  single	  gene	  analysis	  (Table	  5.4).	  Active	  (βactin)	  and	  
silent	   (Myf5)	   show	   the	   same	   trend	   in	   both.	   In	   contrast,	   Math1	   and	   Nkx2-­‐2	   were	   not	  
classified	   in	   the	   microarray	   as	   showing	   significant	   deregulation.	   However,	   they	   are	  
upregulated	   significantly	  when	   studied	   by	   RT-­‐PCR.	  Nkx2-­‐9	   is	   upregulated	   in	   both	   analyses	  
while	  HoxA7	  shows	  no	  change	  by	  microarray	  and	  a	  small	  change	  by	  RT-­‐PCR.	  Gata4	  shows	  no	  



















































































































Figure	  5.18	  PRC-­‐repressed	  genes,	  Math1,	  Nkx2-­‐9	  and	  Nkx2-­‐2,	  are	  upregulated	  in	  the	  RNA	  samples	  used	  for	  
microarray	  analysis.	  Total	  RNA	  samples	  from	  ES-­‐OS25	  (untreated,	  scrambled	  siRNA	  and	  Exosc3)	  were	  the	  same	  
as	   those	  used	   in	  microarray	  analysis	   from	  a	  48	  h	  treatment.	  Samples	  were	  converted	  to	  cDNA	  using	  random	  
primers	  and	  analysed	  by	  RT-­‐PCR	  at	  single	  genes.	  Primers	  at	  the	  5’	  ends	  of	  genes	  were	  used	  to	  detect	  total	  RNA	  
independent	  of	   splicing.	  A	  panel	  of	  active,	  PRC-­‐active,	  PRC-­‐repressed	  and	   inactive	   transcripts	  were	  analysed.	  
RNA	  levels	  were	  normalised	  to	  3	   individual	  housekeeping	  genes	  (βactin,	  UBC,	  G6PD),	   that	  remain	  unchanged	  
during	   siRNA	   treatment,	   and	   depicted	   relative	   to	   levels	   in	   Untreated	   cells.	   The	   same	   three	   PRC-­‐repressed	  
transcripts	   are	   upregulated	   as	   previously	   seen.	   No	   change	   at	   HoxA7	   and	  Gata4.	   Mean	   and	   SD	   are	   from	   4	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Table	  5.4	  Comparison	  of	  Log2FC	  from	  the	  same	  sample	  between	  microarray	  and	  RT-­‐PCR	  at	  a	  panel	  of	  active,	  















Reasons	   for	   discrepancies	   seen	   between	   the	   two	   analyses	   from	   the	   same	   samples	   are	  
unknown.	  Samples	  prepared	  for	  microarray	  analysis	  undergo	  intensive	  preparation	  protocols	  
with	  numerous	  cDNA	  conversions,	  fragmentation	  and	  labelling	  procedures,	  which	  may	  result	  
in	  losses.	  Both	  technologies	  rely	  on	  oligonucleotide	  probes	  and	  primers	  being	  positioned	  in	  
places	  where	  deregulation	  of	   transcription	  may	  be	  occurring	   in	   the	  gene	   length.	  However,	  
PolyA+	   analysis	   (Fig.	   5.12)	   suggests	   the	   PRC-­‐repressed	   genes	   analysed	   here	   are	   expressed	  
upon	   exosome	   depletion	   which	   would	   mean	   that	   wherever	   probes	   are	   positioned	   their	  
upregulation	  by	  microarray	  should	  be	  detected.	  
	  
It	  is	  known	  that	  the	  exosome	  regulates	  coding	  and	  non-­‐coding	  transcription	  in	  the	  sense	  and	  
antisense	  directions.	  Microarray	  analysis	  allows	  us	  to	  ask	  specific	  quantitative	  questions	  but	  
not	   the	  characterisation	  of	   transcript	   features,	  which	  may	  be	   important	   to	  understand	  the	  
role	  of	   the	  exosome	   in	  ES	  cells	  and	  at	  PRC-­‐repressed	  genes.	  Further	  studies	  would	  require	  
NGS	  analysis	  of	  exosome	  knockdowns	  to	  understand	  unequivocally	  what	  is	  happening	  at	  the	  
level	  of	  transcription.	  
5.2.11 PRC-­‐repressed	   transcripts	   show	   increased	   levels	   of	   capped	   transcripts	   by	   CAGE	  
after	  exosome	  knockout	  
Alongside	  microarray	  analysis	  matched	  samples	  were	  also	  sent	  for	  CAGE	  sequencing	  (RIKEN	  
OSC,	   Japan).	   CAGE	  was	   used	   to	   study	   5’	   cap	   dependent	   PRC-­‐repressed	   transcript	   changes	  
upon	  exosome	  knockdown.	  It	  can	  also	  be	  used	  as	  an	  independent	  verification	  of	  microarray	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analysis	   that	   does	   not	   depend	   on	   oligonucleotide	   probes.	   CAGE	   also	   allows	   us	   to	   look	   at	  
changes	   in	   antisense	   transcription	   and	   TSS	   usage	   on	   exosome	   depletion	   based	   on	   5’	   cap	  
presence.	  Antisense	  transcription	  from	  human	  promoters	  of	  active	  genes	  is	  regulated	  by	  the	  
exosome	  (Preker	  et	  al.,	  2008)	  and	  a	  panel	  of	  genes	  have	  been	  shown	  to	  be	  capped	  (Preker	  et	  
al.,	  2011).	   In	  ES	  cells,	  antisense	  transcripts	   from	  active	  genes	  are	  detected	  by	  RNAPII	  RNA-­‐
ChIP	   (Fig.	  3.15)	  which	  are	  at	   least	   in	  part	  capped	  as	  detected	  by	  CAGE	  analysis	   (Figs.	  4.21,	  
4.22).	   PRC-­‐repressed	   gene	   transcripts	   intriguingly	   show	   a	   range	   of	   levels	   of	   capped	  
transcripts,	  which	  appears	  to	  be	  distributed	  into	  two	  distinct	  populations	  (Figs.	  4.21,	  4.22).	  
	  
To	  explore	  whether	  we	  can	  detect	   transcript	   changes	  upon	  exosome	  depletion	  with	  CAGE	  
and	   whether	   promoter	   associated	   anti-­‐sense	   transcription	   at	   PRC-­‐repressed	   genes	   are	  
controlled	  by	  the	  exosome,	  we	  made	  average	  profiles	  of	  sequenced	  CAGE	  reads	   (tags;	  Fig.	  
5.19)	   at	   Active	   (highest	   20%	   expressed),	   PRC-­‐repressed	   and	   Silent	   genes	   (lowest	   20%	  
expressed)	  in	  ES	  cells.	  These	  groups	  are	  the	  same	  groups	  used	  in	  Chapter	  4.	  
	  
Active	   genes	   show	   no	   change	   in	   level	   of	   detection	   of	   capped	   transcripts	   in	   the	   sense	  
orientation	  with	  exosome	  knockout	  (Fig.	  5.19A).	  The	  TSS	  usage	  pattern	  also	  remains	  similar.	  
In	   contrast,	   antisense	   transcription	   from	   the	   promoters	   of	   active	   genes	   increases	  
dramatically	   with	   exosome	   knockdown,	   a	   feature	   demonstrated	   in	   human	   cells	   by	  
microarray	  (Preker	  et	  al.,	  2008).	   In	  contrast,	  at	  PRC-­‐repressed	  genes	  there	  is	  an	  increase	  in	  
sense	  orientated	  capping	  and	   transcription	  upon	  exosome	  depletion	   (Fig.	  5.19B),	  although	  
the	   profile	   of	   sense	   TSS	   usage	   does	   not	   change.	   Antisense	   transcription	   shows	   minimal	  
change	   suggesting	   that	   antisense	   transcripts	   are	   either	   not	   capped	   and	   undetectable	   by	  
CAGE,	   or	   not	   present	   at	   all	   and	   there	   is	   regulation	   of	   RNAPII	   in	   the	   presence	   of	   PRC	   by	  
unknown	  means.	   It	   is	   not	   known	  what	   happens	   to	   PRC	   and	   RNAPII	   occupancy	   as	  well	   as	  
RNAPII	   CTD	   modification	   upon	   exosome	   knockdown,	   although	   these	   analyses	   may	   help	  
decipher	  regulatory	  mechanism.	  Levels	  of	  PRC-­‐repressed	  capped	  transcripts	  are	  broad	  (Fig.	  
4.20A)	  with	  two	  seemingly	  distinct	  populations	  (Fig.	  4.20B).	  Exosome	  depletion	  results	  in	  an	  
increase	  in	  PRC-­‐repressed	  capped	  transcripts	  which	  is	  significant	  (Fig.	  4.20A,	  B;	  permutation	  
t-­‐test,	  p-­‐value	  <2x10-­‐16).	  There	  is	  no	  change	  at	  active	  and	  a	  minimal	  change	  at	  silent	  genes	  
which	  is	  not	  significant	  (p-­‐value	  <0.67).	  	  




Figure	   5.19	   Average	   profiles	   of	   CAGE	   signal	   at	   active,	   PRC-­‐repressed	   and	   silent	   genes	   upon	   exosome	  
depletion.	  Total	  RNA	  was	  extracted	   from	  ES-­‐OS25	  cells	  before	  or	  after	  Exosc3	   siRNA	   treatment	  and	   sent	   for	  
CAGE	  sequencing	   (Riken	  OSC,	   Japan).	  Average	   tags	  per	  million	  were	  calculated	  across	   the	  TSS	  and	  TES	   (-­‐1	   to	  
+1kb)	   for	   sense	   and	   antisense	   reads	   of	   active	   (20%	   most	   expressed),	   PRC-­‐repressed	   and	   silent	   (20%	   least	  
active).	  Upon	  exosome	  depletion,	  antisense	  transcripts	  at	  promoters	  increase	  at	  active	  genes.	  In	  contrast,	  PRC-­‐
repressed	  genes	  show	  higher	   levels	  of	  capped	  transcripts	   in	  the	  sense	  orientation	  and	  minimal	  change	  in	  the	  
antisense	  orientation.	  
	  




Figure	  5.20	  PRC-­‐repressed	  capped	  transcripts	  increase	  upon	  exosome	  knockdown.	  CAGE	  data	  was	  assessed	  to	  
look	  at	  the	  level	  of	  capped	  transcripts	  detected	  for	  Active,	  Silent	  and	  PRC-­‐repressed	  genes.	  (A)	  Levels	  of	  binding	  
were	  assessed	  by	  taking	  the	  sum	  of	  the	  tags	  per	  million	  (TPM)	  at	  the	  TSS	  (+/-­‐1kb).	  (B)	  Bean	  plots	  represent	  the	  
distribution	  within	  the	  gene	  group.	  Active	  genes	  have	  high	  levels	  of	  capped	  transcripts	  that	  do	  not	  change	  upon	  
exosome	  knockout.	  PRC-­‐repressed	  transcripts	  have	  broad	  levels	  of	  capping	  with	  two	  seemingly	  distinct	  groups.	  
Exosome	  depletion	  is	  marked	  by	  an	  increase	  in	  the	  low	  capped	  transcripts.	  Bioinformatic	  analysis	  performed	  by	  
N.Harmston.	  	  
 
5.2.12 Exosome	  associates	  with	  PRC-­‐repressed	  chromatin	  
The	  exosome	  has	  been	  shown	  to	  associate	  with	  RNAPII	  at	  chromatin	  (Andrulis	  et	  al.,	  2002)	  
regulating	   RNA	   production	   co-­‐transcriptionally.	   Our	   genome-­‐wide	   microarray	   analysis	  
demonstrates	  deregulation	  of	  transcription	  at	  a	  modest	  number	  of	  genes,	  many	  of	  which	  are	  
associated	  with	  PRC	  and	  RNAPII.	   In	  parallel	  with	  transcription	  studies	   I	  also	  asked	  whether	  
exosome	   associates	   with	   chromatin	   in	   ES	   cells	   at	   PRC	   bound	   genes	   and	   may	   act	   co-­‐
transcriptionally	  to	  regulate	  PRC	  repression,	   I	  performed	  DNA-­‐ChIP	  for	  Exosc7	  (Fig.	  5.21),	  a	  
structural	  subunit	  of	  the	  exosome	  (Fig.	  5.1).	  In	  preliminary	  analysis	  I	  focused	  on	  analysing	  a	  
panel	  of	  active,	  PRC-­‐repressed	  and	  silent	  genes	  shown	  previously,	  some	  of	  which	  are	  have	  
been	  shown	  to	  be	  under	  the	  influence	  of	  the	  exosome	  (Figs.	  5.8,	  5.10).	  














































































































Figure	  5.21	  Chromatin	  occupancy	  of	  the	  Exosc7	  subunit	  of	  the	  exosome	  at	  PRC-­‐repressed	  genes	   in	  ES	  cells.	  
Binding	  of	  exosome	  (Exosc7)	  to	  active,	  PRC-­‐repressed	  and	  silent	  genes	  in	  ES-­‐OS25	  cells	  was	  assessed	  by	  DNA-­‐
ChIP	  and	  RT-­‐PCR	  at	  promoters	   (red	  bars)	  and	  coding	  regions	  (blue	  bars).	  PRC-­‐repressed	  genes	  are	  associated	  
with	  Exosc7	  at	  promoters	  and	  coding	   regions.	  Enrichment	   is	  expressed	  relative	   to	   input	  DNA	  using	   the	  same	  
amount	   of	   DNA	   in	   the	   PCR.	   Background	   levels	   (mean	   enrichment	   from	   control	   antibodies)	   at	   promoter	   and	  
coding	   regions	   are	   shown	   as	   yellow	   or	   light	   blue	   bars,	   respectively.	   Mean	   and	   standard	   deviations	   are	  
presented	  from	  2	  independent	  biological	  replicates.	  
	  
	  
Interestingly,	  Exosc7	  associates	  with	  PRC-­‐repressed	  gene	  promoter	  and	  coding	   regions	  but	  
not	  active	  or	  silent	  genes.	  Lack	  of	  binding	  at	  active	  genes	  (βactin,	  Oct4)	  is	  consistent	  with	  the	  
fact	   that	   exosome	   knockdown	  with	   any	   of	   the	   subunits	   does	   not	   greatly	   affect	   transcript	  
levels	   (Fig	   5.8,	   5.10),	   also	   shown	   in	   the	   microarray	   where	   both	   are	   characterised	   as	  
unchanged	   (not	   shown).	   Surprisingly,	  binding	  occurs	  at	  all	   the	  PRC-­‐repressed	  genes	   tested	  
even	   though	   some	   were	   not	   affected	   (Gata4)	   or	   minimally	   affected	   (Cdx2,	   HoxA7)	   by	  
exosome	  knockdown,	  with	  the	  four	  subunits	  tested	  (Fig.	  5.8,	  5.10).	  Enrichment	  levels	  are	  low	  
but	  pattern	  of	  binding	  at	  PRC-­‐repressed	  genes	   is	   striking.	  Genome-­‐wide	  analysis	  of	  Exosc7	  
binding	   is	   underway	   to	   determine	   where	   in	   the	   genome	   exosome	   is	   bound	   and	   whether	  
there	   is	   specific	  binding	  at	  PRC-­‐repressed	  genes.	  These	   results	   in	   contrast	   to	   the	   low	   level	  
effects	  seen	  at	  PRC-­‐repressed	  genes	   in	   the	  genome-­‐wide	  microarray	  analysis	  of	  Exosc3	  KD	  
suggest	   further	  more	  detailed	  exploration	   is	  necessary	  to	   fully	  understand	  the	  roles	  of	   the	  
exosome	  in	  ES	  cells.	  	  




Disparity	   between	   RNAPII-­‐S5p	   abundance	   and	   low	   level	   transcription	   at	   PRC-­‐repressed	  
genes	  led	  to	  the	  hypothesis	  that	  regulation	  may	  involve	  RNA	  degradation.	  Differentiation	  of	  
ES	  cells	  reveals	  a	  decrease	  in	  expression	  levels	  of	  multiple	  components	  of	  the	  exosome	  (Fig.	  
5.2).	  This	  led	  us	  to	  ask	  whether	  the	  exosome	  which	  possesses	  endo-­‐	  and	  exonuclease	  activity	  
(Lebreton	  et	  al.,	  2008)	  is	  involved	  in	  ES	  cell	  gene	  regulation	  and	  possible	  PRC-­‐repressed	  gene	  
silencing.	   Xrn2,	   another	   important	   component	   of	   RNA	   surveillance	   systems	   in	   yeast	   and	  
mammals,	  was	  tested	  in	  parallel.	  
	  
Xrn2	  is	  important	  for	  transcription	  termination	  in	  yeast	  and	  mammals	  (Kim	  et	  al.,	  2004;	  West	  
et	  al.,	  2004)	  and	  has	  also	   implicated	   in	   regulation	  of	   transcription	  elongation	   in	  mammals,	  
with	  occupancy	  mirroring	  that	  of	  RNAPII	  through	  gene	  coding	  regions	  (Brannan	  et	  al.,	  2012).	  
We	   show	   that	   in	   ES	   cells	   Xrn2	  does	  not	   seem	   to	  have	   a	   significant	   role	   in	   repression	   at	   a	  
panel	  of	  PRC-­‐repressed	  genes	  or	  regulation	  of	  active	  genes	  at	  single	  gene	  level	  upon	  siRNA	  
knockdown	   (Fig.	   5.5).	   However,	   further	   analysis	   is	   required	   to	   understand	   whether	  
knockdown	  was	  sufficient	  to	  be	  able	  to	  observe	  a	  phenotype.	  Xrn2	  has	  been	  shown	  to	  work	  
alongside	   termination	   factors	   and	   de-­‐capping	   enzyme	   Dcp1	   in	   human	   cells	   to	   regulate	  
transcription	  elongation.	  Significant	  effects	  on	  RNAPII	  occupancy	  were	  only	  observed	  upon	  
knocking	   down	   both	   Xrn2	   and	   termination	   factor	   TTF2	   (Brannan	   et	   al.,	   2012),	   suggesting	  
cooperation	   at	   the	   level	   of	   gene	   regulation.	   Abundant	   RNAPII-­‐S5p	   and	   low	   level	   capping	  
suggest	   that	   a	   similar	   situation	   is	   possible	   at	   PRC-­‐repressed	   genes	   where	   many	   proteins	  
regulate	  one	  pathway	  of	  degradation.	  
	  
In	  contrast,	  exosome	  knockdown	  resulted	  in	  substantial	  upregulation	  at	  three	  PRC-­‐repressed	  
transcripts	   in	   ES	   cells	   (Figs.	   5.8,	   5.10,	   5.11,	   5.12).	   Encouragingly,	   identical	   deregulation	   of	  
three	   neural	   lineage	   genes	   was	   seen	   with	   knockdown	   of	   four	   separate	   subunits	   of	   the	  
complex	   (Figs.	   5.8,	   5.10).	   Transcript	   deregulation	   was	   seen	   at	   the	   level	   of	   primary	  
transcription	  and	  splicing	  (Fig.	  5.11)	  and	  polyadenylation	  (Fig.	  5.12).	  An	  increase	  in	  primary	  
transcription	   suggested	   that	   regulation	   occurs	   at	   the	   level	   of	   RNAPII	   transcription	   and	  
opened	  the	  intriguing	  possibility	  that	  exosome	  may	  synergize	  with	  RNAPII	  and	  PRC	  function.	  
Exosome	   can	   associate	   at	   active	   genes	   with	   RNAPII	   and	   elongation	   factors	   in	   Drosophila	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suggesting	   a	   role	   in	   RNA	   surveillance	   at	   the	   level	   of	   chromatin	   (Andrulis	   et	   al.,	   2002).	  
Association	  with	  hnRNP’s	  also	  occurs	  in	  Drosophila	  with	  the	  implication	  that	  exosome	  can	  be	  
recruited	   to	   all	   transcribing	   RNA’s	   (Hessle	   et	   al.,	   2009).	   Interestingly,	   exosome	   subunit	  
Exosc7	  associates	  with	  a	  panel	  of	  PRC-­‐repressed	  genes	  in	  ES	  cells	  (Fig.	  5.21),	  suggesting	  that	  
exosome	  may	  play	  a	  role	  in	  transcription	  regulation.	  	  
	  
However,	   genome-­‐wide	  microarray	   analysis	   did	  not	   find	   a	   significant	   deregulation	  of	   PRC-­‐
repressed	   gene	   transcription	   (Fig.	   5.16)	   and	   the	   percentage	   of	   genes	   with	   a	   fold	   change	  
above	  one	  was	  low	  genome-­‐wide	  (Table	  5.3).	  However,	  an	  appreciable	  percentage	  of	  genes	  
displayed	  very	  low	  fold	  changes,	  which	  were	  not	  significant	  by	  microarray	  (Table	  5.3).	  More	  
sensitive	  methods	  such	  as	  NGS	  may	  be	  more	  effective	  at	  studying	  low	  level	  changes	  which	  
are	   likely	   to	   be	   prevalent	   from	   an	   RNA	   surveillance	   mechanism	   which	   fine	   tunes	  
transcription	   levels.	   In	   addition,	   PRC-­‐repressed	   genes	   transcribe	   at	   low	   levels	   and	   fold	  
change	   quantification	   by	   microarray	   requires	   robust	   detection	   across	   all	   replicates	   and	  
conditions,	  which	  may	  be	  hard	   to	  detect	   from	   this	   group	  of	   genes.	  Modest	   changes	  were	  
detected	  primarily	  at	  active	  genes	  (Fig.	  5.16).	  A	  group	  of	  expressed	  PRC	  target	  genes	  termed	  
PRC-­‐active	  were	  the	  second	  most	  deregulated	  gene	  group	  studied	  (Fig.	  5.16).	  This	  group	  of	  
genes	  exists	  in	  an	  active	  or	  repressed	  state	  in	  cells	  among	  a	  heterogeneous	  population	  and	  
are	  enriched	  for	  developmental	  and	  metabolic	  genes	  (Brookes	  et	  al.,	  2012).	  PRC-­‐repressed	  
genes	  showed	  little	  change	  upon	  Exosc3	  knockdown	  (Fig.	  5.16).	  This	  is	  surprising	  when	  three	  
of	   the	   six	   genes	   tested	  by	  RT-­‐PCR	   showed	   significant	   upregulation	   among	   a	   genome-­‐wide	  
population	   of	   1,065	   PRC-­‐repressed	   genes	   (Figs.	   5.8,	   5.10).	   Verification	   of	   microarray	   by	  
single	   gene	   RT-­‐PCR	   analysis	   was	   generally	   in	   agreement	   (Fig.	   5.17).	   However,	   slight	  
discrepancies	   were	   detected	   at	   PRC-­‐repressed	   gene	  Gata5	   and	   Inactive	   gene	  Nhlh1	   (Fig.	  
5.17).	  Differences	  were	  also	  detected	   for	   the	  original	  panel	  of	  PRC-­‐repressed	  genes	   tested	  
where	  Math1	  and	  Nkx2-­‐2	  were	   upregulated	  by	  RT-­‐PCR	  but	   not	   by	  microarray	   (Table	   5.4).	  
Nkx2-­‐2	  exists	  in	  two	  isoforms	  and	  Gata5	  is	  overlapped	  with	  a	  predicted	  gene	  at	  its	  promoter	  
region	  (based	  on	  RefSeq	  annotations).	  Microarray	  oligonucleotide	  positioning	  is	  not	  known	  
and	  means	  that	  we	  cannot	  be	  sure	  what	  is	  being	  detected	  within	  the	  genes	  and	  also	  relative	  
to	  RT-­‐PCR	  where	  5’	  exonic	  primers	  were	  used	  to	  detect	  total	  transcripts.	  Math1	  and	  Nhlh1	  
are	   absent	   for	   overlapping	   transcripts	   or	   isoforms	   so	   reasons	   for	   the	   differences	   are	  
unknown.	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CAGE	  analysis	  at	  active	  genes	  shows	  an	  increase	  in	  capped	  antisense	  transcription,	  a	  feature	  
documented	   previously	   at	   a	   limited	   number	   of	   genes	   (Preker	   et	   al.,	   2011).	   Here,	   we	  
demonstrate	   that	  antisense	   transcripts	   identified	  at	  active	  genes	   in	  ES	  cells,	  which	  are	  de-­‐
repressed	  upon	  exosome	  knockdown,	  are	  capped	  (Figs.	  5.19,	  5.20).	  A	  significant	  increase	  in	  
PRC-­‐repressed	   capped	   transcripts	   (Fig.	   5.20)	   seen	   at	   the	   TSS	   in	   a	   sense	   orientation	   is	   in	  
contrast	  to	  microarray	  analysis	  which	  detected	  minimal	  changes	  in	  transcription	  (Fig.	  5.16).	  
The	   two	   technologies	   are	   vastly	  different	  and	   further	  analysis	  of	  CAGE	  data	   is	   required	   to	  
understand	  the	  commonalities	  and	  differences.	  More	  detailed	  analysis	   into	   the	  population	  
of	   genes	   that	   change	   by	   CAGE	   is	   required.	   For	   example,	   they	   could	   belong	   to	   the	   PRC-­‐
repressed	   genes	   that	   have	   RNAPII-­‐S5p	   at	   the	   TSS	   only	   and	   capping	   at	   these	   genes	   is	   a	  
regulatory	  step	  as	  opposed	  to	  those	  where	  RNAPII-­‐S5p	  can	  traverse	  to	  the	  TES,	  or	  vice	  versa	  
(Chapter	   4).	   	   Interestingly,	   there	   is	   no	   real	   change	   in	   antisense	   transcription	   at	   PRC-­‐
repressed	  genes	  (Fig.	  5.19)	  suggesting	  that	  that	  they	  either	  increase	  but	  are	  not	  capped	  and	  
therefore	  not	  detected,	  or	   that	  antisense	  transcription	   is	  not	   regulated	  by	   the	  exosome	  at	  
PRC-­‐repressed	  genes.	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6 RNAPII	  CTD	  Glycosylation	  in	  ES	  cells	  
6.1 Introduction	  
All	  residues	  that	  make	  up	  the	  CTD	  heptapeptide	  repeat	  have	  the	  potential	  to	  be	  dynamically	  
and	   reversibly	   modified.	   Phosphorylation	   can	   occur	   at	   tyrosine,	   threonine	   and	   serine	  
residues,	  glycosylation	  at	  serines	  and	  threonine,	  and	  isomerization	  of	  prolines	  (Egloff	  2012,	  
Kelly	  and	  Hart	  1993,	  Fuchs	  2009;	  Fig.	  6.1).	  Non-­‐canonical	  aminoacids	  at	  the	  CTD	  can	  also	  be	  
modified,	   such	   as	   a	   single	   arginine	   found	   at	   the	   vertebrate	   CTD	  which	   has	   recently	   been	  
shown	  to	  be	  methylated	  in	  human	  cells	  (Sims	  et	  al.,	  2011). Linking	  modifications	  to	  biological	  
function	  is	  an	  ongoing	  effort,	  and	  the	  combinatorial	  effects	  of	  different	  modifications	  are	  still	  














Figure	   6.1	  Modifications	   of	   the	   RNAPII	   CTD.	   The	   largest	   subunit	   of	   RNAPII,	   RPB1,	   contains	   a	   heptapeptide	  
repeat	   where	   each	   residue	   has	   the	   potential	   to	   be	   modified.	   Modifications	   depicted	   are	   known	   or	  
hypothesized.	  Modifications	  known	  to	  occur	  in	  vitro	  or	  in	  vivo	  with	  links	  to	  important	  transcriptional	  processes	  
are	  Ser5p,	  Ser2p,	  Ser7p,	  Thr4p	  and	  Tyr1p.	  Other	  putative	  modifications	  have	  so	   far	  been	   largely	  unexplored,	  
including	   glucosylation	   of	   serines	   or	   threonine.	   In	  mammals,	   the	   CTD	   has	   52	   repeats	   giving	   scope	   for	  many	  
combinations	  of	  modifications	  on	  the	  same	  or	  different	  repeats.	   	  All	  modifications	  above	  are	  depicted	  on	  the	  
same	  repeat	  for	  simplicity	  but	  can	  occur	  in	  the	  same	  or	  different	  CTD	  repeats.	  
	  
Only	  a	  few	  CTD	  modifications	  have	  been	  studied	  in	  detail	  including	  phosphorylation	  of	  S5,	  S2	  
and	   more	   recently	   S7	   residues,	   all	   of	   which	   orchestrate	   transcription	   with	   chromatin	  
modifications	   and	   RNA	   processing.	   Other	   modifications,	   including	   tyrosine	   and	   threonine	  
phosphorylation,	  have	  only	  recently	  been	  proposed	  to	  have	  functional	  roles	  in	  transcription.	  
Tyrosine	  phosphorylation	   is	   linked	  to	  termination	  control	   in	  yeast	   (Mayer	  et	  al.,	  2012)	  and	  
threonine	  phosphorylation	  with	  histone	  mRNA	  processing	  in	  yeast,	  and	  elongation	  control	  in	  
mammals	  (Hsin	  et	  al.,	  2011;	  Hintermair	  et	  al.,	  2012).	  Structural	  changes	  of	  the	  CTD	  can	  occur	  
through	  proline	  isomerization	  between	  cis	  and	  trans	  conformations.	  Interestingly,	  structural	  
changes	  in	  the	  CTD	  are	  suggested	  to	  prevent	  accessibility	  of	  proteins	  and	  the	  cis-­‐isomer	  form	  
of	  the	  CTD	  was	  shown	  to	  be	  the	  preferred	  substrate	  of	  the	  S5p	  phosphatase	  Ssu72,	  linking	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proline	   isomerisation	   and	   transcription	   (Werner-­‐Allen	   et	   al.,	   2011).	   Additional	   CTD	  
modifications	   are	  possible	   in	  higher	   eukaryotes	   at	   lysine	   and	  arginine	   residues,	   present	   at	  
non-­‐consensus	   repeats	   of	   the	   CTD,	   adding	   additional	   layers	   of	  modification	   potential	   and	  
complexity.	  Methylation	  of	  the	  arginine	  residue	  of	  human	  CTD	  has	  been	  demonstrated,	  and	  
is	  important	  for	  the	  correct	  expression	  of	  snRNA	  and	  snoRNA	  genes	  (Sims	  et	  al.,	  2011);	  a	  link	  
with	  RNAPII	  transcription	  is,	  as	  yet,	  unknown.	  	  	  
6.1.1 RNAPII	  Glycosylation	  
Serine	  and	  threonine	  residues	  of	   the	  CTD	  repeat	  have	   the	  potential	   to	  be	  glycosylated	   (O-­‐
GlcNAc),	   a	   modification	   demonstrated	   in	   vitro	   over	   15	   years	   ago	   (Kelly	   et	   al.,	   1993)	   but	  
studied	   in	  vivo	   only	   recently	   in	   the	   context	   of	   transcriptional	   regulation	   (Ranuncolo	   et	   al.,	  
2012).	   In	   vitro,	   phosphorylation	   and	   glycosylation	   on	   the	   same	   CTD	   repeat	   appear	   to	   be	  
mutually	   exclusive,	   which	   has	   suggested	   that	   glycosylation	  may	   have	   a	   repressive	   role	   in	  
transcription	   (Comer	  and	  Hart,	  2001).	  More	  recently,	  O-­‐GlcNAc	  modification	  of	  RNAPII	  has	  
been	   identified	   at	   gene	   promoters,	   suggesting	   it	   may	   play	   a	   role	   in	   regulation	   of	  
transcription	  initiation	  and	  formation	  of	  the	  PIC	  (Ranuncolo	  et	  al.,	  2012).	  
	  
O-­‐GlcNAc	   is	   added	   and	   removed	   by	   the	   enzymes	  OGT	   and	  OGA,	   respectively	   (Hart	   et	   al.,	  
2007,	  Ranuncolo	  et	   al.,	   2012).	  OGT	  has	  been	   shown	   to	   co-­‐immunoprecipitate	  with	  RNAPII	  
(Ranuncolo	   et	   al.,	   2012).	   Intriguingly,	   OGT	   is	   required	   for	   viability	   of	   ES	   cells	   (Shafi	   et	   al.,	  
2000)	  and	  has	  been	  shown	  to	  play	  a	  role	  in	  Polycomb	  mediated	  repression	  of	  target	  genes	  in	  
Drosophila	  (Gambetta	  et	  al.,	  2009),	  although	  how	  this	  occurs	  is	  not	  known.	  	  
	  
The	   separate	   observations	   that	   an	   unusual	   silent	   form	   of	   RNAPII	   is	   detected	   at	   PRC-­‐
repressed	  genes	  in	  ES	  cells,	  its	  ability	  to	  be	  glycosylated	  and	  the	  link	  to	  transcription	  control	  
and	  gene	  repression	  led	  us	  to	  ask	  whether	  RNAPII	  at	  PRC-­‐repressed	  genes	  is	  glycosylated.	  
6.1.2 Aims	  
My	  aim	  was	  to	  explore	  the	  presence	  of	  RNAPII	  glycosylation	  in	  ES	  cells.	  In	  particular,	  I	  asked	  
whether	  this	  modification	  was	  a	  feature	  of	  RNAPII	  at	  active	  and/or	  PRC-­‐repressed	  genes	  at	  
single	  genes	  and	  genome-­‐wide	  in	  ES	  cells.	  Serine	  and	  threonine	  residues	  within	  the	  CTD	  have	  
the	  potential	   to	  be	   glycosylated	  and	   therefore	  may	  play	   similar	   or	   distinct	   roles	   in	  RNAPII	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regulation.	   Using	   antibodies	   specific	   for	   S5	   or	   T4	   glycosylation	   (kindly	   donated	   by	   D.Eick,	  
Helmholtz	   Center	   for	   Environmental	   Health,	   Munich),	   I	   characterised	   their	   specificity	  
towards	   RNAPII	   isoforms	   and	   relationship	   with	   CTD	   phosphorylation.	   I	   went	   on	   to	   study	  
binding	  of	  glycosylated	  RNAPII	  to	  a	  panel	  of	  active,	  PRC-­‐repressed	  and	  silent	  genes	  followed	  
by	  genome-­‐wide	  analysis	  by	  NGS.	  	  	  
	  
Raw	  sequencing	  files	  were	  processed	  and	  UCSC	  compatible	  files	  generated	  by	  A.Geiss	  (MRC	  
Genomics	   Laboratory).	   All	   bioinformatic	   analyses	   in	   this	   chapter	   were	   performed	   by	   I.de	  
Santiago	   (our	   laboratory).	   An	   experiment	   shown	   in	   Fig.	   6.2B	  was	   performed	   by	   E.Brookes	  
(our	   laboratory)	  and	  shown	  here	  to	  help	  demonstrate	  the	  effects	  of	   flavopiridol	  on	  RNAPII	  
phosphorylation	   patterns	   and	   aid	   interpretation	   of	   my	   own	   results.	   Immunofluorescence	  



































6.2.1 Characterising	  RNAPII-­‐CTD	  Glycosylation	  antibodies	  
Glycosylation	  of	  the	  RNAPII	  CTD	  has	  been	  shown	  in	  vitro	  to	  preferentially	  occur	  on	  its	  hypo-­‐
phosphorylated	  form	  (Comer	  and	  Hart,	  2001).	  However,	   the	  specific	  glycosylation	  patterns	  
of	   S5	   and	   T4	   have	   not	   been	   studied	   in	   vivo	   including	   whether	   these	   modifications	  
preferentially	   occur	   on	   different	   phospho-­‐isoforms	   of	   RNAPII.	   Antibodies	   towards	   S5	  
glycosylation	  (S5G)	  and	  T4	  glycosylation	  (T4G)	  were	  developed	  and	  kindly	  provided	  by	  Dirk	  
Eick’s	  laboratory	  (Helmholtz	  Center	  for	  Environmental	  Health,	  Munich).	  	  
	  
To	   understand	   specificity	   of	   the	   S5G	   and	   T4G	   antibodies	   for	   RNAPII	   and	   their	   binding	   to	  
hypo-­‐	   or	   hyper-­‐phosphorylated	   RNAPII,	   I	   started	   by	   performing	   western	   blot	   analysis	   on	  
whole	   extracts	   from	   ES-­‐OS25	   cells	   (Fig.	   6.2A).	   Antibody	   8WG16	   with	   preference	   for	  
unphospho	  S2	  residues	   (Stock	  et	  al.,	  2007)	  was	  used	  as	  a	  control	   to	  depict	   the	  position	  of	  
hypo-­‐phosphorylated	   RNAPII	   (form	   IIa).	   S5G	   antibodies	   bind	   specifically	   to	   RNAPII	   and	  
preferentially	   associate	   with	   the	   hypo-­‐phosphorylated	   form	   (IIa)	   and	   intermediately	  
phosphorylated	   bands.	   In	   contrast,	   T4G	   antibodies	   preferentially	   associate	   with	   hyper-­‐
phosphorylated	  RNAPII	  (IIo)	  and	  intermediate	  forms	  of	  RNAPII.	  This	  is	  surprising	  as	  previous	  
work	   suggested	   that	  glycosylation	  and	  phosphorylation	  are	  mutually	  exclusive	   (Comer	  and	  
Hart,	  2001).	  However,	   the	  present	  analysis	  does	  not	   tell	  us	  whether	   the	  modifications	  are	  
occurring	  on	   the	   same	   repeats,	   repeats	   in	   close	  proximity	  or	   those	   that	  are	   far	   from	  each	  
other.	  Binding	  of	  S5G	  and	  T4G	  to	  alternate	  isoforms	  of	  RNAPII	  (Fig.	  6.2A),	  already	  suggests	  
possible	   differing	   roles	   for	   each	  modification	   in	   RNAPII	   function,	   and	   raises	   the	   possibility	  
that	  glycosylation	  may	  be	  important	  during	  active	  transcription,	  unlike	  what	  was	  previously	  
thought	  based	  on	  in	  vitro	  experiments.	  
	  
To	  investigate	  the	  relationship	  between	  CTD	  phosphorylation	  and	  S5	  and	  T4	  glycosylation,	  I	  
performed	  western	   analysis	   on	   extracts	   from	  ES	   cells	   that	   had	  undergone	  CDK9	   inhibition	  
using	   transcriptional	   inhibitor	   flavopiridol.	   CDK9	   phosphorylates	   S2	   residues	   and	   its	  
inhibition	  results	  in	  cellular	  depletion	  of	  S2p	  within	  1	  h	  of	  treatment	  with	  10µM	  flavopiridol	  
(Fig.	   6.2B;	   E.Brookes).	   S5	   phosphorylation	   shows	  minimal	   depletion	  while	   levels	   of	   RNAPII	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(8WG16)	   do	   not	   change;	   in	   both	   cases	   the	   lowest	   migration	   intensity	   is	   depleted	   with	  
flavopiridol	   consistent	  with	   the	   loss	   of	   S2p	   hyperphosphorylated	   form.	   In	   the	   presence	   of	  
increasing	  flavopiridol	  concentration,	  the	  S5G	  modification	  is	  depleted	  to	  the	  same	  extent	  as	  
S5p,	  reaching	  a	  similar	  level	  to	  that	  seen	  for	  S5p	  at	  10µM	  	  (Fig.	  6.2B,C).	  T4G	  is	  dramatically	  
depleted	   at	   lower	   concentrations	   of	   flavopiridol	   and	   almost	   completely	   absent	   at	   10µM,	  
similar	  to	  the	  effects	  seen	  for	  S2p.	  The	  association	  of	  T4G	  modification	  with	  lower	  mobility	  
RPB1	  bands	  and	  the	  similarity	  between	  its	  depletion	  kinetics	  following	  flavopiridol	  treatment	  
suggest	  that	  T4G	  may	  be	  linked	  to	  transcription	  elongation	  and	  be	  CDK9	  dependent.	  
	  
Figure	  6.2	  Characterising	  S5G	  and	  T4G	  antibodies	  by	  western	  blotting.	   (A)	  Reactivity	  of	  RNAPII	  Glycosylation	  
antibodies	  against	  hyper-­‐	  (IIo)	  and	  hypo-­‐phosphorylated	  (IIa)	  forms	  of	  the	  largest	  subunit	  of	  RNAPII,	  RPB1,	  was	  
assessed	  by	  western	  blotting	  using	  whole-­‐cell	  extracts	  from	  untreated	  ES-­‐OS25	  cells.	  8WG16	  has	  a	  preference	  
for	   unphospho-­‐S2	   residues	   and	   is	   used	   as	   a	   control	   to	  demonstrate	   the	  migration	  of	   the	   IIa	  Rpb1	  band	  and	  
intermediately	  phosphorylated	  bands.	  Antibodies	  against	  S5G	  (clone	  SG8)	  recognize	  the	  IIa	  and	  intermediately	  
phosphorylated	   bands	   while	   T4G	   (clone	   SC7)	   recognizes	   IIo	   and	   intermediate	   bands.	   (B)	   Effects	   of	   CDK9	  
inhibition	  on	  phosphorylation	  status	  of	  RNAPII.	  Whole	  cell	  extracts	  were	  prepared	  from	  cells	  treated	  (1h)	  with	  
0.1-­‐10	  μM	  flavopiridol	  in	  DMSO,	  separated	  by	  SDS-­‐PAGE	  and	  analysed	  by	  western	  blotting.	  RNAPII-­‐S2p	  is	  highly	  
sensitive	   to	   CDK9	   inhibition.	   S5p	   residues	   are	   still	   detected	   at	   10µM	   flavopiridol	   albeit	   at	   a	   reduced	   signal.	  
There	  is	  no	  detectable	  change	  in	  RNAPII	  levels	  as	  shown	  by	  8WG16.	  	  Figure	  from	  E.Brookes.	  (C)	  Effects	  of	  CDK9	  
inhibition	  on	  the	  glycosylation	  status	  of	  RNAPII.	  Whole	  cell	  extracts	  were	  prepared	  from	  cells	  treated	  (1h)	  with	  
0.1-­‐10	  μM	  flavopiridol	   in	  DMSO,	  separated	  by	  SDS-­‐PAGE	  and	  analysed	  by	  western	  blotting.	  RNAPII-­‐S5G	  is	  still	  
detected	   at	   10µM	   flavopiridol	   albeit	   at	   a	   reduced	   signal,	   with	   a	   similar	   profile	   as	   S5p.	   RNAPII-­‐T4G	   is	   highly	  
sensitive	  to	  CDK9	  inhibition.	  Detection	  of	  PCNA	  was	  used	  as	  loading	  control.	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The	   new	   S5G	   and	   T4G	   antibodies	   were	   also	   characterized	   by	   immunofluorescence	   in	   ES-­‐
OS25	   cells	   on	   ultrathin	   cryosections	   (Fig.	   6.3),	   which	   allows	   detection	   at	   high	   spatial	  
resolution.	  Immunodetection	  of	  RNAPII-­‐S5p	  distribution	  using	  the	  same	  antibody	  as	  in	  DNA-­‐	  
and	  RNA-­‐ChIP	   (Chapter	  3	  and	  4)	   is	   included	  for	  comparison.	  All	   forms	  of	  RNAPII	  are	   found	  
within	   discrete	   sites	   in	   the	   nucleoplasm,	   mostly	   outside	   heterochromatic	   regions	   and	  
nucleoli.	   RNAPII-­‐T4G	   and,	   in	   particular,	   RNAPII-­‐S5G	   are	   also	   found	   in	   the	   cytoplasm,	   in	  
contrast	   with	   S5p	   (and	   S2p;	   not	   shown)	   modification	   (Fig.	   6.3).	   Detection	   is	   likely	   to	   be	  
specific	  as	  cytoplasmic	  staining	  is	  also	  apparent	  with	  other	  RNAPII	  antibodies	  (H224;	  RPB1	  N-­‐
term)	  and	  is	  thought	  to	  be	  RPB1	  proteins	  in	  transit	  from	  the	  site	  of	  translation	  to	  the	  nucleus	  
(Xie	   and	  Pombo,	   2006).	   RNAPII-­‐T4G	  may	   therefore	  be	   involved	   in	  RNAPII	   regulation	  when	  
not	  associated	  with	  the	  chromatin	  template	  during	  transcription.	  Both	  S5G	  and	  T4G	  show	  a	  
more	   discrete	   pattern	   than	   RNAPII-­‐S5p,	  which	  may	   be	   due	   to	   a	  more	   restricted	   presence	  
throughout	   the	   genome,	   if	   these	   marks	   associate	   with	   active	   complexes	   or	   with	   lower	  












Figure	   6.3	   Characterising	   S5G	   and	   T4G	   cellular	   distribution	   in	   ES	   cells	   by	   immunofluorescence.	   Ultrathin	  
cryosections	   (~150nm	   thick)	   of	   ES-­‐OS25	   cells	   were	   indirectly	   immunolabelled	   with	   antibodies	   specific	   for	  
glycosylated	   and	   phosphorylated	   RNAPII,	   including	   RNAPII-­‐T4G	   (A,	   B,	   C),	   RNAPII-­‐S5G	   (D,	   E,	   F)	   and	   RNAPII-­‐S5p	  
(G,H,I),	  as	   indicated	   in	  representative	  confocal	   images	  at	   lower	  (green;	  A,	  D,	  G;	  bars:	  20µm)	   	  and	  higher	  (B&C;	  
E&F;	  H&I;	  bars:	  1µm)	  magnification.	  Nuclei	  were	  counterstained	  with	  TOTO-­‐3	  (red).	   	  All	   forms	  of	  RNAPII	   (T4G,	  
S5G,	  S5p)	  are	  found	  in	  discrete	  sites	  throughout	  the	  nucleoplasm	  (dotted	  line;	  B;	  E;	  H),	  mostly	  outside	  nucleoli,	  
with	   a	   fraction	  of	   RNAPII-­‐S5G	   found	   in	   the	   cytoplasm	   (arrowheads,	   E,	   F).	   T4G	   and	   S5G	   show	  a	  more	  discrete	  
pattern	  than	  S5p.	  RNAPII-­‐T4G	  was	  detected	  with	  rat	  anti-­‐T4G	  (clone	  SC7)	  antibodies.	  RNAPII-­‐S5G	  was	  detected	  
with	   rat	   anti-­‐S5G	   (clone	   SG8).	   	   RNAPII-­‐S5p	  was	  detected	  with	  mouse	  anti-­‐S5p	   (clone	  4H8;	  G,	  H,	   I)	   antibodies.	  
Experiments	  were	  performed	  by	  Sheila	  Q	  Xie	  (our	  laboratory).	  
	  
6.2.2 Glycosylated	  RNAPII-­‐CTD	  is	  a	  marker	  of	  active	  and	  not	  PRC-­‐repressed	  genes;	  single	  
gene	  studies	  
To	  investigate	  whether	  RNAPII-­‐S5G	  and	  RNAPII-­‐T4G	  are	  involved	  in	  gene	  transcription	  and	  in	  
particular	  are	  associated	  with	  RNAPII	  present	  at	  PRC-­‐repressed	  genes,	  I	  performed	  DNA-­‐ChIP	  
focusing	  on	  a	  panel	  of	  active,	  PRC-­‐repressed	  and	  silent	  genes	   (Fig.	  6.4).	   Interestingly,	  both	  
S5G	   and	   T4G	   abundantly	   associate	  with	   active	   genes.	   S5G	   binds	   at	   very	   low	   levels	   to	   the	  
panel	   of	   PRC-­‐repressed	   genes	   while	   there	   is	   no	   enrichment	   for	   T4G;	   the	   latter	   is	   again	  
consistent	  with	  similarities	  between	  T4G	  and	  S2p	  as	  revealed	  by	  western	  blot	  analyses	  (Fig.	  
6.2).	   RNAPII-­‐S5G	   associates	  with	   promoter	   regions	   of	   active	   genes	   decreasing	   into	   coding	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regions	  of	  βactin	  and	  Oct4.	  RNAPII-­‐T4G	  also	  associates	  with	  active	  gene	  promoters	  and,	   in	  
contrast	   to	   S5G	   it	   increases	   into	   coding	   regions	  of	  βactin	   and	  Oct4,	   in	   agreement	  with	   its	  
similar	   behaviour	   to	   S2p	  modification	   (Fig.	   6.2C).	   There	   is	   no	   binding	   at	   silent	   genes	  with	  
either	  antibody	  showing	   the	  specificity	  of	   the	  ChIP	  assay.	  The	  higher	  abundance	  of	  S5G	  at	  
promoters	   and	   T4G	   at	   coding	   regions	   suggest	   alternate	   roles	   for	   these	   modifications	   in	  








































































































































Figure	  6.4	  RNAPII-­‐S5G	  and	  RNAPII-­‐T4G	  bind	   to	  active	  and	  not	  PRC-­‐repressed	  genes.	  Binding	  of	  RNAPII-­‐S5G	  
and	  RNAPII-­‐T4G	  at	  active,	  PRC-­‐repressed	  and	  silent	  genes	  in	  ES-­‐OS25	  cells	  were	  assessed	  by	  DNA-­‐ChIP	  and	  RT-­‐
PCR	  at	  promoters	  (blue	  bars)	  and	  coding	  regions	  (red	  bars).	  RNAPII-­‐S5p	  is	   included	  from	  Chapter	  3	  Figure	  3.2	  
for	  comparison.	  Background	  levels	  (mean	  enrichment	  from	  control	  antibodies	  or	  beads	  alone)	  at	  promoter	  and	  
coding	   regions	   are	   shown	   as	   burgundy	   or	   light	   blue	   bars,	   respectively.	   RNAPII-­‐S5G	   binds	   to	   active	   gene	  
promoters	   with	   lower	   levels	   in	   coding	   regions,	   excluding	   Sox2.	   RNAPII-­‐T4G	   binds	   to	   active	   gene	   promoters	  
increasing	  through	  coding	  regions.	  Low-­‐level	  binding	  is	  seen	  at	  PRC-­‐repressed	  genes	  for	  S5G	  and	  none	  for	  T4G.	  
RNAPII-­‐S5p	  demonstrates	  binding	  at	  active	  and	  PRC-­‐repressed	  genes.	  Enrichment	  is	  expressed	  relative	  to	  input	  
DNA	   using	   the	   same	   amount	   of	   DNA	   in	   the	   PCR.	   Mean	   and	   standard	   deviations	   are	   presented	   from	   3	  
independent	  biological	  replicates.	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6.2.3 Glycosylated	  RNAPII	  is	  associated	  with	  active	  genes	  genome-­‐wide	  
The	  intriguing	  presence	  of	  glycosylated	  RNAPII	  at	  active	  genes	  in	  ES	  cells	  suggests	  a	  role	  for	  
glycosylation	   in	   transcriptional	   regulation	  and	   in	  particular	  a	   role	   in	  elongation	   for	  RNAPII-­‐
T4G.	  In	  addition,	  binding	  at	  a	  panel	  of	  active	  genes	  and	  the	  association	  of	  low	  level	  RNAPII-­‐
S5G	  with	  a	  panel	  of	  PRC-­‐repressed	  genes	  encouraged	  us	  to	  ask	  where	  glycosylated	  RNAPII	  
binds	  genome-­‐wide.	  To	  this	  end,	  I	  made	  ChIP-­‐seq	  multiplex	  libraries	  for	  both	  modifications.	  
Samples	  went	  through	  quality	  control	  testing	  by	  RT-­‐PCR	  for	  active,	  PRC-­‐repressed	  and	  silent	  
genes,	   as	   above,	   prior	   to	   library	   preparation	   (not	   shown),	   followed	   by	   sequencing	   on	   an	  
Illumina	  HiSeq	  machine.	  Read	  numbers	  and	  alignments	  for	  the	  two	  libraries	  are	  represented	  
in	  Table	  6.1.	  
	  















To	  begin	  exploring	  characteristics	  of	  RNAPII-­‐S5G	  and	  T4G	  binding	  at	  single	  genes,	  sequenced	  
reads	  were	  aligned	   to	   the	   reference	  murine	  genome	   (assembly	  mm9)	  and	  visualized	  using	  
the	  Genome	  Browser	  UCSC	   (Figs.	   6.5,	   6.6).	   Profiles	   of	   published	   RNAPII-­‐S5p,	   S2p	   and	   S7p	  
DNA-­‐ChIP-­‐seq	  in	  the	  same	  cell	  line	  are	  included	  for	  comparison	  (Brookes	  et	  al.,	  2012).	  	  
	  
Both	  S5G	  and	  T4G	  are	  detected	  at	  active	  genes	  along	  with	  the	  other	  phospho	  -­‐modifications,	  
S5p,	   S2p	   and	   S7p	   (Fig.	   6.5).	   Patterns	   of	   S5G	   closely	   resemble	   those	   of	   S7p,	   a	   marker	   of	  
productive	  transcription	  (Brookes	  et	  al.,	  2012).	  There	  is	  a	  sharp	  peak	  of	  S5G	  at	  promoters	  of	  
active	   genes,	   Top2a	   and	   Eed,	   with	   comparatively	   lower	   occupancy	   through	   the	   coding	  
region,	   followed	   by	   enrichment	   after	   the	   TES.	   The	   peak	   after	   the	   TES	   appears	   slightly	  
delocalised	   relative	   to	   all	   other	   RNAPII	   phospho-­‐isoforms	   possibly	   suggesting	   a	   role	   for	  
glycosylation	   in	   transcription	   termination.	   RNAPII-­‐T4G	  presents	   a	   small	   peak	   at	   promoters	  
with	  relatively	  high	  levels	  of	  binding	  throughout	  coding	  regions,	  followed	  by	  a	  peak	  after	  the	  
TES	  which	  appears	  to	  match	  those	  of	  phosphorylation.	  

































Figure	  6.5	  RNAPII-­‐S5G	  peaks	  at	  promoters	  and	  RNAPII-­‐T4G	  increases	  through	  coding	  regions	  of	  active	  genes.	  
Distribution	  of	  S5G	  and	  T4G	  ChIP-­‐seq	  profiles	  across	  active	  genes	  Top2a	  and	  Eed	  were	  generated	  by	  mapping	  
sequenced	  reads	  to	  the	  mouse	  genome	  (assembly	  mm9)	  and	  visualising	  in	  the	  UCSC	  genome	  browser.	  ChIP-­‐seq	  
profiles	  of	  RNAPII	  phospho-­‐isoforms	  S5p,	  S2p	  and	  S7p	  as	  well	  as	  mRNA	  are	  included	  from	  published	  datasets	  
(Brookes	  et	  al.,	  2012).	  S5G	  peaks	  at	  promoters,	  decreases	  into	  coding	  regions	  and	  peaks	  again	  after	  the	  gene	  
TES.	   T4G	   binds	   at	   promoters	   and	   coding	   regions	   peaking	  with	   enrichment	   after	   the	   TES.	   A.Geiss	   generated	  
UCSC	  compatible	  files.	  
	  
Chromatin	  occupancy	  of	  RNAPII-­‐S5G	  at	  PRC-­‐repressed	  genes	  was	  measured	  at	  single	  genes	  
by	  RT-­‐PCR,	  and	  detected	  at	  low	  levels	  above	  background	  (Fig.	  6.4).	  ChIP-­‐seq	  profiles	  of	  PRC-­‐
repressed	  genes	  show	  minimal	  binding	  of	  S5G	  and	  T4G	  at	  PRC-­‐repressed	  genes,	  Mash1	  and	  
Cdx2	   with	   similar	   levels	   seen	   for	   silent	   gene	   Gpr55.	   RNAPII-­‐S5p	   profiles	   demonstrate	   the	  
presence	  of	  ‘poised’	  RNAPII	  in	  the	  absence	  of	  RNAPII-­‐S2p,	  S7p	  and	  mRNA	  at	  PRC-­‐repressed	  
but	  not	  silent	  genes.	  	  







































Figure	  6.6	  PRC-­‐repressed	  genes	  are	  not	  associated	  with	  RNAPII-­‐S5G	  or	  T4G	  in	  ES	  cells.	  Distribution	  of	  S5G	  and	  
T4G	   ChIP-­‐seq	   profiles	   across	   PRC-­‐repressed	   genes	  Mash1,	   Cdx2	   and	   silent	   gene	   Gpr55	  were	   generated	   by	  
mapping	   sequenced	   reads	   to	   the	   genome	   and	   visualising	   in	   the	   UCSC	   genome	   browser	   (mouse	   reference	  
genome	  mm9).	  ChIP-­‐seq	  profiles	  of	  RNAPII	  phospho-­‐isoforms	  S5p,	   S2p	  and	  S7p	  are	   included	   from	  published	  
datasets	  (Brookes	  et	  al.,	  2012).	  S5G	  and	  T4G	  show	  low	  chromatin	  occupancy	  at	  PRC-­‐repressed	  genes	  at	  levels	  
similar	  to	  Silent	  gene	  Gpr55.	  A.	  Geiss	  generated	  UCSC	  compatible	  files.	  
	  
These	   results	   show	   that	   glycosylation	   is	   a	   modification	   present	   on	   RNAPII	   bound	   to	  
chromatin	  in	  ES	  cells.	  From	  these	  analyses	  at	  single	  genes,	  glycosylation	  appears	  to	  primarily	  
mark	  active	  genes	  with	  S5G	  and	  T4G	  showing	  different	  preferences	  for	  RNAPII	  and	  alternate	  
binding	  patterns	  at	  genes.	  	  
	  
To	  understand	  whether	   features	   seen	  at	   single	   genes	   are	   common	  genome-­‐wide,	   average	  
profiles	   were	   generated	   for	   the	   groups	   of	   genes	   previously	   characterized:	   active,	   PRC-­‐
repressed	   and	   inactive	   (Brookes	   et	   al.,	   2012).	   A	   summary	  of	   the	   properties	   of	   these	   gene	  
groups	  was	  presented	  in	  Chapter	  5	  (Fig.	  5.15);	  for	  simplicity,	  the	  additional	  groups	  of	  genes	  
reported	   previously	   (PRCo,	   PRCi	   and	   PRCa;	   Brookes	   et	   al.,	   2012)	  were	   not	   analysed	   here.	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Also	   included	  for	  comparison,	  are	  average	  profiles	  of	  other	  RNAPII	  phospho-­‐isoforms	  (S5p,	  
S7p,	  S2p)	  from	  published	  datasets	  that	  have	  characterised	  roles	  in	  transcription	  (Brookes	  et	  
al.,	  2012).	  
	  
Genome-­‐wide	  occupancy	  of	  S5G	  shows	  association	  with	  active	  gene	  promoters,	  decreasing	  
dramatically	   after	   the	   TSS.	   The	   distribution	   observed	   is	   remarkably	   similar	   to	   RNAPII-­‐S7p	  
(Fig.	   6.7;	   right	   panel).	   There	   is	   comparatively	   low-­‐level	   binding	   throughout	   coding	   regions	  
with	   an	   accumulation	   after	   the	   TES.	  At	   single	   genes,	   the	   S5G	  peak	  detected	   after	   the	   TES	  
appeared	   slightly	   de-­‐localised	   relative	   to	   other	   markers	   (S5p,	   S7p;	   Fig.	   6.5).	   However,	  
average	  profiles	  at	  active	  genes	  do	  not	  show	  a	  striking	  de-­‐localisation	  although	  distribution	  is	  
broad.	   Further	   detailed	   analyses	   would	   be	   required	   to	   investigate	   this	   issue,	   such	   as	  
comparisons	   of	   enrichment	   for	   different	   RNAPII	   modifications,	   for	   example	   at	   regions	  
including	   TES	   0-­‐1kb	   and	   TES	   1-­‐2kb.	   Average	   profiles	   mainly	   recapitulate	   results	   seen	   by	  
single	   gene	   RT-­‐PCR	   (Fig.	   6.4)	   and	   single	   gene	   profiles	   at	   active	   genes	   (Fig.	   6.5).	   Striking	  
similarity	   to	   RNAPII-­‐S7p	  may	   suggest	   that	   the	   S7p	   and	   S5G	  modifications	   co-­‐exist	   on	   the	  
same	   RNAPII	   molecules,	   in	   an	   antagonistic	   nature	   (Comer	   and	   Hart,	   2001).	   It	   could	   be	  
envisaged	  that	  RNAPII-­‐S5G	  may	  play	  a	   role	   in	  modulating	  S7	  phosphorylation	   levels	  across	  
active	   genes	   thereby	   helping	   control	   the	   recruitment	   of	   nuclear	   machineries	   for	   RNA	  
processing	   and	   chromatin	   modification.	   Sequential	   ChIP	   studies	   would	   start	   to	   answer	  
whether	  these	  two	  modifications	  co-­‐exist	  on	  the	  same	  RNAPII	  complexes.	  S5G	  itself	  may	  also	  
play	   specific	   roles	   in	   recruitment	   of	   machineries	   important	   in	   transcription,	   chromatin	  
remodelling	  or	  RNA	  processing.	  
	  
RNAPII-­‐T4G	   peaks	   at	   promoters	   of	   active	   genes	   and	   extends	   into	   coding	   regions.	   Levels	  
decrease	   immediately	   after	   the	   TSS	   but	   increase	   again	   through	   coding	   regions	   with	  
accumulation	   after	   the	   TES,	   showing	   that	   T4G	   modification	   is	   also	   present	   during	  
transcription	  termination.	  The	  T4G	  pattern	  is	  more	  unique	  in	  terms	  of	  other	  phosphorylation	  
marks;	   it	   peaks	   at	   promoters	   like	   modifications	   S5p	   and	   S7p,	   but	   also	   shows	   increased	  
occupancy	   through	   coding	   regions	   and	   after	   the	   TES,	   more	   like	   S2p.	   	   Presence	   of	   T4G	  
through	  coding	  regions	  and	  after	  the	  TES	  supports	  its	  preference	  for	  highly	  phosphorylated	  
RNAPII	   and	   correlation	  with	  RNAPII-­‐S2p,	   as	   detected	  by	  western	   blotting	   (Fig.	   6.2).	  Unlike	  
previous	   suggestions	   that	   glycosylation	   of	   the	   CTD	   opposes	   phosphorylation,	   the	   present	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analyses	  suggest	  that	  T4G	  may	  be	  important	  during	  the	  transcription	  process,	  where	  it	  may	  
be	  important	  for	  the	  specific	  recruitment	  of	  enzymatic	  activities	  to	  chromatin	  to	  regulate	  co-­‐
transcriptional	  processes.	  The	  presence	  of	  T4G	  through	  coding	  regions	  at	  active	  genes	  might	  
be	   reconciled	  with	  previous	   suggestions	   that	  glycosylation	  may	  oppose	  phosphorylation,	   if	  
T4G	  has	  roles	  in	  modulating	  phosphorylation	  levels.	  Both	  S5G	  and	  T4G	  show	  little	  detectable	  
association	  with	  PRC-­‐repressed	  genes,	  further	  adding	  to	  the	  unique	  configuration	  of	  RNAPII	  

























































































Figure	   6.7	   RNAPII	   complexes	   modified	   on	   S5G	   and	   T4G	   associate	   genome-­‐wide	   with	   active	   genes.	  
Distribution	  of	  S5G	  and	  T4G	  modifications	  of	  RNAPII	  was	  assessed	  alongside	  S5p,	  S2p	  and	  S7p	  modifications,	  at	  
active	   (green,	   n=5707),	   PRC-­‐repressed	   (pink,	   n=1632),	   and	   silent	   (grey,	   n=5296)	   genes.	   Average	   depth	   of	  
sequencing	  reads	  per	  nucleotide	  was	  analysed	  in	  the	  regions	  around	  the	  TSS	  and	  TES	  (-­‐5	  to	  +5kb).	  S5G	  peaks	  at	  
promoters	  of	  active	  genes,	  decreasing	   through	  coding	   regions	  and	  accumulating	  after	   the	  TES.	  There	   is	   little	  
detectable	  binding	  at	  PRC-­‐repressed	  genes	  above	  inactive	  genes	  at	  the	  TSS.	  T4G	  peaks	  at	  promoters	  and	  binds	  
through	   coding	   regions	   of	   active	   genes,	   peaking	   after	   the	   TES.	   There	   is	   very	   low	   binding	   at	   PRC-­‐repressed	  











Modification	   to	   the	  RNAPII-­‐CTD	   is	   varied	   and	   complex	  with	  many	  modifications,	   and	   their	  
functional	   relevance	   is	   still	   largely	   unexplored.	   Glycosylation	   of	   the	   RNAPII-­‐CTD	   has	   been	  
known	  to	  occur	  for	  many	  years	  (Kelly	  et	  al.,	  1993)	  but	  to	  date	  few	  studies	  have	  focused	  on	  
the	   functional	   relevance	   this	   modification	   may	   hold	   in	   transcription.	   In	   ES	   cells,	   RNAPII	  
glycosylation	  has	  not	  been	  explored.	  
6.3.1 RNAPII	  glycosylation	  at	  active	  genes	  
Glycosylation	   of	   RNAPII	   has	   been	   suggested	   to	   have	   a	   role	   in	   the	   control	   of	   transcription	  
initiation	  (Kelly	  et	  al.,	  1993;	  Comer	  and	  Hart,	  2001;	  Ranuncolo	  et	  al.,	  2012)	  with	  glycosylated	  
RNAPII	   being	   associated	  with	   a	   panel	   of	   genes	   in	   B-­‐lymphocytes	   (Ranuncolo	   et	   al.,	   2012).	  
This	   study	   focused	  on	  general	  RNAPII	   glycosylation	  without	  distinguishing	   the	  presence	  or	  
modulation	  of	  this	  modification	  at	  specific	  CTD	  residues,	  although	  both	  serine	  and	  threonine	  
residues	  have	  the	  potential	  to	  be	  modified.	  We	  used	  antibodies	  directed	  against	   individual	  
glycosylated	  residues	  (S5G	  and	  T4G)	  to	  ask	  questions	  about	  this	  modification	  in	  ES	  cells;	  S2G	  
and	  S7G	  putative	  modifications	  of	  the	  RNAPII	  CTD	  remain	  unexplored.	  
	  
With	   western	   blotting	   analyses,	   I	   found	   that	   S5G	   is	   preferentially	   detected	   at	   hypo-­‐
phosphorylated	   RPB1,	   and	   minimally	   affected	   upon	   CDK9	   inhibition	   and	   depletion	   of	  
elongation	   associated	   RNAPII-­‐S2p	   (Fig.	   6.2).	   S5G	   modification	   is	   detected	   at	   RNAPII	  
complexes	   associated	  with	   chromatin,	   highly	   enriched	   at	   promoters	   of	   active	   genes	  while	  
showing	   a	   decrease	   into	   coding	   regions	   as	   shown	   by	   single	   gene	   DNA-­‐ChIP	   (Fig.	   6.4).	  
Genome-­‐wide,	   S5G	   is	   abundantly	   enriched	   at	   active	   genes	   peaking	   at	   promoters	   and	  
decreasing	   into	   coding	   regions,	   followed	   by	   a	   small	   accumulation	   after	   the	   TES	   (Figs.	   6.5,	  
6.6).	  High	  levels	  of	  S5G	  at	  the	  promoters	  of	  active	  genes	  suggests	  possible	  roles	  in	  regulation	  
of	   transcription	   initiation	  a	  hypothesis	  previously	   suggested	   (Kelly	  et	   al.,	   1993;	  Comer	  and	  
Hart,	   2001;	   Ranuncolo	   et	   al.,	   2012).	   For	   example,	   glycosylation	  may	   block	   recruitment	   of	  
factors	   (Kelly	   et	   al.,	   1993)	   such	   as	   those	   involved	   in	   transcription	   and	   RNA	   processing.	  
Glycosylation	   may	   also	   play	   a	   role	   in	   recruiting	   regulatory	   factors	   to	   the	   RNAPII-­‐CTD.	  
Removal	   of	   glycosylation	   by	   inhibition	   of	  OGT	   resulted	   in	   a	   decrease	   in	   RNAPII	   binding	   at	  
promoters	  (Ranuncolo	  et	  al.,	  2012)	  suggesting	  a	  role	  for	  glycosylation	  in	  RNAPII	  assembly	  at	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promoters	  rather	  than	  the	  process	  of	  transcription.	  However,	  its	  low	  level	  presence	  through	  
coding	  regions	  and	  after	  the	  TES	  genome-­‐wide	  suggests	  that	  S5G	  may	  play	  a	  more	  general	  
role	  in	  transcription.	  Its	  striking	  similarity	  to	  S7p	  pattern	  of	  occupancy	  at	  active	  genes	  in	  ES	  
cells	  (Fig.	  6.6;	  Brookes	  et	  al.,	  2012)	  suggests	  a	  role	  in	  modulating	  S7	  phosphorylation	  levels	  
on	  the	  same	  RNAPII	  complexes,	  as	  the	  two	  modifications	  are	  not	  able	  to	  exist	  on	  the	  same	  
CTD	   repeat	   (Comer	   and	   Hart,	   2001).	   Modulation	   may	   regulate	   of	   co-­‐transcriptional	  
recruitment	  of	  chromatin	  modifiers	  and	  RNA	  processing	  enzymes.	  S5G	  is	  minimally	  affected	  
upon	   S2p	   removal	   and	   is	   present	   primarily	   at	   promoters	   suggesting	   a	   role	   in	   initiation.	  
RNAPII-­‐S7p	   is	   important	   for	   PTEFb	   binding	   in	   vitro	   (Czudnochowski	   et	   al.,	   2012)	   and	  
therefore	  may	  be	  important	  to	  regulate	  the	  transition	  from	  initiation	  to	  elongation.	  RNAPII-­‐
S5G	  could	  be	  an	  important	  player	  in	  regulating	  this	  function.	  
	  	  
Surprisingly	   investigation	  of	   the	  T4G	  modification	   revealed	  preferential	  presence	  at	  hyper-­‐
phosphorylated	   RNAPII	   forms,	   and	   was	   highly	   sensitive	   to	   RNAPII-­‐S2p	   depletion	   with	  
flavopiridol	  (Fig.	  6.2).	  A	  functional	  link	  with	  the	  S2p	  modification	  was	  revealed	  when	  the	  T4G	  
modification	  was	  detected	  at	   the	  chromatin	  of	  active	  genes,	  at	  promoters	  and	  abundantly	  
through	  coding	  regions	  with	  substantial	  accumulation	  after	  the	  TES	  (Figs.	  6.4,	  6.5,	  6.6).	  These	  
results	   suggest	   that,	   in	   contrast	   to	   S5G,	   the	   T4G	  modification	  may	   be	  more	   tightly	   linked	  
with	  transcription	  elongation	  and	  possibly	  termination.	  It	  likely	  that	  T4G	  and	  S2p	  co-­‐exist	  on	  
the	  same	  RNAPII	  complex,	  with	  the	  presence	  of	  glycosylation	  having	  roles	  in	  modulating	  the	  
levels	   of	   phosphorylation,	   and	   therefore	   regulating	   transcription	   of	   active	   genes.	   Further	  
bioinformatics	   analyses	   will	   uncover	   the	   correlations	   between	   the	   levels	   of	   different	  
modifications	  at	  regions	  of	  interest	  (such	  as	  TSS,	  coding	  and	  TES),	  and	  how	  they	  relate	  with	  
levels	   of	   transcription	   (detected	   at	   the	   level	   of	   RNA-­‐ChIP;	   see	   chapter	   4),	   and	   of	   gene	  
expression	  (through	  comparison	  with	  mRNA	  levels).	  
	  
OGT	  is	  the	  enzyme	  responsible	  for	  adding	  O-­‐GlcNAc	  to	  proteins	  (Hart	  et	  al.,	  2007),	  and	  it	  is	  
know	   to	   to	   directly	   bind	   and	   glycosylate	   RNAPII	   in	   B-­‐cells	   (Ranuncolo	   et	   al.,	   2012).	  
Understanding	  whether	  OGT	  is	  also	  able	  to	  associate	  with	  RNAPII	  at	  active	  genes	  in	  ES	  cells	  
would	  give	  clues	  into	  the	  regulation	  of	  this	  modification.	  Sequential	  ChIP	  studies	  would	  also	  
help	   to	   understand	   whether	   phosphorylation	   and	   glycosylation	   are	   indeed	   opposing	  
Chapter	  6	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modification	  of	  RPB1	  or	  can	  exist	  on	  the	  same	  RNAPII	  complexes	  bound	  to	  chromatin	  in	  ES	  
cells.	  	  
6.3.2 RNAPII	  glycosylation	  at	  PRC-­‐repressed	  genes	  in	  ES	  cells	  
OGT	   is	   essential	   for	   embryonic	   stem	   cell	   viability	   (Shafi	   et	   al.,	   2000)	   and	   is	   implicated	   in	  
Polycomb	   repression	   in	   ES	   cell	   although	   the	   mechanism	   is	   not	   known	   (Gambetta	   et	   al.,	  
2009).	   Presence	  of	  RNAPII	   at	  PRC-­‐repressed	  genes	   led	  us	   to	  hypothesise	   that	   glycosylated	  
RNAPII	  may	  be	  present	  as	  a	  possibly	  mechanism	  to	  prevent	  S7p	  and	  S2p	  modifications,	  both	  
of	   which	   are	   absent	   and	   a	   feature	   of	   RNAPII	   thought	   to	   be	   important	   in	   PRC	   silencing	  
(Brookes	   and	   Pombo,	   2009).	   Studies	   at	   single	   genes	   demonstrated	   low	   level	   detection	   or	  
absence	  of	   S5G	  and	  T4G	  modifications	   at	   PRC-­‐repressed	   genes,	   respectively,	   compared	   to	  
active	   genes	   and	   (Figs.	   6.4,	   6.7).	   Absence	   of	   S2p	   and	   T4G	   at	   PRC-­‐repressed	   genes	   is	  
consistent	  with	  the	  finding	  that	  T4G	  is	  linked	  with	  S2p.	  These	  results	  show	  that	  glycosylation	  
of	  RNAPII	  at	  S5	  and	  T4	  residues	  is	  not	  a	  predominant	  modification	  linked	  with	  PRC-­‐repressed	  
genes	   genome-­‐wide.	  Although	   it	   remains	   to	  be	   tested	  whether	   glycosylation	  of	   S2	   and	  S7	  
residues	  may	  help	  explain	  the	  relationship	  between	  PRC	  and	  OGT,	  and	  a	  possible	  role	  of	  OGT	  
in	  the	  mechanisms	  of	  silencing	  present	  at	  PRC-­‐repressed	  chromatin.	  	  
	  
 







In	  this	  thesis,	  I	  have	  investigated	  transcription	  of	  PRC-­‐repressed	  genes	  in	  murine	  ES	  cells	  to	  
explore	   regulatory	   interplay	   between	   PRC	   and	   RNAPII.	   To	   capture	   RNAPII	   transcription	   at	  
active	   and	   PRC-­‐repressed	   genes	   in	   ES	   cells,	   I	   optimised	   a	  method,	   RNA-­‐ChIP	   using	   RNAPII	  
antibodies	  that	  capture	  specific	  modifications	  (Chapter	  3).	  Extensive	  analyses	  at	  single	  genes	  
and	   genome-­‐wide	   of	   RNAPII-­‐S5p	   RNA-­‐ChIP	   demonstrated	   its	   ability	   to	   detect	   newly-­‐made	  
transcripts	  from	  active	  genes,	  including	  many	  non-­‐coding	  transcripts,	  characteristic	  of	  active	  
gene	   transcription	   in	   many	   cell	   types.	   Transcription	   at	   PRC-­‐repressed	   genes	   was	   also	  
explored	   at	   single	   genes	   and	   genome-­‐wide	   using	   RNAPII-­‐S5p	   RNA-­‐ChIP	   (Chapter	   4)	   and	  
interpreted	  in	  comparison	  with	  published	  datasets	  of	  mRNA	  and	  RNAPII	  modifications,	  PRC	  
and	  histone	  modifications	  (Brookes	  et	  al.,	  2012).	  We	  demonstrate	  that	  PRC-­‐repressed	  genes	  
are	   transcribed	   at	   low	   level	   and	   in	   the	   correct	   orientation	   (Figs.	   4.9,	   4.10,	   4.11),	   in	   the	  
absence	  of	  detectable	  antisense	   transcription	  upstream	  of	   the	  TSS,	  and	  of	   transcription	  of	  
terminating	  RNAPII	   complexes	  downstream	  of	  TES	   (Fig.	   4.9,	  4.12,	  4.15),	   the	   latter	  a	  major	  
features	   of	   transcription	   at	   active	   genes	   in	   the	   absence	   of	   Polycomb	   repression.	   These	  
unexpected	   features	   suggest	   intriguing	   regulatory	   features	   in	   the	   interplay	   between	  
Polycomb	   repression	   and	   RNAPII	   at	   PRC-­‐repressed	   chromatin.	   Two	   patterns	   of	   transcript	  
distribution	   are	   seen	   at	   PRC-­‐repressed	   genes.	   At	   some	   PRC-­‐repressed	   genes,	   nascent	  
transcripts	  are	  highly	  abundant	   immediately	  downstream	  of	   the	  TSS,	  at	  others,	   transcripts	  
are	  more	  homogeneously	  detected	  through	  coding	  regions	  up	  to	  the	  TES	  (Figs.	  4.12,	  4.15).	  
These	   two	   profiles	   suggest	   there	  may	   be	   differential	   mechanisms	   of	   regulation	   occurring	  
throughout	  PRC-­‐repressed	  genes,	  a	  topic	  that	  deserves	  more	  in-­‐depth	  investigation.	  	  
	  
Irrespectively	   of	   differences	   in	   transcript	   distribution	   through	   the	   coding	   regions	   of	   PRC-­‐
repressed	  genes,	  RNAPII-­‐S5p	  occupancy	  (in	  the	  absence	  of	  S2p	  and	  S7p)	  is	  mirrored	  by	  PRC	  
distribution	   throughout	   the	   coding	   regions	   of	   PRC-­‐repressed	   genes	   (Figs.	   4.14,	   4.17).	   The	  
unusual	   RNAPII	   configuration	   at	   PRC-­‐repressed	   genes	   suggests	   that	   the	   S2p-­‐dependent	  
recruitment	   of	   chromatin	   modifiers,	   important	   for	   productive	   transcription,	   and	   of	   RNA	  
processing	  machinery,	  such	  as	  splicing	  and	  polyadenylation	  factors,	  might	  be	  compromised	  
and	  act	  as	  a	  silencing	  mechanism	  to	  repress	  lineage	  specific	  genes	  in	  ES	  cells.	  CAGE	  analysis	  
shows	   low	  level	  capping	  of	  PRC-­‐repressed	  genes	  although	  intriguingly,	  there	  appears	  to	  be	  





two	  sub-­‐populations	  of	  genes	  that	  show	  higher	  and	  lower	  levels	  of	  capped	  transcripts	  (Figs.	  
4.21,	   4.22,	   4.23)	   suggesting	   that	   capping	  may	   be	   important	   to	   regulate	   transcription	   at	   a	  
proportion	   of	   PRC-­‐repressed	   genes.	   It	   remains	   undetermined	   whether	   the	   two	   groups	   of	  
genes	  with	  different	   levels	   in	   capping	   relate	  with	   the	   two	  groups	  of	   genes	  where	  nascent	  
transcripts	   are	   mostly	   found	   at	   the	   5’	   ends	   of	   PRC-­‐repressed	   genes	   or	   present	   through	  
coding	   regions.	   PRC1	   removal	   results	   in	   an	   increase	   in	   nascent	   transcript	   levels	   (Fig.	   4.19,	  
4.20)	  that	  accompanies	  higher	  mRNA	  expression	  (Jorgensen	  et	  al.,	  2006;	  Stock	  et	  al.,	  2007),	  
confirming	  the	  view	  that	  PRC1	  acts	  by	  limiting	  the	  levels	  of	  transcription,	  either	  directly	  by	  
compromising	   the	   rate	   of	   RNAPII	   elongation,	   or	   possibly	   by	   other	   mechanisms	   such	   as	  
increased	   instability	   of	   nascent	   transcripts.	   The	   features	   of	   nascent	   transcripts	   observed	  
after	  PRC1	  knockout	  are	  reminiscent	  of	  active	  genes,	  although	  previous	  work	  has	  shown,	  for	  
a	   panel	   of	   PRC-­‐target	   genes,	   that	   PRC2	   and	   H3K27me3	   are	   still	   present	   and	   S2p	   remains	  
absent	   (Stock	   et	   al.,	   2007),	   suggesting	   a	   complex	   interplay	   between	   PRC	   and	   RNAPII	  
transcription.	   
	  
Transcription	  defects	  are	  generally	  monitored	  by	  surveillance	  mechanisms	  to	  rid	  the	  cell	  of	  
unwanted	   or	   improperly	   processed	   RNA.	   Intriguingly,	   exosome	   subunit	   expression	   was	  
higher	   in	   ES	   cells	   and	   decreases	   during	   differentiation.	   I	   explored	   the	   possibility	   that	  
exosome	  might	  be	  important	  for	  PRC-­‐repressed	  gene	  regulation,	  and	  if	  it	  contributed	  to	  the	  
depletion	   of	   newly-­‐made	   transcripts	   (Chapter	   5).	   I	   showed	   that	   exosome	   associates	   with	  
PRC-­‐repressed	   genes	   and	   its	   depletion	   deregulates	   PRC-­‐repressed	   genes	  when	   probed	   by	  
RT-­‐PCR	   analyses	   at	   single	   genes.	   Microarray	   analysis	   did	   not	   reveal	   wide-­‐spread	   de-­‐
repression,	  probably	  due	   to	   limitations	   in	  detecting	  expression	  changes	   in	   lowly-­‐expressed	  
genes.	   In	   contrast,	   CAGE	   analysis	   reveals	   a	   substantial	   increase	   in	   capped	   transcripts	   at	   a	  
population	  of	   PRC-­‐repressed	   genes	  upon	  exosome	   removal.	   Further	   analysis	   is	   ongoing	   to	  
understand	  effects	  of	  exosome	  genome-­‐wide	  at	  PRC	  target	  genes.	  	  	  
	  
Finally,	   I	   explored	   the	   possibility	   of	   additional	   RNAPII	   CTD	   modifications	   marking	   PRC-­‐
repressed	   genes,	   namely	   glycosylation,	   a	   modification	   previously	   thought	   to	   oppose	  
phosphorylation	   and	   contribute	   to	   RNAPII	   inhibition	   (Chapter	   6).	   Abundant	   CTD	  
glycosylation	  of	  T4	  and	  S5	  CTD	  residues	  was	  unexpectedly	  found	  at	  active	  genes,	  suggesting	  
roles	   in	   transcriptional	   regulation.	   Absence	   of	   T4G	   and	   S5G	   at	   PRC-­‐repressed	   genes	   adds	  





additional	  layers	  of	  complexity	  and	  possible	  regulatory	  restraints	  that	  maintain	  repression	  at	  
PRC	  genes	  in	  ES	  cells,	  but	  are	  so	  far	  not	  understood.	  
	  
7.1 RNA-­‐ChIP	  as	  a	  method	  to	  study	  transcription	  in	  ES	  cells	  
RNAPII	   transcription	  has	  been	   investigated	  using	  various	  approaches	   in	  many	  systems	  (Fig.	  
1.4).	  Each	  approach	  is	  used	  to	  answer	  slightly	  different	  objectives.	  Here,	  we	  wanted	  to	  study	  
RNAPII	   transcription	   in	   situ	   on	   the	   DNA	   template	   as	   opposed	   to	   mRNA	   or	   total	   RNA	  
expression.	  	  Methods	  developed	  previously	  that	  isolate	  chromatin	  bound	  RNA	  are	  RNA-­‐ChIP	  
(Sun	  et	  al.,	  2006;	  Bittencourt	  et	  al.,	  2008;	  Churchman	  and	  Weissman,	  2011),	  GRO-­‐seq	  (Core	  
et	  al.,	  2008;	  Min	  et	  al.,	  2011)	  and	  chromatin	  fractionation	  of	  RNA	  (Carrillo	  Oesterreich	  et	  al.,	  
2010;	   Khodor	   et	   al.,	   2011;	   Rodriguez	   et	   al.,	   2012).	   We	   wanted	   to	   develop	   RNA-­‐ChIP	   to	  
achieve	   the	   aim	   of	   isolating	   RNA	   specifically	   associated	   with	   RNAPII	   and	   PRC-­‐bound	  
chromatin.	  The	  availability	  of	  genome-­‐wide	  DNA-­‐ChIP	  datasets	  for	  RNAPII	  modifications,	  PRC	  
and	  associated	  histone	  modifications	  as	  well	  as	  mRNA	  in	  the	  same	  cell	   line	  (Brookes	  et	  al.,	  
2012)	  meant	  that	  we	  could	  relate	  RNA-­‐ChIP	  results	  with	  numerous	  other	  datasets	  with	  the	  
aim	   of	   asking	   how	   interplay	   between	   RNAPII	   and	   PRC	   regulates	   transcription.	   Initial	  
optimisations	   confirmed	   that	   we	   could	   use	   RNA-­‐ChIP	   to	   detect	   nascent	   transcription	   at	  
active	   and	   PRC-­‐repressed	   genes	   (Figs.	   3.3,	   3.4,	   4.3,	   4.5).	   Extensive	   analysis	   was	   done	   at	  
active	   genes	  which	  demonstrated	   that	  we	  are	   able	   to	  detect	   transcription	   along	   the	   gene	  
length	  as	  well	   as	  non-­‐coding	   transcription	  antisense	   to	  promoters	  and	  downstream	  of	   the	  
TES	   (Figs.	   3.15,	   3.16).	   Non-­‐coding	   transcription	   surrounding	   active	   genes	   has	   been	  
documented	  using	  a	  variety	  of	  methods	   (Core	  et	  al.,	  2008;	  Preker	  et	  al.,	  2008;	  Seila	  et	  al.,	  
2008)	  but	  never	  with	  RNA-­‐ChIP,	  and	  intriguingly	  promoter	  associated	  antisense	  transcription	  
is	   thought	   to	  hold	   regulatory	  potential	   that	   is	  not	   fully	  understood.	   Importantly,	  RNA-­‐ChIP	  
allows	   us	   to	   study	   co-­‐transcriptional	   splicing	   (Fig.	   3.20),	  which	  we	   are	   currently	  mining	   to	  
investigate	  in	  more	  detail	  splicing	  at	  PRC-­‐repressed	  genes,	  genome-­‐wide	  splicing	  fidelity	  and	  
trans-­‐splicing	   and	   relating	   epigenetic	   modifications	   and	   RNAPII	   occupancy	   with	   splicing	  
kinetics.	  RNAPII	  binds	  to	  many	  regions	  outside	  of	  protein-­‐coding	  genes	  in	  intergenic	  regions,	  
including	   enhancers	   and	   non-­‐coding	   RNA	   (Koch	   et	   al.,	   2008)	   with	   transcription	   being	  
detected	  widespread	   across	   the	   genome	   (Birney	   et	   al.,	   2007;	  Djebali	   et	   al.,	   2012).	   RNAPII	  
RNA-­‐ChIP	   has	   the	   potential	   to	   be	   used	   for	  wide	   ranging	   investigations	   into	   characterizing	  





transcripts	  genome-­‐wide	  especially	   in	  parallel	  with	  published	  DNA-­‐ChIP	  datasets	  of	  RNAPII	  
modifications	  genome	  wide.	  	  
	  
7.2 RNAPII	  transcription	  at	  active	  genes	  in	  ES	  cells	  
RNAPII-­‐S5p	  RNA-­‐ChIP	  allows	  interrogation	  of	  active	  and	  PRC-­‐repressed	  gene	  transcription	  at	  
single	   genes	   (Figs.	   3.4,	   4.3)	   and	   genome-­‐wide	   (Figs.	   3.12,	   3.15,	   3.16).	   Active	   gene	  
transcription	  was	   readily	   detected	   by	   RNAPII-­‐S5p	   RNA-­‐ChIP	   genome-­‐wide	   (Fig.	   3.15,	   3.16)	  
and	  can	  be	  defined	  by	  profiles	  across	  genes	  that	  are	  indicative	  of	  nascent	  transcription	  (Figs.	  
3.15,	  3.16)	  as	  well	  as	  sensitivity	  to	  transcriptional	  inhibitors	  at	  a	  panel	  of	  genes	  (Fig.	  3.4).	  Co-­‐
transcriptional	   splicing	   is	   a	   prominent	   feature	   of	   active	   genes	   in	   ES	   cells	   (Figs.	   3.15,	   3.16,	  
3.17)	  and	  all	  RefSeq	  genes	  (Fig.	  3.20).	  Non-­‐coding	  promoter-­‐associated	  antisense	  transcripts	  
are	   a	   feature	   of	   highly	   active	   genes	   in	   ES	   cells	   (Figs.	   3.12,	   3.15)	   a	   feature	   that	  may	   hold	  
regulatory	   value	   (Core	   et	   al.,	   2008;	   Preker	   et	   al.,	   2008;	   Seila	   et	   al.,	   2008).	   Non-­‐coding	  
termination-­‐associated	   transcripts	   are	   also	   detected	   (Figs.	   3.12,	   3.15)	   demonstrating	   that	  
RNAPII-­‐S5p	  RNA-­‐ChIP	  can	  detect	  the	  full	  complement	  of	  transcription	  at	  active	  genes	   in	  ES	  
cells.	  This	  analysis	  also	  provided	  two	  gene	  groups,	  active	  and	  silent,	  with	  which	  to	  compare	  
PRC-­‐repressed	   transcription.	   In	   this	   thesis,	   I	   focused	  my	  analyses	  of	  RNA-­‐ChIP	  datasets	  on	  
the	  study	  of	  PRC-­‐repressed	  genes,	  in	  comparison	  to	  transcription	  at	  the	  most	  active	  genes	  or	  
silent	  genes,	  to	  identify	  novel	  regulatory	  features	  of	  PRC-­‐repressed	  transcription.	  	  
	  
7.3 Regulation	  of	  transcription	  at	  PRC-­‐repressed	  genes	  
PRC-­‐repressed	  genes	  are	  associated	  with	  a	  form	  of	  RNAPII	  that	  presents	  a	  novel	  combination	  
of	  CTD	  modifications	   that	  may	  be	   important	   for	  gene	  priming	  and	   transcription	   regulation	  
(Brookes	  and	  Pombo,	  2009).	  RNAPII	  at	  PRC-­‐repressed	  genes	   is	  defined	  by	  abundant	  S5p	   in	  
the	  absence	  of	  other	  active	  markers,	  S2p	  and	  S7p,	  as	  well	  as	  lack	  of	  binding	  of	  an	  antibody	  
(8WG16)	   that	   recognizes	   unphosphorylated	   S2	   residues.	   Simultaneous	   binding	   of	   PRC	   and	  
RNAPII	   at	  PRC-­‐repressed	  genes	   in	  ES	   cells	   (Brookes	  et	  al.,	   2012)	   creates	  a	   situation	   that	   is	  
incompatible	  with	   gene	  expression,	   but	   the	  mechanisms	  by	  which	   silencing	   is	   achieved	  or	  
the	  RNAPII	  configuration	  is	  established	  remain	  unknown.	  	  
	  





Previous	  work	   had	   shown	   that	   RNAPII	   can	   elongate	   into	   coding	   regions	   and	   at	   a	   panel	   of	  
genes	   produces	   nascent	   transcripts	   that	   show	   some	   level	   of	   splicing	   (Stock	   et	   al.,	   2007).	  
More	   recently,	   RNAPII	   was	   found	   to	   occupy	   the	   entirety	   of	   the	   gene-­‐coding	   regions	   at	   a	  
significant	  population	  of	  PRC-­‐target	  genes	  (Brookes	  et	  al.,	  2012).	  Mechanisms	  of	  repression	  
at	  PRC-­‐repressed	  genes	  and	  how	  RNAPII	  transcripts	  are	  kept	  at	  a	  low	  level	  in	  the	  presence	  of	  
PRC	  are	  not	  known.	  Here,	  we	  show	  that	  PRC-­‐repressed	  genes	  are	  transcribed	  genome-­‐wide	  
in	   ES	   cells	   (Figs.	   4.9,	   4.10,	   4.12,	   4.15,	   4.20),	   and	   in	   the	   sense	   orientation	   (Fig.	   4.11,	   4.12),	  
although	   transcript	   levels	   captured	   are	   in	   general	   low	   (Fig.	   4.11),	   even	   in	   the	   presence	   of	  
abundant	   RNAPII-­‐S5p	   occupancy	   (Brookes	   et	   al.,	   2012;	   Figs.	   4.1,	   4.6,	   4.13,	   4.16,).	  
Discrepancy	  between	  RNAPII-­‐S5p	  abundance	  and	  nascent	  transcript	  detection	  at	  chromatin	  
by	  RNA-­‐ChIP	  suggests	  regulation	  of	  PRC-­‐repressed	  genes	  is	  primarily	  linked	  with	  the	  process	  
of	   RNAPII	   transcription	   in	   the	   presence	  of	   PRC,	   or	   at	   the	   level	   of	   RNA	   stability	   during	   the	  
transcription	   process.	   RNAPII	   at	   active	   genes	   is	   able	   to	   orchestrate	   transcription	   with	  
chromatin	  modifications	  and	  RNA-­‐processing	  to	  ensure	  robust	  RNA	  production	  (Fig.	  1.2).	  Any	  
of	  the	  processes	  by	  which	  RNAPII	  modification	  interplays	  with	  co-­‐transcriptional	  recruitment	  
of	   chromatin	  modifiers	  or	  RNA	  processing	  machinery	  have	   the	  potential	   to	  be	   targeted	  at	  
PRC-­‐repressed	   genes.	  We	   previously	   knew	   that	   S7p	   and	   S2p	   are	   absent	   at	   PRC-­‐repressed	  
genes,	  and	  in	  Chapter	  6	  I	  showed	  that	  two	  novel	  RNAPII	  modification	  T4G	  and	  S5G	  are	  also	  
only	  present	   at	   active	   genes	   and	  absent	   at	   PRC-­‐repressed	   chromatin,	   reinforcing	   the	   view	  
that	  PRC-­‐silencing	  is	  tightly	  linked	  with	  RNAPII	  regulation	  at	  PRC-­‐target	  genes	  in	  ES	  cells.	  
	  
7.4 Indications	  of	  RNA	  processing	  regulation	  at	  PRC-­‐repressed	  genes	  
Transcription	   occurs	   in	   the	   absence	   of	   S2p	   and	   S7p	  modifications	   at	   PRC-­‐repressed	   genes	  
(Brookes	  et	  al.,	  2012;	  Figs.	  4.1,	  4.13,	  4.16),	  suggesting	  that	  RNA	  processing	  may	  be	  targeted	  
possibly	   by	   inhibiting	   recruitment	   of	   processing	   factors	   for	   co-­‐transcriptional	   splicing	   (Fig.	  
4.24;	   Brookes	   and	   Pombo,	   2009).	   A	   number	   of	   PRC-­‐repressed	   genes	   show	   transcription	  
throughout	  coding	  regions	  to	  the	  TES	  (Figs.	  4.12,	  4.15).	  Genes	  occupied	  by	  abundant	  S5p	  to	  
the	   TES	   (RNAPII-­‐S5pEnd+;	   Fig.	   4.16)	   are	   transcribed	   throughout	   coding	   regions	   where	  
transcript	  accumulation	  can	  be	  detected	  prior	  to	  the	  TES	  (Fig.	  4.15).	  Transcription	  occurs	  in	  
the	   presence	   of	   high	   level	   PRC1	   and	   2	   and	   RNAPII-­‐S5p,	   but	   in	   the	   absence	   of	   RNAPII-­‐S2p	  
(Figs.	  4.16,	  4.17).	  Transcripts	  are	  absent	  after	   the	  TES	  relative	  to	   that	  seen	  at	  active	  genes	  





and	  in	  accordance	  with	  absence	  of	  RNAPII-­‐S5p	  binding	  (Figs.	  4.13,	  4.16;	  Brookes	  et	  al.,	  2012),	  
which	   suggests	   that	   preventing	   RNAPII	   tracking	   beyond	   the	   TES,	   which	   is	   thought	   to	   be	  
important	   for	   co-­‐transcriptional	   polyadenylation,	   may	   be	   important	   in	   preventing	  
production	   of	   mRNA	   at	   this	   group	   of	   genes.	   This	   may	   involve	   lack	   of	   cleavage	   and	  
polyadenylation	  factor	  recruitment	  to	  RNAPII	  which	  is	  linked	  to	  S2p	  (Proudfoot	  et	  al.,	  2002).	  
Interestingly,	   inhibition	   of	   CDK9	   and	   therefore	   absence	   of	   S2p	   in	   Drosophila	   led	   to	  
accumulation	   of	   transcripts	   from	   heat	   shock	   genes	   on	   the	   chromatin	   template,	  
demonstrating	   importance	  of	  RNAPII-­‐S2p	  and	  PTEFb	  mediated	  elongation	  on	  3’	  processing	  
(Ni	   et	   al.,	   2004).	   Evidence	   described	   here	   that	   PRC-­‐target	   genes	   are	   transcribed	   through	  
coding	   regions	   is	   in	   contrast	   to	   reports	   that	   suggest	   transcription	   initiation	   is	   the	   step	   of	  
regulation	   for	   the	   majority	   of	   RNAPII	   occupied,	   silent	   genes	   in	   ES	   cells	   (Guenther	   et	   al.,	  
2007).	   The	   work	   presented	   here	   suggests	   there	   may	   be	   different	   forms	   of	   regulation	   at	  
different	  stages	  of	  the	  transcription	  cycle.	  	  
	  
PRC-­‐repressed	   genes	   that	   do	  not	   transcribe	   to	   the	   TES	  may	  be	   regulated	   at	   stages	  during	  
earlier	   phases	   of	   transcription	   possibly	   during	   capping	   and	   splicing.	   Interestingly,	   there	   is	  
evidence	  for	  low	  levels	  of	  transcript	  capping	  at	  PRC-­‐repressed	  genes	  (Figs.	  4.22,	  5.19,	  5.20).	  
There	   appears	   to	   be	   two	   populations	   of	   PRC-­‐repressed	   genes	   (Fig.	   4.22).	   One	   group	   has	  
higher	   levels	   of	   capped	   transcripts	   that	   although	   lower,	   are	   more	   comparable	   to	   active	  
genes,	  and	  the	  second	  group	  that	  shows	  background	  levels	  of	  capped	  transcripts	  similar	  to	  
silent	  genes	  (Fig.	  4.22).	  This	  could	  suggest	  populations	  of	  genes	  with	  differential	  regulation	  
at	  the	  level	  of	  5’	  processing	  within	  PRC-­‐repressed	  genes.	  For	  example,	  PRC-­‐repressed	  genes	  
where	  transcription	  does	  not	  proceed	  until	  the	  TES	  and	  elongates	  slightly	  into	  coding	  regions	  
(Figs.	  4.12,	  4.13)	  may	  be	  regulated	  at	  the	  level	  of	  capping	  as	  opposed	  to	  genes	  that	  elongate	  
to	   the	   TES,	   where	   capping	   may	   be	   prevented.	   Further	   comparisons	   between	   the	   novel	  
datasets	  presented	  here,	  together	  with	  published	  datasets,	  are	  required	  to	  understand	  the	  
correlations	  of	  genes	  with	  different	  transcript	  capping	  abundance	  and	  the	  relationship	  with	  
RNAPII,	  PRC,	  transcription	  and	  mRNA	  expression.	  	  
	  
Mapping	  nascent	   transcripts	  at	  active	  and	  PRC-­‐repressed	  genes	   indicate	   that	   low	   level	   co-­‐
transcriptional	   splicing	   can	   occur	   at	   PRC-­‐repressed	   genes	   (Figs.	   4.9,	   4.10),	   even	   in	   the	  
absence	   of	   S2p	   (Fig.	   4.2,	   Brookes	   et	   al.,	   2012)	   or	   H3K36me3	   which	   are	   important	   for	  





recruiting	  the	  splicing	  machinery	  (Neugebauer,	  2002;	  Luco	  et	  al.,	  2011).	  Further	  analyses	  are	  
required	   to	   distinguish	   the	   extent	   of	   co-­‐transcriptional	   splicing,	   and	  whether	   it	   is	   efficient	  
and	  robust.	  Inducible	  genes	  in	  macrophages	  show	  some	  similarities	  to	  that	  seen	  here,	  where	  
transcripts	  are	  produced	  at	  low	  level	  in	  the	  absence	  of	  S2p.	  In	  this	  instance,	  transcripts	  are	  
unspliced	  and	  upon	  induction	  recruit	  PTEFb	  to	  genes	  via	  BRD4	  (Hargreaves	  et	  al.,	  2009).	  Low	  
level	   splicing	   at	   PRC-­‐repressed	   genes	   and	   the	   presence	   of	   CDK9	   (J.K.Stock,	   unpublished)	  
suggest	   that	   there	   are	   other	   regulatory	   implications	   at	   PRC-­‐repressed	   genes.	   Further	  
investigation	   into	   processing	   factor	   recruitment	   at	   PRC-­‐repressed	   genes	   will	   help	   to	  
understand	  features	  of	  PRC-­‐repressed	  transcription	  we	  detect	  by	  RNAPII	  RNA-­‐ChIP.	  	  	  
	  
Intriguingly,	  PRC-­‐repressed	  genes	  are	  devoid	  of	  promoter-­‐associated	  antisense	  transcription	  
(Fig.	  4.9)	  which	  have	  been	   shown	  at	  a	  panel	  of	   gene	   in	  human	  cells	   to	  be	  S2p	  dependent	  
sharing	   characteristics	   with	   mRNA	   (Preker	   et	   al.,	   2011).	   Absence	   of	   S2p	   and	   antisense	  
transcripts	  at	  PRC-­‐repressed	  genes	  may	  suggest	  an	  active	  mechanism	  of	  prevention	   in	   the	  
presence	  of	  PRC.	  Promoter-­‐associated	  antisense	  transcripts	  are	  linked	  to	  highly	  active	  gene	  
transcription,	   although	   whether	   they	   are	   the	   cause	   or	   consequence	   of	   highly	   processive	  
genes	   is	   unknown	   (Core	   et	   al.,	   2008;	   Preker	   et	   al.,	   2008;	   Seila	   et	   al.,	   2008).	   Interestingly,	  
antisense	  transcripts	  are	  exosome	  dependent	   in	  humans;	  we	  confirm	  this	   feature	  at	  active	  
genes	  in	  ES	  cells,	  and	  find	  that	  antisense	  transcription	  is	  not	  detected	  PRC-­‐repressed	  genes,	  
even	   upon	   exosome	   depletion	   (Fig.	   5.19),	   suggestive	   of	   more	   complex	   regulation	   at	   the	  
latter.	  
	  
PRC1	  knockouts	  revealed	  that	  nascent	  transcript	  increases	  at	  PRC-­‐repressed	  genes	  in	  parallel	  
with	   the	   promoter-­‐associated	   antisense	   transcription	   and	   increase	   detection	   of	   capped	  
transcripts	   (Figs.	  4.19,	  4.20,	  4.23),	   revealing	  a	   role	  of	  PRC1	   in	  preventing	   these	   features	  of	  
‘normal’	   transcription	   (Stock	   et	   al.,	   2007;	   Endoh	   et	   al.,	   2012).	   RNAPII-­‐S5p	   levels	   do	   not	  
increase	  and	  S2p	   is	  not	   restored	  at	  a	  panel	  of	  genes	  after	  Ring1B	  knockdown,	  albeit	   some	  
changes	  in	  its	  configuration	  are	  revealed	  by	  acquired	  binding	  of	  the	  8WG16	  antibody	  (Stock	  
et	  al.,	  2007).	  Restoration	  of	   transcription	   that	   resembles	   that	  of	  active	  genes	  upon	  Ring1B	  
knockdown	  may	  suggest	   that	  PRC1	  has	  a	  direct	   role	   in	  preventing	  RNA	  processing	  at	  PRC-­‐
repressed	  genes	  and	  that	  upon	  removal	  expression	  occurs,	  even	  in	  the	  absence	  of	  S2p.	  An	  
intriguing	  proposal	  has	  been	  put	  forward	  that	  PRC1	  may	  directly	  modify	  RNAPII,	  interfering	  





with	  RNAPII	  processivity	   (Brookes	  and	  Pombo,	  2009).	  Projects	   studying	   the	  possibility	   that	  
non-­‐consensus	  lysine	  residues	  in	  the	  CTD	  are	  modified	  are	  underway.	  	  
 
7.5 Degradation	   of	   nascent	   transcripts	   as	   a	   mechanism	   of	   PRC-­‐repressed	  
gene	  silencing	  
RNA	  surveillance	  mechanisms	  within	  the	  cell	  ensure	  that	  unwanted	  or	  improperly	  processed	  
transcripts	  are	  degraded.	  We	  hypothesized	  that	  PRC-­‐repressed	  transcripts	  may	  be	  degraded	  
at	   the	   level	   of	   transcription,	   possibly	   as	   a	   result	   of	   improper	   processing.	   This	   would	   also	  
explain	   the	   discrepancy	   between	   high	   levels	   of	   RNAPII-­‐S5p	   occupancy	   and	   low-­‐level	  
transcript	   detection	   at	   PRC-­‐repressed	   genes.	   The	   expression	   levels	   of	   multiple	   exosome	  
subunits	  decrease	  through	  ES	  cell	  differentiation	  (Fig.	  5.2).	  Knockout	  of	   four	  subunits	   in	  ES	  
cells	  resulted	  in	  substantial	  deregulation	  of	  three	  PRC-­‐repressed	  genes.	  De-­‐repression	  after	  
exosome	   depletion	   was	   seen	   at	   all	   levels	   of	   RNA	   maturation	   including	   levels	   of	   primary	  
transcripts	  (Figs.	  5.11,	  5.12),	  suggesting	  exosome	  could	  play	  a	  role	  in	  Polycomb	  repression	  by	  
degrading	   RNAPII	   transcripts	   co-­‐transcriptionally.	   In	   accordance,	   exosome	   subunits	   can	   be	  
detected	  bound	  to	  chromatin	  at	  PRC-­‐repressed,	  but	  not	  at	  active	  genes	  (Fig.	  5.21).	  However,	  
genome-­‐wide	  analysis	  of	  exosome	  knockdown	  by	  microarray	  only	  detected	  deregulation	  at	  a	  
small	  number	  of	  PRC-­‐repressed	  genes	  (Fig.	  5.16);	  RNA-­‐seq	  analyses	  are	  ongoing	  to	  probe	  in	  
more	  detail	  at	  changes	   in	   transcription.	   Intriguingly,	  CAGE	  analyses	  revealed	  that	  exosome	  
regulates	   transcription	   of	   a	   proportion	   of	   capped	   RNAs	   from	   PRC-­‐repressed	   genes	   (Figs.	  
5.19,	   5.20)	   in	   the	   sense	   orientation	   only.	   The	   population	   of	   PRC-­‐repressed	   genes	   that	  
showed	  lowest	  level	  of	  capping	  in	  ES	  cells	  show	  a	  significant	  increase	  in	  capped	  transcripts	  
after	  exosome	  knockdown,	  suggesting	  that	  exosome	  may	  have	  a	  specific	  role	  at	  a	  population	  
of	   PRC-­‐repressed	   genes	   (Fig.	   5.20).	   Future	   analysis	   regarding	   this	   population	   and	   their	  
















Over	  the	  course	  of	  this	  thesis,	  much	  of	  the	  evidence	  of	  transcription	  at	  PRC-­‐repressed	  genes	  
has	  led	  to	  unexpected	  clues	  regarding	  the	  mechanisms	  of	  PRC-­‐repression	  and	  their	  influence	  
on	  multiple	  stages	  of	  the	  RNAPII	  transcription	  cycle.	  Interference	  with	  various	  aspects	  of	  co-­‐
transcriptional	   RNA	   processing	   is	   becoming	   increasingly	   evident	   from	   studying	   PRC-­‐
repressed	   transcription.	   Transcripts	   from	   PRC-­‐repressed	   genes	   are	   detected	   only	   at	   low	  
levels	   in	   the	   presence	   of	   abundant	   RNAPII-­‐S5p.	   We	   have	   shown	   that	   PRC-­‐repressed	  
transcripts	  are	  detected	  at	  disproportionately	  low	  levels;	  detection	  of	  chromatin	  associated	  
exosome	  specifically	  enriched	  at	  Polycomb-­‐repressed	  genes	  raises	  the	  tantalizing	  possibility	  
that	   PRC-­‐repression	   acts	   downstream	   of	   transcription,	   at	   least	   in	   part	   through	  
destabilization	  of	  nascent	  transcripts.	  Transcription	  profiles	  suggest	  there	  may	  be	  regulatory	  
constraints	  at	  the	  level	  of	  capping	  and	  termination,	  which	  will	  result	  in	  low	  level	  expression	  
and	  a	  possible	  role	  for	  degradation.	  Future	  work	  into	  understanding	  details	  of	  possible	  RNA	  
processing	   defects	   in	   parallel	   with	   the	   data	   presented	   here	   will	   help	   to	   elucidate	   the	  
interplay	  between	  RNAPII	  and	  PRC	  at	  developmental	  genes	  in	  ES	  cells	  and	  how	  these	  genes	  
remain	  repressed	  but	  primed	  for	  expression	  upon	  differentiation.	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